CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: trovafloxacin
Accession: CHEBI:9763
browse the term
Definition: A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 6-amino-3-azabicyclo[3.1.0]hex-3-yl substituents at positions 1, 6 and 7 respectively. A broad-spectrum antibiotic that was withdrawn from the market due to risk of liver failure.
Synonyms: exact_synonym: 7-[(1R,5S,6s)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
related_synonym: Formula=C20H15F3N4O3; InChI=1S/C20H15F3N4O3/c21-8-1-2-15(13(22)3-8)27-7-12(20(29)30)17(28)9-4-14(23)19(25-18(9)27)26-5-10-11(6-26)16(10)24/h1-4,7,10-11,16H,5-6,24H2,(H,29,30)/t10-,11+,16+; InChIKey=WVPSKSLAZQPAKQ-CDMJZVDBSA-N; SMILES=N[C@H]1[C@@H]2CN(C[C@H]12)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1F; trovafloxacine; trovafloxacino; trovafloxacinum
xref: CAS:147059-72-1; DrugBank:DB00685; Drug_Central:2777; HMDB:HMDB0014823; KEGG:C07664; KEGG:D08654
xref_mesh: MESH:C080163
xref: PMID:20022474; PMID:20462743; PMID:20538741; PMID:20655887; PMID:21151465; PMID:22305082; PMID:23727874; PMID:24097668; PMID:24525298; Reaxys:8172628; Wikipedia:Trovafloxacin
cyclic_relationship: is_conjugate_base_of CHEBI:77569
G
Aars1
alanyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of AARS1 mRNA
CTD
PMID:35537566
NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147
G
Aarsd1
alanyl-tRNA synthetase domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of AARSD1 mRNA
CTD
PMID:35537566
NCBI chr10:86,340,625...86,353,732
Ensembl chr10:86,340,626...86,353,729
G
Aatk
apoptosis-associated tyrosine kinase
decreases expression
ISO
trovafloxacin results in decreased expression of AATK mRNA
CTD
PMID:35537566
NCBI chr10:105,290,752...105,327,219
Ensembl chr10:105,291,585...105,327,112
G
Abca2
ATP binding cassette subfamily A member 2
decreases expression
ISO
trovafloxacin results in decreased expression of ABCA2 mRNA
CTD
PMID:35537566
NCBI chr 3:8,244,515...8,264,545
Ensembl chr 3:8,244,639...8,264,537
G
Abca5
ATP binding cassette subfamily A member 5
decreases expression
ISO
trovafloxacin results in decreased expression of ABCA5 mRNA
CTD
PMID:35537566
NCBI chr10:95,240,159...95,309,195
Ensembl chr10:95,240,154...95,308,976
G
Abca7
ATP binding cassette subfamily A member 7
decreases expression
ISO
trovafloxacin results in decreased expression of ABCA7 mRNA
CTD
PMID:35537566
NCBI chr 7:9,691,452...9,711,466
Ensembl chr 7:9,691,449...9,711,425
G
Abca8
ATP binding cassette subfamily A member 8
decreases expression
ISO
trovafloxacin results in decreased expression of ABCA8B mRNA
CTD
PMID:35537566
NCBI chr10:94,917,520...94,991,199
Ensembl chr10:94,917,520...94,990,988
G
Abcb7
ATP binding cassette subfamily B member 7
decreases expression
ISO
trovafloxacin results in decreased expression of ABCB7 mRNA
CTD
PMID:35537566
NCBI chr X:69,295,598...69,436,775
Ensembl chr X:69,295,552...69,436,858
G
Abcd2
ATP binding cassette subfamily D member 2
decreases expression
ISO
trovafloxacin results in decreased expression of ABCD2 mRNA
CTD
PMID:35537566
NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642
G
Abhd15
abhydrolase domain containing 15
decreases expression
ISO
trovafloxacin results in decreased expression of ABHD15 mRNA
CTD
PMID:35537566
NCBI chr10:62,363,209...62,368,600
Ensembl chr10:62,363,209...62,368,600
G
Acaca
acetyl-CoA carboxylase alpha
decreases expression
EXP
trovafloxacin results in decreased expression of ACACA mRNA
CTD
PMID:24136188
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Acap1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
decreases expression
ISO
trovafloxacin results in decreased expression of ACAP1 mRNA
CTD
PMID:35537566
NCBI chr10:54,605,323...54,619,472
Ensembl chr10:54,605,323...54,619,472
G
Ackr4
atypical chemokine receptor 4
increases expression
ISO
trovafloxacin results in increased expression of ACKR4 mRNA
CTD
PMID:35537566
NCBI chr 8:104,716,537...104,720,972
Ensembl chr 8:104,716,067...104,723,617
G
Acot3
acyl-CoA thioesterase 3
decreases expression
ISO
trovafloxacin results in decreased expression of ACOT3 mRNA
CTD
PMID:35537566
NCBI chr 6:103,682,518...103,688,735
Ensembl chr 6:103,682,596...103,688,427 Ensembl chr 6:103,682,596...103,688,427
G
Acot4
acyl-CoA thioesterase 4
decreases expression
ISO
trovafloxacin results in decreased expression of ACOT4 mRNA
CTD
PMID:35537566
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
G
Acrbp
acrosin binding protein
increases expression
ISO
trovafloxacin results in increased expression of ACRBP mRNA
CTD
PMID:35537566
NCBI chr 4:157,851,149...157,864,211
Ensembl chr 4:157,841,841...157,864,213
G
Acsf2
acyl-CoA synthetase family member 2
decreases expression
EXP
trovafloxacin results in decreased expression of ACSF2 mRNA
CTD
PMID:24136188
NCBI chr10:79,504,510...79,546,714
Ensembl chr10:79,504,511...79,546,673
G
Acsf3
acyl-CoA synthetase family member 3
decreases expression
ISO
trovafloxacin results in decreased expression of ACSF3 mRNA
CTD
PMID:35537566
NCBI chr19:50,835,116...50,875,557
Ensembl chr19:50,835,221...50,875,553
G
Acss1
acyl-CoA synthetase short-chain family member 1
decreases expression
ISO
trovafloxacin results in decreased expression of ACSS1 mRNA
CTD
PMID:35537566
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
G
Acss2
acyl-CoA synthetase short-chain family member 2
decreases expression
ISO
trovafloxacin results in decreased expression of ACSS2 mRNA
CTD
PMID:35537566
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
G
Actb
actin, beta
decreases expression
EXP
trovafloxacin results in decreased expression of ACTB mRNA
CTD
PMID:24136188
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Actg1
actin, gamma 1
decreases expression
EXP
trovafloxacin results in decreased expression of ACTG1 mRNA
CTD
PMID:24136188
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
G
Actr3b
actin related protein 3B
decreases expression
ISO
trovafloxacin results in decreased expression of ACTR3B mRNA
CTD
PMID:35537566
NCBI chr 4:9,261,631...9,355,496
Ensembl chr 4:9,262,233...9,355,441
G
Acvrl1
activin A receptor like type 1
increases expression
ISO
trovafloxacin results in increased expression of ACVRL1 mRNA
CTD
PMID:35537566
NCBI chr 7:132,239,200...132,256,592
Ensembl chr 7:132,239,729...132,256,591
G
Acy1
aminoacylase 1
decreases expression
EXP
trovafloxacin results in decreased expression of ACY1 mRNA
CTD
PMID:24136188
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
G
Adam1a
ADAM metallopeptidase domain 1a
increases expression
ISO
trovafloxacin results in increased expression of ADAM1A mRNA
CTD
PMID:35537566
NCBI chr12:35,017,433...35,020,300
Ensembl chr12:35,017,315...35,020,311
G
Adam22
ADAM metallopeptidase domain 22
increases expression
ISO
trovafloxacin results in increased expression of ADAM22 mRNA
CTD
PMID:35537566
NCBI chr 4:25,716,055...25,970,932
Ensembl chr 4:25,715,990...25,964,962
G
Adam33
ADAM metallopeptidase domain 33
increases expression
ISO
trovafloxacin results in increased expression of ADAM33 mRNA
CTD
PMID:35537566
NCBI chr 3:118,262,395...118,283,456
Ensembl chr 3:118,271,029...118,283,461
G
Adam3a
ADAM metallopeptidase domain 3A
decreases expression
ISO
trovafloxacin results in decreased expression of ADAM3 mRNA
CTD
PMID:35537566
NCBI chr16:67,299,949...67,349,970
Ensembl chr16:67,299,949...67,349,968
G
Adam8
ADAM metallopeptidase domain 8
increases expression
ISO
trovafloxacin results in increased expression of ADAM8 mRNA
CTD
PMID:35537566
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
G
Adamts4
ADAM metallopeptidase with thrombospondin type 1 motif, 4
decreases expression
ISO
trovafloxacin results in decreased expression of ADAMTS4 mRNA
CTD
PMID:35537566
NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
G
Adap2
ArfGAP with dual PH domains 2
increases expression decreases expression
EXP ISO
trovafloxacin results in increased expression of ADAP2 mRNA trovafloxacin results in decreased expression of ADAP2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr10:65,138,006...65,166,147
Ensembl chr10:65,138,020...65,165,604
G
Add3
adducin 3
decreases expression
ISO
trovafloxacin results in decreased expression of ADD3 mRNA
CTD
PMID:35537566
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
G
Adgre4
adhesion G protein-coupled receptor E4
increases expression
ISO
trovafloxacin results in increased expression of ADGRE4 mRNA
CTD
PMID:35537566
NCBI chr 9:9,758,106...9,901,908
Ensembl chr 9:9,760,355...9,900,760
G
Adgrl1
adhesion G protein-coupled receptor L1
decreases expression
ISO
trovafloxacin results in decreased expression of ADGRL1 mRNA
CTD
PMID:35537566
NCBI chr19:24,202,405...24,244,137
Ensembl chr19:24,204,360...24,244,139
G
Adgrv1
adhesion G protein-coupled receptor V1
decreases expression
ISO
trovafloxacin results in decreased expression of ADGRV1 mRNA
CTD
PMID:35537566
NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688
G
Adh7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
decreases expression
ISO
trovafloxacin results in decreased expression of ADH7 mRNA
CTD
PMID:35537566
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
G
Adipor2
adiponectin receptor 2
decreases expression
EXP
trovafloxacin results in decreased expression of ADIPOR2 mRNA
CTD
PMID:24136188
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
G
Adm
adrenomedullin
decreases expression
ISO
trovafloxacin results in decreased expression of ADM mRNA
CTD
PMID:35537566
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Adra1a
adrenoceptor alpha 1A
increases expression
ISO
trovafloxacin results in increased expression of ADRA1A mRNA
CTD
PMID:35537566
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
G
Adrb2
adrenoceptor beta 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ADRB2 mRNA
CTD
PMID:18930950
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Aen
apoptosis enhancing nuclease
increases expression
ISO
trovafloxacin results in increased expression of AEN mRNA
CTD
PMID:35537566
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
G
Afap1l1
actin filament associated protein 1-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of AFAP1L1 mRNA
CTD
PMID:35537566
NCBI chr18:55,183,786...55,244,174
Ensembl chr18:55,183,786...55,244,146
G
Agbl3
AGBL carboxypeptidase 3
decreases expression
ISO
trovafloxacin results in decreased expression of AGBL3 mRNA
CTD
PMID:35537566
NCBI chr 4:63,448,789...63,535,538
Ensembl chr 4:63,453,940...63,531,188
G
Agbl5
AGBL carboxypeptidase 5
decreases expression
ISO
trovafloxacin results in decreased expression of AGBL5 mRNA
CTD
PMID:35537566
NCBI chr 6:25,472,333...25,492,173
Ensembl chr 6:25,472,333...25,490,738
G
Agl
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
decreases expression
ISO
trovafloxacin results in decreased expression of AGL mRNA
CTD
PMID:35537566
NCBI chr 2:204,705,053...204,760,966
Ensembl chr 2:204,705,053...204,760,828
G
Agmo
alkylglycerol monooxygenase
decreases expression
ISO
trovafloxacin results in decreased expression of AGMO mRNA
CTD
PMID:35537566
NCBI chr 6:53,986,236...54,317,838
Ensembl chr 6:53,986,292...54,317,623
G
Agtpbp1
ATP/GTP binding carboxypeptidase 1
decreases expression
ISO
trovafloxacin results in decreased expression of AGTPBP1 mRNA
CTD
PMID:35537566
NCBI chr17:5,120,540...5,238,874
Ensembl chr17:5,120,609...5,238,869
G
Ahcyl1
adenosylhomocysteinase-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of AHCYL1 mRNA
CTD
PMID:35537566
NCBI chr 2:195,294,149...195,328,586
Ensembl chr 2:195,294,153...195,345,815
G
Ahi1
Abelson helper integration site 1
decreases expression
ISO
trovafloxacin results in decreased expression of AHI1 mRNA
CTD
PMID:35537566
NCBI chr 1:15,762,485...15,891,213
Ensembl chr 1:15,762,462...15,891,041
G
Ak1
adenylate kinase 1
increases expression
ISO
trovafloxacin results in increased expression of AK1 mRNA
CTD
PMID:35537566
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
G
Ak6
adenylate kinase 6
increases expression
ISO
trovafloxacin results in increased expression of AK6 mRNA
CTD
PMID:35537566
NCBI chr 2:31,794,316...31,806,375
Ensembl chr 2:31,794,519...31,806,371 Ensembl chr20:31,794,519...31,806,371
G
Akap7
A-kinase anchoring protein 7
decreases expression
ISO
trovafloxacin results in decreased expression of AKAP7 mRNA
CTD
PMID:35537566
NCBI chr 1:20,087,190...20,217,799
Ensembl chr 1:20,087,373...20,217,797
G
Akna
AT-hook transcription factor
decreases expression
ISO
trovafloxacin results in decreased expression of AKNA mRNA
CTD
PMID:35537566
NCBI chr 5:76,777,415...76,824,380
Ensembl chr 5:76,777,415...76,816,017
G
Akr1b7
aldo-keto reductase family 1, member B7
decreases expression
ISO
trovafloxacin results in decreased expression of AKR1B7 mRNA
CTD
PMID:35537566
NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502
G
Akr7a3
aldo-keto reductase family 7 member A3
decreases expression
EXP
trovafloxacin results in decreased expression of AKR7A3 mRNA
CTD
PMID:24136188
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
G
Akt1
AKT serine/threonine kinase 1
increases phosphorylation multiple interactions
ISO
trovafloxacin results in increased phosphorylation of AKT1 protein TNF protein promotes the reaction [trovafloxacin results in increased phosphorylation of AKT1 protein]
CTD
PMID:33609687
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Aldh16a1
aldehyde dehydrogenase 16 family, member A1
decreases expression
ISO
trovafloxacin results in decreased expression of ALDH16A1 mRNA
CTD
PMID:35537566
NCBI chr 1:95,626,727...95,639,808
Ensembl chr 1:95,613,558...95,640,131
G
Aldh18a1
aldehyde dehydrogenase 18 family, member A1
decreases expression
ISO
trovafloxacin results in decreased expression of ALDH18A1 mRNA
CTD
PMID:35537566
NCBI chr 1:239,375,657...239,407,956
Ensembl chr 1:239,375,669...239,407,890
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
decreases expression
EXP
trovafloxacin results in decreased expression of ALDH1A1 mRNA
CTD
PMID:24136188
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1b1
aldehyde dehydrogenase 1 family, member B1
decreases expression
EXP
trovafloxacin results in decreased expression of ALDH1B1 mRNA
CTD
PMID:24136188
NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
G
Aldh1l2
aldehyde dehydrogenase 1 family, member L2
decreases expression
ISO
trovafloxacin results in decreased expression of ALDH1L2 mRNA
CTD
PMID:35537566
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
G
Alkbh4
alkB homolog 4, lysine demethylase
increases expression
ISO
trovafloxacin results in increased expression of ALKBH4 mRNA
CTD
PMID:35537566
NCBI chr12:20,524,030...20,529,947
Ensembl chr12:20,524,030...20,529,947
G
Alms1
ALMS1, centrosome and basal body associated protein
decreases expression
ISO
trovafloxacin results in decreased expression of ALMS1 mRNA
CTD
PMID:35537566
NCBI chr 4:118,125,581...118,226,005
Ensembl chr 4:118,125,607...118,226,005
G
Amacr
alpha-methylacyl-CoA racemase
decreases expression
ISO
trovafloxacin results in decreased expression of AMACR mRNA
CTD
PMID:35537566
NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255
G
Amd1
adenosylmethionine decarboxylase 1
decreases expression
EXP
trovafloxacin results in decreased expression of AMD1 mRNA
CTD
PMID:24136188
NCBI chr20:43,695,783...43,711,476
Ensembl chr20:43,697,237...43,711,476
G
Amdhd2
amidohydrolase domain containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of AMDHD2 mRNA
CTD
PMID:35537566
NCBI chr10:13,187,579...13,196,148
Ensembl chr10:13,187,578...13,196,095
G
Amh
anti-Mullerian hormone
increases expression
ISO
trovafloxacin results in increased expression of AMH mRNA
CTD
PMID:35537566
NCBI chr 7:8,906,776...8,909,192
Ensembl chr 7:8,906,836...8,909,282
G
Amigo3
adhesion molecule with Ig like domain 3
increases expression
ISO
trovafloxacin results in increased expression of AMIGO3 mRNA
CTD
PMID:35537566
NCBI chr 8:108,741,899...108,743,425
Ensembl chr 8:108,693,060...108,744,555
G
Ammecr1l
AMMECR1 like
increases expression
EXP
trovafloxacin results in increased expression of AMMECR1L mRNA
CTD
PMID:24136188
NCBI chr18:23,386,114...23,411,177
Ensembl chr18:23,386,903...23,410,920
G
Amotl1
angiomotin-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of AMOTL1 mRNA
CTD
PMID:35537566
NCBI chr 8:11,348,651...11,467,564
Ensembl chr 8:11,353,674...11,467,573
G
Amotl2
angiomotin like 2
decreases expression
ISO
trovafloxacin results in decreased expression of AMOTL2 mRNA
CTD
PMID:35537566
NCBI chr 8:103,303,368...103,319,161
Ensembl chr 8:103,302,992...103,318,910
G
Amz1
archaelysin family metallopeptidase 1
decreases expression
ISO
trovafloxacin results in decreased expression of AMZ1 mRNA
CTD
PMID:35537566
NCBI chr12:13,886,518...13,924,275
Ensembl chr12:13,891,123...13,909,783
G
Anapc1
anaphase promoting complex subunit 1
decreases expression
ISO
trovafloxacin results in decreased expression of ANAPC1 mRNA
CTD
PMID:35537566
NCBI chr 3:115,850,117...115,930,259
Ensembl chr 3:115,850,185...115,930,273
G
Anapc5
anaphase-promoting complex subunit 5
decreases expression
ISO
trovafloxacin results in decreased expression of ANAPC5 mRNA
CTD
PMID:35537566
NCBI chr12:33,748,709...33,781,709
Ensembl chr12:33,748,735...33,781,781
G
Ang
angiogenin
decreases expression
ISO
trovafloxacin results in decreased expression of ANG mRNA
CTD
PMID:35537566
NCBI chr15:24,312,711...24,323,361
G
Angel1
angel homolog 1
decreases expression
ISO
trovafloxacin results in decreased expression of ANGEL1 mRNA
CTD
PMID:35537566
NCBI chr 6:106,349,125...106,386,202
Ensembl chr 6:106,349,126...106,386,209
G
Angel2
angel homolog 2
decreases expression
ISO
trovafloxacin results in decreased expression of ANGEL2 mRNA
CTD
PMID:35537566
NCBI chr13:102,509,111...102,529,501
Ensembl chr13:102,510,589...102,529,493
G
Angptl3
angiopoietin-like 3
increases expression
ISO
trovafloxacin results in increased expression of ANGPTL3 mRNA
CTD
PMID:35537566
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
G
Angptl4
angiopoietin-like 4
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ANGPTL4 mRNA
CTD
PMID:18930950
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
G
Angptl6
angiopoietin-like 6
decreases expression
ISO
trovafloxacin results in decreased expression of ANGPTL6 mRNA
CTD
PMID:35537566
NCBI chr 8:19,413,617...19,419,925
Ensembl chr 8:19,413,619...19,419,925
G
Ankhd1
ankyrin repeat and KH domain containing 1
increases expression
EXP
trovafloxacin results in increased expression of ANKHD1-EIF4EBP3 mRNA
CTD
PMID:24136188
NCBI chr18:28,161,882...28,260,917
Ensembl chr18:28,162,311...28,268,024
G
Ankle1
ankyrin repeat and LEM domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of ANKLE1 mRNA
CTD
PMID:35537566
NCBI chr16:18,076,413...18,082,356
Ensembl chr16:18,076,492...18,083,729
G
Ankrd23
ankyrin repeat domain 23
increases expression
ISO
trovafloxacin results in increased expression of ANKRD23 mRNA
CTD
PMID:35537566
NCBI chr 9:38,773,234...38,778,705
Ensembl chr 9:38,773,240...38,779,839
G
Ankrd55
ankyrin repeat domain 55
decreases expression
ISO
trovafloxacin results in decreased expression of ANKRD55 mRNA
CTD
PMID:35537566
NCBI chr 2:43,883,877...43,983,820
Ensembl chr 2:43,883,857...43,983,680
G
Ankzf1
ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ANKZF1 mRNA
CTD
PMID:35537566
NCBI chr 9:76,688,194...76,695,162
Ensembl chr 9:76,688,194...76,696,469
G
Anln
anillin, actin binding protein
decreases expression
ISO
trovafloxacin results in decreased expression of ANLN mRNA
CTD
PMID:35537566
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
G
Ano7
anoctamin 7
increases expression
ISO
trovafloxacin results in increased expression of ANO7 mRNA
CTD
PMID:35537566
NCBI chr 9:93,917,524...93,945,323
Ensembl chr 9:93,917,524...93,945,323
G
Antkmt
adenine nucleotide translocase lysine methyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of FAM173A mRNA
CTD
PMID:35537566
NCBI chr10:14,812,274...14,814,798
Ensembl chr10:14,812,269...14,814,193
G
Antxr2
ANTXR cell adhesion molecule 2
increases expression
ISO
trovafloxacin results in increased expression of ANTXR2 mRNA
CTD
PMID:35537566
NCBI chr14:11,541,718...11,682,110
Ensembl chr14:11,541,772...11,682,094
G
Anxa9
annexin A9
decreases expression
ISO
trovafloxacin results in decreased expression of ANXA9 mRNA
CTD
PMID:35537566
NCBI chr 2:182,873,185...182,884,501
Ensembl chr 2:182,872,929...182,883,374
G
Ap1g2
adaptor related protein complex 1 subunit gamma 2
decreases expression
ISO
trovafloxacin results in decreased expression of AP1G2 mRNA
CTD
PMID:35537566
NCBI chr15:28,571,571...28,579,421
Ensembl chr15:28,571,568...28,589,004
G
Ap1s1
adaptor related protein complex 1 subunit sigma 1
decreases expression
EXP
trovafloxacin results in decreased expression of AP1S1 mRNA
CTD
PMID:24136188
NCBI chr12:19,625,267...19,635,792
Ensembl chr12:19,625,332...19,756,713
G
Ap5z1
adaptor related protein complex 5 subunit zeta 1
decreases expression
ISO
trovafloxacin results in decreased expression of AP5Z1 mRNA
CTD
PMID:35537566
NCBI chr12:12,093,834...12,109,043
Ensembl chr12:12,093,834...12,108,511
G
Apbb3
amyloid beta precursor protein binding family B member 3
increases expression
ISO
trovafloxacin results in increased expression of APBB3 mRNA
CTD
PMID:35537566
NCBI chr18:28,273,168...28,280,347
Ensembl chr18:28,270,545...28,280,094
G
Apc2
APC regulator of WNT signaling pathway 2
increases expression
ISO
trovafloxacin results in increased expression of APC2 mRNA
CTD
PMID:35537566
NCBI chr 7:9,392,336...9,414,364
Ensembl chr 7:9,392,336...9,414,310
G
Apeh
acylaminoacyl-peptide hydrolase
decreases expression
ISO
trovafloxacin results in decreased expression of APEH mRNA
CTD
PMID:35537566
NCBI chr 8:108,773,791...108,782,903
Ensembl chr 8:108,773,794...108,782,933
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of APEX1 mRNA
CTD
PMID:18930950
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
G
Apex2
apurinic/apyrimidinic endodeoxyribonuclease 2
increases expression
ISO
trovafloxacin results in increased expression of APEX2 mRNA
CTD
PMID:35537566
NCBI chr X:19,425,684...19,508,459
Ensembl chr X:19,487,419...19,508,439
G
Apoa5
apolipoprotein A5
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of APOA5 mRNA
CTD
PMID:18930950
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
G
Apoe
apolipoprotein E
increases expression
ISO
trovafloxacin results in increased expression of APOE mRNA
CTD
PMID:35537566
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Aqp9
aquaporin 9
decreases expression
ISO
trovafloxacin results in decreased expression of AQP9 mRNA
CTD
PMID:35537566
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
G
Arf2
ADP-ribosylation factor 2
increases expression
ISO
trovafloxacin results in increased expression of ARF2 mRNA
CTD
PMID:35537566
NCBI chr10:88,867,836...88,889,654
Ensembl chr10:88,867,836...88,889,659
G
Arhgap19
Rho GTPase activating protein 19
decreases expression
ISO
trovafloxacin results in decreased expression of ARHGAP19 mRNA
CTD
PMID:35537566
NCBI chr 1:240,571,554...240,617,361
Ensembl chr 1:240,580,871...240,617,287
G
Arhgap24
Rho GTPase activating protein 24
decreases expression
EXP
trovafloxacin results in decreased expression of ARHGAP24 mRNA
CTD
PMID:24136188
NCBI chr14:6,800,624...7,183,877
Ensembl chr14:6,800,631...7,183,823
G
Arhgap26
Rho GTPase activating protein 26
decreases expression
ISO
trovafloxacin results in decreased expression of ARHGAP26 mRNA
CTD
PMID:35537566
NCBI chr18:30,835,806...31,237,945
Ensembl chr18:30,838,671...31,235,194
G
Arhgap33
Rho GTPase activating protein 33
decreases expression
ISO
trovafloxacin results in decreased expression of ARHGAP33 mRNA
CTD
PMID:35537566
NCBI chr 1:85,776,112...85,789,767
Ensembl chr 1:85,776,108...85,789,678
G
Arhgap6
Rho GTPase activating protein 6
decreases expression
ISO
trovafloxacin results in decreased expression of ARHGAP6 mRNA
CTD
PMID:35537566
NCBI chr X:24,953,464...25,490,003
Ensembl chr X:24,953,464...25,488,663
G
Arhgef17
Rho guanine nucleotide exchange factor 17
decreases expression
ISO
trovafloxacin results in decreased expression of ARHGEF17 mRNA
CTD
PMID:35537566
NCBI chr 1:155,230,607...155,290,163
Ensembl chr 1:155,233,168...155,290,498
G
Arhgef3
Rho guanine nucleotide exchange factor 3
decreases expression
ISO
trovafloxacin results in decreased expression of ARHGEF3 mRNA
CTD
PMID:35537566
NCBI chr16:2,301,573...2,581,951
Ensembl chr16:2,300,138...2,581,945
G
Arhgef39
Rho guanine nucleotide exchange factor 39
decreases expression
ISO
trovafloxacin results in decreased expression of ARHGEF39 mRNA
CTD
PMID:35537566
NCBI chr 5:57,752,509...57,756,079
Ensembl chr 5:57,752,509...57,756,109
G
Arid5a
AT-rich interaction domain 5A
decreases expression
ISO
trovafloxacin results in decreased expression of ARID5A mRNA
CTD
PMID:35537566
NCBI chr 9:38,534,612...38,549,467
Ensembl chr 9:38,534,590...38,547,597
G
Arid5b
AT-rich interaction domain 5B
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ARID5B mRNA
CTD
PMID:18930950
NCBI chr20:20,307,731...20,490,746
Ensembl chr20:20,307,731...20,487,433
G
Arl10
ADP-ribosylation factor like GTPase 10
increases expression
ISO
trovafloxacin results in increased expression of ARL10 mRNA
CTD
PMID:35537566
NCBI chr17:10,030,213...10,038,625
Ensembl chr17:10,030,213...10,038,703
G
Arl11
ADP-ribosylation factor like GTPase 11
decreases expression
ISO
trovafloxacin results in decreased expression of ARL11 mRNA
CTD
PMID:35537566
NCBI chr15:35,483,330...35,485,579
Ensembl chr15:35,480,018...35,496,596
G
Arl4c
ADP ribosylation factor like GTPase 4C
decreases expression
ISO
trovafloxacin results in decreased expression of ARL4C mRNA
CTD
PMID:35537566
NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:89,298,005...89,304,513
G
Arl4d
ADP-ribosylation factor like GTPase 4D
increases expression
ISO
trovafloxacin results in increased expression of ARL4D mRNA
CTD
PMID:35537566
NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
G
Arl6ip5
ADP-ribosylation factor like GTPase 6 interacting protein 5
increases expression
ISO
trovafloxacin results in increased expression of ARL6IP5 mRNA
CTD
PMID:35537566
NCBI chr 4:129,810,650...129,838,628
Ensembl chr 4:129,810,645...129,838,608
G
Armc2
armadillo repeat containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of ARMC2 mRNA
CTD
PMID:35537566
NCBI chr20:45,395,859...45,501,808
Ensembl chr20:45,394,127...45,504,819
G
Armc7
armadillo repeat containing 7
increases expression
ISO
trovafloxacin results in increased expression of ARMC7 mRNA
CTD
PMID:35537566
NCBI chr10:100,723,080...100,739,636
Ensembl chr10:100,723,105...100,739,636
G
Armt1
acidic residue methyltransferase 1
decreases expression
EXP
trovafloxacin results in decreased expression of ARMT1 mRNA
CTD
PMID:24136188
NCBI chr 1:40,894,558...40,918,302
Ensembl chr 1:40,894,550...40,918,302
G
Arrb1
arrestin, beta 1
decreases expression
ISO
trovafloxacin results in decreased expression of ARRB1 mRNA
CTD
PMID:35537566
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
G
Arsa
arylsulfatase A
decreases expression
ISO
trovafloxacin results in decreased expression of ARSA mRNA
CTD
PMID:35537566
NCBI chr 7:120,542,788...120,547,577
Ensembl chr 7:120,543,362...120,548,783
G
Arv1
ARV1 homolog, fatty acid homeostasis modulator
increases expression
ISO
trovafloxacin results in increased expression of ARV1 mRNA
CTD
PMID:35537566
NCBI chr19:52,692,337...52,704,156
Ensembl chr19:52,692,337...52,704,156
G
Asb10
ankyrin repeat and SOCS box-containing 10
decreases expression
ISO
trovafloxacin results in decreased expression of ASB10 mRNA
CTD
PMID:35537566
NCBI chr 4:10,630,318...10,644,270
Ensembl chr 4:10,630,448...10,639,060
G
Asb6
ankyrin repeat and SOCS box-containing 6
increases expression
ISO
trovafloxacin results in increased expression of ASB6 mRNA
CTD
PMID:35537566
NCBI chr 3:14,110,628...14,115,274
Ensembl chr 3:14,110,628...14,115,242
G
Asf1b
anti-silencing function 1B histone chaperone
decreases expression
ISO
trovafloxacin results in decreased expression of ASF1B mRNA
CTD
PMID:35537566
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
decreases expression
ISO
trovafloxacin results in decreased expression of ASNS mRNA
CTD
PMID:35537566
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Aspm
assembly factor for spindle microtubules
decreases expression
ISO
trovafloxacin results in decreased expression of ASPM mRNA
CTD
PMID:35537566
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
G
Aspscr1
ASPSCR1 tether for SLC2A4, UBX domain containing
decreases expression
ISO
trovafloxacin results in decreased expression of ASPSCR1 mRNA
CTD
PMID:35537566
NCBI chr10:105,952,215...105,990,059
Ensembl chr10:105,952,227...105,989,904
G
Asrgl1
asparaginase and isoaspartyl peptidase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ASRGL1 mRNA
CTD
PMID:35537566
NCBI chr 1:206,006,103...206,027,115
Ensembl chr 1:206,006,109...206,027,108
G
Atf2
activating transcription factor 2
multiple interactions increases phosphorylation
ISO
pyrazolanthrone inhibits the reaction [trovafloxacin results in increased phosphorylation of ATF2 protein]
CTD
PMID:24525298
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
G
Atf4
activating transcription factor 4
decreases expression
ISO
trovafloxacin results in decreased expression of ATF4 mRNA
CTD
PMID:35537566
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atf5
activating transcription factor 5
decreases expression
ISO
trovafloxacin results in decreased expression of ATF5 mRNA
CTD
PMID:35537566
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
G
Atg10
autophagy related 10
multiple interactions
ISO
[trovafloxacin co-treated with TNF protein] results in increased expression of ATG10 mRNA
CTD
PMID:33609687
NCBI chr 2:22,109,304...22,398,313
Ensembl chr 2:22,108,426...22,398,233
G
Atg101
autophagy related 101
increases expression
ISO
trovafloxacin results in increased expression of ATG101 mRNA
CTD
PMID:33609687
NCBI chr 7:132,398,477...132,407,643
Ensembl chr 7:132,398,483...132,407,633
G
Atg12
autophagy related 12
increases expression
ISO
trovafloxacin results in increased expression of ATG12 mRNA
CTD
PMID:33609687 PMID:35537566
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
G
Atg14
autophagy related 14
increases expression multiple interactions
ISO
trovafloxacin results in increased expression of ATG14 mRNA TNF protein inhibits the reaction [trovafloxacin results in increased expression of ATG14 mRNA]
CTD
PMID:33609687
NCBI chr15:20,795,750...20,827,113
Ensembl chr15:20,795,750...20,827,113
G
Atg16l1
autophagy related 16-like 1
increases expression multiple interactions
ISO
trovafloxacin results in increased expression of ATG16L1 mRNA [trovafloxacin co-treated with TNF protein] results in increased expression of ATG16L1 mRNA
CTD
PMID:33609687
NCBI chr 9:88,420,737...88,457,530
Ensembl chr 9:88,422,038...88,457,529
G
Atg16l2
autophagy related 16-like 2
decreases expression
ISO
trovafloxacin results in decreased expression of ATG16L2 mRNA
CTD
PMID:33609687
NCBI chr 1:155,687,386...155,703,419
Ensembl chr 1:155,684,564...155,703,420
G
Atg2a
autophagy related 2A
multiple interactions
ISO
[trovafloxacin co-treated with TNF protein] results in increased expression of ATG2A mRNA
CTD
PMID:33609687
NCBI chr 1:203,542,559...203,562,242
Ensembl chr 1:203,542,559...203,562,242
G
Atg2b
autophagy related 2B
increases expression
ISO
trovafloxacin results in increased expression of ATG2B mRNA
CTD
PMID:33609687
NCBI chr 6:124,522,283...124,592,412
Ensembl chr 6:124,525,523...124,592,015
G
Atg3
autophagy related 3
increases expression multiple interactions
ISO
trovafloxacin results in increased expression of ATG3 mRNA [trovafloxacin co-treated with TNF protein] results in increased expression of ATG3 mRNA
CTD
PMID:33609687
NCBI chr11:55,624,914...55,653,249
Ensembl chr11:55,624,917...55,653,224
G
Atg4a
autophagy related 4A, cysteine peptidase
increases expression multiple interactions
ISO
trovafloxacin results in increased expression of ATG4A mRNA [trovafloxacin co-treated with TNF protein] results in increased expression of ATG4A mRNA
CTD
PMID:33609687
NCBI chr X:104,665,345...104,765,271
Ensembl chr X:104,665,345...104,765,268
G
Atg4c
autophagy related 4C, cysteine peptidase
multiple interactions
ISO
[trovafloxacin co-treated with TNF protein] results in decreased expression of ATG4C mRNA
CTD
PMID:33609687
NCBI chr 5:113,867,218...113,935,534
Ensembl chr 5:113,867,092...113,934,830
G
Atg5
autophagy related 5
affects response to substance increases expression multiple interactions
ISO
ATG5 protein affects the susceptibility to trovafloxacin trovafloxacin results in increased expression of ATG5 mRNA ATG5 protein affects the reaction [trovafloxacin results in increased cleavage of CASP3 protein]; ATG5 protein affects the reaction [trovafloxacin results in increased cleavage of PARP1 protein]; ATG5 protein affects the reaction [trovafloxacin results in increased phosphorylation of MAPK1 protein]; ATG5 protein affects the reaction [trovafloxacin results in increased phosphorylation of MAPK3 protein]; ATG5 protein affects the reaction [trovafloxacin results in increased phosphorylation of MAPK8 protein]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of ATG5 mRNA]
CTD
PMID:33609687
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
G
Atg9b
autophagy related 9B
increases expression multiple interactions
ISO
trovafloxacin results in increased expression of ATG9B mRNA TNF protein promotes the reaction [trovafloxacin results in increased expression of ATG9B mRNA]; trovafloxacin promotes the reaction [TNF protein results in increased expression of ATG9B mRNA]
CTD
PMID:33609687
NCBI chr 4:10,784,934...10,793,832
Ensembl chr 4:10,786,114...10,793,651
G
Atm
ATM serine/threonine kinase
decreases expression
ISO
trovafloxacin results in decreased expression of ATM mRNA
CTD
PMID:35537566
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Atosb
atos homolog B
increases expression
ISO
trovafloxacin results in increased expression of ATOSB mRNA
CTD
PMID:35537566
NCBI chr 5:57,260,839...57,274,524
Ensembl chr 5:57,260,841...57,268,892
G
Atp11c
ATPase phospholipid transporting 11C
decreases expression
ISO
trovafloxacin results in decreased expression of ATP11C mRNA
CTD
PMID:35537566
NCBI chr X:138,564,459...138,752,116
Ensembl chr X:138,565,836...138,751,204
G
Atp1a3
ATPase Na+/K+ transporting subunit alpha 3
decreases expression
ISO
trovafloxacin results in decreased expression of ATP1A3 mRNA
CTD
PMID:35537566
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
G
Atp5mc3
ATP synthase membrane subunit c locus 3
increases expression
ISO
trovafloxacin results in increased expression of ATP5MC3 mRNA
CTD
PMID:35537566
NCBI chr 3:58,810,535...58,813,185
Ensembl chr 3:58,810,535...58,814,279
G
Atp5me
ATP synthase membrane subunit e
increases expression
ISO
trovafloxacin results in increased expression of ATP5ME mRNA
CTD
PMID:35537566
NCBI chr14:1,319,868...1,320,996
Ensembl chr14:1,319,868...1,321,013
G
Atp5mk
ATP synthase membrane subunit K
increases expression
ISO
trovafloxacin results in increased expression of ATP5MK mRNA
CTD
PMID:35537566
NCBI chr 1:245,973,910...245,980,702
Ensembl chr 1:245,973,914...245,980,761 Ensembl chr10:245,973,914...245,980,761
G
Atp6v0e2
ATPase, H+ transporting V0 subunit e2
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of ATP6V0E2 mRNA trovafloxacin results in increased expression of ATP6V0E2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 4:77,484,868...77,488,016
Ensembl chr 4:77,482,226...77,488,777
G
Atp8a1
ATPase phospholipid transporting 8A1
decreases expression
ISO
trovafloxacin results in decreased expression of ATP8A1 mRNA
CTD
PMID:35537566
NCBI chr14:40,315,013...40,557,572
Ensembl chr14:40,315,049...40,554,611
G
Atr
ATR serine/threonine kinase
multiple interactions decreases expression
ISO
4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of ATR protein]; 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin results in increased phosphorylation of ATR protein]; [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of and results in increased activity of ATR protein; trovafloxacin results in increased phosphorylation of and results in increased activity of ATR protein; U 0126 inhibits the reaction [trovafloxacin results in increased activity of ATR protein] trovafloxacin results in decreased expression of ATR mRNA
CTD
PMID:25748550 PMID:35537566
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
G
Atrn
attractin
increases expression
EXP
trovafloxacin results in increased expression of ATRN mRNA
CTD
PMID:24136188
NCBI chr 3:118,110,320...118,244,326
Ensembl chr 3:118,110,229...118,244,322
G
Atxn7l3b
ataxin 7-like 3B
increases expression
ISO
trovafloxacin results in increased expression of ATXN7L3B mRNA
CTD
PMID:35537566
NCBI chr 7:48,322,451...48,325,975
Ensembl chr 7:48,321,755...48,328,878
G
Aunip
aurora kinase A and ninein interacting protein
decreases expression
ISO
trovafloxacin results in decreased expression of AUNIP mRNA
CTD
PMID:35537566
NCBI chr 5:146,722,329...146,734,924
Ensembl chr 5:146,722,337...146,736,501
G
Aurka
aurora kinase A
decreases expression
ISO
trovafloxacin results in decreased expression of AURKA mRNA
CTD
PMID:35537566
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
G
Aurkb
aurora kinase B
decreases expression
ISO
trovafloxacin results in decreased expression of AURKB mRNA
CTD
PMID:35537566
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
B2m
beta-2 microglobulin
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of B2M mRNA
CTD
PMID:18930950
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
G
B4galnt2
beta-1,4-N-acetyl-galactosaminyl transferase 2
decreases expression
ISO
trovafloxacin results in decreased expression of B4GALNT2 mRNA
CTD
PMID:35537566
NCBI chr10:80,801,594...80,828,005
Ensembl chr10:80,802,941...80,857,700
G
Baiap2l1
BAR/IMD domain containing adaptor protein 2 like 1
decreases expression
ISO
trovafloxacin results in decreased expression of BAIAP2L1 mRNA
CTD
PMID:35537566
NCBI chr12:10,250,434...10,339,937
Ensembl chr12:10,250,473...10,339,928
G
Bard1
BRCA1 associated RING domain 1
decreases expression
ISO
trovafloxacin results in decreased expression of BARD1 mRNA
CTD
PMID:35537566
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
G
Batf2
basic leucine zipper ATF-like transcription factor 2
increases expression
ISO
trovafloxacin results in increased expression of BATF2 mRNA
CTD
PMID:35537566
NCBI chr 1:203,467,291...203,479,428
Ensembl chr 1:203,468,097...203,475,889
G
Bbs9
Bardet-Biedl syndrome 9
increases expression
ISO
trovafloxacin results in increased expression of BBS9 mRNA
CTD
PMID:35537566
NCBI chr 8:21,013,865...21,437,934
Ensembl chr 8:21,013,944...21,437,930
G
Bcar3
BCAR3 adaptor protein, NSP family member
increases expression
ISO
trovafloxacin results in increased expression of BCAR3 mRNA
CTD
PMID:35537566
NCBI chr 2:210,525,260...210,638,674
Ensembl chr 2:210,525,260...210,638,798
G
Bcat1
branched chain amino acid transaminase 1
decreases expression
ISO
trovafloxacin results in decreased expression of BCAT1 mRNA
CTD
PMID:35537566
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:177,964,834...178,046,597
G
Bcdin3d
BCDIN3 domain containing RNA methyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of BCDIN3D mRNA
CTD
PMID:35537566
NCBI chr 7:130,605,540...130,610,134
Ensembl chr 7:130,605,541...130,610,115
G
Bco2
beta-carotene oxygenase 2
decreases expression
ISO
trovafloxacin results in decreased expression of BCO2 mRNA
CTD
PMID:35537566
NCBI chr 8:50,882,174...50,907,676
Ensembl chr 8:50,882,181...50,915,467
G
Bdh1
3-hydroxybutyrate dehydrogenase 1
increases expression
ISO
trovafloxacin results in increased expression of BDH1 mRNA
CTD
PMID:35537566
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
G
Bdh2
3-hydroxybutyrate dehydrogenase 2
increases expression
ISO
trovafloxacin results in increased expression of BDH2 mRNA
CTD
PMID:35537566
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
G
Bend6
BEN domain containing 6
decreases expression
ISO
trovafloxacin results in decreased expression of BEND6 mRNA
CTD
PMID:35537566
NCBI chr 9:36,081,033...36,135,309
Ensembl chr 9:36,081,484...36,135,228
G
Bet1l
Bet1 golgi vesicular membrane trafficking protein-like
increases expression
ISO
trovafloxacin results in increased expression of BET1L mRNA
CTD
PMID:35537566
NCBI chr 1:195,931,407...195,935,072
Ensembl chr 1:195,931,411...195,935,040
G
Bhlhe40
basic helix-loop-helix family, member e40
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of BHLHE40 mRNA
CTD
PMID:18930950
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
G
Birc2
baculoviral IAP repeat-containing 2
multiple interactions decreases expression
ISO
trovafloxacin inhibits the reaction [TNF protein results in increased expression of BIRC2 mRNA] trovafloxacin results in decreased expression of BIRC2 protein [trovafloxacin co-treated with TNF protein] results in decreased expression of BIRC2 mRNA trovafloxacin results in decreased expression of BIRC2 mRNA
CTD
PMID:32035082
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Birc3
baculoviral IAP repeat-containing 3
multiple interactions decreases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of BIRC3 mRNA [trovafloxacin co-treated with TNF protein] results in increased expression of BIRC3 mRNA trovafloxacin results in decreased expression of BIRC3 mRNA
CTD
PMID:18930950 PMID:32035082
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
trovafloxacin results in decreased expression of BIRC5 mRNA
CTD
PMID:35537566
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Blm
BLM RecQ like helicase
decreases expression
ISO
trovafloxacin results in decreased expression of BLM mRNA
CTD
PMID:35537566
NCBI chr 1:134,409,832...134,496,073
Ensembl chr 1:134,409,857...134,484,312
G
Bloc1s2
biogenesis of lysosomal organelles complex-1, subunit 2
increases expression
ISO
trovafloxacin results in increased expression of BLOC1S2 mRNA
CTD
PMID:35537566
NCBI chr 1:243,024,611...243,031,749
Ensembl chr 1:243,024,614...243,031,653
G
Blzf1
basic leucine zipper nuclear factor 1
increases expression
ISO
trovafloxacin results in increased expression of BLZF1 mRNA
CTD
PMID:35537566
NCBI chr13:76,641,757...76,656,977
Ensembl chr13:76,641,515...76,656,999
G
Bmf
Bcl2 modifying factor
decreases expression
ISO
trovafloxacin results in decreased expression of BMF mRNA
CTD
PMID:35537566
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
G
Bok
BCL2 family apoptosis regulator BOK
decreases expression
ISO
trovafloxacin results in decreased expression of BOK mRNA
CTD
PMID:35537566
NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476
G
Bora
bora, aurora kinase A activator
decreases expression
ISO
trovafloxacin results in decreased expression of BORA mRNA
CTD
PMID:35537566
NCBI chr15:75,797,624...75,835,599
Ensembl chr15:75,797,891...75,821,322
G
Borcs5
BLOC-1 related complex subunit 5
decreases expression
ISO
trovafloxacin results in decreased expression of BORCS5 mRNA
CTD
PMID:35537566
NCBI chr 4:167,458,640...167,543,556
Ensembl chr 4:167,473,177...167,540,993
G
Bphl
biphenyl hydrolase like
decreases expression
ISO
trovafloxacin results in decreased expression of BPHL mRNA
CTD
PMID:35537566
NCBI chr17:30,800,939...30,837,277
Ensembl chr17:30,799,629...30,837,288
G
Bpnt1
3'(2'), 5'-bisphosphate nucleotidase 1
decreases expression
EXP
trovafloxacin results in decreased expression of BPNT1 mRNA
CTD
PMID:24136188
NCBI chr13:96,865,634...96,893,506
Ensembl chr13:96,868,580...96,893,503
G
Brca1
BRCA1, DNA repair associated
decreases expression
ISO
trovafloxacin results in decreased expression of BRCA1 mRNA
CTD
PMID:35537566
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
G
Brca2
BRCA2, DNA repair associated
decreases expression
ISO
trovafloxacin results in decreased expression of BRCA2 mRNA
CTD
PMID:35537566
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
G
Brd2
bromodomain containing 2
increases expression
ISO
trovafloxacin results in increased expression of BRD2 mRNA
CTD
PMID:35537566
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
G
Brdt
bromodomain testis associated
decreases expression
ISO
trovafloxacin results in decreased expression of BRDT mRNA
CTD
PMID:35537566
NCBI chr14:2,387,372...2,445,857
Ensembl chr14:2,387,796...2,445,842
G
Brip1
BRCA1 interacting helicase 1
decreases expression
ISO
trovafloxacin results in decreased expression of BRIP1 mRNA
CTD
PMID:35537566
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
G
Bsdc1
BSD domain containing 1
increases expression
ISO
trovafloxacin results in increased expression of BSDC1 mRNA
CTD
PMID:35537566
NCBI chr 5:141,798,918...141,827,091
Ensembl chr 5:141,798,981...141,827,092
G
Bst2
bone marrow stromal cell antigen 2
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of BST2 mRNA trovafloxacin results in increased expression of BST2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
G
Bub1
BUB1 mitotic checkpoint serine/threonine kinase
decreases expression
ISO
trovafloxacin results in decreased expression of BUB1 mRNA
CTD
PMID:35537566
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
decreases expression
ISO
trovafloxacin results in decreased expression of BUB1B mRNA
CTD
PMID:35537566
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
G
C11h21orf91
similar to human chromosome 21 open reading frame 91
decreases expression
ISO
trovafloxacin results in decreased expression of D16ERTD472E mRNA
CTD
PMID:35537566
NCBI chr11:17,229,129...17,262,307
Ensembl chr11:17,229,138...17,262,483
G
C1d
C1D nuclear receptor corepressor
increases expression
ISO
trovafloxacin results in increased expression of C1D mRNA
CTD
PMID:35537566
NCBI chr14:91,660,951...91,673,177
Ensembl chr14:91,660,989...91,672,852
G
C1qtnf12
C1q and TNF related 12
increases expression
ISO
trovafloxacin results in increased expression of FAM132A mRNA
CTD
PMID:35537566
NCBI chr 5:166,551,628...166,556,003
Ensembl chr 5:166,551,628...166,556,003
G
C1qtnf6
C1q and TNF related 6
decreases expression
ISO
trovafloxacin results in decreased expression of C1QTNF6 mRNA
CTD
PMID:35537566
NCBI chr 7:110,077,867...110,084,584
Ensembl chr 7:110,077,878...110,084,412
G
C1rl
complement C1r subcomponent like
decreases expression
ISO
trovafloxacin results in decreased expression of C1RL mRNA
CTD
PMID:35537566
NCBI chr 4:157,394,183...157,410,771
Ensembl chr 4:157,394,200...157,410,134
G
C2cd5
C2 calcium-dependent domain containing 5
decreases expression
ISO
trovafloxacin results in decreased expression of C2CD5 mRNA
CTD
PMID:35537566
NCBI chr 4:175,969,544...176,055,597
Ensembl chr 4:175,969,545...176,055,558
G
C2h4orf33
similar to human chromosome 4 open reading frame 33
decreases expression
ISO
trovafloxacin results in decreased expression of D3ERTD751E mRNA
CTD
PMID:35537566
NCBI chr 2:124,764,263...124,830,001
Ensembl chr 2:124,769,940...124,832,449
G
C5h1orf50
similar to human chromosome 1 open reading frame 50
increases expression
EXP
trovafloxacin results in increased expression of C5H1ORF50 mRNA
CTD
PMID:24136188
NCBI chr 5:132,837,135...132,841,744
Ensembl chr 5:132,836,506...132,841,762
G
C5l1
complement C5 like 1
increases expression
EXP
trovafloxacin results in increased expression of C5L1 mRNA
CTD
PMID:24136188
NCBI chr 3:18,401,716...18,420,064
Ensembl chr 3:18,404,899...18,420,054
G
C8h11orf54
similar to human chromosome 11 open reading frame 54
decreases expression
EXP
trovafloxacin results in decreased expression of C8H11ORF54 mRNA
CTD
PMID:24136188
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
decreases expression
ISO
trovafloxacin results in decreased expression of CACNA1D mRNA
CTD
PMID:35537566
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
decreases expression
ISO
trovafloxacin results in decreased expression of CAD mRNA
CTD
PMID:35537566
NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861
G
Calhm2
calcium homeostasis modulator family member 2
decreases expression
ISO
trovafloxacin results in decreased expression of CALHM2 mRNA
CTD
PMID:35537566
NCBI chr 1:246,022,324...246,028,050
Ensembl chr 1:246,022,324...246,028,218
G
Calhm6
calcium homeostasis modulator family member 6
decreases expression
ISO
trovafloxacin results in decreased expression of FAM26F mRNA
CTD
PMID:35537566
NCBI chr20:26,095,591...26,097,336
Ensembl chr20:26,095,592...26,097,278
G
Camkk2
calcium/calmodulin-dependent protein kinase kinase 2
decreases expression
ISO
trovafloxacin results in decreased expression of CAMKK2 mRNA
CTD
PMID:35537566
NCBI chr12:33,791,023...33,845,000
Ensembl chr12:33,791,052...33,843,279
G
Camsap3
calmodulin regulated spectrin-associated protein family, member 3
increases expression
ISO
trovafloxacin results in increased expression of CAMSAP3 mRNA
CTD
PMID:35537566
NCBI chr12:1,643,062...1,666,685
Ensembl chr12:1,643,251...1,666,685
G
Caprin1
cell cycle associated protein 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CAPRIN1 mRNA
CTD
PMID:18930950
NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502
G
Car12
carbonic anhydrase 12
decreases expression
ISO
trovafloxacin results in decreased expression of CAR12 mRNA
CTD
PMID:35537566
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
G
Car7
carbonic anhydrase 7
decreases expression
ISO
trovafloxacin results in decreased expression of CAR7 mRNA
CTD
PMID:35537566
NCBI chr19:429,063...438,478
Ensembl chr19:429,075...438,467
G
Card11
caspase recruitment domain family, member 11
decreases expression
ISO
trovafloxacin results in decreased expression of CARD11 mRNA
CTD
PMID:35537566
NCBI chr12:13,621,140...13,758,115
Ensembl chr12:13,621,087...13,758,112
G
Carmil2
capping protein regulator and myosin 1 linker 2
increases expression
ISO
trovafloxacin results in increased expression of RLTPR mRNA
CTD
PMID:35537566
NCBI chr19:33,571,255...33,586,783
Ensembl chr19:33,574,257...33,586,965
G
Cars1
cysteinyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of CARS1 mRNA
CTD
PMID:35537566
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
G
Casd1
CAS1 domain containing 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CASD1 mRNA
CTD
PMID:18930950
NCBI chr 4:32,659,196...32,739,228
Ensembl chr 4:32,658,748...32,739,202
G
Casp3
caspase 3
multiple interactions increases cleavage increases activity
ISO
[TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [trovafloxacin results in increased activity of CASP3 protein]; [TNF protein co-treated with trovafloxacin] results in increased activity of CASP3 protein; [trovafloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [trovafloxacin co-treated with IL1B protein] results in increased activity of CASP3 protein; [trovafloxacin co-treated with IL6 protein] results in increased activity of CASP3 protein; [trovafloxacin co-treated with TNF protein] results in increased activity of CASP3 protein; ATG5 protein affects the reaction [trovafloxacin results in increased cleavage of CASP3 protein]; U 0126 inhibits the reaction [[TNF protein co-treated with trovafloxacin] results in increased activity of CASP3 protein] [TNF protein co-treated with trovafloxacin] results in increased cleavage of CASP3 protein
CTD
PMID:19638433 PMID:24097668 PMID:25748550 PMID:30876886 PMID:33609687
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
increases expression
EXP
trovafloxacin results in increased expression of CASP6 mRNA
CTD
PMID:24136188
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp7
caspase 7
decreases expression
EXP
trovafloxacin results in decreased expression of CASP7 mRNA
CTD
PMID:24136188
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
multiple interactions
ISO
[trovafloxacin co-treated with TNF protein] results in increased activity of CASP8 protein
CTD
PMID:24097668
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions
ISO
[trovafloxacin co-treated with TNF protein] results in increased activity of CASP9 protein
CTD
PMID:24097668
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cav1
caveolin 1
increases expression
ISO
trovafloxacin results in increased expression of CAV1 mRNA
CTD
PMID:35537566
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Cbfa2t3
CBFA2/RUNX1 partner transcriptional co-repressor 3
decreases expression
ISO
trovafloxacin results in decreased expression of CBFA2T3 mRNA
CTD
PMID:35537566
NCBI chr19:50,679,897...50,750,028
Ensembl chr19:50,680,729...50,749,610
G
Cbs
cystathionine beta synthase
decreases expression
ISO
trovafloxacin results in decreased expression of CBS mRNA
CTD
PMID:35537566
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
G
Cc2d1b
coiled-coil and C2 domain containing 1B
decreases expression
ISO
trovafloxacin results in decreased expression of CC2D1B mRNA
CTD
PMID:35537566
NCBI chr 5:123,353,289...123,367,343
Ensembl chr 5:123,353,292...123,367,318
G
Cc2d2a
coiled-coil and C2 domain containing 2A
decreases expression
ISO
trovafloxacin results in decreased expression of CC2D2A mRNA
CTD
PMID:35537566
NCBI chr14:67,349,004...67,435,883
Ensembl chr14:67,351,353...67,435,949
G
Ccdc137
coiled-coil domain containing 137
increases expression
ISO
trovafloxacin results in increased expression of CCDC137 mRNA
CTD
PMID:35537566
NCBI chr10:105,730,776...105,737,158
Ensembl chr10:105,730,739...105,737,158
G
Ccdc15
coiled-coil domain containing 15
decreases expression
ISO
trovafloxacin results in decreased expression of CCDC15 mRNA
CTD
PMID:35537566
NCBI chr 8:36,991,147...37,068,849
Ensembl chr 8:36,998,867...37,068,919
G
Ccdc163
coiled-coil domain containing 163
decreases expression
ISO
trovafloxacin results in decreased expression of CCDC163 mRNA
CTD
PMID:35537566
NCBI chr 5:130,172,014...130,178,934
Ensembl chr 5:130,172,774...130,178,929
G
Ccdc18
coiled-coil domain containing 18
decreases expression
ISO
trovafloxacin results in decreased expression of CCDC18 mRNA
CTD
PMID:35537566
NCBI chr14:1,501,749...1,607,672
Ensembl chr14:1,501,784...1,607,711
G
Ccdc181
coiled-coil domain containing 181
decreases expression
ISO
trovafloxacin results in decreased expression of CCDC181 mRNA
CTD
PMID:35537566
NCBI chr13:76,624,567...76,638,224
Ensembl chr13:76,624,567...76,638,224
G
Ccdc34
coiled-coil domain containing 34
decreases expression
ISO
trovafloxacin results in decreased expression of CCDC34 mRNA
CTD
PMID:35537566
NCBI chr 3:96,553,074...96,588,310
Ensembl chr 3:96,552,992...96,588,146
G
Ccdc6
coiled-coil domain containing 6
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CCDC6 mRNA
CTD
PMID:18930950
NCBI chr20:18,432,177...18,528,186
Ensembl chr20:18,433,695...18,528,658
G
Ccdc62
coiled-coil domain containing 62
decreases expression
ISO
trovafloxacin results in decreased expression of CCDC62 mRNA
CTD
PMID:35537566
NCBI chr12:32,623,170...32,659,912
Ensembl chr12:32,623,170...32,660,017
G
Ccdc74a
coiled-coil domain containing 74A
increases expression
ISO
trovafloxacin results in increased expression of CCDC74A mRNA
CTD
PMID:35537566
NCBI chr11:83,355,888...83,360,269
Ensembl chr11:83,355,874...83,360,378
G
Ccdc86
coiled-coil domain containing 86
increases expression
ISO
trovafloxacin results in increased expression of CCDC86 mRNA
CTD
PMID:35537566
NCBI chr 1:207,590,167...207,596,547
Ensembl chr 1:207,590,168...207,596,544
G
Ccdc91
coiled-coil domain containing 91
decreases expression
ISO
trovafloxacin results in decreased expression of CCDC91 mRNA
CTD
PMID:35537566
NCBI chr 4:180,402,327...180,574,364
Ensembl chr 4:180,402,376...180,574,364
G
Ccdc96
coiled-coil domain containing 96
increases expression
ISO
trovafloxacin results in increased expression of CCDC96 mRNA
CTD
PMID:35537566
NCBI chr14:74,276,568...74,279,072
Ensembl chr14:74,276,960...74,278,888
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
trovafloxacin promotes the reaction [TNF protein results in increased expression of CCL2 protein]
CTD
PMID:19638433
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl22
C-C motif chemokine ligand 22
increases expression
ISO
trovafloxacin results in increased expression of CCL22 mRNA
CTD
PMID:35537566
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccl3
C-C motif chemokine ligand 3
increases expression
ISO
trovafloxacin results in increased expression of CCL3 mRNA
CTD
PMID:35537566
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
increases expression
ISO
trovafloxacin results in increased expression of CCL4 mRNA
CTD
PMID:35537566
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccna2
cyclin A2
decreases expression
ISO
trovafloxacin results in decreased expression of CCNA2 mRNA
CTD
PMID:35537566
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
decreases expression
ISO
trovafloxacin results in decreased expression of CCNB1 mRNA
CTD
PMID:35537566
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnb2
cyclin B2
decreases expression
EXP ISO
trovafloxacin results in decreased expression of CCNB2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccnd1
cyclin D1
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of CCND1 mRNA trovafloxacin results in increased expression of CCND1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccng2
cyclin G2
decreases expression
ISO
trovafloxacin results in decreased expression of CCNG2 mRNA
CTD
PMID:35537566
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Ccnj
cyclin J
increases expression
ISO
trovafloxacin results in increased expression of CCNJ mRNA
CTD
PMID:35537566
NCBI chr 1:239,659,588...239,677,367
G
Ccnl1
cyclin L1
increases expression
ISO
trovafloxacin results in increased expression of CCNL1 mRNA
CTD
PMID:35537566
NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368
G
Ccr10
C-C motif chemokine receptor 10
increases expression
ISO
trovafloxacin results in increased expression of CCR10 mRNA
CTD
PMID:35537566
NCBI chr10:86,108,551...86,110,988
Ensembl chr10:86,108,551...86,110,988
G
Ccsap
centriole, cilia and spindle-associated protein
decreases expression
ISO
trovafloxacin results in decreased expression of CCSAP mRNA
CTD
PMID:35537566
NCBI chr19:51,824,954...51,843,469
Ensembl chr19:51,826,994...51,842,753
G
Cd101
CD101 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD101 mRNA
CTD
PMID:35537566
NCBI chr 2:188,422,989...188,459,536
Ensembl chr 2:188,422,351...188,459,502
G
Cd109
CD109 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD109 mRNA
CTD
PMID:35537566
NCBI chr 8:79,454,480...79,569,195
Ensembl chr 8:79,454,480...79,569,194
G
Cd200r1l
CD200 receptor 1-like
decreases expression
ISO
trovafloxacin results in decreased expression of CD200R4 mRNA
CTD
PMID:35537566
NCBI chr11:55,842,632...55,860,914
Ensembl chr11:55,842,634...55,885,680
G
Cd207
CD207 molecule
increases expression
ISO
trovafloxacin results in increased expression of CD207 mRNA
CTD
PMID:35537566
NCBI chr 4:116,155,229...116,161,587
Ensembl chr 4:116,155,212...116,161,518
G
Cd24
CD24 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD24A mRNA
CTD
PMID:35537566
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
G
Cd244
CD244 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD244 mRNA
CTD
PMID:35537566
NCBI chr13:84,051,339...84,082,864
Ensembl chr13:84,052,493...84,074,492
G
Cd27
CD27 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD27 mRNA
CTD
PMID:35537566
NCBI chr 4:158,030,700...158,035,862
Ensembl chr 4:158,030,703...158,035,592
G
Cd300lb
CD300 molecule-like family member b
increases expression
ISO
trovafloxacin results in increased expression of CD300LB mRNA
CTD
PMID:35537566
NCBI chr10:99,964,801...99,974,790
Ensembl chr10:99,964,801...99,974,790
G
Cd33
CD33 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD33 mRNA
CTD
PMID:35537566
NCBI chr 1:93,935,418...93,940,452
Ensembl chr 1:93,930,971...93,950,149
G
Cd36
CD36 molecule
decreases expression
EXP
trovafloxacin results in decreased expression of CD36 mRNA
CTD
PMID:24136188
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd5
Cd5 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD5 mRNA
CTD
PMID:35537566
NCBI chr 1:207,365,337...207,386,313
Ensembl chr 1:207,365,337...207,386,313
G
Cd80
Cd80 molecule
increases expression
ISO
trovafloxacin results in increased expression of CD80 mRNA
CTD
PMID:35537566
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Cd86
CD86 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD86 mRNA
CTD
PMID:35537566
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cd8b
CD8 subunit beta
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CD8B mRNA
CTD
PMID:18930950
NCBI chr 4:103,312,596...103,328,523
Ensembl chr 4:103,312,578...103,328,553
G
Cdc20
cell division cycle 20
decreases expression
EXP ISO
trovafloxacin results in decreased expression of CDC20 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
G
Cdc25b
cell division cycle 25B
decreases expression
ISO
trovafloxacin results in decreased expression of CDC25B mRNA
CTD
PMID:35537566
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
G
Cdc25c
cell division cycle 25C
decreases expression
ISO
trovafloxacin results in decreased expression of CDC25C mRNA
CTD
PMID:35537566
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
G
Cdc26
cell division cycle 26
increases expression
ISO
trovafloxacin results in increased expression of CDC26 mRNA
CTD
PMID:35537566
NCBI chr 5:75,844,852...75,859,830
G
Cdc34
cell division cycle 34, ubiqiutin conjugating enzyme
increases expression
ISO
trovafloxacin results in increased expression of CDC34 mRNA
CTD
PMID:35537566
NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186
G
Cdc42ep4
CDC42 effector protein 4
increases expression
EXP
trovafloxacin results in increased expression of CDC42EP4 mRNA
CTD
PMID:24136188
NCBI chr10:98,772,613...98,797,924
Ensembl chr10:98,772,495...98,797,695
G
Cdca2
cell division cycle associated 2
decreases expression
ISO
trovafloxacin results in decreased expression of CDCA2 mRNA
CTD
PMID:35537566
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
G
Cdca3
cell division cycle associated 3
decreases expression
ISO
trovafloxacin results in decreased expression of CDCA3 mRNA
CTD
PMID:35537566
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cdca5
cell division cycle associated 5
decreases expression
ISO
trovafloxacin results in decreased expression of CDCA5 mRNA
CTD
PMID:35537566
NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
G
Cdca8
cell division cycle associated 8
decreases expression
ISO
trovafloxacin results in decreased expression of CDCA8 mRNA
CTD
PMID:35537566
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
G
Cdin1
CDAN1 interacting nuclease 1
decreases expression
ISO
trovafloxacin results in decreased expression of CDIN1 mRNA
CTD
PMID:35537566
NCBI chr 3:102,441,553...102,646,935
Ensembl chr 3:102,441,704...102,646,682
G
Cdk1
cyclin-dependent kinase 1
decreases expression
EXP ISO
trovafloxacin results in decreased expression of CDK1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk10
cyclin-dependent kinase 10
decreases expression
ISO
trovafloxacin results in decreased expression of CDK10 mRNA
CTD
PMID:35537566
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
G
Cdk16
cyclin-dependent kinase 16
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CDK16 mRNA
CTD
PMID:18930950
NCBI chr X:1,492,814...1,504,309
Ensembl chr X:1,492,814...1,504,148
G
Cdk2ap2
cyclin-dependent kinase 2 associated protein 2
increases expression
ISO
trovafloxacin results in increased expression of CDK2AP2 mRNA
CTD
PMID:35537566
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
G
Cdk5rap2
CDK5 regulatory subunit associated protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of CDK5RAP2 mRNA
CTD
PMID:35537566
NCBI chr 5:83,792,282...83,961,129
Ensembl chr 5:83,792,284...83,960,782
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CDKN1A mRNA trovafloxacin results in increased expression of CDKN1A mRNA
CTD
PMID:18930950 PMID:25748550 PMID:35537566
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2c
cyclin-dependent kinase inhibitor 2C
decreases expression
ISO
trovafloxacin results in decreased expression of CDKN2C mRNA
CTD
PMID:35537566
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
G
Cdkn2d
cyclin dependent kinase inhibitor 2D
decreases expression
ISO
trovafloxacin results in decreased expression of CDKN2D mRNA
CTD
PMID:35537566
NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
G
Cdkn3
cyclin-dependent kinase inhibitor 3
decreases expression
EXP ISO
trovafloxacin results in decreased expression of CDKN3 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
G
Cdo1
cysteine dioxygenase type 1
increases expression
ISO
trovafloxacin results in increased expression of CDO1 mRNA
CTD
PMID:35537566
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
G
Cdon
cell adhesion associated, oncogene regulated
decreases expression
ISO
trovafloxacin results in decreased expression of CDON mRNA
CTD
PMID:35537566
NCBI chr 8:33,775,123...33,861,635
Ensembl chr 8:33,806,183...33,859,033
G
Cdsn
corneodesmosin
decreases expression
ISO
trovafloxacin results in decreased expression of CDSN mRNA
CTD
PMID:35537566
NCBI chr20:3,179,432...3,184,252
Ensembl chr20:3,179,438...3,184,250
G
Cebpa
CCAAT/enhancer binding protein alpha
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CEBPA mRNA
CTD
PMID:18930950
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cebpg
CCAAT/enhancer binding protein gamma
decreases expression
ISO
trovafloxacin results in decreased expression of CEBPG mRNA
CTD
PMID:35537566
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
G
Celf6
CUGBP, Elav-like family member 6
decreases expression
ISO
trovafloxacin results in decreased expression of CELF6 mRNA
CTD
PMID:35537566
NCBI chr 8:59,975,095...60,006,060
Ensembl chr 8:59,975,088...60,005,041
G
Cenatac
centrosomal AT-AC splicing factor
increases expression
ISO
trovafloxacin results in increased expression of CENATAC mRNA
CTD
PMID:35537566
NCBI chr 8:44,735,968...44,742,859
Ensembl chr 8:44,735,972...44,742,837
G
Cenpa
centromere protein A
decreases expression
ISO
trovafloxacin results in decreased expression of CENPA mRNA
CTD
PMID:35537566
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
G
Cenpe
centromere protein E
decreases expression
ISO
trovafloxacin results in decreased expression of CENPE mRNA
CTD
PMID:35537566
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
G
Cenpf
centromere protein F
decreases expression
ISO
trovafloxacin results in decreased expression of CENPF mRNA
CTD
PMID:35537566
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
G
Cenpi
centromere protein I
decreases expression
ISO
trovafloxacin results in decreased expression of CENPI mRNA
CTD
PMID:35537566
NCBI chr X:97,515,919...97,567,671
Ensembl chr X:97,515,972...97,567,657
G
Cenpk
centromere protein K
decreases expression
ISO
trovafloxacin results in decreased expression of CENPK mRNA
CTD
PMID:35537566
NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706
G
Cenpl
centromere protein L
decreases expression
ISO
trovafloxacin results in decreased expression of CENPL mRNA
CTD
PMID:35537566
NCBI chr13:73,337,235...73,352,115
Ensembl chr13:73,337,257...73,352,114
G
Cenpm
centromere protein M
decreases expression
ISO
trovafloxacin results in decreased expression of CENPM mRNA
CTD
PMID:35537566
NCBI chr 7:113,748,026...113,759,296
Ensembl chr 7:113,747,516...113,764,258
G
Cenpn
centromere protein N
decreases expression
ISO
trovafloxacin results in decreased expression of CENPN mRNA
CTD
PMID:35537566
NCBI chr19:44,971,265...44,994,019
Ensembl chr19:44,968,308...44,994,012
G
Cenpp
centromere protein P
decreases expression
ISO
trovafloxacin results in decreased expression of CENPP mRNA
CTD
PMID:35537566
NCBI chr17:15,014,087...15,189,312
Ensembl chr17:15,014,058...15,189,304
G
Cenpq
centromere protein Q
decreases expression
ISO
trovafloxacin results in decreased expression of CENPQ mRNA
CTD
PMID:35537566
NCBI chr 9:19,957,122...19,972,807
Ensembl chr 9:19,957,048...19,972,789
G
Cenpu
centromere protein U
decreases expression
ISO
trovafloxacin results in decreased expression of CENPU mRNA
CTD
PMID:35537566
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
G
Cep128
centrosomal protein 128
decreases expression
ISO
trovafloxacin results in decreased expression of CEP128 mRNA
CTD
PMID:35537566
NCBI chr 6:109,951,009...110,328,686
Ensembl chr 6:109,951,061...110,328,713
G
Cep131
centrosomal protein 131
decreases expression
ISO
trovafloxacin results in decreased expression of CEP131 mRNA
CTD
PMID:35537566
NCBI chr10:105,346,015...105,370,380
Ensembl chr10:105,346,015...105,370,380
G
Cep162
centrosomal protein 162
decreases expression
ISO
trovafloxacin results in decreased expression of CEP162 mRNA
CTD
PMID:35537566
NCBI chr 8:88,149,726...88,208,249
Ensembl chr 8:88,149,726...88,206,830
G
Cep192
centrosomal protein 192
decreases expression
ISO
trovafloxacin results in decreased expression of CEP192 mRNA
CTD
PMID:35537566
NCBI chr18:61,373,937...61,458,405
Ensembl chr18:61,332,158...61,458,379
G
Cep290
centrosomal protein 290
decreases expression
ISO
trovafloxacin results in decreased expression of CEP290 mRNA
CTD
PMID:35537566
NCBI chr 7:35,310,071...35,399,388
Ensembl chr 7:35,310,199...35,399,392
G
Cep55
centrosomal protein 55
decreases expression
ISO
trovafloxacin results in decreased expression of CEP55 mRNA
CTD
PMID:35537566
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
G
Cep57l1
centrosomal protein 57-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of CEP57L1 mRNA
CTD
PMID:35537566
NCBI chr20:45,238,039...45,294,575
Ensembl chr20:45,238,044...45,294,540
G
Cep72
centrosomal protein 72
decreases expression
ISO
trovafloxacin results in decreased expression of CEP72 mRNA
CTD
PMID:35537566
NCBI chr 1:29,225,312...29,255,294
Ensembl chr 1:29,225,361...29,255,271
G
Cep78
centrosomal protein 78
decreases expression
ISO
trovafloxacin results in decreased expression of CEP78 mRNA
CTD
PMID:35537566
NCBI chr 1:213,246,183...213,275,275
Ensembl chr 1:213,246,187...213,275,181
G
Cep83
centrosomal protein 83
decreases expression
ISO
trovafloxacin results in decreased expression of CEP83 mRNA
CTD
PMID:35537566
NCBI chr 7:29,280,358...29,389,574
Ensembl chr 7:29,280,419...29,389,574
G
Cerkl
ceramide kinase-like
decreases expression
ISO
trovafloxacin results in decreased expression of CERKL mRNA
CTD
PMID:35537566
NCBI chr 3:64,238,714...64,344,695
Ensembl chr 3:64,237,522...64,340,675
G
Cfl2
cofilin 2
increases expression
ISO
trovafloxacin results in increased expression of CFL2 mRNA
CTD
PMID:35537566
NCBI chr 6:72,355,664...72,359,709
Ensembl chr 6:72,355,664...72,359,674
G
Chac1
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of CHAC1 mRNA
CTD
PMID:35537566
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
G
Chadl
chondroadherin-like
increases expression
ISO
trovafloxacin results in increased expression of CHADL mRNA
CTD
PMID:35537566
NCBI chr 7:113,205,323...113,218,678
Ensembl chr 7:113,210,748...113,217,272
G
Chd5
chromodomain helicase DNA binding protein 5
decreases expression
ISO
trovafloxacin results in decreased expression of CHD5 mRNA
CTD
PMID:35537566
NCBI chr 5:162,848,273...162,898,997
Ensembl chr 5:162,848,394...162,896,291
G
Chfr
checkpoint with forkhead and ring finger domains
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CHFR mRNA
CTD
PMID:18930950
NCBI chr12:46,504,497...46,538,104
Ensembl chr12:46,504,497...46,538,014
G
Chka
choline kinase alpha
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CHKA mRNA
CTD
PMID:18930950
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
G
Chpf
chondroitin polymerizing factor
increases expression
ISO
trovafloxacin results in increased expression of CHPF mRNA
CTD
PMID:35537566
NCBI chr 9:76,963,178...76,967,878
Ensembl chr 9:76,963,184...76,967,878
G
Chst1
carbohydrate sulfotransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of CHST1 mRNA
CTD
PMID:35537566
NCBI chr 3:78,552,059...78,574,740
Ensembl chr 3:78,548,525...78,574,883
G
Chst7
carbohydrate sulfotransferase 7
decreases expression
ISO
trovafloxacin results in decreased expression of CHST7 mRNA
CTD
PMID:35537566
NCBI chr X:2,396,260...2,432,828
Ensembl chr X:2,393,874...2,432,840
G
Chtf18
chromosome transmission fidelity factor 18
decreases expression
ISO
trovafloxacin results in decreased expression of CHTF18 mRNA
CTD
PMID:35537566
NCBI chr10:14,743,006...14,751,044
Ensembl chr10:14,742,621...14,751,050
G
Cib2
calcium and integrin binding family member 2
decreases expression
ISO
trovafloxacin results in decreased expression of CIB2 mRNA
CTD
PMID:35537566
NCBI chr 8:54,930,265...54,947,157
G
Cip2a
cellular inhibitor of PP2A
decreases expression
ISO
trovafloxacin results in decreased expression of CIP2A mRNA
CTD
PMID:35537566
NCBI chr11:51,792,143...51,823,016
Ensembl chr11:51,795,024...51,822,938
G
Cit
citron rho-interacting serine/threonine kinase
decreases expression
ISO
trovafloxacin results in decreased expression of CIT mRNA
CTD
PMID:35537566
NCBI chr12:40,603,073...40,764,846
Ensembl chr12:40,605,563...40,763,860
G
Ckap2
cytoskeleton associated protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of CKAP2 mRNA
CTD
PMID:35537566
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
G
Ckap2l
cytoskeleton associated protein 2-like
decreases expression
ISO
trovafloxacin results in decreased expression of CKAP2L mRNA
CTD
PMID:35537566
NCBI chr 3:116,497,186...116,524,302
Ensembl chr 3:116,498,022...116,524,366
G
Ckap5
cytoskeleton associated protein 5
decreases expression
ISO
trovafloxacin results in decreased expression of CKAP5 mRNA
CTD
PMID:35537566
NCBI chr 3:77,491,195...77,593,300
Ensembl chr 3:77,491,276...77,593,264
G
Cks2
CDC28 protein kinase regulatory subunit 2
decreases expression
EXP
trovafloxacin results in decreased expression of CKS2 mRNA
CTD
PMID:24136188
NCBI chr17:13,570,611...13,575,770
G
Clcn5
chloride voltage-gated channel 5
decreases expression
ISO
trovafloxacin results in decreased expression of CLCN5 mRNA
CTD
PMID:35537566
NCBI chr X:15,185,380...15,339,977
Ensembl chr X:15,185,451...15,334,264
G
Cldn11
claudin 11
decreases expression
ISO
trovafloxacin results in decreased expression of CLDN11 mRNA
CTD
PMID:35537566
NCBI chr 2:112,207,745...112,221,050
Ensembl chr 2:112,207,745...112,221,050
G
Cldn14
claudin 14
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CLDN14 mRNA
CTD
PMID:18930950
NCBI chr11:33,232,281...33,329,440
Ensembl chr11:33,232,220...33,329,171
G
Clec2l
C-type lectin domain family 2, member L
decreases expression
ISO
trovafloxacin results in decreased expression of CLEC2L mRNA
CTD
PMID:35537566
NCBI chr 4:67,392,118...67,414,539
Ensembl chr 4:67,397,873...67,414,537
G
Clec4a1
C-type lectin domain family 4, member A1
decreases expression
ISO
trovafloxacin results in decreased expression of CLEC4A1 mRNA
CTD
PMID:35537566
NCBI chr 4:156,173,894...156,186,009
Ensembl chr 4:156,173,894...156,186,008
G
Clec7a
C-type lectin domain containing 7A
decreases expression
ISO
trovafloxacin results in decreased expression of CLEC7A mRNA
CTD
PMID:35537566
NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
G
Clint1
clathrin interactor 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CLINT1 mRNA
CTD
PMID:18930950
NCBI chr10:30,298,618...30,353,185
Ensembl chr10:30,298,704...30,353,063
G
Clip2
CAP-GLY domain containing linker protein 2
increases expression
ISO
trovafloxacin results in increased expression of CLIP2 mRNA
CTD
PMID:35537566
NCBI chr12:22,163,044...22,227,023
Ensembl chr12:22,163,218...22,227,023
G
Clk1
CDC-like kinase 1
increases expression
ISO
trovafloxacin results in increased expression of CLK1 mRNA
CTD
PMID:35537566
NCBI chr 9:59,947,774...59,959,002
Ensembl chr 9:59,947,764...59,957,000
G
Cln6
CLN6, transmembrane ER protein
decreases expression
ISO
trovafloxacin results in decreased expression of CLN6 mRNA
CTD
PMID:35537566
NCBI chr 8:63,303,356...63,318,360
Ensembl chr 8:63,303,029...63,318,360
G
Clspn
claspin
decreases expression
ISO
trovafloxacin results in decreased expression of CLSPN mRNA
CTD
PMID:35537566
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
G
Cmahp
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene
decreases expression
ISO
trovafloxacin results in decreased expression of CMAH mRNA
CTD
PMID:35537566
NCBI chr17:40,557,161...40,642,350
Ensembl chr17:40,583,667...40,642,275
G
Cmbl
carboxymethylenebutenolidase homolog
decreases expression
ISO
trovafloxacin results in decreased expression of CMBL mRNA
CTD
PMID:35537566
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
G
Cmpk2
cytidine/uridine monophosphate kinase 2
increases expression
ISO
trovafloxacin results in increased expression of CMPK2 mRNA
CTD
PMID:35537566
NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183
G
Cntln
centlein
decreases expression
ISO
trovafloxacin results in decreased expression of CNTLN mRNA
CTD
PMID:35537566
NCBI chr 5:99,295,865...99,576,402
Ensembl chr 5:99,296,000...99,576,396
G
Cntrl
centriolin
decreases expression
ISO
trovafloxacin results in decreased expression of CNTRL mRNA
CTD
PMID:35537566
NCBI chr 3:18,428,147...18,500,362
Ensembl chr 3:18,428,103...18,500,380
G
Cntrob
centrobin, centriole duplication and spindle assembly protein
decreases expression
ISO
trovafloxacin results in decreased expression of CNTROB mRNA
CTD
PMID:35537566
NCBI chr10:54,022,523...54,047,793
Ensembl chr10:54,022,852...54,044,849
G
Coasy
Coenzyme A synthase
decreases expression
ISO
trovafloxacin results in decreased expression of COASY mRNA
CTD
PMID:35537566
NCBI chr10:86,014,566...86,018,849
Ensembl chr10:86,014,597...86,018,841
G
Col14a1
collagen type XIV alpha 1 chain
decreases expression
ISO
trovafloxacin results in decreased expression of COL14A1 mRNA
CTD
PMID:35537566
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
G
Col15a1
collagen type XV alpha 1 chain
decreases expression
ISO
trovafloxacin results in decreased expression of COL15A1 mRNA
CTD
PMID:35537566
NCBI chr 5:61,501,963...61,607,591
Ensembl chr 5:61,501,963...61,607,591
G
Comt
catechol-O-methyltransferase
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of COMT mRNA
CTD
PMID:18930950
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Copg1
COPI coat complex subunit gamma 1
decreases expression
EXP
trovafloxacin results in decreased expression of COPG1 mRNA
CTD
PMID:24136188
NCBI chr 4:120,366,540...120,392,502
Ensembl chr 4:120,366,542...120,415,616
G
Cops9
COP9 signalosome subunit 9
increases expression
ISO
trovafloxacin results in increased expression of MYEOV2 mRNA
CTD
PMID:35537566
NCBI chr 9:93,209,843...93,214,774
Ensembl chr 9:93,209,843...93,213,317
G
Coq10a
coenzyme Q10A
decreases expression
ISO
trovafloxacin results in decreased expression of COQ10A mRNA
CTD
PMID:35537566
NCBI chr 7:792,089...798,392
Ensembl chr 7:792,089...800,161
G
Coq2
coenzyme Q2, polyprenyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of COQ2 mRNA
CTD
PMID:35537566
NCBI chr14:8,941,429...8,961,418
Ensembl chr14:8,941,461...8,960,891
G
Coro1b
coronin 1B
decreases expression
ISO
trovafloxacin results in decreased expression of CORO1B mRNA
CTD
PMID:35537566
NCBI chr 1:201,442,977...201,448,416
Ensembl chr 1:201,443,014...201,448,416
G
Coro6
coronin 6
decreases expression
ISO
trovafloxacin results in decreased expression of CORO6 mRNA
CTD
PMID:35537566
NCBI chr10:62,311,552...62,319,659
Ensembl chr10:62,311,660...62,319,659
G
Coro7
coronin 7
decreases expression
ISO
trovafloxacin results in decreased expression of CORO7 mRNA
CTD
PMID:35537566
NCBI chr10:10,880,299...10,941,001
Ensembl chr10:10,885,196...10,941,001
G
Cox4i2
cytochrome c oxidase subunit 4i2
increases expression
ISO
trovafloxacin results in increased expression of COX4I2 mRNA
CTD
PMID:35537566
NCBI chr 3:141,228,443...141,239,337
Ensembl chr 3:141,228,443...141,239,331
G
Cox6a2
cytochrome c oxidase subunit 6A2
decreases expression
ISO
trovafloxacin results in decreased expression of COX6A2 mRNA
CTD
PMID:35537566
NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274
G
Cpe
carboxypeptidase E
increases expression
ISO
trovafloxacin results in increased expression of CPE mRNA
CTD
PMID:35537566
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
G
Cpeb4
cytoplasmic polyadenylation element binding protein 4
increases expression
ISO
trovafloxacin results in increased expression of CPEB4 mRNA
CTD
PMID:35537566
NCBI chr10:15,717,794...15,780,482
Ensembl chr10:15,717,794...15,780,603
G
Cped1
cadherin-like and PC-esterase domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of CPED1 mRNA
CTD
PMID:35537566
NCBI chr 4:50,516,712...50,789,651
Ensembl chr 4:50,516,819...50,788,674
G
Cpox
coproporphyrinogen oxidase
decreases expression
EXP
trovafloxacin results in decreased expression of CPOX mRNA
CTD
PMID:24136188
NCBI chr11:41,936,585...41,946,568
Ensembl chr11:41,936,591...41,946,746
G
Cpsf1
cleavage and polyadenylation specific factor 1
decreases expression
ISO
trovafloxacin results in decreased expression of CPSF1 mRNA
CTD
PMID:35537566
NCBI chr 7:108,319,429...108,330,018
Ensembl chr 7:108,319,434...108,329,934
G
Cpt1a
carnitine palmitoyltransferase 1A
increases expression
EXP
trovafloxacin results in increased expression of CPT1A mRNA
CTD
PMID:24136188
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Cradd
CASP2 and RIPK1 domain containing adaptor with death domain
decreases expression
ISO
trovafloxacin results in decreased expression of CRADD mRNA
CTD
PMID:35537566
NCBI chr 7:29,940,240...29,952,907
Ensembl chr 7:29,798,586...29,952,907
G
Crebzf
CREB/ATF bZIP transcription factor
increases expression
ISO
trovafloxacin results in increased expression of CREBZF mRNA
CTD
PMID:35537566
NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553
G
Crk
CRK proto-oncogene, adaptor protein
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CRK mRNA
CTD
PMID:18930950
NCBI chr10:60,530,469...60,556,703
Ensembl chr10:60,530,464...60,553,406
G
Cryzl1
crystallin zeta like 1
decreases expression
ISO
trovafloxacin results in decreased expression of CRYZL1 mRNA
CTD
PMID:35537566
NCBI chr11:30,933,140...30,977,936
Ensembl chr11:30,933,144...30,977,867
G
Cs
citrate synthase
decreases expression
EXP
trovafloxacin results in decreased expression of CS mRNA
CTD
PMID:24136188
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
G
Csad
cysteine sulfinic acid decarboxylase
decreases expression
ISO
trovafloxacin results in decreased expression of CSAD mRNA
CTD
PMID:35537566
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
G
Csrnp1
cysteine and serine rich nuclear protein 1
increases expression
ISO
trovafloxacin results in increased expression of CSRNP1 mRNA
CTD
PMID:35537566
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
G
Cst7
cystatin F
decreases expression
ISO
trovafloxacin results in decreased expression of CST7 mRNA
CTD
PMID:35537566
NCBI chr 3:139,396,830...139,405,557
Ensembl chr 3:139,396,850...139,405,557
G
Cstf2t
cleavage stimulation factor subunit 2, tau variant
increases expression
ISO
trovafloxacin results in increased expression of CSTF2T mRNA
CTD
PMID:35537566
NCBI chr 1:228,952,617...228,956,183
Ensembl chr 1:228,952,504...228,955,873
G
Ctdsp1
CTD small phosphatase 1
decreases expression
ISO
trovafloxacin results in decreased expression of CTDSP1 mRNA
CTD
PMID:35537566
NCBI chr 9:75,973,694...75,979,298
Ensembl chr 9:75,973,962...75,979,297
G
Cth
cystathionine gamma-lyase
decreases expression
ISO
trovafloxacin results in decreased expression of CTH mRNA
CTD
PMID:35537566
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Ctsc
cathepsin C
decreases expression
ISO
trovafloxacin results in decreased expression of CTSC mRNA
CTD
PMID:35537566
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
G
Ctse
cathepsin E
decreases expression
ISO
trovafloxacin results in decreased expression of CTSE mRNA
CTD
PMID:35537566
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
G
Ctsf
cathepsin F
decreases expression
ISO
trovafloxacin results in decreased expression of CTSF mRNA
CTD
PMID:35537566
NCBI chr 1:202,152,777...202,158,525
Ensembl chr 1:202,152,728...202,158,525
G
Cttnbp2nl
CTTNBP2 N-terminal like
increases expression
ISO
trovafloxacin results in increased expression of CTTNBP2NL mRNA
CTD
PMID:35537566
NCBI chr 2:192,507,963...192,554,548
Ensembl chr 2:192,507,963...192,541,101
G
Cutc
cutC copper transporter
decreases expression
ISO
trovafloxacin results in decreased expression of CUTC mRNA
CTD
PMID:35537566
NCBI chr 1:242,622,281...242,637,048
Ensembl chr 1:242,622,276...242,637,047
G
Cux2
cut-like homeobox 2
increases expression
ISO
trovafloxacin results in increased expression of CUX2 mRNA
CTD
PMID:35537566
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CXCL2 mRNA; trovafloxacin promotes the reaction [TNF protein results in increased expression of CXCL2 protein] trovafloxacin results in increased expression of CXCL2 mRNA
CTD
PMID:18930950 PMID:19638433 PMID:35537566
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CXCL3 mRNA; trovafloxacin promotes the reaction [TNF protein results in increased expression of CXCL1 protein]
CTD
PMID:18930950 PMID:19638433
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cyb5a
cytochrome b5 type A
increases expression
ISO
trovafloxacin results in increased expression of CYB5A mRNA
CTD
PMID:35537566
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
G
Cyb5d1
cytochrome b5 domain containing 1
increases expression
ISO
trovafloxacin results in increased expression of CYB5D1 mRNA
CTD
PMID:35537566
NCBI chr10:54,113,428...54,117,744
Ensembl chr10:54,113,438...54,117,911
G
Cyb5rl
cytochrome b5 reductase-like
decreases expression
ISO
trovafloxacin results in decreased expression of CYB5RL mRNA
CTD
PMID:35537566
NCBI chr 5:121,846,223...121,868,287
Ensembl chr 5:121,847,952...121,868,745
G
Cyfip2
cytoplasmic FMR1 interacting protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of CYFIP2 mRNA
CTD
PMID:35537566
NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
decreases activity
ISO
trovafloxacin results in decreased activity of CYP19A1 protein
CTD
PMID:26141389
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
ISO
trovafloxacin results in decreased expression of CYP27A1 mRNA
CTD
PMID:35537566
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp2b12
cytochrome P450, family 2, subfamily b, polypeptide 12
decreases expression
EXP
trovafloxacin results in decreased expression of CYP2B12 mRNA
CTD
PMID:24136188
NCBI chr 1:82,007,609...82,019,409
Ensembl chr 1:82,007,609...82,080,480
G
Cyp2u1
cytochrome P450, family 2, subfamily u, polypeptide 1
decreases expression
ISO
trovafloxacin results in decreased expression of CYP2U1 mRNA
CTD
PMID:35537566
NCBI chr 2:219,849,403...219,866,959
Ensembl chr 2:219,849,407...219,866,882
G
Cyp4f39
cytochrome P450, family 4, subfamily f, polypeptide 39
decreases expression
ISO
trovafloxacin results in decreased expression of CYP4F39 mRNA
CTD
PMID:35537566
NCBI chr 7:11,426,806...11,505,553
Ensembl chr 7:11,433,371...11,536,181
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CYP7A1 mRNA
CTD
PMID:18930950
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
increases expression
EXP
trovafloxacin results in increased expression of CYP8B1 mRNA
CTD
PMID:24136188
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Cyren
cell cycle regulator of NHEJ
decreases expression
ISO
trovafloxacin results in decreased expression of CYREN mRNA
CTD
PMID:35537566
NCBI chr 4:63,547,311...63,553,394
Ensembl chr 4:63,547,335...63,551,602
G
Cyth4
cytohesin 4
increases expression
ISO
trovafloxacin results in increased expression of CYTH4 mRNA
CTD
PMID:35537566
NCBI chr 7:110,152,232...110,176,726
Ensembl chr 7:110,152,272...110,176,741
G
Dancr
differentiation antagonizing non-protein coding RNA
increases expression
ISO
trovafloxacin results in increased expression of DANCR mRNA
CTD
PMID:35537566
NCBI chr14:34,126,956...34,127,936
G
Dapk1
death associated protein kinase 1
decreases expression
EXP
trovafloxacin results in decreased expression of DAPK1 mRNA
CTD
PMID:24136188
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
G
Dars2
aspartyl-tRNA synthetase 2 (mitochondrial)
decreases expression
ISO
trovafloxacin results in decreased expression of DARS2 mRNA
CTD
PMID:35537566
NCBI chr13:73,308,726...73,336,558
Ensembl chr13:73,308,726...73,336,934
G
Daxx
death-domain associated protein
increases expression
ISO
trovafloxacin results in increased expression of DAXX mRNA
CTD
PMID:35537566
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
G
Dbf4
DBF4-CDC7 kinase regulatory subunit
decreases expression
ISO
trovafloxacin results in decreased expression of DBF4 mRNA
CTD
PMID:35537566
NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:25,676,634...25,701,066
G
Dcp1b
decapping mRNA 1B
decreases expression
ISO
trovafloxacin results in decreased expression of DCP1B mRNA
CTD
PMID:35537566
NCBI chr 4:152,358,267...152,395,747
Ensembl chr 4:152,358,241...152,397,145
G
Ddit3
DNA-damage inducible transcript 3
decreases expression
ISO
trovafloxacin results in decreased expression of DDIT3 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddx1
DEAD-box helicase 1
decreases expression
EXP
trovafloxacin results in decreased expression of DDX1 mRNA
CTD
PMID:24136188
NCBI chr 6:35,996,469...36,027,340
Ensembl chr 6:35,996,469...36,027,365
G
Ddx17
DEAD-box helicase 17
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of DDX17 mRNA
CTD
PMID:18930950
NCBI chr 7:111,091,127...111,109,353
Ensembl chr 7:111,089,445...111,109,193
G
Ddx23
DEAD-box helicase 23
increases expression
ISO
trovafloxacin results in increased expression of DDX23 mRNA
CTD
PMID:35537566
NCBI chr 7:129,797,620...129,814,909
Ensembl chr 7:129,797,614...129,814,949
G
Ddx59
DEAD-box helicase 59
decreases expression
ISO
trovafloxacin results in decreased expression of DDX59 mRNA
CTD
PMID:35537566
NCBI chr13:47,876,258...47,901,214
Ensembl chr13:47,876,261...47,901,214
G
Ddx6
DEAD-box helicase 6
increases expression
ISO
trovafloxacin results in increased expression of DDX6 mRNA
CTD
PMID:35537566
NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405
G
Ddx60
DEXD/H-box helicase 60
increases expression
ISO
trovafloxacin results in increased expression of DDX60 mRNA
CTD
PMID:35537566
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
G
Dek
DEK proto-oncogene
decreases expression
ISO
trovafloxacin results in decreased expression of DEK mRNA
CTD
PMID:35537566
NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
G
Dennd2d
DENN domain containing 2D
decreases expression
ISO
trovafloxacin results in decreased expression of DENND2D mRNA
CTD
PMID:35537566
NCBI chr 2:193,973,231...193,992,275
Ensembl chr 2:193,973,231...193,992,270
G
Dennd4a
DENN domain containing 4A
decreases expression
ISO
trovafloxacin results in decreased expression of DENND4A mRNA
CTD
PMID:35537566
NCBI chr 8:65,322,920...65,436,331
Ensembl chr 8:65,322,941...65,436,330
G
Dennd5b
DENN domain containing 5B
increases expression
ISO
trovafloxacin results in increased expression of DENND5B mRNA
CTD
PMID:35537566
NCBI chr 4:181,959,597...182,089,661
Ensembl chr 4:181,961,386...182,089,362
G
Depdc1
DEP domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of DEPDC1A mRNA
CTD
PMID:35537566
NCBI chr 2:248,684,508...248,717,951
Ensembl chr 2:248,684,523...248,717,951
G
Depdc1b
DEP domain containing 1B
decreases expression
ISO
trovafloxacin results in decreased expression of DEPDC1B mRNA
CTD
PMID:35537566
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
G
Depdc7
DEP domain containing 7
decreases expression
ISO
trovafloxacin results in decreased expression of DEPDC7 mRNA
CTD
PMID:35537566
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
G
Deptor
DEP domain containing MTOR-interacting protein
decreases expression
ISO
trovafloxacin results in decreased expression of DEPTOR mRNA
CTD
PMID:35537566
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
G
Derl2
derlin 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of DERL2 mRNA
CTD
PMID:18930950
NCBI chr10:55,727,764...55,739,442
Ensembl chr10:55,727,643...55,739,518
G
Det1
DET1 partner of COP1 E3 ubiquitin ligase
decreases expression
ISO
trovafloxacin results in decreased expression of DET1 mRNA
CTD
PMID:35537566
NCBI chr 1:132,749,736...132,765,963
Ensembl chr 1:132,749,756...132,765,923
G
Dffb
DNA fragmentation factor subunit beta
increases expression
ISO
trovafloxacin results in increased expression of DFFB mRNA
CTD
PMID:35537566
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
G
Dgat2
diacylglycerol O-acyltransferase 2
decreases expression
EXP ISO
trovafloxacin results in decreased expression of DGAT2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
G
Dgke
diacylglycerol kinase epsilon
increases expression
ISO
trovafloxacin results in increased expression of DGKE mRNA
CTD
PMID:35537566
NCBI chr10:73,853,030...73,877,334
Ensembl chr10:73,855,583...73,877,100
G
Dgkg
diacylglycerol kinase, gamma
decreases expression
ISO
trovafloxacin results in decreased expression of DGKG mRNA
CTD
PMID:35537566
NCBI chr11:78,384,212...78,579,158
Ensembl chr11:78,384,458...78,577,212
G
Dguok
deoxyguanosine kinase
decreases expression
ISO
trovafloxacin results in decreased expression of DGUOK mRNA
CTD
PMID:35537566
NCBI chr 4:115,987,101...116,014,733
Ensembl chr 4:115,979,094...116,014,733
G
Dhrs3
dehydrogenase/reductase 3
decreases expression
ISO
trovafloxacin results in decreased expression of DHRS3 mRNA
CTD
PMID:35537566
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
G
Dhrs4
dehydrogenase/reductase 4
decreases expression
ISO
trovafloxacin results in decreased expression of DHRS4 mRNA
CTD
PMID:35537566
NCBI chr15:28,966,544...28,978,135
Ensembl chr15:28,966,553...28,978,127
G
Dhx58
DEXH-box helicase 58
increases expression
ISO
trovafloxacin results in increased expression of DHX58 mRNA
CTD
PMID:35537566
NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
G
Diaph3
diaphanous-related formin 3
decreases expression
ISO
trovafloxacin results in decreased expression of DIAPH3 mRNA
CTD
PMID:35537566
NCBI chr15:62,543,375...63,013,060
Ensembl chr15:62,543,375...63,012,975
G
Disp3
dispatched RND transporter family member 3
decreases expression
ISO
trovafloxacin results in decreased expression of DISP3 mRNA
CTD
PMID:35537566
NCBI chr 5:158,672,015...158,720,806
Ensembl chr 5:158,672,015...158,720,806
G
Dixdc1
DIX domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of DIXDC1 mRNA
CTD
PMID:35537566
NCBI chr 8:51,007,835...51,081,191
Ensembl chr 8:51,007,838...51,081,090
G
Dlgap5
DLG associated protein 5
decreases expression
ISO
trovafloxacin results in decreased expression of DLGAP5 mRNA
CTD
PMID:35537566
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
G
Dlst
dihydrolipoamide S-succinyltransferase
decreases expression
EXP
trovafloxacin results in decreased expression of DLST mRNA
CTD
PMID:24136188
NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296
G
Dmac1
distal membrane arm assembly component 1
increases expression
ISO
trovafloxacin results in increased expression of DMAC1 mRNA
CTD
PMID:35537566
NCBI chr 5:89,241,173...89,243,793
Ensembl chr 5:89,242,661...89,243,757
G
Dmpk
DM1 protein kinase
increases expression
ISO
trovafloxacin results in increased expression of DMPK mRNA
CTD
PMID:35537566
NCBI chr 1:78,730,255...78,740,585
Ensembl chr 1:78,730,275...78,740,593
G
Dnah17
dynein, axonemal, heavy chain 17
increases expression
ISO
trovafloxacin results in increased expression of DNAH17 mRNA
CTD
PMID:35537566
NCBI chr10:103,244,144...103,364,953
Ensembl chr10:103,249,363...103,364,901
G
Dnajb2
DnaJ heat shock protein family (Hsp40) member B2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of DNAJB2 mRNA
CTD
PMID:18930950
NCBI chr 9:76,731,060...76,739,278
Ensembl chr 9:76,731,065...76,739,277
G
Dnase2
deoxyribonuclease 2, lysosomal
decreases expression
ISO
trovafloxacin results in decreased expression of DNASE2A mRNA
CTD
PMID:35537566
NCBI chr19:23,244,656...23,247,376
Ensembl chr19:23,244,664...23,247,376
G
Dnd1
DND microRNA-mediated repression inhibitor 1
increases expression
ISO
trovafloxacin results in increased expression of DND1 mRNA
CTD
PMID:35537566
NCBI chr18:28,378,692...28,381,316
Ensembl chr18:28,378,692...28,381,316
G
Dnmt1
DNA methyltransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of DNMT1 mRNA
CTD
PMID:35537566
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
G
Dnmt3l
DNA methyltransferase 3 like
decreases expression
ISO
trovafloxacin results in decreased expression of DNMT3L mRNA
CTD
PMID:35537566
NCBI chr20:10,614,933...10,629,337
Ensembl chr20:10,614,934...10,629,516
G
Dnph1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
decreases expression
EXP
trovafloxacin results in decreased expression of DNPH1 mRNA
CTD
PMID:24136188
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
G
Dock11
dedicator of cytokinesis 11
decreases expression
ISO
trovafloxacin results in decreased expression of DOCK11 mRNA
CTD
PMID:35537566
NCBI chr X:115,131,720...115,314,854
Ensembl chr X:115,131,909...115,314,854
G
Dock2
dedicator of cytokinesis 2
decreases expression
ISO
trovafloxacin results in decreased expression of DOCK2 mRNA
CTD
PMID:35537566
NCBI chr10:18,827,237...19,244,832
Ensembl chr10:18,827,239...19,244,808
G
Dock9
dedicator of cytokinesis 9
decreases expression
ISO
trovafloxacin results in decreased expression of DOCK9 mRNA
CTD
PMID:35537566
NCBI chr15:98,611,518...98,883,306
Ensembl chr15:98,618,084...98,883,153
G
Donson
DNA replication fork stabilization factor DONSON
decreases expression
ISO
trovafloxacin results in decreased expression of DONSON mRNA
CTD
PMID:35537566
NCBI chr11:30,919,834...30,933,150
Ensembl chr11:30,923,239...30,932,889
G
Dpf1
double PHD fingers 1
increases expression
ISO
trovafloxacin results in increased expression of DPF1 mRNA
CTD
PMID:35537566
NCBI chr 1:84,602,212...84,615,954
Ensembl chr 1:84,602,336...84,615,950
G
Drc3
dynein regulatory complex subunit 3
decreases expression
ISO
trovafloxacin results in decreased expression of DRC3 mRNA
CTD
PMID:35537566
NCBI chr10:45,149,094...45,200,659
Ensembl chr10:45,157,354...45,199,369
G
Dscc1
DNA replication and sister chromatid cohesion 1
decreases expression
ISO
trovafloxacin results in decreased expression of DSCC1 mRNA
CTD
PMID:35537566
NCBI chr 7:86,482,588...86,498,212
Ensembl chr 7:86,482,588...86,498,212
G
Dsn1
DSN1 component of MIS12 kinetochore complex
decreases expression
ISO
trovafloxacin results in decreased expression of DSN1 mRNA
CTD
PMID:35537566
NCBI chr 3:145,652,741...145,668,025
Ensembl chr 3:145,652,737...145,665,856
G
Dtnb
dystrobrevin, beta
decreases expression
ISO
trovafloxacin results in decreased expression of DTNB mRNA
CTD
PMID:35537566
NCBI chr 6:26,566,418...26,763,467
Ensembl chr 6:26,566,925...26,766,335
G
Dtnbp1
dystrobrevin binding protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of DTNBP1 mRNA
CTD
PMID:35537566
NCBI chr17:19,685,218...19,776,668
Ensembl chr17:19,685,215...19,776,661
G
Dtx1
deltex E3 ubiquitin ligase 1
decreases expression
ISO
trovafloxacin results in decreased expression of DTX1 mRNA
CTD
PMID:35537566
NCBI chr12:35,849,647...35,880,835
Ensembl chr12:35,849,617...35,880,838
G
Dtymk
deoxythymidylate kinase
decreases expression
EXP
trovafloxacin results in decreased expression of DTYMK mRNA
CTD
PMID:24136188
NCBI chr 9:94,315,552...94,324,386
Ensembl chr 9:94,315,552...94,324,870
G
Dus1l
dihydrouridine synthase 1-like
decreases expression
ISO
trovafloxacin results in decreased expression of DUS1L mRNA
CTD
PMID:35537566
NCBI chr10:106,055,519...106,062,656
Ensembl chr10:106,055,519...106,062,781
G
Dus4l
dihydrouridine synthase 4-like
decreases expression
ISO
trovafloxacin results in decreased expression of DUS4L mRNA
CTD
PMID:35537566
NCBI chr 6:48,228,111...48,242,553
Ensembl chr 6:48,228,111...48,242,449
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
trovafloxacin results in increased expression of DUSP1 mRNA
CTD
PMID:35537566
NCBI chr10:16,680,478...16,683,275
G
Dusp16
dual specificity phosphatase 16
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of DUSP16 mRNA
CTD
PMID:18930950
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
G
Dusp2
dual specificity phosphatase 2
increases expression
ISO
trovafloxacin results in increased expression of DUSP2 mRNA
CTD
PMID:35537566
NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499
G
Dusp5
dual specificity phosphatase 5
increases expression
ISO
trovafloxacin results in increased expression of DUSP5 mRNA
CTD
PMID:35537566
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
G
Dusp8
dual specificity phosphatase 8
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of DUSP8 mRNA
CTD
PMID:18930950
NCBI chr 1:197,167,392...197,184,285
Ensembl chr 1:197,169,422...197,182,921
G
Dut
deoxyuridine triphosphatase
decreases expression
EXP ISO
trovafloxacin results in decreased expression of DUT mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
G
Dym
dymeclin
decreases expression
ISO
trovafloxacin results in decreased expression of DYM mRNA
CTD
PMID:35537566
NCBI chr18:68,605,131...68,900,905
Ensembl chr18:68,605,185...68,900,903
G
Dync2i2
dynein 2 intermediate chain 2
decreases expression
ISO
trovafloxacin results in decreased expression of DYNC2I2 mRNA
CTD
PMID:35537566
NCBI chr 3:13,306,039...13,322,121
Ensembl chr 3:13,306,039...13,322,121
G
Dyrk1b
dual specificity tyrosine phosphorylation regulated kinase 1B
increases expression
ISO
trovafloxacin results in increased expression of DYRK1B mRNA
CTD
PMID:35537566
NCBI chr 1:83,479,168...83,497,011
Ensembl chr 1:83,479,147...83,487,169
G
Dyrk3
dual specificity tyrosine phosphorylation regulated kinase 3
increases expression
ISO
trovafloxacin results in increased expression of DYRK3 mRNA
CTD
PMID:35537566
NCBI chr13:42,594,120...42,604,898
Ensembl chr13:42,594,121...42,604,778
G
Dzip3
DAZ interacting zinc finger protein 3
decreases expression
ISO
trovafloxacin results in decreased expression of DZIP3 mRNA
CTD
PMID:35537566
NCBI chr11:51,823,235...51,893,353
Ensembl chr11:51,823,231...51,893,353
G
E2f1
E2F transcription factor 1
decreases expression
ISO
trovafloxacin results in decreased expression of E2F1 mRNA
CTD
PMID:35537566
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
E2f7
E2F transcription factor 7
decreases expression
ISO
trovafloxacin results in decreased expression of E2F7 mRNA
CTD
PMID:35537566
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
G
E2f8
E2F transcription factor 8
decreases expression
ISO
trovafloxacin results in decreased expression of E2F8 mRNA
CTD
PMID:35537566
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Eaf1
ELL associated factor 1
increases expression
ISO
trovafloxacin results in increased expression of EAF1 mRNA
CTD
PMID:35537566
NCBI chr16:6,698,322...6,713,071
Ensembl chr16:6,698,322...6,713,071
G
Ears2
glutamyl-tRNA synthetase 2, mitochondrial
decreases expression
ISO
trovafloxacin results in decreased expression of EARS2 mRNA
CTD
PMID:35537566
NCBI chr 1:176,597,986...176,625,848
Ensembl chr 1:176,597,986...176,625,836
G
Echdc2
enoyl CoA hydratase domain containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of ECHDC2 mRNA
CTD
PMID:35537566
NCBI chr 5:122,915,874...122,934,860
Ensembl chr 5:122,916,134...122,934,859
G
Echdc3
enoyl CoA hydratase domain containing 3
decreases expression
ISO
trovafloxacin results in decreased expression of ECHDC3 mRNA
CTD
PMID:35537566
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
G
Eci1
enoyl-CoA delta isomerase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ECI1 mRNA
CTD
PMID:35537566
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
G
Ect2
epithelial cell transforming 2
decreases expression
ISO
trovafloxacin results in decreased expression of ECT2 mRNA
CTD
PMID:35537566
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
G
Eda2r
ectodysplasin A2 receptor
increases expression
ISO
trovafloxacin results in increased expression of EDA2R mRNA
CTD
PMID:35537566
NCBI chr X:62,224,763...62,269,333
Ensembl chr X:62,228,229...62,269,268
G
Eef2k
eukaryotic elongation factor-2 kinase
decreases expression
ISO
trovafloxacin results in decreased expression of EEF2K mRNA
CTD
PMID:35537566
NCBI chr 1:175,393,119...175,456,756
Ensembl chr 1:175,393,154...175,455,164
G
Eef2kmt
eukaryotic elongation factor 2 lysine methyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of EEF2KMT mRNA
CTD
PMID:35537566
NCBI chr10:10,336,933...10,349,463
Ensembl chr10:10,336,974...10,347,039
G
Efcab11
EF-hand calcium binding domain 11
decreases expression
ISO
trovafloxacin results in decreased expression of EFCAB11 mRNA
CTD
PMID:35537566
NCBI chr 6:119,008,908...119,162,994
Ensembl chr 6:119,008,919...119,162,046
G
Efcab2
EF-hand calcium binding domain 2
decreases expression
ISO
trovafloxacin results in decreased expression of EFCAB2 mRNA
CTD
PMID:35537566
NCBI chr13:90,152,002...90,237,918
Ensembl chr13:90,152,185...90,238,218
G
Efcab5
EF-hand calcium binding domain 5
decreases expression
ISO
trovafloxacin results in decreased expression of EFCAB5 mRNA
CTD
PMID:35537566
NCBI chr10:61,926,419...62,042,745
Ensembl chr10:61,926,953...62,042,749
G
Efnb3
ephrin B3
increases expression
ISO
trovafloxacin results in increased expression of EFNB3 mRNA
CTD
PMID:35537566
NCBI chr10:54,274,506...54,281,951
Ensembl chr10:54,274,506...54,280,471
G
Egfl7
EGF-like-domain, multiple 7
decreases expression
ISO
trovafloxacin results in decreased expression of EGFL7 mRNA
CTD
PMID:35537566
NCBI chr 3:9,404,622...9,416,879
Ensembl chr 3:9,407,520...9,416,879
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of EGFR mRNA
CTD
PMID:18930950
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Egr3
early growth response 3
decreases expression
ISO
trovafloxacin results in decreased expression of EGR3 mRNA
CTD
PMID:35537566
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
G
Ei24
EI24, autophagy associated transmembrane protein
increases expression
ISO
trovafloxacin results in increased expression of EI24 mRNA
CTD
PMID:35537566
NCBI chr 8:36,494,289...36,510,653
Ensembl chr 8:36,494,289...36,510,571
G
Eid1
EP300 interacting inhibitor of differentiation 1
increases expression
ISO
trovafloxacin results in increased expression of EID1 mRNA
CTD
PMID:35537566
NCBI chr 3:112,922,961...112,924,680
Ensembl chr 3:112,922,668...112,924,752
G
Eid2b
EP300 interacting inhibitor of differentiation 2B
increases expression
ISO
trovafloxacin results in increased expression of EID2B mRNA
CTD
PMID:35537566
NCBI chr 1:83,545,530...83,547,338
Ensembl chr 1:83,545,563...83,546,734
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
increases expression
ISO
trovafloxacin results in increased expression of EIF2AK2 mRNA
CTD
PMID:35537566
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
G
Eif2b2
eukaryotic translation initiation factor 2B subunit beta
decreases expression
ISO
trovafloxacin results in decreased expression of EIF2B2 mRNA
CTD
PMID:35537566
NCBI chr 6:104,866,926...104,873,351
Ensembl chr 6:104,866,753...104,873,353
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
decreases expression
EXP
trovafloxacin results in decreased expression of EIF2S1 mRNA
CTD
PMID:24136188
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Eif2s2
eukaryotic translation initiation factor 2 subunit beta
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of EIF2S2 mRNA
CTD
PMID:18930950
NCBI chr 3:143,374,652...143,395,460
Ensembl chr 3:143,373,686...143,395,432
G
Eif3a
eukaryotic translation initiation factor 3, subunit A
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of EIF3A mRNA
CTD
PMID:18930950
NCBI chr 1:259,902,767...259,932,976
Ensembl chr 1:259,902,680...259,932,976
G
Eif3c
eukaryotic translation initiation factor 3, subunit C
decreases expression
EXP
trovafloxacin results in decreased expression of EIF3C mRNA
CTD
PMID:24136188
NCBI chr 1:181,134,604...181,152,489
Ensembl chr 1:181,134,604...181,152,493
G
Eif3l
eukaryotic translation initiation factor 3, subunit L
decreases expression
EXP
trovafloxacin results in decreased expression of EIF3L mRNA
CTD
PMID:24136188
NCBI chr 7:110,652,565...110,663,614
Ensembl chr 7:110,627,107...110,663,614
G
Eif4a2
eukaryotic translation initiation factor 4A2
increases expression
EXP ISO
trovafloxacin results in increased expression of EIF4A2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
multiple interactions decreases expression
ISO
[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of EIF4EBP1 protein; Sirolimus inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of EIF4EBP1 protein] trovafloxacin results in decreased expression of EIF4EBP1 mRNA
CTD
PMID:33609687 PMID:35537566
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Eif6
eukaryotic translation initiation factor 6
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of EIF6 mRNA
CTD
PMID:18930950
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
G
Ell2
elongation factor for RNA polymerase II 2
increases expression
ISO
trovafloxacin results in increased expression of ELL2 mRNA
CTD
PMID:35537566
NCBI chr 2:5,189,375...5,258,781
Ensembl chr 2:5,189,971...5,258,781
G
Elmo3
engulfment and cell motility 3
increases expression
ISO
trovafloxacin results in increased expression of ELMO3 mRNA
CTD
PMID:35537566
NCBI chr19:33,181,952...33,186,399
Ensembl chr19:33,182,036...33,186,410
G
Elovl6
ELOVL fatty acid elongase 6
decreases expression
EXP
trovafloxacin results in decreased expression of ELOVL6 mRNA
CTD
PMID:24136188
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
G
Emc1
ER membrane protein complex subunit 1
decreases expression
EXP
trovafloxacin results in decreased expression of EMC1 mRNA
CTD
PMID:24136188
NCBI chr 5:151,608,557...151,633,888
Ensembl chr 5:151,608,568...151,633,888
G
Eme1
essential meiotic structure-specific endonuclease 1
decreases expression
ISO
trovafloxacin results in decreased expression of EME1 mRNA
CTD
PMID:35537566
NCBI chr10:79,586,718...79,595,515
Ensembl chr10:79,586,729...79,595,435
G
Eml6
EMAP like 6
decreases expression
ISO
trovafloxacin results in decreased expression of EML6 mRNA
CTD
PMID:35537566
NCBI chr14:103,471,537...103,806,120
Ensembl chr14:103,476,372...103,805,849
G
Endog
endonuclease G
decreases expression
ISO
trovafloxacin results in decreased expression of ENDOG mRNA
CTD
PMID:35537566
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
G
Eno3
enolase 3
decreases expression
ISO
trovafloxacin results in decreased expression of ENO3 mRNA
CTD
PMID:35537566
NCBI chr10:55,370,531...55,375,921
Ensembl chr10:55,366,975...55,375,921
G
Enpp1
ectonucleotide pyrophosphatase/phosphodiesterase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ENPP1 mRNA
CTD
PMID:35537566
NCBI chr 1:20,698,746...20,763,741
Ensembl chr 1:20,698,764...20,763,715
G
Enpp6
ectonucleotide pyrophosphatase/phosphodiesterase 6
decreases expression
ISO
trovafloxacin results in decreased expression of ENPP6 mRNA
CTD
PMID:35537566
NCBI chr16:45,165,883...45,294,126
Ensembl chr16:45,169,178...45,294,077
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ENTPD1 mRNA
CTD
PMID:35537566
NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
G
Epha2
Eph receptor A2
increases expression
ISO
trovafloxacin results in increased expression of EPHA2 mRNA
CTD
PMID:35537566
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
G
Ephx1
epoxide hydrolase 1
decreases expression
EXP
trovafloxacin results in decreased expression of EPHX1 mRNA
CTD
PMID:24136188
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Epm2a
EPM2A glucan phosphatase, laforin
decreases expression
ISO
trovafloxacin results in decreased expression of EPM2A mRNA
CTD
PMID:35537566
NCBI chr 1:5,727,111...5,845,338
Ensembl chr 1:5,727,066...5,920,555
G
Epm2aip1
EPM2A interacting protein 1
increases expression
ISO
trovafloxacin results in increased expression of EPM2AIP1 mRNA
CTD
PMID:35537566
NCBI chr 8:111,233,871...111,241,219
Ensembl chr 8:111,233,826...111,241,871
G
Eprs1
glutamyl-prolyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of EPRS1 mRNA
CTD
PMID:35537566
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
decreases expression
ISO
trovafloxacin results in decreased expression of ERCC1 mRNA
CTD
PMID:35537566
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
G
Ercc6l
ERCC excision repair 6 like, spindle assembly checkpoint helicase
decreases expression
ISO
trovafloxacin results in decreased expression of ERCC6L mRNA
CTD
PMID:35537566
NCBI chr X:67,245,414...67,261,222
Ensembl chr X:67,245,414...67,280,756
G
Ergic1
endoplasmic reticulum-golgi intermediate compartment 1
decreases expression
EXP
trovafloxacin results in decreased expression of ERGIC1 mRNA
CTD
PMID:24136188
NCBI chr10:16,531,192...16,626,974
Ensembl chr10:16,531,194...16,626,957
G
Ermp1
endoplasmic reticulum metallopeptidase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ERMP1 mRNA
CTD
PMID:35537566
NCBI chr 1:227,383,992...227,422,120
Ensembl chr 1:227,387,920...227,436,909
G
Erp29
endoplasmic reticulum protein 29
decreases expression
EXP
trovafloxacin results in decreased expression of ERP29 mRNA
CTD
PMID:24136188
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
G
Errfi1
ERBB receptor feedback inhibitor 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ERRFI1 mRNA
CTD
PMID:18930950
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
G
Esco2
establishment of sister chromatid cohesion N-acetyltransferase 2
decreases expression
ISO
trovafloxacin results in decreased expression of ESCO2 mRNA
CTD
PMID:35537566
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
G
Esd
esterase D
increases expression
ISO
trovafloxacin results in increased expression of ESD mRNA
CTD
PMID:35537566
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
G
Espl1
extra spindle pole bodies like 1, separase
decreases expression
ISO
trovafloxacin results in decreased expression of ESPL1 mRNA
CTD
PMID:35537566
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
G
Esr1
estrogen receptor 1
decreases expression
ISO
trovafloxacin results in decreased expression of ESR1 mRNA
CTD
PMID:35537566
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esyt1
extended synaptotagmin 1
decreases expression
ISO
trovafloxacin results in decreased expression of ESYT1 mRNA
CTD
PMID:35537566
NCBI chr 7:928,848...946,199
Ensembl chr 7:928,848...946,199
G
Esyt2
extended synaptotagmin 2
decreases expression
ISO
trovafloxacin results in decreased expression of ESYT2 mRNA
CTD
PMID:35537566
NCBI chr 6:137,219,653...137,312,590
Ensembl chr 6:137,219,707...137,312,590
G
Ets2
ETS proto-oncogene 2, transcription factor
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ETS2 mRNA
CTD
PMID:18930950
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
G
Etv3
ETS variant transcription factor 3
increases expression
ISO
trovafloxacin results in increased expression of ETV3 mRNA
CTD
PMID:35537566
NCBI chr 2:172,965,461...172,980,320
Ensembl chr 2:172,965,588...172,980,314
G
Evi2a
ecotropic viral integration site 2A
increases expression
ISO
trovafloxacin results in increased expression of EVI2A mRNA
CTD
PMID:35537566
NCBI chr10:64,485,760...64,489,660
Ensembl chr10:64,485,200...64,489,843
G
Evi5
ecotropic viral integration site 5
decreases expression
ISO
trovafloxacin results in decreased expression of EVI5 mRNA
CTD
PMID:35537566
NCBI chr14:1,875,601...2,021,678
Ensembl chr14:1,875,647...2,021,678
G
Exd2
exonuclease 3'-5' domain containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of EXD2 mRNA
CTD
PMID:35537566
NCBI chr 6:100,116,867...100,150,452
Ensembl chr 6:100,116,867...100,150,442
G
Extl1
exostosin-like glycosyltransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of EXTL1 mRNA
CTD
PMID:35537566
NCBI chr 5:146,573,911...146,589,115
Ensembl chr 5:146,573,912...146,589,115
G
Eya4
EYA transcriptional coactivator and phosphatase 4
decreases expression
ISO
trovafloxacin results in decreased expression of EYA4 mRNA
CTD
PMID:35537566
NCBI chr 1:22,172,275...22,415,978
Ensembl chr 1:22,172,275...22,415,976
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
decreases expression
ISO
trovafloxacin results in decreased expression of EZH2 mRNA
CTD
PMID:35537566
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
G
F10
coagulation factor X
decreases expression
ISO
trovafloxacin results in decreased expression of F10 mRNA
CTD
PMID:35537566
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
G
F12
coagulation factor XII
increases expression
ISO
trovafloxacin results in increased expression of F12 mRNA
CTD
PMID:35537566
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
G
F2
coagulation factor II, thrombin
multiple interactions
ISO
[Lipopolysaccharides co-treated with trovafloxacin] results in increased activity of F2 protein
CTD
PMID:19367693
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
F7
coagulation factor VII
decreases expression
ISO
trovafloxacin results in decreased expression of F7 mRNA
CTD
PMID:35537566
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
Faah
fatty acid amide hydrolase
decreases expression
ISO
trovafloxacin results in decreased expression of FAAH mRNA
CTD
PMID:35537566
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
G
Faap100
FA core complex associated protein 100
decreases expression
ISO
trovafloxacin results in decreased expression of FAAP100 mRNA
CTD
PMID:35537566
NCBI chr10:105,641,677...105,653,809
Ensembl chr10:105,639,414...105,653,494
G
Faf1
Fas associated factor 1
decreases expression
ISO
trovafloxacin results in decreased expression of FAF1 mRNA
CTD
PMID:35537566
NCBI chr 5:124,426,032...124,790,014
Ensembl chr 5:124,426,062...124,789,977
G
Fam120c
family with sequence similarity 120 member C
decreases expression
ISO
trovafloxacin results in decreased expression of FAM120C mRNA
CTD
PMID:35537566
NCBI chr X:20,324,046...20,477,831
Ensembl chr X:20,323,381...20,477,275
G
Fam131a
family with sequence similarity 131, member A
decreases expression
ISO
trovafloxacin results in decreased expression of FAM131A mRNA
CTD
PMID:35537566
NCBI chr11:80,211,577...80,221,527
Ensembl chr11:80,211,745...80,221,511
G
Fam13c
family with sequence similarity 13, member C
decreases expression
ISO
trovafloxacin results in decreased expression of FAM13C mRNA
CTD
PMID:35537566
NCBI chr20:18,065,625...18,187,792
Ensembl chr20:18,065,628...18,187,592
G
Fam171a2
family with sequence similarity 171, member A2
decreases expression
ISO
trovafloxacin results in decreased expression of FAM171A2 mRNA
CTD
PMID:35537566
NCBI chr10:87,393,888...87,404,051
Ensembl chr10:87,394,007...87,404,053
G
Fam171b
family with sequence similarity 171, member B
decreases expression
ISO
trovafloxacin results in decreased expression of FAM171B mRNA
CTD
PMID:35537566
NCBI chr 3:68,930,755...68,986,113
Ensembl chr 3:68,930,822...68,986,127
G
Fam222b
family with sequence similarity 222, member B
increases expression
ISO
trovafloxacin results in increased expression of FAM222B mRNA
CTD
PMID:35537566
NCBI chr10:62,986,571...63,052,350
Ensembl chr10:62,986,571...63,052,350
G
Fam83d
family with sequence similarity 83, member D
decreases expression
ISO
trovafloxacin results in decreased expression of FAM83D mRNA
CTD
PMID:35537566
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
G
Fam83h
family with sequence similarity 83, member H
increases expression
ISO
trovafloxacin results in increased expression of FAM83H mRNA
CTD
PMID:35537566
NCBI chr 7:107,716,431...107,724,619
Ensembl chr 7:107,716,431...107,728,672
G
Fam98a
family with sequence similarity 98, member A
decreases expression
EXP
trovafloxacin results in decreased expression of FAM98A mRNA
CTD
PMID:24136188
NCBI chr 6:19,874,082...19,888,744
Ensembl chr 6:19,874,071...19,888,742
G
Fanca
FA complementation group A
decreases expression
ISO
trovafloxacin results in decreased expression of FANCA mRNA
CTD
PMID:35537566
NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527
G
Fancb
FA complementation group B
decreases expression
ISO
trovafloxacin results in decreased expression of FANCB mRNA
CTD
PMID:35537566
NCBI chr X:29,403,771...29,420,484
Ensembl chr X:29,403,771...29,420,192
G
Fancc
FA complementation group C
decreases expression
ISO
trovafloxacin results in decreased expression of FANCC mRNA
CTD
PMID:35537566
NCBI chr17:1,680,660...1,822,610
Ensembl chr17:1,681,324...1,829,376
G
Fancd2
FA complementation group D2
decreases expression
ISO
trovafloxacin results in decreased expression of FANCD2 mRNA
CTD
PMID:35537566
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
G
Fanci
FA complementation group I
decreases expression
ISO
trovafloxacin results in decreased expression of FANCI mRNA
CTD
PMID:35537566
NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640
G
Fasn
fatty acid synthase
multiple interactions decreases expression
ISO EXP
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of FASN mRNA trovafloxacin results in decreased expression of FASN mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fbxl12
F-box and leucine-rich repeat protein 12
increases expression
ISO
trovafloxacin results in increased expression of FBXL12 mRNA
CTD
PMID:35537566
NCBI chr 8:19,175,864...19,183,373
Ensembl chr 8:19,160,352...19,183,607
G
Fbxo15
F-box protein 15
decreases expression
ISO
trovafloxacin results in decreased expression of FBXO15 mRNA
CTD
PMID:35537566
NCBI chr18:78,319,577...78,634,695
Ensembl chr18:78,319,534...78,390,765
G
Fbxo33
F-box protein 33
increases expression
ISO
trovafloxacin results in increased expression of FBXO33 mRNA
CTD
PMID:35537566
NCBI chr 6:76,900,619...76,934,232
Ensembl chr 6:76,900,631...76,932,669
G
Fbxo36
F-box protein 36
increases expression
ISO
trovafloxacin results in increased expression of FBXO36 mRNA
CTD
PMID:35537566
NCBI chr 9:86,042,522...86,107,220
Ensembl chr 9:86,040,862...86,107,229
G
Fbxo48
F-box protein 48
decreases expression
ISO
trovafloxacin results in decreased expression of FBXO48 mRNA
CTD
PMID:35537566
NCBI chr14:91,380,857...91,382,314
Ensembl chr14:91,380,857...91,382,314
G
Fbxo5
F-box protein 5
decreases expression
ISO
trovafloxacin results in decreased expression of FBXO5 mRNA
CTD
PMID:35537566
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
G
Fbxo9
f-box protein 9
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of FBXO9 mRNA
CTD
PMID:18930950
NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949
G
Fbxw10
F-box and WD repeat domain containing 10
decreases expression
ISO
trovafloxacin results in decreased expression of FBXW10 mRNA
CTD
PMID:35537566
NCBI chr10:47,513,313...47,551,909
Ensembl chr10:47,486,297...47,551,907
G
Fcf1
Fcf1 rRNA-processing protein
increases expression
ISO
trovafloxacin results in increased expression of FCF1 mRNA
CTD
PMID:35537566
NCBI chr 6:104,617,780...104,629,643
Ensembl chr 6:104,617,770...104,629,643
G
Fcgr2b
Fc gamma receptor 2B
decreases expression
ISO
trovafloxacin results in decreased expression of FCGR2B mRNA
CTD
PMID:35537566
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
G
Fchsd1
FCH and double SH3 domains 1
increases expression
ISO
trovafloxacin results in increased expression of FCHSD1 mRNA
CTD
PMID:35537566
NCBI chr18:29,793,899...29,804,533
Ensembl chr18:29,793,899...29,804,466
G
Fdxr
ferredoxin reductase
decreases expression
ISO
trovafloxacin results in decreased expression of FDXR mRNA
CTD
PMID:35537566
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
G
Ffar4
free fatty acid receptor 4
decreases expression
ISO
trovafloxacin results in decreased expression of FFAR4 mRNA
CTD
PMID:35537566
NCBI chr 1:235,873,576...235,891,597
Ensembl chr 1:235,873,576...235,891,597
G
Fga
fibrinogen alpha chain
multiple interactions
ISO
[Lipopolysaccharides co-treated with trovafloxacin] results in increased expression of FGA protein
CTD
PMID:19367693
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fgd4
FYVE, RhoGEF and PH domain containing 4
decreases expression
ISO
trovafloxacin results in decreased expression of FGD4 mRNA
CTD
PMID:35537566
NCBI chr11:84,399,989...84,551,013
Ensembl chr11:84,399,816...84,546,972
G
Fgf22
fibroblast growth factor 22
increases expression
ISO
trovafloxacin results in increased expression of FGF22 mRNA
CTD
PMID:35537566
NCBI chr 7:9,947,632...9,956,918
Ensembl chr 7:9,948,071...9,950,486
G
Fignl2
fidgetin-like 2
increases expression
ISO
trovafloxacin results in increased expression of FIGNL2 mRNA
CTD
PMID:35537566
NCBI chr 7:132,160,006...132,187,896
Ensembl chr 7:132,162,390...132,164,336
G
Filip1l
filamin A interacting protein 1-like
decreases expression
ISO
trovafloxacin results in decreased expression of FILIP1L mRNA
CTD
PMID:35537566
NCBI chr11:42,937,353...43,177,085
Ensembl chr11:42,940,467...43,177,415
G
Fkbp11
FKBP prolyl isomerase 11
decreases expression
ISO
trovafloxacin results in decreased expression of FKBP11 mRNA
CTD
PMID:35537566
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
G
Fkbp15
FKBP prolyl isomerase family member 15
decreases expression
ISO
trovafloxacin results in decreased expression of FKBP15 mRNA
CTD
PMID:35537566
NCBI chr 5:75,750,786...75,815,038
Ensembl chr 5:75,750,787...75,814,990
G
Fkbp4
FKBP prolyl isomerase 4
decreases expression
EXP
trovafloxacin results in decreased expression of FKBP4 mRNA
CTD
PMID:24136188
NCBI chr 4:161,703,379...161,711,833
Ensembl chr 4:161,703,379...161,711,833
G
Fkbp8
FKBP prolyl isomerase 8
decreases expression
ISO
trovafloxacin results in decreased expression of FKBP8 mRNA
CTD
PMID:35537566
NCBI chr16:18,895,608...18,902,648
Ensembl chr16:18,893,576...18,902,612
G
Fkbpl
FKBP prolyl isomerase like
decreases expression
ISO
trovafloxacin results in decreased expression of FKBPL mRNA
CTD
PMID:35537566
NCBI chr20:4,099,845...4,101,315
Ensembl chr20:4,099,806...4,101,368
G
Flrt2
fibronectin leucine rich transmembrane protein 2
increases expression
ISO
trovafloxacin results in increased expression of FLRT2 mRNA
CTD
PMID:35537566
NCBI chr 6:114,777,547...114,872,688
Ensembl chr 6:114,777,599...114,872,785
G
Fmo3
flavin containing dimethylaniline monoxygenase 3
increases expression
EXP
trovafloxacin results in increased expression of FMO3 mRNA
CTD
PMID:24136188
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
G
Fmo5
flavin containing dimethylaniline monoxygenase 5
decreases expression
ISO
trovafloxacin results in decreased expression of FMO5 mRNA
CTD
PMID:35537566
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
G
Fnbp1l
formin binding protein 1-like
increases expression
ISO
trovafloxacin results in increased expression of FNBP1L mRNA
CTD
PMID:35537566
NCBI chr 2:210,647,241...210,748,203
Ensembl chr 2:210,647,246...210,738,455
G
Fnbp4
formin binding protein 4
increases expression
ISO
trovafloxacin results in increased expression of FNBP4 mRNA
CTD
PMID:35537566
NCBI chr 3:76,733,012...76,763,077
Ensembl chr 3:76,733,027...76,763,079
G
Fndc8
fibronectin type III domain containing 8
increases expression
ISO
trovafloxacin results in increased expression of FNDC8 mRNA
CTD
PMID:35537566
NCBI chr10:67,825,952...67,834,090
Ensembl chr10:67,825,952...67,834,090
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of FOS mRNA trovafloxacin results in increased expression of FOS mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
ISO
trovafloxacin results in increased expression of FOSL1 mRNA
CTD
PMID:35537566
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
increases expression
ISO
trovafloxacin results in increased expression of FOSL2 mRNA
CTD
PMID:35537566
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
G
Foxm1
forkhead box M1
decreases expression
ISO
trovafloxacin results in decreased expression of FOXM1 mRNA
CTD
PMID:35537566
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
G
Frat2
FRAT regulator of WNT signaling pathway 2
decreases expression
ISO
trovafloxacin results in decreased expression of FRAT2 mRNA
CTD
PMID:35537566
NCBI chr 1:240,654,120...240,656,449
Ensembl chr 1:240,654,137...240,656,517
G
Frs3
fibroblast growth factor receptor substrate 3
increases expression
ISO
trovafloxacin results in increased expression of FRS3 mRNA
CTD
PMID:35537566
NCBI chr 9:13,288,559...13,297,285
Ensembl chr 9:13,288,667...13,295,382
G
Fry
FRY microtubule binding protein
decreases expression
ISO
trovafloxacin results in decreased expression of FRY mRNA
CTD
PMID:35537566
NCBI chr12:4,493,890...4,887,118
Ensembl chr12:4,493,891...4,799,116
G
Fubp1
far upstream element binding protein 1
increases expression
ISO
trovafloxacin results in increased expression of FUBP1 mRNA
CTD
PMID:35537566
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
G
Fut10
fucosyltransferase 10
decreases expression
ISO
trovafloxacin results in decreased expression of FUT10 mRNA
CTD
PMID:35537566
NCBI chr16:60,868,761...60,958,762
Ensembl chr16:60,877,952...60,958,683
G
Fut4
fucosyltransferase 4
increases expression
ISO
trovafloxacin results in increased expression of FUT4 mRNA
CTD
PMID:35537566
NCBI chr 8:11,586,721...11,590,682
Ensembl chr 8:11,586,721...11,590,682
G
Fut8
fucosyltransferase 8
decreases expression
ISO
trovafloxacin results in decreased expression of FUT8 mRNA
CTD
PMID:35537566
NCBI chr 6:95,949,246...96,176,677
Ensembl chr 6:95,949,991...96,176,677
G
Fuz
fuzzy planar cell polarity protein
decreases expression
ISO
trovafloxacin results in decreased expression of FUZ mRNA
CTD
PMID:35537566
NCBI chr 1:95,379,542...95,384,532
Ensembl chr 1:95,379,587...95,384,530
G
Fzd7
frizzled class receptor 7
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of FZD7 mRNA
CTD
PMID:18930950
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
G
Fzd8
frizzled class receptor 8
increases expression
ISO
trovafloxacin results in increased expression of FZD8 mRNA
CTD
PMID:35537566
NCBI chr17:57,312,924...57,320,551
Ensembl chr17:57,314,450...57,320,650
G
G2e3
G2/M-phase specific E3 ubiquitin protein ligase
decreases expression
ISO
trovafloxacin results in decreased expression of G2E3 mRNA
CTD
PMID:35537566
NCBI chr 6:68,763,847...68,795,305
Ensembl chr 6:68,764,185...68,793,924
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of G6PC1 mRNA
CTD
PMID:18930950
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
G6pd
glucose-6-phosphate dehydrogenase
decreases expression
EXP
trovafloxacin results in decreased expression of G6PD mRNA
CTD
PMID:24136188
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gaa
alpha glucosidase
decreases expression
ISO
trovafloxacin results in decreased expression of GAA mRNA
CTD
PMID:35537566
NCBI chr10:104,529,673...104,546,836
Ensembl chr10:104,529,747...104,546,836
G
Gabarapl1
GABA type A receptor associated protein like 1
multiple interactions increases expression
ISO
[trovafloxacin co-treated with TNF protein] results in increased expression of GABARAPL1 mRNA trovafloxacin results in increased expression of GABARAPL1 mRNA
CTD
PMID:33609687
NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450
G
Gabarapl2
GABA type A receptor associated protein like 2
multiple interactions increases expression
ISO
TNF protein inhibits the reaction [trovafloxacin results in increased expression of GABARAPL2 mRNA]
CTD
PMID:33609687
NCBI chr19:39,910,572...39,921,408
Ensembl chr19:39,910,534...39,924,628 Ensembl chr 8:39,910,534...39,924,628
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
decreases expression
ISO
trovafloxacin results in decreased expression of GADD45A mRNA
CTD
PMID:35537566
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
ISO
trovafloxacin results in increased expression of GADD45B mRNA
CTD
PMID:35537566
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gadd45g
growth arrest and DNA-damage-inducible, gamma
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of GADD45G mRNA trovafloxacin results in increased expression of GADD45G mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
G
Gal3st4
galactose-3-O-sulfotransferase 4
increases expression
ISO
trovafloxacin results in increased expression of GAL3ST4 mRNA
CTD
PMID:35537566
NCBI chr12:17,267,963...17,276,951
Ensembl chr12:17,267,963...17,276,833
G
Galc
galactosylceramidase
decreases expression
ISO
trovafloxacin results in decreased expression of GALC mRNA
CTD
PMID:35537566
NCBI chr 6:117,452,888...117,522,281
Ensembl chr 6:117,452,895...117,515,830
G
Gan
gigaxonin
increases expression
ISO
trovafloxacin results in increased expression of GAN mRNA
CTD
PMID:35537566
NCBI chr19:45,207,783...45,265,066
Ensembl chr19:45,207,184...45,254,107
G
Ganc
glucosidase, alpha; neutral C
decreases expression
ISO
trovafloxacin results in decreased expression of GANC mRNA
CTD
PMID:35537566
NCBI chr 3:107,353,369...107,406,104
Ensembl chr 3:107,353,369...107,405,241
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
decreases expression
EXP
trovafloxacin results in decreased expression of GAPDH mRNA
CTD
PMID:24136188
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gapdhs
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic
increases expression
ISO
trovafloxacin results in increased expression of GAPDHS mRNA
CTD
PMID:35537566
NCBI chr 1:85,979,096...85,994,153
Ensembl chr 1:85,979,098...85,993,640
G
Gars1
glycyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of GARS1 mRNA
CTD
PMID:35537566
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
G
Gas2
growth arrest-specific 2
decreases expression
ISO
trovafloxacin results in decreased expression of GAS2 mRNA
CTD
PMID:35537566
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
G
Gas5
growth arrest specific 5
increases expression
ISO
trovafloxacin results in increased expression of GAS5 mRNA
CTD
PMID:35537566
NCBI chr13:73,303,611...73,306,932
G
Gas8
growth arrest specific 8
increases expression
ISO
trovafloxacin results in increased expression of GAS8 mRNA
CTD
PMID:35537566
NCBI chr19:51,552,770...51,572,323
Ensembl chr19:51,552,816...51,572,305
G
Gbp1
guanylate binding protein 1
increases expression
ISO
trovafloxacin results in increased expression of GBP2B mRNA
CTD
PMID:35537566
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
G
Gbp2
guanylate binding protein 2
increases expression
ISO
trovafloxacin results in increased expression of GBP2 mRNA
CTD
PMID:35537566
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
G
Gbp6
guanylate binding protein family member 6
increases expression
ISO
trovafloxacin results in increased expression of GBP6 mRNA
CTD
PMID:35537566
NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062 Ensembl chr14:4,730,453...4,839,062
G
Gbp7
guanylate binding protein 7
increases expression
ISO
trovafloxacin results in increased expression of GBP7 mRNA
CTD
PMID:35537566
NCBI chr 2:231,275,521...231,297,289
Ensembl chr 2:231,275,640...231,297,278
G
Gcat
glycine C-acetyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of GCAT mRNA
CTD
PMID:35537566
NCBI chr 7:110,595,126...110,601,474
Ensembl chr 7:110,595,091...110,601,473
G
Gcgr
glucagon receptor
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of GCGR mRNA
CTD
PMID:18930950
NCBI chr10:105,808,474...105,816,641
Ensembl chr10:105,808,473...105,816,640
G
Gclc
glutamate-cysteine ligase, catalytic subunit
decreases expression multiple interactions
EXP ISO
trovafloxacin results in decreased expression of GCLC mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of GCLC mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gen1
GEN1 Holliday junction 5' flap endonuclease
decreases expression
ISO
trovafloxacin results in decreased expression of GEN1 mRNA
CTD
PMID:35537566
NCBI chr 6:33,947,599...33,978,461
Ensembl chr 6:33,948,206...33,978,401
G
Gfm1
G elongation factor, mitochondrial 1
decreases expression
EXP
trovafloxacin results in decreased expression of GFM1 mRNA
CTD
PMID:24136188
NCBI chr 2:151,700,573...151,745,477
Ensembl chr 2:151,700,564...151,745,471
G
Gfod2
Gfo/Idh/MocA-like oxidoreductase domain containing 2
increases expression
ISO
trovafloxacin results in increased expression of GFOD2 mRNA
CTD
PMID:35537566
NCBI chr19:33,599,689...33,647,060
Ensembl chr19:33,604,187...33,647,004
G
Ggcx
gamma-glutamyl carboxylase
decreases expression
EXP
trovafloxacin results in decreased expression of GGCX mRNA
CTD
PMID:24136188
NCBI chr 4:104,469,737...104,485,631
Ensembl chr 4:104,469,765...104,487,063
G
Gins2
GINS complex subunit 2
decreases expression
ISO
trovafloxacin results in decreased expression of GINS2 mRNA
CTD
PMID:35537566
NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
G
Gipc1
GIPC PDZ domain containing family, member 1
decreases expression
ISO
trovafloxacin results in decreased expression of GIPC1 mRNA
CTD
PMID:35537566
NCBI chr19:24,474,291...24,487,083
Ensembl chr19:24,453,123...24,486,997
G
Gja1
gap junction protein, alpha 1
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of GJA1 mRNA trovafloxacin results in increased expression of GJA1 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Glis2
GLIS family zinc finger 2
increases expression
ISO
trovafloxacin results in increased expression of GLIS2 mRNA
CTD
PMID:35537566
NCBI chr10:10,951,157...10,978,524
Ensembl chr10:10,951,371...10,971,578
G
Glmp
glycosylated lysosomal membrane protein
decreases expression
ISO
trovafloxacin results in decreased expression of GLMP mRNA
CTD
PMID:35537566
NCBI chr 2:173,794,273...173,797,863
Ensembl chr 2:173,794,255...173,799,960
G
Glp2r
glucagon-like peptide 2 receptor
increases expression
ISO
trovafloxacin results in increased expression of GLP2R mRNA
CTD
PMID:35537566
NCBI chr10:52,402,748...52,466,012
Ensembl chr10:52,402,748...52,466,012
G
Glrx3
glutaredoxin 3
decreases expression
EXP
trovafloxacin results in decreased expression of GLRX3 mRNA
CTD
PMID:24136188
NCBI chr 1:192,241,707...192,272,012
Ensembl chr 1:192,241,701...192,272,010
G
Gls2
glutaminase 2
decreases expression
ISO
trovafloxacin results in decreased expression of GLS2 mRNA
CTD
PMID:35537566
NCBI chr 7:617,252...633,424
Ensembl chr 7:617,288...633,426
G
Glyat
glycine-N-acyltransferase
increases expression
EXP
trovafloxacin results in increased expression of GLYAT mRNA
CTD
PMID:24136188
NCBI chr 1:209,704,213...209,724,949
Ensembl chr 1:209,704,268...209,724,942
G
Gmfb
glia maturation factor, beta
increases expression
ISO
trovafloxacin results in increased expression of GMFB mRNA
CTD
PMID:35537566
NCBI chr15:20,069,923...20,081,005
Ensembl chr15:20,067,263...20,080,331
G
Gnat2
G protein subunit alpha transducin 2
decreases expression
ISO
trovafloxacin results in decreased expression of GNAT2 mRNA
CTD
PMID:35537566
NCBI chr 2:195,726,371...195,735,866
Ensembl chr 2:195,726,762...195,735,866
G
Gnl3
G protein nucleolar 3
increases expression
EXP
trovafloxacin results in increased expression of GNL3 mRNA
CTD
PMID:24136188
NCBI chr16:6,207,402...6,213,491
Ensembl chr16:6,207,402...6,213,392
G
Gnpat
glyceronephosphate O-acyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of GNPAT mRNA
CTD
PMID:35537566
NCBI chr19:52,822,326...52,848,872
Ensembl chr19:52,822,319...52,852,361
G
Gnpnat1
glucosamine-phosphate N-acetyltransferase 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of GNPNAT1 mRNA
CTD
PMID:18930950
NCBI chr15:18,596,180...18,608,854
Ensembl chr15:18,596,442...18,608,739
G
Gnptg
N-acetylglucosamine-1-phosphate transferase subunit gamma
decreases expression
ISO
trovafloxacin results in decreased expression of GNPTG mRNA
CTD
PMID:35537566
NCBI chr10:14,252,186...14,257,128
Ensembl chr10:14,251,136...14,257,096
G
Golga2
golgin A2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of GOLGA2 mRNA
CTD
PMID:18930950
NCBI chr 3:15,583,862...15,604,279
Ensembl chr 3:15,584,039...15,604,279
G
Golga4
golgin A4
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of GOLGA4 mRNA
CTD
PMID:18930950
NCBI chr 8:118,208,200...118,285,003
G
Gpaa1
glycosylphosphatidylinositol anchor attachment 1
decreases expression
ISO
trovafloxacin results in decreased expression of GPAA1 mRNA
CTD
PMID:35537566
NCBI chr 7:108,051,896...108,055,479
Ensembl chr 7:108,051,861...108,055,484
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
decreases expression
EXP
trovafloxacin results in decreased expression of GPAM mRNA
CTD
PMID:24136188
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
G
Gpat3
glycerol-3-phosphate acyltransferase 3
decreases expression
ISO
trovafloxacin results in decreased expression of AGPAT9 mRNA
CTD
PMID:35537566
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
G
Gpatch3
G patch domain containing 3
increases expression
ISO
trovafloxacin results in increased expression of GPATCH3 mRNA
CTD
PMID:35537566
NCBI chr 5:145,800,107...145,809,519
Ensembl chr 5:145,800,111...145,809,250
G
Gpc1
glypican 1
increases expression
ISO
trovafloxacin results in increased expression of GPC1 mRNA
CTD
PMID:35537566
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
G
Gphn
gephyrin
decreases expression
ISO
trovafloxacin results in decreased expression of GPHN mRNA
CTD
PMID:35537566
NCBI chr 6:96,954,365...97,483,617
Ensembl chr 6:96,892,148...97,483,612
G
Gpld1
glycosylphosphatidylinositol specific phospholipase D1
increases expression
EXP
trovafloxacin results in increased expression of GPLD1 mRNA
CTD
PMID:24136188
NCBI chr17:40,084,427...40,132,035
Ensembl chr17:40,084,617...40,126,939
G
Gpr155
G protein-coupled receptor 155
decreases expression
ISO
trovafloxacin results in decreased expression of GPR155 mRNA
CTD
PMID:35537566
NCBI chr 3:58,216,422...58,270,350
Ensembl chr 3:58,216,423...58,270,275
G
Gpr160
G protein-coupled receptor 160
decreases expression
ISO
trovafloxacin results in decreased expression of GPR160 mRNA
CTD
PMID:35537566
NCBI chr 2:112,483,364...112,563,072
Ensembl chr 2:112,484,935...112,563,148
G
Gpr17
G protein-coupled receptor 17
increases expression
ISO
trovafloxacin results in increased expression of GPR17 mRNA
CTD
PMID:35537566
NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966
G
Gpr176
G protein-coupled receptor 176
decreases expression
ISO
trovafloxacin results in decreased expression of GPR176 mRNA
CTD
PMID:35537566
NCBI chr 3:105,236,794...105,337,664
Ensembl chr 3:105,236,795...105,337,226
G
Gpr19
G protein-coupled receptor 19
decreases expression
ISO
trovafloxacin results in decreased expression of GPR19 mRNA
CTD
PMID:35537566
NCBI chr 4:167,710,944...167,739,232
Ensembl chr 4:167,710,666...167,741,036
G
Gpr34
G protein-coupled receptor 34
decreases expression
ISO
trovafloxacin results in decreased expression of GPR34 mRNA
CTD
PMID:35537566
NCBI chr X:9,104,829...9,113,796
Ensembl chr X:9,104,565...9,148,601
G
Gpr35
G protein-coupled receptor 35
decreases expression
ISO
trovafloxacin results in decreased expression of GPR35 mRNA
CTD
PMID:35537566
NCBI chr 9:93,527,165...93,539,573
Ensembl chr 9:93,527,127...93,539,299
G
Gpr65
G-protein coupled receptor 65
decreases expression
ISO
trovafloxacin results in decreased expression of GPR65 mRNA
CTD
PMID:35537566
NCBI chr 6:117,515,786...117,536,514
Ensembl chr 6:117,515,648...117,536,512
G
Gpsm2
G-protein signaling modulator 2
decreases expression
ISO
trovafloxacin results in decreased expression of GPSM2 mRNA
CTD
PMID:35537566
NCBI chr 2:196,327,149...196,375,322
Ensembl chr 2:196,327,149...196,375,154
G
Gpt2
glutamic--pyruvic transaminase 2
decreases expression
ISO
trovafloxacin results in decreased expression of GPT2 mRNA
CTD
PMID:35537566
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
G
Grhl1
grainyhead-like transcription factor 1
increases expression
ISO
trovafloxacin results in increased expression of GRHL1 mRNA
CTD
PMID:35537566
NCBI chr 6:41,207,325...41,257,516
Ensembl chr 6:41,207,348...41,254,301
G
Grin3b
glutamate ionotropic receptor NMDA type subunit 3B
increases expression
ISO
trovafloxacin results in increased expression of GRIN3B mRNA
CTD
PMID:35537566
NCBI chr 7:9,730,861...9,737,183
Ensembl chr 7:9,730,862...9,737,183
G
Grwd1
glutamate-rich WD repeat containing 1
increases expression
ISO
trovafloxacin results in increased expression of GRWD1 mRNA
CTD
PMID:35537566
NCBI chr 1:96,301,260...96,306,962
Ensembl chr 1:96,301,261...96,307,201
G
Gsr
glutathione-disulfide reductase
decreases expression
EXP
trovafloxacin results in decreased expression of GSR mRNA
CTD
PMID:24136188
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gss
glutathione synthetase
decreases expression
EXP
trovafloxacin results in decreased expression of GSS mRNA
CTD
PMID:24136188
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
G
Gsta3
glutathione S-transferase alpha 3
decreases expression
EXP
trovafloxacin results in decreased expression of GSTA3 mRNA
CTD
PMID:24136188
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
G
Gtf3a
general transcription factor III A
decreases expression
ISO
trovafloxacin results in decreased expression of GTF3A mRNA
CTD
PMID:35537566
NCBI chr12:8,136,746...8,144,690
Ensembl chr12:8,136,747...8,144,690
G
Gtpbp2
GTP binding protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of GTPBP2 mRNA
CTD
PMID:35537566
NCBI chr 9:14,813,964...14,823,419
Ensembl chr 9:14,813,964...14,823,241
G
Gtpbp6
GTP binding protein 6 (putative)
increases expression
ISO
trovafloxacin results in increased expression of GTPBP6 mRNA
CTD
PMID:35537566
NCBI chr12:46,574,913...46,578,873
Ensembl chr12:46,574,435...46,578,873
G
Gtse1
G-2 and S-phase expressed 1
increases expression
ISO
trovafloxacin results in increased expression of GTSE1 mRNA
CTD
PMID:35537566
NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
G
Gvin1
GTPase, very large interferon inducible 1
increases expression
ISO
trovafloxacin results in increased expression of GVIN2 mRNA
CTD
PMID:35537566
NCBI chr 1:160,279,767...160,306,701
Ensembl chr 1:160,277,126...160,306,331
G
H1f0
H1.0 linker histone
decreases expression
ISO
trovafloxacin results in decreased expression of H1F0 mRNA
CTD
PMID:35537566
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
G
H1f10
H1.10 linker histone
decreases expression
ISO
trovafloxacin results in decreased expression of H1F10 mRNA
CTD
PMID:35537566
NCBI chr 4:120,440,515...120,441,578
Ensembl chr 4:120,440,870...120,441,448
G
H1f2
H1.2 linker histone, cluster member
decreases expression
ISO
trovafloxacin results in decreased expression of H1F2 mRNA
CTD
PMID:35537566
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
G
H1f4
H1.4 linker histone, cluster member
decreases expression
ISO
trovafloxacin results in decreased expression of H1F4 mRNA
CTD
PMID:35537566
NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403
G
H1f5
H1.5 linker histone, cluster member
decreases expression
ISO
trovafloxacin results in decreased expression of H1F5 mRNA
CTD
PMID:35537566
NCBI chr17:42,726,132...42,727,162
Ensembl chr17:42,726,127...42,769,160
G
H2ac10
H2A clustered histone 10
decreases expression
ISO
trovafloxacin results in decreased expression of H2AC10 mRNA
CTD
PMID:35537566
NCBI chr17:41,570,532...41,571,020
Ensembl chr17:41,570,273...41,571,049
G
H2ac4
H2A clustered histone 4
decreases expression
ISO
trovafloxacin results in decreased expression of H2AC4 mRNA
CTD
PMID:35537566
NCBI chr17:42,799,884...42,800,387
Ensembl chr17:42,799,652...42,800,381
G
H2ax
H2A.X variant histone
multiple interactions decreases expression increases phosphorylation increases expression
ISO
[TNF protein co-treated with trovafloxacin] results in increased expression of H2AX protein modified form; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[TNF protein co-treated with trovafloxacin] results in increased expression of H2AX protein modified form]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [trovafloxacin results in increased expression of H2AX protein modified form]; TNF protein promotes the reaction [trovafloxacin results in increased expression of H2AX protein modified form] trovafloxacin results in decreased expression of H2AX mRNA trovafloxacin results in increased phosphorylation of H2AX protein
CTD
PMID:24817034 PMID:25748550 PMID:35537566
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
H2bc18
H2B clustered histone 18
decreases expression
ISO
trovafloxacin results in decreased expression of H2BC18 mRNA
CTD
PMID:35537566
NCBI chr 2:183,838,331...183,842,769
Ensembl chr 2:183,838,334...183,841,529
G
H2bc3
H2B clustered histone 3
decreases expression
ISO
trovafloxacin results in decreased expression of H2BC3 mRNA
CTD
PMID:35537566
NCBI chr17:41,380,056...41,380,686
G
H2bc6
H2B clustered histone 6
decreases expression
ISO
trovafloxacin results in decreased expression of H2BC6 mRNA
CTD
PMID:35537566
NCBI chr17:41,520,775...41,521,238
G
H2bc8
H2B clustered histone 8
decreases expression
ISO
trovafloxacin results in decreased expression of H2BC8 mRNA
CTD
PMID:35537566
NCBI chr17:42,708,658...42,709,408
G
H2bc9
H2B clustered histone 9
decreases expression
ISO
trovafloxacin results in decreased expression of H2BC9 mRNA
CTD
PMID:35537566
NCBI chr17:42,470,593...42,478,590
G
H3c1
H3 clustered histone 1
decreases expression
ISO
trovafloxacin results in decreased expression of H3C10 mRNA; trovafloxacin results in decreased expression of H3C4 mRNA
CTD
PMID:35537566
NCBI chr17:41,368,379...41,368,902
Ensembl chr17:41,368,386...41,368,856 Ensembl chr17:41,368,386...41,368,856 Ensembl chr17:41,368,386...41,368,856 Ensembl chr17:41,368,386...41,368,856
G
H4cl1
histone H4C like 1
decreases expression
ISO
trovafloxacin results in decreased expression of H4C6 mRNA
CTD
PMID:35537566
NCBI chr17:41,368,743...41,426,735
G
H4f3
H1.3 linker histone, cluster member
decreases expression
ISO
trovafloxacin results in decreased expression of H1F3 mRNA
CTD
PMID:35537566
NCBI chr17:41,551,524...41,552,303
Ensembl chr17:41,529,667...41,552,334
G
Hacd3
3-hydroxyacyl-CoA dehydratase 3
decreases expression
EXP
trovafloxacin results in decreased expression of HACD3 mRNA
CTD
PMID:24136188
NCBI chr 8:65,501,240...65,538,507
Ensembl chr 8:65,501,240...65,538,507
G
Hacd4
3-hydroxyacyl-CoA dehydratase 4
decreases expression
ISO
trovafloxacin results in decreased expression of HACD4 mRNA
CTD
PMID:35537566
NCBI chr 5:102,887,597...102,915,376
Ensembl chr 5:102,887,588...102,915,338
G
Hacl1
2-hydroxyacyl-CoA lyase 1
increases expression decreases expression
EXP ISO
trovafloxacin results in increased expression of HACL1 mRNA trovafloxacin results in decreased expression of HACL1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr16:6,826,881...6,863,027
Ensembl chr16:6,824,906...6,863,027
G
Hao2
hydroxyacid oxidase 2
increases expression
EXP
trovafloxacin results in increased expression of HAO2 mRNA
CTD
PMID:24136188
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
G
Haspin
histone H3 associated protein kinase
decreases expression
ISO
trovafloxacin results in decreased expression of GSG2 mRNA
CTD
PMID:35537566
NCBI chr10:57,747,731...57,750,518
Ensembl chr10:57,747,573...57,750,512
G
Haus4
HAUS augmin-like complex, subunit 4
decreases expression
ISO
trovafloxacin results in decreased expression of HAUS4 mRNA
CTD
PMID:35537566
NCBI chr15:27,994,530...28,006,147
Ensembl chr15:27,994,532...28,005,938
G
Haus5
HAUS augmin-like complex, subunit 5
decreases expression
ISO
trovafloxacin results in decreased expression of HAUS5 mRNA
CTD
PMID:35537566
NCBI chr 1:85,912,371...85,924,327
Ensembl chr 1:85,912,374...85,923,337
G
Hbegf
heparin-binding EGF-like growth factor
increases expression
ISO
trovafloxacin results in increased expression of HBEGF mRNA
CTD
PMID:35537566
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Hcn2
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
decreases expression
ISO
trovafloxacin results in decreased expression of HCN2 mRNA
CTD
PMID:35537566
NCBI chr 7:9,969,801...9,988,839
Ensembl chr 7:9,970,368...9,988,841
G
Hdhd3
haloacid dehalogenase-like hydrolase domain containing 3
increases expression
ISO
trovafloxacin results in increased expression of HDHD3 mRNA
CTD
PMID:35537566
NCBI chr 5:75,951,308...75,954,775
Ensembl chr 5:75,946,013...75,955,266
G
Hdlbp
high density lipoprotein binding protein
decreases expression
ISO
trovafloxacin results in decreased expression of HDLBP mRNA
CTD
PMID:35537566
NCBI chr 9:93,948,099...94,018,040
Ensembl chr 9:93,949,913...94,018,048
G
Hemk1
HemK methyltransferase family member 1
decreases expression
ISO
trovafloxacin results in decreased expression of HEMK1 mRNA
CTD
PMID:35537566
NCBI chr 8:107,999,658...108,010,732
Ensembl chr 8:107,999,644...108,010,256
G
Herc1
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1
decreases expression
ISO
trovafloxacin results in decreased expression of HERC1 mRNA
CTD
PMID:35537566
NCBI chr 8:66,857,169...67,070,318
Ensembl chr 8:66,856,935...67,070,312
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
decreases expression
ISO
trovafloxacin results in decreased expression of HERPUD1 mRNA
CTD
PMID:35537566
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Hilpda
hypoxia inducible lipid droplet-associated
increases expression
ISO
trovafloxacin results in increased expression of HILPDA mRNA
CTD
PMID:35537566
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
G
Hip1r
huntingtin interacting protein 1 related
decreases expression
ISO
trovafloxacin results in decreased expression of HIP1R mRNA
CTD
PMID:35537566
NCBI chr12:32,590,164...32,618,841
Ensembl chr12:32,590,165...32,618,734
G
Hirip3
HIRA interacting protein 3
decreases expression
ISO
trovafloxacin results in decreased expression of HIRIP3 mRNA
CTD
PMID:35537566
NCBI chr 1:181,472,537...181,475,082
Ensembl chr 1:181,472,056...181,475,079
G
Hist1h2af
histone cluster 1 H2A family member F
decreases expression
ISO
trovafloxacin results in decreased expression of H2AC8 mRNA
CTD
PMID:35537566
NCBI chr17:41,379,404...41,379,796
Ensembl chr17:41,379,404...41,379,796
G
Hist1h2ail1
histone cluster 1 H2a family member I like 1
decreases expression
ISO
trovafloxacin results in decreased expression of H3C6 mRNA
CTD
PMID:35537566
NCBI chr17:41,568,181...41,569,093
Ensembl chr17:41,568,471...41,569,109
G
Hist1h2bc
histone cluster 1, H2bc
decreases expression
ISO
trovafloxacin results in decreased expression of H2BC4 mRNA
CTD
PMID:35537566
NCBI chr17:42,692,335...42,696,601
Ensembl chr17:42,694,723...42,696,642
G
Hist1h4b
histone cluster 1 H4 family member B
decreases expression
ISO
trovafloxacin results in decreased expression of H4C9 mRNA
CTD
PMID:35537566
NCBI chr17:42,480,467...42,484,912
Ensembl chr17:42,480,313...42,485,370
G
Hist1h4m
histone cluster 1, H4m
decreases expression
ISO
trovafloxacin results in decreased expression of H4C1 mRNA
CTD
PMID:35537566
NCBI chr17:42,698,016...42,698,420
Ensembl chr17:42,698,025...42,698,958
G
Hltf
helicase-like transcription factor
decreases expression
ISO
trovafloxacin results in decreased expression of HLTF mRNA
CTD
PMID:35537566
NCBI chr 2:102,549,724...102,609,492
Ensembl chr 2:102,549,724...102,609,327
G
Hmga2
high mobility group AT-hook 2
increases expression
ISO
trovafloxacin results in increased expression of HMGA2 mRNA
CTD
PMID:35537566
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
G
Hmgb2
high mobility group box 2
decreases expression
ISO
trovafloxacin results in decreased expression of HMGB2 mRNA
CTD
PMID:35537566
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
G
Hmgb3
high mobility group box 3
decreases expression
ISO
trovafloxacin results in decreased expression of HMGB3 mRNA
CTD
PMID:35537566
NCBI chr X:149,296,303...149,301,290
Ensembl chr X:149,296,375...149,301,292
G
Hmgn3
high mobility group nucleosomal binding domain 3
decreases expression
EXP
trovafloxacin results in decreased expression of HMGN3 mRNA
CTD
PMID:24136188
NCBI chr 8:84,022,493...84,059,329
Ensembl chr 8:84,022,495...84,062,976
G
Hmgn5
high mobility group nucleosome binding domain 5
decreases expression
ISO
trovafloxacin results in decreased expression of HMGN5 mRNA
CTD
PMID:35537566
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441
G
Hmmr
hyaluronan-mediated motility receptor
decreases expression
ISO
trovafloxacin results in decreased expression of HMMR mRNA
CTD
PMID:35537566
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of HMOX1 mRNA
CTD
PMID:18930950
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
increases expression
ISO
trovafloxacin results in increased expression of HNRNPA1 mRNA
CTD
PMID:35537566
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
G
Hnrnpdl
heterogeneous nuclear ribonucleoprotein D-like
increases expression
ISO
trovafloxacin results in increased expression of HNRNPDL mRNA
CTD
PMID:35537566
NCBI chr14:9,557,430...9,563,659
Ensembl chr14:9,557,425...9,562,506
G
Hnrnpf
heterogeneous nuclear ribonucleoprotein F
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of HNRNPF mRNA
CTD
PMID:18930950
NCBI chr 4:151,083,262...151,104,464
Ensembl chr 4:151,083,062...151,109,038
G
Hnrnpl
heterogeneous nuclear ribonucleoprotein L
increases expression
ISO
trovafloxacin results in increased expression of HNRNPL mRNA
CTD
PMID:35537566
NCBI chr 1:84,098,558...84,111,568
Ensembl chr 1:84,100,879...84,111,553
G
Hoxb5
homeo box B5
decreases expression
ISO
trovafloxacin results in decreased expression of HOXB5 mRNA
CTD
PMID:35537566
NCBI chr10:81,269,372...81,271,580
Ensembl chr10:81,269,372...81,271,580
G
Hoxb8
homeo box B8
increases expression
ISO
trovafloxacin results in increased expression of HOXB8 mRNA
CTD
PMID:35537566
NCBI chr10:81,248,313...81,251,261
Ensembl chr10:81,248,887...81,250,638
G
Hp
haptoglobin
decreases expression
ISO
trovafloxacin results in decreased expression of HP mRNA
CTD
PMID:35537566
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Hs3st3b1
heparan sulfate-glucosamine 3-sulfotransferase 3B1
decreases expression
ISO
trovafloxacin results in decreased expression of HS3ST3B1 mRNA
CTD
PMID:35537566
NCBI chr10:48,561,473...48,593,970
Ensembl chr10:48,561,473...48,593,970
G
Hspb6
heat shock protein family B (small) member 6
decreases expression
ISO
trovafloxacin results in decreased expression of HSPB6 mRNA
CTD
PMID:35537566
NCBI chr 1:85,806,898...85,809,072
Ensembl chr 1:85,806,146...85,809,071
G
Hspb7
heat shock protein family B (small) member 7
decreases expression
ISO
trovafloxacin results in decreased expression of HSPB7 mRNA
CTD
PMID:35537566
NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:153,727,588...153,731,266
G
Hsph1
heat shock protein family H (Hsp110) member 1
decreases expression
EXP
trovafloxacin results in decreased expression of HSPH1 mRNA
CTD
PMID:24136188
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Htatip2
HIV-1 Tat interactive protein 2
decreases expression
EXP
trovafloxacin results in decreased expression of HTATIP2 mRNA
CTD
PMID:24136188
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
G
Htra2
HtrA serine peptidase 2
decreases expression
ISO
trovafloxacin results in decreased expression of HTRA2 mRNA
CTD
PMID:35537566
NCBI chr 4:115,556,914...115,560,202
Ensembl chr 4:115,556,916...115,560,095
G
Huwe1
HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1
decreases expression
ISO
trovafloxacin results in decreased expression of HUWE1 mRNA
CTD
PMID:35537566
NCBI chr X:20,873,795...21,001,378
Ensembl chr X:20,873,795...21,001,262
G
Hyi
hydroxypyruvate isomerase
decreases expression
ISO
trovafloxacin results in decreased expression of HYI mRNA
CTD
PMID:35537566
NCBI chr 5:131,894,575...131,897,709
Ensembl chr 5:131,894,598...131,897,251
G
Hyls1
HYLS1, centriolar and ciliogenesis associated
decreases expression
ISO
trovafloxacin results in decreased expression of HYLS1 mRNA
CTD
PMID:35537566
NCBI chr 8:33,912,692...33,921,760
Ensembl chr 8:33,912,692...33,921,760
G
Iars1
isoleucyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of IARS1 mRNA
CTD
PMID:35537566
NCBI chr17:14,940,919...14,987,277
Ensembl chr17:14,940,924...14,987,237
G
Iars2
isoleucyl-tRNA synthetase 2, mitochondrial
decreases expression
ISO
trovafloxacin results in decreased expression of IARS2 mRNA
CTD
PMID:35537566
NCBI chr13:96,831,484...96,865,518
Ensembl chr13:96,831,484...96,865,501
G
Icam1
intercellular adhesion molecule 1
multiple interactions increases expression decreases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ICAM1 mRNA; trovafloxacin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] trovafloxacin results in increased expression of ICAM1 mRNA [trovafloxacin co-treated with TNF protein] results in increased expression of ICAM1 mRNA trovafloxacin results in decreased expression of ICAM1 mRNA
CTD
PMID:18930950 PMID:32035082 PMID:35537566
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Icam2
intercellular adhesion molecule 2
decreases expression
ISO
trovafloxacin results in decreased expression of ICAM2 mRNA
CTD
PMID:35537566
NCBI chr10:91,308,608...91,319,536
Ensembl chr10:91,308,538...91,315,293
G
Icam4
intercellular adhesion molecule 4, Landsteiner-Wiener blood group
decreases expression
ISO
trovafloxacin results in decreased expression of ICAM4 mRNA
CTD
PMID:35537566
NCBI chr 8:19,566,075...19,567,171
Ensembl chr 8:19,566,075...19,567,171
G
Id1
inhibitor of DNA binding 1
increases expression
ISO
trovafloxacin results in increased expression of ID1 mRNA
CTD
PMID:35537566
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Id2
inhibitor of DNA binding 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of ID2 mRNA
CTD
PMID:18930950
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Ide
insulin degrading enzyme
decreases expression
EXP
trovafloxacin results in decreased expression of IDE mRNA
CTD
PMID:24136188
NCBI chr 1:235,002,984...235,102,448
Ensembl chr 1:234,995,351...235,102,440
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
decreases expression
EXP ISO
trovafloxacin results in decreased expression of IDH2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Ier3
immediate early response 3
increases expression
ISO
trovafloxacin results in increased expression of IER3 mRNA
CTD
PMID:35537566
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Ier5l
immediate early response 5-like
decreases expression
ISO
trovafloxacin results in decreased expression of IER5L mRNA
CTD
PMID:35537566
NCBI chr 3:13,744,056...13,745,647
Ensembl chr 3:13,744,078...13,745,647
G
Ifi35
interferon-induced protein 35
increases expression
ISO
trovafloxacin results in increased expression of IFI35 mRNA
CTD
PMID:35537566
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
G
Ifi44
interferon-induced protein 44
increases expression
ISO
trovafloxacin results in increased expression of IFI44 mRNA
CTD
PMID:35537566
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
G
Ifi44l
interferon-induced protein 44-like
increases expression
ISO
trovafloxacin results in increased expression of IFI44L mRNA
CTD
PMID:35537566
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
G
Ifit1
interferon-induced protein with tetratricopeptide repeats 1
increases expression
ISO
trovafloxacin results in increased expression of IFIT1 mRNA
CTD
PMID:35537566
NCBI chr 1:232,152,038...232,154,103
Ensembl chr 1:232,127,170...232,154,435
G
Ifit2
interferon-induced protein with tetratricopeptide repeats 2
increases expression
ISO
trovafloxacin results in increased expression of IFIT2 mRNA
CTD
PMID:35537566
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
increases expression
ISO
trovafloxacin results in increased expression of IFIT3 mRNA
CTD
PMID:35537566
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Ifitm3
interferon induced transmembrane protein 3
increases expression
ISO
trovafloxacin results in increased expression of IFITM3 mRNA
CTD
PMID:35537566
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
G
Ifng
interferon gamma
multiple interactions
ISO EXP
IFNG protein promotes the reaction [[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of TNF protein]; IFNG protein results in increased susceptibility to [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5]; trovafloxacin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNG protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of IFNG protein] [IFNG protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to trovafloxacin
CTD
PMID:18930950 PMID:19362101 PMID:19638433
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ifrd1
interferon-related developmental regulator 1
increases expression decreases expression multiple interactions
EXP ISO
trovafloxacin results in increased expression of IFRD1 mRNA trovafloxacin results in decreased expression of IFRD1 mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IFRD1 mRNA
CTD
PMID:18930950 PMID:24136188 PMID:35537566
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
G
Ifrd2
interferon-related developmental regulator 2
decreases expression
ISO
trovafloxacin results in decreased expression of IFRD2 mRNA
CTD
PMID:35537566
NCBI chr 8:108,260,969...108,266,191
Ensembl chr 8:108,260,969...108,266,194
G
Ift140
intraflagellar transport 140
decreases expression
ISO
trovafloxacin results in decreased expression of IFT140 mRNA
CTD
PMID:35537566
NCBI chr10:14,032,665...14,121,682
Ensembl chr10:14,032,648...14,120,433
G
Ift172
intraflagellar transport 172
decreases expression
ISO
trovafloxacin results in decreased expression of IFT172 mRNA
CTD
PMID:35537566
NCBI chr 6:25,081,933...25,121,271
Ensembl chr 6:25,081,980...25,120,860
G
Igf1
insulin-like growth factor 1
increases expression
ISO
trovafloxacin results in increased expression of IGF1 mRNA
CTD
PMID:35537566
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf2bp1
insulin-like growth factor 2 mRNA binding protein 1
increases expression
ISO
trovafloxacin results in increased expression of IGF2BP1 mRNA
CTD
PMID:35537566
NCBI chr10:80,908,300...80,951,097
Ensembl chr10:80,908,076...80,951,129
G
Igfbp1
insulin-like growth factor binding protein 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IGFBP1 mRNA
CTD
PMID:18930950
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Ighmbp2
immunoglobulin mu DNA binding protein 2
increases expression
ISO
trovafloxacin results in increased expression of IGHMBP2 mRNA
CTD
PMID:35537566
NCBI chr 1:200,506,641...200,529,293
Ensembl chr 1:200,506,338...200,529,514
G
Igsf3
immunoglobulin superfamily, member 3
increases expression
ISO
trovafloxacin results in increased expression of IGSF3 mRNA
CTD
PMID:35537566
NCBI chr 2:188,811,394...188,899,645
Ensembl chr 2:188,811,380...188,899,645
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
decreases expression
ISO
trovafloxacin results in decreased expression of IKBKB mRNA
CTD
PMID:35537566
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il12rb2
interleukin 12 receptor subunit beta 2
decreases expression
ISO
trovafloxacin results in decreased expression of IL12RB2 mRNA
CTD
PMID:35537566
NCBI chr 4:96,426,396...96,515,251
Ensembl chr 4:96,426,842...96,515,289
G
Il15
interleukin 15
increases expression
ISO
trovafloxacin results in increased expression of IL15 mRNA
CTD
PMID:35537566
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il16
interleukin 16
decreases expression
ISO
trovafloxacin results in decreased expression of IL16 mRNA
CTD
PMID:35537566
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
G
Il17ra
interleukin 17 receptor A
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IL17RA mRNA
CTD
PMID:18930950
NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:153,667,534...153,690,174
G
Il18
interleukin 18
multiple interactions
ISO
IL18 protein results in increased susceptibility to [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5]; trovafloxacin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL18 protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of IL18 protein]
CTD
PMID:18930950 PMID:19638433
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il18bp
interleukin 18 binding protein
increases expression
ISO
trovafloxacin results in increased expression of IL18BP mRNA
CTD
PMID:35537566
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
G
Il18rap
interleukin 18 receptor accessory protein
decreases expression
ISO
trovafloxacin results in decreased expression of IL18RAP mRNA
CTD
PMID:35537566
NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959
G
Il1a
interleukin 1 alpha
multiple interactions increases expression
ISO EXP
[IFNG protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to trovafloxacin; [IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to trovafloxacin trovafloxacin results in increased expression of IL1A mRNA
CTD
PMID:19362101 PMID:35537566
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [trovafloxacin results in increased activity of CASP3 protein]; [trovafloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [trovafloxacin co-treated with IL1B protein] affects the localization of SELE protein; [trovafloxacin co-treated with IL1B protein] results in increased activity of CASP3 protein; [trovafloxacin co-treated with IL1B protein] results in increased expression of SELE mRNA; trovafloxacin promotes the reaction [IL1B protein results in increased secretion of SELE protein] trovafloxacin promotes the reaction [TNF protein results in increased expression of IL1B protein]
CTD
PMID:10822086 PMID:19638433 PMID:30876886
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il21r
interleukin 21 receptor
decreases expression
ISO
trovafloxacin results in decreased expression of IL21R mRNA
CTD
PMID:35537566
NCBI chr 1:180,168,028...180,195,690
Ensembl chr 1:180,168,097...180,195,522
G
Il27
interleukin 27
increases expression
ISO
trovafloxacin results in increased expression of IL27 mRNA
CTD
PMID:35537566
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
G
Il6
interleukin 6
multiple interactions
ISO
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to trovafloxacin; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [trovafloxacin results in increased activity of CASP3 protein]; [trovafloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [trovafloxacin co-treated with IL6 protein] results in increased activity of CASP3 protein trovafloxacin promotes the reaction [TNF protein results in increased expression of IL6 protein]
CTD
PMID:19362101 PMID:19638433 PMID:30876886
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Immp2l
inner mitochondrial membrane peptidase subunit 2
decreases expression
ISO
trovafloxacin results in decreased expression of IMMP2L mRNA
CTD
PMID:35537566
NCBI chr 6:58,070,035...58,970,165
Ensembl chr 6:58,070,283...58,969,840
G
Impa2
inositol monophosphatase 2
decreases expression
ISO
trovafloxacin results in decreased expression of IMPA2 mRNA
CTD
PMID:35537566
NCBI chr18:60,834,206...60,867,575
Ensembl chr18:60,834,246...60,865,641
G
Ina
internexin neuronal intermediate filament protein, alpha
increases expression
ISO
trovafloxacin results in increased expression of INA mRNA
CTD
PMID:35537566
NCBI chr 1:245,896,775...245,908,330
Ensembl chr 1:245,896,775...245,908,330
G
Incenp
inner centromere protein
decreases expression
ISO
trovafloxacin results in decreased expression of INCENP mRNA
CTD
PMID:35537566
NCBI chr 1:206,520,655...206,550,575
Ensembl chr 1:206,523,380...206,553,265
G
Inka2
inka box actin regulator 2
increases expression
ISO
trovafloxacin results in increased expression of FAM212B mRNA
CTD
PMID:35537566
NCBI chr 2:193,185,275...193,200,643
Ensembl chr 2:193,185,275...193,200,642
G
Ints6l
integrator complex subunit 6 like
decreases expression
ISO
trovafloxacin results in decreased expression of DDX26B mRNA
CTD
PMID:35537566
NCBI chr X:134,258,117...134,325,706
Ensembl chr X:134,258,125...134,309,617
G
Invs
inversin
decreases expression
ISO
trovafloxacin results in decreased expression of INVS mRNA
CTD
PMID:35537566
NCBI chr 5:62,610,916...62,763,813
Ensembl chr 5:62,610,968...62,763,350
G
Ip6k2
inositol hexakisphosphate kinase 2
increases expression
EXP
trovafloxacin results in increased expression of IP6K2 mRNA
CTD
PMID:24136188
NCBI chr 8:109,483,843...109,510,172
Ensembl chr 8:109,484,310...109,510,166
G
Iqcd
IQ motif containing D
increases expression
ISO
trovafloxacin results in increased expression of IQCD mRNA
CTD
PMID:35537566
NCBI chr12:35,955,522...35,972,420
G
Iqgap3
IQ motif containing GTPase activating protein 3
decreases expression
ISO
trovafloxacin results in decreased expression of IQGAP3 mRNA
CTD
PMID:35537566
NCBI chr 2:173,542,151...173,583,956
Ensembl chr 2:173,542,110...173,583,956
G
Irf1
interferon regulatory factor 1
multiple interactions decreases expression
ISO EXP
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IRF1 mRNA trovafloxacin results in decreased expression of IRF1 mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Irf4
interferon regulatory factor 4
decreases expression
ISO
trovafloxacin results in decreased expression of IRF4 mRNA
CTD
PMID:35537566
NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070
G
Irf7
interferon regulatory factor 7
increases expression
ISO
trovafloxacin results in increased expression of IRF7 mRNA
CTD
PMID:35537566
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
G
Irgm
immunity-related GTPase M
increases expression
ISO
trovafloxacin results in increased expression of IRGM1 mRNA
CTD
PMID:35537566
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
G
Isg20
interferon stimulated exonuclease gene 20
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ISG20 mRNA
CTD
PMID:18930950
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Ist1
IST1 factor associated with ESCRT-III
increases expression
EXP
trovafloxacin results in increased expression of IST1 mRNA
CTD
PMID:24136188
NCBI chr19:37,648,840...37,671,019
Ensembl chr19:37,648,095...37,670,956
G
Isyna1
inositol-3-phosphate synthase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ISYNA1 mRNA
CTD
PMID:35537566
NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979
G
Itgax
integrin subunit alpha X
decreases expression
ISO
trovafloxacin results in decreased expression of ITGAX mRNA
CTD
PMID:35537566
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:182,719,609...182,740,698
G
Itgb5
integrin subunit beta 5
decreases expression
ISO
trovafloxacin results in decreased expression of ITGB5 mRNA
CTD
PMID:35537566
NCBI chr11:66,828,428...66,944,231
Ensembl chr11:66,829,285...66,944,472
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
decreases expression
ISO
trovafloxacin results in decreased expression of ITPR1 mRNA
CTD
PMID:35537566
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Itpr2
inositol 1,4,5-trisphosphate receptor, type 2
decreases expression
ISO
trovafloxacin results in decreased expression of ITPR2 mRNA
CTD
PMID:35537566
NCBI chr 4:179,028,594...179,434,657
Ensembl chr 4:179,027,281...179,404,164
G
Ivns1abp
influenza virus NS1A binding protein
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IVNS1ABP mRNA
CTD
PMID:18930950
NCBI chr13:63,427,040...63,446,701
Ensembl chr13:63,427,041...63,446,701
G
Izumo4
IZUMO family member 4
decreases expression
ISO
trovafloxacin results in decreased expression of IZUMO4 mRNA
CTD
PMID:35537566
NCBI chr 7:9,007,276...9,010,428
Ensembl chr 7:9,007,280...9,010,032
G
Jade1
jade family PHD finger 1
decreases expression
ISO
trovafloxacin results in decreased expression of JADE1 mRNA
CTD
PMID:35537566
NCBI chr 2:124,543,233...124,596,361
Ensembl chr 2:124,543,286...124,596,354
G
Jag1
jagged canonical Notch ligand 1
increases expression
ISO
trovafloxacin results in increased expression of JAG1 mRNA
CTD
PMID:35537566
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
G
Jak3
Janus kinase 3
decreases expression
ISO
trovafloxacin results in decreased expression of JAK3 mRNA
CTD
PMID:35537566
NCBI chr16:18,386,330...18,398,542
Ensembl chr16:18,386,405...18,398,536
G
Jaml
junction adhesion molecule like
decreases expression
ISO
trovafloxacin results in decreased expression of JAML mRNA
CTD
PMID:35537566
NCBI chr 8:45,384,836...45,415,459
Ensembl chr 8:45,383,495...45,416,565
G
Jdp2
Jun dimerization protein 2
increases expression
ISO
trovafloxacin results in increased expression of JDP2 mRNA
CTD
PMID:35537566
NCBI chr 6:105,261,619...105,302,386
Ensembl chr 6:105,261,373...105,301,485
G
Jpx
JPX transcript, XIST activator
decreases expression
ISO
trovafloxacin results in decreased expression of JPX mRNA
CTD
PMID:35537566
NCBI chr X:68,511,491...68,665,132
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of JUNB mRNA
CTD
PMID:18930950
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Kansl1l
KAT8 regulatory NSL complex subunit 1-like
decreases expression
ISO
trovafloxacin results in decreased expression of KANSL1L mRNA
CTD
PMID:35537566
NCBI chr 9:68,211,151...68,316,992
Ensembl chr 9:68,211,189...68,300,222
G
Kbtbd11
kelch repeat and BTB domain containing 11
increases expression
ISO
trovafloxacin results in increased expression of KBTBD11 mRNA
CTD
PMID:35537566
NCBI chr16:74,618,291...74,638,010
Ensembl chr16:74,615,792...74,637,736
G
Kbtbd6
kelch repeat and BTB domain containing 6
decreases expression
ISO
trovafloxacin results in decreased expression of KBTBD6 mRNA
CTD
PMID:35537566
NCBI chr15:54,848,285...54,850,042
Ensembl chr15:54,848,446...54,850,453
G
Kbtbd8
kelch repeat and BTB domain containing 8
increases expression
ISO
trovafloxacin results in increased expression of KBTBD8 mRNA
CTD
PMID:35537566
NCBI chr 4:127,675,967...127,688,785
Ensembl chr 4:127,676,141...127,687,697
G
Kcna3
potassium voltage-gated channel subfamily A member 3
decreases expression
ISO
trovafloxacin results in decreased expression of KCNA3 mRNA
CTD
PMID:35537566
NCBI chr 2:194,632,106...194,634,059
Ensembl chr 2:194,632,196...194,650,138
G
Kcnab2
potassium voltage-gated channel subfamily A regulatory beta subunit 2
decreases expression
ISO
trovafloxacin results in decreased expression of KCNAB2 mRNA
CTD
PMID:35537566
NCBI chr 5:162,899,511...162,988,057
Ensembl chr 5:162,901,896...162,988,243
G
Kcne3
potassium voltage-gated channel subfamily E regulatory subunit 3
decreases expression
ISO
trovafloxacin results in decreased expression of KCNE3 mRNA
CTD
PMID:35537566
NCBI chr 1:154,523,903...154,530,865
Ensembl chr 1:154,523,830...154,532,020
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
increases expression
ISO
trovafloxacin results in increased expression of KCNN4 mRNA
CTD
PMID:35537566
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
G
Kctd12b
potassium channel tetramerisation domain containing 12b
decreases expression
ISO
trovafloxacin results in decreased expression of KCTD12B mRNA
CTD
PMID:35537566
NCBI chr X:17,643,707...17,654,820
Ensembl chr X:17,643,615...17,654,820
G
Kdr
kinase insert domain receptor
decreases expression
ISO
trovafloxacin results in decreased expression of KDR mRNA
CTD
PMID:35537566
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Khdc4
KH domain containing 4, pre-mRNA splicing factor
increases expression
ISO
trovafloxacin results in increased expression of KHDC4 mRNA
CTD
PMID:35537566
NCBI chr 2:174,149,059...174,177,816
Ensembl chr 2:174,149,141...174,177,504
G
Khk
ketohexokinase
decreases expression
ISO
trovafloxacin results in decreased expression of KHK mRNA
CTD
PMID:35537566
NCBI chr 6:25,445,298...25,455,834
Ensembl chr 6:25,445,300...25,455,717
G
Kiaa0232
KIAA0232 homolog
increases expression
ISO
trovafloxacin results in increased expression of D5ERTD579E mRNA
CTD
PMID:35537566
NCBI chr14:74,094,421...74,159,316
Ensembl chr14:74,094,488...74,159,326
G
Kif13a
kinesin family member 13A
decreases expression
ISO
trovafloxacin results in decreased expression of KIF13A mRNA
CTD
PMID:35537566
NCBI chr17:17,766,597...17,948,517
Ensembl chr17:17,766,597...17,943,615
G
Kif14
kinesin family member 14
decreases expression
ISO
trovafloxacin results in decreased expression of KIF14 mRNA
CTD
PMID:35537566
NCBI chr13:47,926,975...47,990,598
Ensembl chr13:47,927,044...47,989,164
G
Kif15
kinesin family member 15
decreases expression
ISO
trovafloxacin results in decreased expression of KIF15 mRNA
CTD
PMID:35537566
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
G
Kif18a
kinesin family member 18A
decreases expression
ISO
trovafloxacin results in decreased expression of KIF18A mRNA
CTD
PMID:35537566
NCBI chr 3:95,764,388...95,824,756
Ensembl chr 3:95,764,388...95,824,582
G
Kif18b
kinesin family member 18B
decreases expression
ISO
trovafloxacin results in decreased expression of KIF18B mRNA
CTD
PMID:35537566
NCBI chr10:87,870,424...87,889,895
Ensembl chr10:87,870,428...87,889,850
G
Kif20a
kinesin family member 20A
decreases expression
ISO
trovafloxacin results in decreased expression of KIF20A mRNA
CTD
PMID:35537566
NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780
G
Kif20b
kinesin family member 20B
decreases expression
ISO
trovafloxacin results in decreased expression of KIF20B mRNA
CTD
PMID:35537566
NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787
G
Kif21b
kinesin family member 21B
decreases expression
ISO
trovafloxacin results in decreased expression of KIF21B mRNA
CTD
PMID:35537566
NCBI chr13:47,576,129...47,626,112
Ensembl chr13:47,576,160...47,626,127
G
Kif22
kinesin family member 22
decreases expression
ISO
trovafloxacin results in decreased expression of KIF22 mRNA
CTD
PMID:35537566
NCBI chr 1:181,635,347...181,650,351
Ensembl chr 1:181,635,183...181,650,401
G
Kif23
kinesin family member 23
decreases expression
ISO
trovafloxacin results in decreased expression of KIF23 mRNA
CTD
PMID:35537566
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
G
Kif24
kinesin family member 24
decreases expression
ISO
trovafloxacin results in decreased expression of KIF24 mRNA
CTD
PMID:35537566
NCBI chr 5:56,561,019...56,628,040
Ensembl chr 5:56,561,154...56,628,025
G
Kif2c
kinesin family member 2C
decreases expression
ISO
trovafloxacin results in decreased expression of KIF2C mRNA
CTD
PMID:35537566
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
G
Kif4a
kinesin family member 4A
decreases expression
ISO
trovafloxacin results in decreased expression of KIF4 mRNA
CTD
PMID:35537566
NCBI chr X:65,721,746...65,824,277
Ensembl chr X:65,721,779...65,824,139
G
Kitlg
KIT ligand
increases expression
ISO
trovafloxacin results in increased expression of KITL mRNA
CTD
PMID:35537566
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
G
Klf11
KLF transcription factor 11
decreases expression
ISO
trovafloxacin results in decreased expression of KLF11 mRNA
CTD
PMID:35537566
NCBI chr 6:41,285,699...41,297,548
Ensembl chr 6:41,285,842...41,297,550
G
Klf4
KLF transcription factor 4
decreases expression
ISO
trovafloxacin results in decreased expression of KLF4 mRNA
CTD
PMID:35537566
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
G
Klf9
KLF transcription factor 9
increases expression
EXP
trovafloxacin results in increased expression of KLF9 mRNA
CTD
PMID:24136188
NCBI chr 1:220,700,108...220,725,110
Ensembl chr 1:220,700,108...220,725,037
G
Klhdc8b
kelch domain containing 8B
increases expression
ISO
trovafloxacin results in increased expression of KLHDC8B mRNA
CTD
PMID:35537566
NCBI chr 8:109,141,594...109,146,584
Ensembl chr 8:109,141,594...109,146,918
G
Klhl12
kelch-like family member 12
increases expression
ISO
trovafloxacin results in increased expression of KLHL12 mRNA
CTD
PMID:35537566
NCBI chr13:45,899,913...45,933,648
Ensembl chr13:45,899,928...45,933,643
G
Klhl24
kelch-like family member 24
increases expression decreases expression
EXP ISO
trovafloxacin results in increased expression of KLHL24 mRNA trovafloxacin results in decreased expression of KLHL24 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636
G
Klhl33
kelch-like family member 33
decreases expression
ISO
trovafloxacin results in decreased expression of KLHL33 mRNA
CTD
PMID:35537566
NCBI chr15:24,105,923...24,114,445
Ensembl chr15:24,105,930...24,114,438
G
Klhl42
kelch-like family, member 42
increases expression
ISO
trovafloxacin results in increased expression of KLHL42 mRNA
CTD
PMID:35537566
NCBI chr 4:179,999,655...180,027,283
Ensembl chr 4:180,004,580...180,027,283
G
Knl1
kinetochore scaffold 1
decreases expression
ISO
trovafloxacin results in decreased expression of KNL1 mRNA
CTD
PMID:35537566
NCBI chr 3:106,029,627...106,091,915
Ensembl chr 3:106,029,661...106,091,915
G
Knstrn
kinetochore-localized astrin/SPAG5 binding protein
decreases expression
ISO
trovafloxacin results in decreased expression of KNSTRN mRNA
CTD
PMID:35537566
NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715
G
Kntc1
kinetochore associated 1
decreases expression
ISO
trovafloxacin results in decreased expression of KNTC1 mRNA
CTD
PMID:35537566
NCBI chr12:32,769,020...32,839,617
Ensembl chr12:32,769,020...32,839,561
G
Kpna2
karyopherin subunit alpha 2
decreases expression
EXP
trovafloxacin results in decreased expression of KPNA2 mRNA
CTD
PMID:24136188
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
G
Kpnb1
karyopherin subunit beta 1
decreases expression
EXP
trovafloxacin results in decreased expression of KPNB1 mRNA
CTD
PMID:24136188
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
G
Kptn
kaptin (actin binding protein)
decreases expression
ISO
trovafloxacin results in decreased expression of KPTN mRNA
CTD
PMID:35537566
NCBI chr 1:76,808,737...76,809,531
G
Krt18
keratin 18
decreases expression
EXP
trovafloxacin results in decreased expression of KRT18 mRNA
CTD
PMID:24136188
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Ksr1
kinase suppressor of ras 1
decreases expression
ISO
trovafloxacin results in decreased expression of KSR1 mRNA
CTD
PMID:35537566
NCBI chr10:63,961,771...64,098,076
Ensembl chr10:63,961,759...64,098,076
G
L1cam
L1 cell adhesion molecule
decreases expression
ISO
trovafloxacin results in decreased expression of L1CAM mRNA
CTD
PMID:35537566
NCBI chr X:151,597,270...151,623,776
Ensembl chr X:151,597,277...151,623,857
G
L3hypdh
trans-L-3-hydroxyproline dehydratase
decreases expression
ISO
trovafloxacin results in decreased expression of L3HYPDH mRNA
CTD
PMID:35537566
NCBI chr 6:90,636,310...90,647,106
Ensembl chr 6:90,636,310...90,647,106
G
Lactb2
lactamase, beta 2
decreases expression
ISO
trovafloxacin results in decreased expression of LACTB2 mRNA
CTD
PMID:35537566
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
G
Laptm4b
lysosomal protein transmembrane 4 beta
decreases expression
EXP
trovafloxacin results in decreased expression of LAPTM4B mRNA
CTD
PMID:24136188
NCBI chr 7:65,434,525...65,477,386
Ensembl chr 7:65,434,394...65,477,383
G
Lars1
leucyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of LARS1 mRNA
CTD
PMID:35537566
NCBI chr18:34,201,555...34,256,003
Ensembl chr18:34,201,549...34,255,931
G
Lasp1
LIM and SH3 protein 1
increases expression
ISO
trovafloxacin results in increased expression of LASP1 mRNA
CTD
PMID:35537566
NCBI chr10:82,795,177...82,835,659
Ensembl chr10:82,795,137...82,943,292
G
Lbr
lamin B receptor
decreases expression
ISO
trovafloxacin results in decreased expression of LBR mRNA
CTD
PMID:35537566
NCBI chr13:93,539,386...93,564,026
Ensembl chr13:93,538,920...93,564,017
G
Lcat
lecithin cholesterol acyltransferase
increases expression
ISO
trovafloxacin results in increased expression of LCAT mRNA
CTD
PMID:35537566
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Ldhal6b
lactate dehydrogenase A-like 6B
increases expression
ISO
trovafloxacin results in increased expression of LDHAL6B mRNA
CTD
PMID:35537566
NCBI chr 1:45,997,845...45,999,268
Ensembl chr 1:45,991,991...45,999,272
G
Ldlr
low density lipoprotein receptor
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of LDLR mRNA
CTD
PMID:18930950
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Ldlrad3
low density lipoprotein receptor class A domain containing 3
decreases expression
ISO
trovafloxacin results in decreased expression of LDLRAD3 mRNA
CTD
PMID:35537566
NCBI chr 3:88,239,529...88,481,340
Ensembl chr 3:88,239,622...88,481,267
G
Ldlrap1
low density lipoprotein receptor adaptor protein 1
increases expression
ISO
trovafloxacin results in increased expression of LDLRAP1 mRNA
CTD
PMID:35537566
NCBI chr 5:146,955,607...146,978,601
Ensembl chr 5:146,955,607...146,978,601
G
Lekr1
leucine, glutamate and lysine rich 1
increases expression
ISO
trovafloxacin results in increased expression of LEKR1 mRNA
CTD
PMID:35537566
NCBI chr 2:149,889,615...150,061,167
Ensembl chr 2:149,891,106...150,060,469
G
Lenep
lens epithelial protein
increases expression
ISO
trovafloxacin results in increased expression of LENEP mRNA
CTD
PMID:35537566
NCBI chr 2:174,819,439...174,820,127
Ensembl chr 2:174,819,459...174,820,127
G
Letm1
leucine zipper and EF-hand containing transmembrane protein 1
decreases expression
EXP
trovafloxacin results in decreased expression of LETM1 mRNA
CTD
PMID:24136188
NCBI chr14:76,942,647...76,982,220
Ensembl chr14:76,942,729...76,984,904
G
Lgals9
galectin 9
increases expression
ISO
trovafloxacin results in increased expression of LGALS9 mRNA
CTD
PMID:35537566
NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045
G
Lgalsl
galectin-like
decreases expression
EXP
trovafloxacin results in decreased expression of LGALSL mRNA
CTD
PMID:24136188
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
G
Lgr4
leucine-rich repeat-containing G protein-coupled receptor 4
increases expression
ISO
trovafloxacin results in increased expression of LGR4 mRNA
CTD
PMID:35537566
NCBI chr 3:96,447,385...96,550,006
Ensembl chr 3:96,447,858...96,548,899
G
Lhx2
LIM homeobox 2
decreases expression
ISO
trovafloxacin results in decreased expression of LHX2 mRNA
CTD
PMID:35537566
NCBI chr 3:22,113,619...22,143,909
Ensembl chr 3:22,126,007...22,143,908
G
Lif
LIF, interleukin 6 family cytokine
increases expression
ISO
trovafloxacin results in increased expression of LIF mRNA
CTD
PMID:35537566
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Lig1
DNA ligase 1
decreases expression
ISO
trovafloxacin results in decreased expression of LIG1 mRNA
CTD
PMID:35537566
NCBI chr 1:74,165,688...74,204,400
Ensembl chr 1:74,165,842...74,204,413
G
Lilrb4
leukocyte immunoglobulin like receptor B4
increases expression
ISO
trovafloxacin results in increased expression of LILRB4B mRNA
CTD
PMID:35537566
NCBI chr 1:69,805,020...69,810,628
Ensembl chr 1:69,805,250...69,810,660
G
Lin54
lin-54 DREAM MuvB core complex component
decreases expression
ISO
trovafloxacin results in decreased expression of LIN54 mRNA
CTD
PMID:35537566
NCBI chr14:9,129,775...9,188,244
Ensembl chr14:9,130,336...9,187,790
G
Lipn
lipase, family member N
decreases expression
ISO
trovafloxacin results in decreased expression of LIPN mRNA
CTD
PMID:35537566
NCBI chr 1:231,584,950...231,603,456
Ensembl chr 1:231,584,956...231,603,468
G
Litaf
lipopolysaccharide-induced TNF factor
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of LITAF mRNA
CTD
PMID:18930950
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
G
Lix1
limb and CNS expressed 1
decreases expression
ISO
trovafloxacin results in decreased expression of LIX1 mRNA
CTD
PMID:35537566
NCBI chr 1:58,128,961...58,187,554
Ensembl chr 1:58,128,961...58,185,964
G
Llgl2
LLGL scribble cell polarity complex component 2
increases expression
ISO
trovafloxacin results in increased expression of LLGL2 mRNA
CTD
PMID:35537566
NCBI chr10:101,050,978...101,086,527
Ensembl chr10:101,051,408...101,086,525
G
Lmna
lamin A/C
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of LMNA mRNA trovafloxacin results in increased expression of LMNA mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
G
Lmnb1
lamin B1
decreases expression
ISO
trovafloxacin results in decreased expression of LMNB1 mRNA
CTD
PMID:35537566
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
G
Lmo4
LIM domain only 4
decreases expression
ISO
trovafloxacin results in decreased expression of LMO4 mRNA
CTD
PMID:35537566
NCBI chr 2:233,264,180...233,280,881
Ensembl chr 2:233,264,182...233,280,880
G
LOC120094467
small nucleolar RNA SNORA43
increases expression
ISO
trovafloxacin results in increased expression of SNORA43 mRNA
CTD
PMID:35537566
NCBI chr 8:110,101,179...110,101,316
Ensembl chr 8:110,101,179...110,101,316
G
Lonp1
lon peptidase 1, mitochondrial
decreases expression
ISO
trovafloxacin results in decreased expression of LONP1 mRNA
CTD
PMID:35537566
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
G
Lpin1
lipin 1
increases expression
EXP
trovafloxacin results in increased expression of LPIN1 mRNA
CTD
PMID:24136188
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Lpin3
lipin 3
increases expression
ISO
trovafloxacin results in increased expression of LPIN3 mRNA
CTD
PMID:35537566
NCBI chr 3:149,533,719...149,558,494
Ensembl chr 3:149,534,051...149,558,327
G
Lrp6
LDL receptor related protein 6
increases expression
EXP
trovafloxacin results in increased expression of LRP6 mRNA
CTD
PMID:24136188
NCBI chr 4:167,269,856...167,400,364
Ensembl chr 4:167,270,353...167,400,497
G
Lrp8
LDL receptor related protein 8
decreases expression
ISO
trovafloxacin results in decreased expression of LRP8 mRNA
CTD
PMID:35537566
NCBI chr 5:122,563,468...122,635,434
Ensembl chr 5:122,563,453...122,631,352
G
Lrrc41
leucine rich repeat containing 41
increases expression
ISO
trovafloxacin results in increased expression of LRRC41 mRNA
CTD
PMID:35537566
NCBI chr 5:129,554,547...129,575,450
Ensembl chr 5:129,554,547...129,575,449
G
Lrrc63
leucine rich repeat containing 63
decreases expression
ISO
trovafloxacin results in decreased expression of LRRC63 mRNA
CTD
PMID:35537566
NCBI chr15:50,400,199...50,437,321
Ensembl chr15:50,400,200...50,437,321
G
Lrrc75a
leucine rich repeat containing 75A
decreases expression
ISO
trovafloxacin results in decreased expression of LRRC75A mRNA
CTD
PMID:35537566
NCBI chr10:47,298,222...47,343,301
Ensembl chr10:47,297,288...47,343,664
G
Lrrc8c
leucine rich repeat containing 8 VRAC subunit C
decreases expression
ISO
trovafloxacin results in decreased expression of LRRC8C mRNA
CTD
PMID:35537566
NCBI chr14:4,223,901...4,315,590
Ensembl chr14:4,227,832...4,315,249
G
Lrrcc1
leucine rich repeat and coiled-coil centrosomal protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of LRRCC1 mRNA
CTD
PMID:35537566
NCBI chr 2:87,025,671...87,060,313
Ensembl chr 2:87,025,598...87,060,294
G
Lrrk2
leucine-rich repeat kinase 2
decreases expression
ISO
trovafloxacin results in decreased expression of LRRK2 mRNA
CTD
PMID:35537566
NCBI chr 7:122,826,696...122,987,711
Ensembl chr 7:122,826,696...122,987,703
G
Lrrn4cl
LRRN4 C-terminal like
decreases expression
ISO
trovafloxacin results in decreased expression of LRRN4CL mRNA
CTD
PMID:35537566
NCBI chr 1:205,743,580...205,759,879
G
Lrwd1
leucine-rich repeats and WD repeat domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of LRWD1 mRNA
CTD
PMID:35537566
NCBI chr12:20,530,035...20,543,078
Ensembl chr12:20,530,012...20,549,536
G
Lsm4
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
decreases expression
EXP
trovafloxacin results in decreased expression of LSM4 mRNA
CTD
PMID:24136188
NCBI chr16:18,755,481...18,761,106
Ensembl chr16:18,755,484...18,760,926
G
Lsm6
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated
increases expression
ISO
trovafloxacin results in increased expression of LSM6 mRNA
CTD
PMID:35537566
NCBI chr19:29,098,254...29,112,858
Ensembl chr13:42,114,032...42,116,484 Ensembl chr19:42,114,032...42,116,484
G
Lta4h
leukotriene A4 hydrolase
decreases expression
EXP
trovafloxacin results in decreased expression of LTA4H mRNA
CTD
PMID:24136188
NCBI chr 7:27,969,796...28,001,600
Ensembl chr 7:27,969,789...28,001,600
G
Ltbp2
latent transforming growth factor beta binding protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of LTBP2 mRNA
CTD
PMID:35537566
NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208
G
Ltbp4
latent transforming growth factor beta binding protein 4
decreases expression
ISO
trovafloxacin results in decreased expression of LTBP4 mRNA
CTD
PMID:35537566
NCBI chr 1:82,600,136...82,634,346
Ensembl chr 1:82,600,136...82,632,178
G
Luc7l
LUC7-like
increases expression
ISO
trovafloxacin results in increased expression of LUC7L mRNA
CTD
PMID:35537566
NCBI chr10:15,273,340...15,307,131
Ensembl chr10:15,273,348...15,303,112
G
Lyl1
LYL1, basic helix-loop-helix family member
decreases expression
ISO
trovafloxacin results in decreased expression of LYL1 mRNA
CTD
PMID:35537566
NCBI chr19:23,452,140...23,455,007
Ensembl chr19:23,452,140...23,455,007
G
Lyz2
lysozyme 2
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of LYZ2 mRNA trovafloxacin results in increased expression of LYZ2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
G
Macf1
microtubule-actin crosslinking factor 1
decreases expression
ISO
trovafloxacin results in decreased expression of MACF1 mRNA
CTD
PMID:35537566
NCBI chr 5:135,623,734...135,949,097
Ensembl chr 5:135,623,742...135,945,905
G
Mad2l1
mitotic arrest deficient 2 like 1
decreases expression
ISO
trovafloxacin results in decreased expression of MAD2L1 mRNA
CTD
PMID:35537566
NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470
G
Maf
MAF bZIP transcription factor
decreases expression
ISO
trovafloxacin results in decreased expression of MAF mRNA
CTD
PMID:35537566
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
G
Mal2
mal, T-cell differentiation protein 2
decreases expression
EXP
trovafloxacin results in decreased expression of MAL2 mRNA
CTD
PMID:24136188
NCBI chr 7:85,900,453...85,933,433
Ensembl chr 7:85,900,453...85,933,429
G
Man2a1
mannosidase, alpha, class 2A, member 1
decreases expression
ISO
trovafloxacin results in decreased expression of MAN2A1 mRNA
CTD
PMID:35537566
NCBI chr 9:104,252,001...104,408,349
Ensembl chr 9:104,252,001...104,408,349
G
Man2a2
mannosidase, alpha, class 2A, member 2
decreases expression
ISO
trovafloxacin results in decreased expression of MAN2A2 mRNA
CTD
PMID:35537566
NCBI chr 1:134,304,714...134,327,611
Ensembl chr 1:134,306,236...134,327,315
G
Manbal
mannosidase beta like
increases expression
ISO
trovafloxacin results in increased expression of MANBAL mRNA
CTD
PMID:35537566
NCBI chr 3:146,035,082...146,064,676
Ensembl chr 3:146,035,066...146,064,676
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MANF mRNA
CTD
PMID:18930950
NCBI chr 8:107,500,856...107,551,595
Ensembl chr 8:107,548,352...107,551,438
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
multiple interactions increases expression
ISO
TNF protein inhibits the reaction [trovafloxacin results in increased expression of MAP1LC3A mRNA]
CTD
PMID:33609687
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions increases expression
ISO
[trovafloxacin co-treated with TNF protein] results in increased expression of MAP1LC3B mRNA; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [trovafloxacin results in increased expression of and results in increased lipidation of MAP1LC3B protein]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of and results in increased lipidation of MAP1LC3B protein]; trovafloxacin results in increased expression of and results in increased lipidation of MAP1LC3B protein trovafloxacin results in increased expression of MAP1LC3B mRNA
CTD
PMID:33609687
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Map2k6
mitogen-activated protein kinase kinase 6
decreases expression
ISO
trovafloxacin results in decreased expression of MAP2K6 mRNA
CTD
PMID:35537566
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
G
Map2k7
mitogen activated protein kinase kinase 7
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MAP2K7 mRNA
CTD
PMID:18930950
NCBI chr12:2,591,312...2,600,534
Ensembl chr12:2,591,219...2,604,222
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MAP3K8 mRNA
CTD
PMID:18930950
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Mapk1
mitogen activated protein kinase 1
increases activity increases phosphorylation multiple interactions
ISO
trovafloxacin results in increased activity of MAPK1 protein trovafloxacin results in increased phosphorylation of MAPK1 protein [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of MAPK1 protein; ATG5 protein affects the reaction [trovafloxacin results in increased phosphorylation of MAPK1 protein] U 0126 inhibits the reaction [trovafloxacin results in increased activity of MAPK1 protein]
CTD
PMID:24525298 PMID:32035082 PMID:33609687
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases activity increases phosphorylation multiple interactions
ISO
trovafloxacin results in increased activity of MAPK3 protein trovafloxacin results in increased phosphorylation of MAPK3 protein [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of MAPK3 protein; ATG5 protein affects the reaction [trovafloxacin results in increased phosphorylation of MAPK3 protein] U 0126 inhibits the reaction [trovafloxacin results in increased activity of MAPK3 protein]
CTD
PMID:24525298 PMID:32035082 PMID:33609687
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation multiple interactions
ISO
trovafloxacin results in increased phosphorylation of MAPK8 protein ATG5 protein affects the reaction [trovafloxacin results in increased phosphorylation of MAPK8 protein]
CTD
PMID:33609687
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk8ip3
mitogen-activated protein kinase 8 interacting protein 3
increases expression
ISO
trovafloxacin results in increased expression of MAPK8IP3 mRNA
CTD
PMID:35537566
NCBI chr10:13,918,417...13,958,335
Ensembl chr10:13,918,400...13,958,273
G
Mapkapk2
MAPK activated protein kinase 2
multiple interactions increases phosphorylation
ISO
SB 203580 inhibits the reaction [trovafloxacin results in increased phosphorylation of MAPKAPK2 protein]
CTD
PMID:24525298
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
G
Marcksl1
MARCKS-like 1
increases expression
ISO
trovafloxacin results in increased expression of MARCKSL1 mRNA
CTD
PMID:35537566
NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:141,850,110...141,853,817
G
Mastl
microtubule associated serine/threonine kinase-like
decreases expression
ISO
trovafloxacin results in decreased expression of MASTL mRNA
CTD
PMID:35537566
NCBI chr17:85,250,512...85,287,479
Ensembl chr17:85,251,997...85,287,353
G
Mavs
mitochondrial antiviral signaling protein
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MAVS mRNA
CTD
PMID:18930950
NCBI chr 3:118,451,650...118,466,094
Ensembl chr 3:118,451,743...118,466,094
G
Maz
MYC associated zinc finger protein
decreases expression
ISO
trovafloxacin results in decreased expression of MAZ mRNA
CTD
PMID:35537566
NCBI chr 1:181,629,742...181,635,193
Ensembl chr 1:181,629,729...181,650,408
G
Mblac1
metallo-beta-lactamase domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of MBLAC1 mRNA
CTD
PMID:35537566
NCBI chr12:17,071,465...17,072,736
Ensembl chr12:17,071,465...17,072,735
G
Mcam
melanoma cell adhesion molecule
decreases expression
ISO
trovafloxacin results in decreased expression of MCAM mRNA
CTD
PMID:35537566
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
Mcf2l
MCF.2 cell line derived transforming sequence-like
decreases expression
ISO
trovafloxacin results in decreased expression of MCF2L mRNA
CTD
PMID:35537566
NCBI chr16:76,507,133...76,652,893
Ensembl chr16:76,507,133...76,652,733
G
Mcm5
minichromosome maintenance complex component 5
decreases expression
ISO
trovafloxacin results in decreased expression of MCM5 mRNA
CTD
PMID:35537566
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
G
Mcm7
minichromosome maintenance complex component 7
decreases expression
ISO
trovafloxacin results in decreased expression of MCM7 mRNA
CTD
PMID:35537566
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
G
Mcm8
minichromosome maintenance 8 homologous recombination repair factor
decreases expression
ISO
trovafloxacin results in decreased expression of MCM8 mRNA
CTD
PMID:35537566
NCBI chr 3:120,086,741...120,117,008
Ensembl chr 3:120,086,763...120,117,008
G
Mcm9
minichromosome maintenance 9 homologous recombination repair factor
decreases expression
ISO
trovafloxacin results in decreased expression of MCM9 mRNA
CTD
PMID:35537566
NCBI chr20:32,818,219...32,929,577
Ensembl chr20:32,844,951...32,929,600
G
Mdc1
mediator of DNA damage checkpoint 1
decreases expression
ISO
trovafloxacin results in decreased expression of MDC1 mRNA
CTD
PMID:35537566
NCBI chr20:2,893,693...2,912,394
Ensembl chr20:2,895,505...2,910,240
G
Mdh2
malate dehydrogenase 2
decreases expression
EXP
trovafloxacin results in decreased expression of MDH2 mRNA
CTD
PMID:24136188
NCBI chr12:20,894,269...20,907,225
Ensembl chr12:20,894,262...20,907,271
G
Mdm1
Mdm1 nuclear protein
decreases expression
ISO
trovafloxacin results in decreased expression of MDM1 mRNA
CTD
PMID:35537566
NCBI chr 7:53,729,603...53,766,034
Ensembl chr 7:53,729,610...53,766,034
G
Mdm2
MDM2 proto-oncogene
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MDM2 mRNA trovafloxacin results in increased expression of MDM2 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Me1
malic enzyme 1
decreases expression
EXP
trovafloxacin results in decreased expression of ME1 mRNA
CTD
PMID:24136188
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Med10
mediator complex subunit 10
increases expression
ISO
trovafloxacin results in increased expression of MED10 mRNA
CTD
PMID:35537566
NCBI chr 1:33,470,064...33,481,698
Ensembl chr 1:33,470,066...33,475,767
G
Med14
mediator complex subunit 14
decreases expression
ISO
trovafloxacin results in decreased expression of MED14 mRNA
CTD
PMID:35537566
NCBI chr X:10,036,749...10,127,910
Ensembl chr X:10,036,805...10,126,240
G
Med20
mediator complex subunit 20
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MED20 mRNA trovafloxacin results in increased expression of MED20 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr 9:13,370,146...13,382,756
Ensembl chr 9:13,370,146...13,382,476
G
Med22
mediator complex subunit 22
increases expression
ISO
trovafloxacin results in increased expression of MED22 mRNA
CTD
PMID:35537566
NCBI chr 3:10,233,754...10,238,836
Ensembl chr 3:10,233,754...10,238,836
G
Med29
mediator complex subunit 29
increases expression
ISO
trovafloxacin results in increased expression of MED29 mRNA
CTD
PMID:35537566
NCBI chr 1:83,677,961...83,683,365
Ensembl chr 1:83,677,961...83,683,365
G
Megf9
multiple EGF-like-domains 9
decreases expression
ISO
trovafloxacin results in decreased expression of MEGF9 mRNA
CTD
PMID:35537566
NCBI chr 5:83,993,565...84,105,622
Ensembl chr 5:83,993,565...84,105,622
G
Melk
maternal embryonic leucine zipper kinase
decreases expression
ISO
trovafloxacin results in decreased expression of MELK mRNA
CTD
PMID:35537566
NCBI chr 5:58,540,393...58,600,562
Ensembl chr 5:58,540,449...58,600,937
G
Mfsd1
major facilitator superfamily domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of MFSD1 mRNA
CTD
PMID:35537566
NCBI chr 2:151,846,130...151,866,168
Ensembl chr 2:151,846,146...151,867,045
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
increases expression
ISO
trovafloxacin results in increased expression of MFSD2A mRNA
CTD
PMID:35537566
NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
G
Mfsd3
major facilitator superfamily domain containing 3
decreases expression
ISO
trovafloxacin results in decreased expression of MFSD3 mRNA
CTD
PMID:35537566
NCBI chr 7:108,419,644...108,423,469
Ensembl chr 7:108,421,350...108,423,461
G
Mgarp
mitochondria-localized glutamic acid-rich protein
decreases expression
ISO
trovafloxacin results in decreased expression of MGARP mRNA
CTD
PMID:35537566
NCBI chr 2:135,431,283...135,439,425
Ensembl chr 2:135,431,283...135,439,612
G
Mgll
monoglyceride lipase
decreases expression
EXP
trovafloxacin results in decreased expression of MGLL mRNA
CTD
PMID:24136188
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
G
Mgmt
O-6-methylguanine-DNA methyltransferase
increases expression
ISO
trovafloxacin results in increased expression of MGMT mRNA
CTD
PMID:35537566
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
G
Micall1
MICAL-like 1
increases expression
ISO
trovafloxacin results in increased expression of MICALL1 mRNA
CTD
PMID:35537566
NCBI chr 7:110,676,706...110,707,171
Ensembl chr 7:110,676,775...110,707,177
G
Micall2
MICAL-like 2
increases expression
ISO
trovafloxacin results in increased expression of MICALL2 mRNA
CTD
PMID:35537566
NCBI chr12:14,899,188...14,927,949
Ensembl chr12:14,899,157...14,927,946
G
Midn
midnolin
increases expression
ISO
trovafloxacin results in increased expression of MIDN mRNA
CTD
PMID:35537566
NCBI chr 7:9,548,100...9,559,605
Ensembl chr 7:9,549,650...9,559,752
G
Mief2
mitochondrial elongation factor 2
increases expression
ISO
trovafloxacin results in increased expression of MIEF2 mRNA
CTD
PMID:35537566
NCBI chr10:45,408,055...45,414,144
Ensembl chr10:45,408,082...45,414,144
G
Miip
migration and invasion inhibitory protein
decreases expression
ISO
trovafloxacin results in decreased expression of MIIP mRNA
CTD
PMID:35537566
NCBI chr 5:158,292,510...158,299,533
Ensembl chr 5:158,292,511...158,299,694
G
Mir877
microRNA 877
increases expression
ISO
trovafloxacin results in increased expression of MIR877 mRNA
CTD
PMID:27713024
NCBI chr20:2,811,476...2,811,560
Ensembl chr20:2,811,476...2,811,560
G
Mirlet7bhg
Mirlet7b host gene
increases expression
ISO
trovafloxacin results in increased expression of LNCPPARA mRNA
CTD
PMID:35537566
G
Mis18a
MIS18 kinetochore protein A
decreases expression
ISO
trovafloxacin results in decreased expression of MIS18A mRNA
CTD
PMID:35537566
NCBI chr11:29,968,030...29,981,058
Ensembl chr11:29,967,701...29,981,062
G
Mis18bp1
MIS18 binding protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of MIS18BP1 mRNA
CTD
PMID:35537566
NCBI chr 6:83,182,497...83,231,978
Ensembl chr 6:83,182,499...83,231,383
G
Mix23
mitochondrial matrix import factor 23
increases expression
ISO
trovafloxacin results in increased expression of MIX23 mRNA
CTD
PMID:35537566
NCBI chr11:64,660,711...64,681,000
Ensembl chr11:64,660,711...64,681,000
G
Mki67
marker of proliferation Ki-67
decreases expression
ISO
trovafloxacin results in decreased expression of MKI67 mRNA
CTD
PMID:35537566
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mknk1
MAPK interacting serine/threonine kinase 1
decreases expression
ISO
trovafloxacin results in decreased expression of MKNK1 mRNA
CTD
PMID:35537566
NCBI chr 5:129,318,128...129,357,641
Ensembl chr 5:129,318,170...129,357,639
G
Mkrn2
makorin, ring finger protein, 2
decreases expression
ISO
trovafloxacin results in decreased expression of MKRN2 mRNA
CTD
PMID:35537566
NCBI chr 4:148,661,529...148,679,580
Ensembl chr 4:148,661,553...148,679,642
G
Mkrn3
makorin, ring finger protein, 3
increases expression
ISO
trovafloxacin results in increased expression of MKRN3 mRNA
CTD
PMID:35537566
NCBI chr 1:115,926,774...115,929,288
Ensembl chr 1:115,926,776...115,929,283
G
Mlf1
myeloid leukemia factor 1
decreases expression
ISO
trovafloxacin results in decreased expression of MLF1 mRNA
CTD
PMID:35537566
NCBI chr 2:151,648,492...151,681,654
Ensembl chr 2:151,648,511...151,681,652
G
Mlxipl
MLX interacting protein-like
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MLXIPL mRNA
CTD
PMID:18930950
NCBI chr12:21,541,608...21,577,120
Ensembl chr12:21,543,576...21,577,112
G
Mmp13
matrix metallopeptidase 13
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MMP13 mRNA
CTD
PMID:18930950
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mnd1
meiotic nuclear divisions 1
decreases expression
ISO
trovafloxacin results in decreased expression of MND1 mRNA
CTD
PMID:35537566
NCBI chr 2:169,433,523...169,496,081
Ensembl chr 2:169,433,540...169,496,096
G
Mnda
myeloid cell nuclear differentiation antigen
increases expression
ISO
trovafloxacin results in increased expression of MNDA mRNA; trovafloxacin results in increased expression of PYHIN1 mRNA
CTD
PMID:35537566
NCBI chr13:86,017,888...86,035,556
Ensembl chr13:86,017,892...86,034,201
G
Mob3b
MOB kinase activator 3B
decreases expression
ISO
trovafloxacin results in decreased expression of MOB3B mRNA
CTD
PMID:35537566
NCBI chr 5:49,546,254...49,737,934
Ensembl chr 5:49,545,815...49,737,934
G
Mogs
mannosyl-oligosaccharide glucosidase
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MOGS mRNA
CTD
PMID:18930950
NCBI chr 4:115,621,623...115,625,026
Ensembl chr 4:115,621,623...115,625,032
G
Mok
MOK protein kinase
increases expression
ISO
trovafloxacin results in increased expression of MOK mRNA
CTD
PMID:35537566
NCBI chr 6:129,823,794...129,854,669
Ensembl chr 6:129,823,795...129,854,700
G
Mpeg1
macrophage expressed 1
increases expression
ISO
trovafloxacin results in increased expression of MPEG1 mRNA
CTD
PMID:35537566
NCBI chr 1:209,452,176...209,456,692
Ensembl chr 1:209,452,133...209,458,855
G
Mpg
N-methylpurine-DNA glycosylase
decreases expression
ISO
trovafloxacin results in decreased expression of MPG mRNA
CTD
PMID:35537566
NCBI chr10:15,396,246...15,402,528
Ensembl chr10:15,395,782...15,402,520
G
Mphosph8
M-phase phosphoprotein 8
increases expression
EXP
trovafloxacin results in increased expression of MPHOSPH8 mRNA
CTD
PMID:24136188
NCBI chr15:30,800,546...30,828,415
Ensembl chr15:30,686,613...30,828,810
G
Mr1
major histocompatibility complex, class I-related
decreases expression
ISO
trovafloxacin results in decreased expression of MR1 mRNA
CTD
PMID:35537566
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
G
Mrc1
mannose receptor, C type 1
decreases expression
ISO
trovafloxacin results in decreased expression of MRC1 mRNA
CTD
PMID:35537566
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
G
Mrnip
MRN complex interacting protein
decreases expression
ISO
trovafloxacin results in decreased expression of MRNIP mRNA
CTD
PMID:35537566
NCBI chr10:34,501,359...34,525,474
Ensembl chr10:34,501,384...34,525,469
G
Mroh1
maestro heat-like repeat family member 1
decreases expression
ISO
trovafloxacin results in decreased expression of MROH1 mRNA
CTD
PMID:35537566
NCBI chr 7:108,098,708...108,172,146
Ensembl chr 7:108,102,734...108,172,146
G
Mrpl12
mitochondrial ribosomal protein L12
decreases expression
EXP
trovafloxacin results in decreased expression of MRPL12 mRNA
CTD
PMID:24136188
NCBI chr10:105,758,410...105,762,913
Ensembl chr10:105,758,410...105,762,913
G
Mrpl38
mitochondrial ribosomal protein L38
decreases expression
ISO
trovafloxacin results in decreased expression of MRPL38 mRNA
CTD
PMID:35537566
NCBI chr10:101,365,353...101,372,159
Ensembl chr10:101,365,353...101,372,171
G
Mrps18b
mitochondrial ribosomal protein S18B
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of MRPS18B mRNA trovafloxacin results in increased expression of MRPS18B mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr20:2,838,174...2,844,260
Ensembl chr20:2,838,030...2,844,260
G
Msh3
mutS homolog 3
decreases expression
ISO
trovafloxacin results in decreased expression of MSH3 mRNA
CTD
PMID:35537566
NCBI chr 2:23,444,326...23,585,777
G
Msh5
mutS homolog 5
decreases expression
ISO
trovafloxacin results in decreased expression of MSH5 mRNA
CTD
PMID:35537566
NCBI chr20:3,773,867...3,793,337
Ensembl chr20:3,776,942...3,793,336
G
Mt1
metallothionein 1
increases expression multiple interactions
EXP ISO
trovafloxacin results in increased expression of MT1A mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MT1E mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
decreases expression
ISO
trovafloxacin results in decreased expression of MT2 mRNA
CTD
PMID:35537566
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mtbp
MDM2 binding protein
decreases expression
ISO
trovafloxacin results in decreased expression of MTBP mRNA
CTD
PMID:35537566
NCBI chr 7:86,973,215...87,055,775
Ensembl chr 7:86,973,069...87,050,827
G
Mtch1
mitochondrial carrier 1
decreases expression
ISO
trovafloxacin results in decreased expression of MTCH1 mRNA
CTD
PMID:35537566
NCBI chr20:7,389,942...7,413,426
Ensembl chr20:7,389,949...7,413,426
G
Mtfr2
mitochondrial fission regulator 2
decreases expression
ISO
trovafloxacin results in decreased expression of MTFR2 mRNA
CTD
PMID:35537566
NCBI chr 1:15,123,232...15,138,632
Ensembl chr 1:15,070,894...15,148,832
G
Mtg1
mitochondrial ribosome-associated GTPase 1
decreases expression
ISO
trovafloxacin results in decreased expression of MTG1 mRNA
CTD
PMID:35537566
NCBI chr 1:194,931,543...194,944,278
Ensembl chr 1:194,931,531...194,944,277
G
Mthfd1l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
decreases expression
ISO
trovafloxacin results in decreased expression of MTHFD1L mRNA
CTD
PMID:35537566
NCBI chr 1:40,443,926...40,632,911
Ensembl chr 1:40,444,008...40,632,905
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
decreases expression
ISO
trovafloxacin results in decreased expression of MTHFD2 mRNA
CTD
PMID:35537566
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
G
Mttp
microsomal triglyceride transfer protein
decreases expression
EXP ISO
trovafloxacin results in decreased expression of MTTP mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Mtus2
microtubule associated scaffold protein 2
increases expression
ISO
trovafloxacin results in increased expression of MTUS2 mRNA
CTD
PMID:35537566
NCBI chr12:6,706,531...7,078,331
Ensembl chr12:6,706,532...7,078,331
G
Mul1
mitochondrial E3 ubiquitin protein ligase 1
increases expression
ISO
trovafloxacin results in increased expression of MUL1 mRNA
CTD
PMID:35537566
NCBI chr 5:150,652,812...150,661,863
Ensembl chr 5:150,652,812...150,661,863
G
Mus81
MUS81 structure-specific endonuclease subunit
decreases expression
ISO
trovafloxacin results in decreased expression of MUS81 mRNA
CTD
PMID:35537566
NCBI chr 1:202,790,295...202,796,008
Ensembl chr 1:202,790,466...202,795,843
G
Mustn1
musculoskeletal, embryonic nuclear protein 1
increases expression
ISO
trovafloxacin results in increased expression of MUSTN1 mRNA
CTD
PMID:35537566
NCBI chr16:6,072,908...6,075,161
Ensembl chr16:6,072,833...6,075,161
G
Mutyh
mutY DNA glycosylase
decreases expression
ISO
trovafloxacin results in decreased expression of MUTYH mRNA
CTD
PMID:35537566
NCBI chr 5:130,274,034...130,286,149
Ensembl chr 5:130,274,122...130,286,146
G
Mx1
MX dynamin like GTPase 1
increases expression
ISO
trovafloxacin results in increased expression of MX2 mRNA
CTD
PMID:35537566
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
G
Mxd3
Max dimerization protein 3
decreases expression
ISO
trovafloxacin results in decreased expression of MXD3 mRNA
CTD
PMID:35537566
NCBI chr17:9,301,430...9,305,156
Ensembl chr17:9,301,399...9,305,157
G
Myadml2
myeloid-associated differentiation marker-like 2
decreases expression
ISO
trovafloxacin results in decreased expression of MYADML2 mRNA
CTD
PMID:35537566
NCBI chr10:105,922,557...105,927,867
Ensembl chr10:105,925,947...105,927,575
G
Mybl2
MYB proto-oncogene like 2
decreases expression
ISO
trovafloxacin results in decreased expression of MYBL2 mRNA
CTD
PMID:35537566
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
G
Mybpc3
myosin binding protein C3
increases expression
ISO
trovafloxacin results in increased expression of MYBPC3 mRNA
CTD
PMID:35537566
NCBI chr 3:77,095,165...77,113,406
Ensembl chr 3:77,095,252...77,113,405
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
trovafloxacin results in increased expression of MYC mRNA
CTD
PMID:35537566
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Mycbp
Myc binding protein
increases expression
ISO
trovafloxacin results in increased expression of MYCBP mRNA
CTD
PMID:35537566
NCBI chr 5:136,135,955...136,143,163
Ensembl chr 5:136,135,931...136,145,616
G
Mycbp2
MYC binding protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of MYCBP2 mRNA
CTD
PMID:35537566
NCBI chr15:79,937,354...80,175,432
Ensembl chr15:79,937,354...80,175,498
G
Mycl
MYCL proto-oncogene, bHLH transcription factor
increases expression
ISO
trovafloxacin results in increased expression of MYCL mRNA
CTD
PMID:35537566
NCBI chr 5:135,274,713...135,281,584
Ensembl chr 5:135,274,748...135,281,582
G
Myd88
MYD88, innate immune signal transduction adaptor
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MYD88 mRNA
CTD
PMID:18930950
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Myh10
myosin heavy chain 10
increases expression
ISO
trovafloxacin results in increased expression of MYH10 mRNA
CTD
PMID:35537566
NCBI chr10:53,393,901...53,525,174
Ensembl chr10:53,394,389...53,525,165
G
Myh14
myosin heavy chain 14
decreases expression
ISO
trovafloxacin results in decreased expression of MYH14 mRNA
CTD
PMID:35537566
NCBI chr 1:95,096,266...95,158,861
Ensembl chr 1:95,096,266...95,158,836
G
Myh7b
myosin heavy chain 7B
decreases expression
ISO
trovafloxacin results in decreased expression of MYH7B mRNA
CTD
PMID:35537566
NCBI chr 3:144,076,911...144,122,714
Ensembl chr 3:144,098,190...144,122,084
G
Myl11
myosin light chain 11
decreases expression
ISO
trovafloxacin results in decreased expression of MYLPF mRNA
CTD
PMID:35537566
NCBI chr 1:181,829,703...181,832,546
Ensembl chr 1:181,829,743...181,832,545
G
Myo9a
myosin IXA
decreases expression
ISO
trovafloxacin results in decreased expression of MYO9A mRNA
CTD
PMID:35537566
NCBI chr 8:60,149,234...60,352,330
Ensembl chr 8:60,149,234...60,350,514
G
Myom1
myomesin 1
decreases expression
ISO
trovafloxacin results in decreased expression of MYOM1 mRNA
CTD
PMID:35537566
NCBI chr 9:110,916,156...111,039,344
Ensembl chr 9:110,915,943...111,039,344
G
Myoz1
myozenin 1
decreases expression
ISO
trovafloxacin results in decreased expression of MYOZ1 mRNA
CTD
PMID:35537566
NCBI chr15:3,644,333...3,651,584
Ensembl chr15:3,644,368...3,652,884
G
Mzf1
myeloid zinc finger 1
decreases expression
ISO
trovafloxacin results in decreased expression of MZF1 mRNA
CTD
PMID:35537566
NCBI chr 1:73,670,522...73,682,885
Ensembl chr 1:73,670,541...73,681,635
G
N4bp2l1
NEDD4 binding protein 2-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of N4BP2L1 mRNA
CTD
PMID:35537566
NCBI chr12:102,572...128,352
Ensembl chr12:102,573...127,257
G
N4bp3
Nedd4 binding protein 3
decreases expression
ISO
trovafloxacin results in decreased expression of N4BP3 mRNA
CTD
PMID:35537566
NCBI chr10:35,898,031...35,906,704
Ensembl chr10:35,899,096...35,907,001
G
Naa15
N(alpha)-acetyltransferase 15, NatA auxiliary subunit
decreases expression
EXP
trovafloxacin results in decreased expression of NAA15 mRNA
CTD
PMID:24136188
NCBI chr 2:135,458,018...135,520,756
Ensembl chr 2:135,457,948...135,520,756
G
Naglu
N-acetyl-alpha-glucosaminidase
decreases expression
ISO
trovafloxacin results in decreased expression of NAGLU mRNA
CTD
PMID:35537566
NCBI chr10:86,001,545...86,009,049
Ensembl chr10:86,001,566...86,008,972
G
Napb
NSF attachment protein beta
increases expression
ISO
trovafloxacin results in increased expression of NAPB mRNA
CTD
PMID:35537566
NCBI chr 3:136,132,248...136,179,280
Ensembl chr 3:136,133,428...136,179,345
G
Naprt
nicotinate phosphoribosyltransferase
increases expression
ISO
trovafloxacin results in increased expression of NAPRT mRNA
CTD
PMID:35537566
NCBI chr 7:107,576,645...107,580,102
Ensembl chr 7:107,576,627...107,580,102
G
Nars1
asparaginyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of NARS1 mRNA
CTD
PMID:35537566
NCBI chr18:57,989,308...58,005,584
Ensembl chr18:57,989,308...58,005,622
G
Nasp
nuclear autoantigenic sperm protein
decreases expression
ISO
trovafloxacin results in decreased expression of NASP mRNA
CTD
PMID:35537566
NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928
G
Naxd
NAD(P)HX dehydratase
decreases expression
ISO
trovafloxacin results in decreased expression of NAXD mRNA
CTD
PMID:35537566
NCBI chr16:77,986,148...78,004,200
Ensembl chr16:77,987,726...78,004,192
G
Nbas
NBAS subunit of NRZ tethering complex
decreases expression
ISO
trovafloxacin results in decreased expression of NBAS mRNA
CTD
PMID:35537566
NCBI chr 6:36,048,357...36,353,206
Ensembl chr 6:36,048,191...36,352,984
G
Ncapd2
non-SMC condensin I complex, subunit D2
decreases expression
ISO
trovafloxacin results in decreased expression of NCAPD2 mRNA
CTD
PMID:35537566
NCBI chr 4:157,968,814...157,992,314
Ensembl chr 4:157,968,815...157,992,020
G
Ncapd3
non-SMC condensin II complex, subunit D3
decreases expression
ISO
trovafloxacin results in decreased expression of NCAPD3 mRNA
CTD
PMID:35537566
NCBI chr 8:25,437,067...25,506,375
Ensembl chr 8:25,437,123...25,506,373
G
Ncapg
non-SMC condensin I complex, subunit G
decreases expression
ISO
trovafloxacin results in decreased expression of NCAPG mRNA
CTD
PMID:35537566
NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902
G
Ncapg2
non-SMC condensin II complex, subunit G2
decreases expression
ISO
trovafloxacin results in decreased expression of NCAPG2 mRNA
CTD
PMID:35537566
NCBI chr 6:137,342,449...137,418,083
Ensembl chr 6:137,342,943...137,415,159
G
Ncaph
non-SMC condensin I complex, subunit H
decreases expression
ISO
trovafloxacin results in decreased expression of NCAPH mRNA
CTD
PMID:35537566
NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180
G
Ncaph2
non-SMC condensin II complex, subunit H2
decreases expression
ISO
trovafloxacin results in decreased expression of NCAPH2 mRNA
CTD
PMID:35537566
NCBI chr 7:120,422,926...120,439,942
Ensembl chr 7:120,422,956...120,439,938
G
Ncbp3
nuclear cap binding subunit 3
decreases expression
ISO
trovafloxacin results in decreased expression of NCBP3 mRNA
CTD
PMID:35537566
NCBI chr10:57,665,716...57,695,432
Ensembl chr10:57,665,716...57,695,432
G
Ndc80
NDC80 kinetochore complex component
decreases expression
ISO
trovafloxacin results in decreased expression of NDC80 mRNA
CTD
PMID:35537566
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
G
Nde1
nudE neurodevelopment protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of NDE1 mRNA
CTD
PMID:35537566
NCBI chr10:839,788...883,946
Ensembl chr10:839,788...883,869
G
Ndrg1
N-myc downstream regulated 1
decreases expression
ISO
trovafloxacin results in decreased expression of NDRG1 mRNA
CTD
PMID:35537566
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Ndufaf4
NADH:ubiquinone oxidoreductase complex assembly factor 4
decreases expression
EXP
trovafloxacin results in decreased expression of NDUFAF4 mRNA
CTD
PMID:24136188
NCBI chr 5:38,605,169...38,610,341
Ensembl chr 5:38,605,153...38,610,336
G
Ndufv1
NADH:ubiquinone oxidoreductase core subunit V1
decreases expression
ISO
trovafloxacin results in decreased expression of NDUFV1 mRNA
CTD
PMID:35537566
NCBI chr 1:201,300,365...201,305,461
Ensembl chr 1:201,299,985...201,305,466
G
Neb
nebulin
increases expression
ISO
trovafloxacin results in increased expression of NEB mRNA
CTD
PMID:35537566
NCBI chr 3:36,613,677...36,811,618
Ensembl chr 3:36,613,716...36,811,574
G
Necap1
NECAP endocytosis associated 1
increases expression
ISO
trovafloxacin results in increased expression of NECAP1 mRNA
CTD
PMID:35537566
NCBI chr 4:156,103,935...156,119,068
Ensembl chr 4:156,103,988...156,119,068
G
Nedd4l
NEDD4 like E3 ubiquitin protein ligase
multiple interactions decreases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NEDD4L mRNA trovafloxacin results in decreased expression of NEDD4L mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr18:58,393,759...58,726,709
Ensembl chr18:58,393,509...58,723,137
G
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
multiple interactions decreases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NEDD9 mRNA trovafloxacin results in decreased expression of NEDD9 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
G
Neil3
nei-like DNA glycosylase 3
decreases expression
ISO
trovafloxacin results in decreased expression of NEIL3 mRNA
CTD
PMID:35537566
NCBI chr16:38,359,305...38,418,528
Ensembl chr16:38,359,371...38,418,527
G
Nek1
NIMA-related kinase 1
decreases expression
ISO
trovafloxacin results in decreased expression of NEK1 mRNA
CTD
PMID:35537566
NCBI chr16:28,998,229...29,125,426
Ensembl chr16:28,998,231...29,117,723
G
Nek8
NIMA-related kinase 8
decreases expression
ISO
trovafloxacin results in decreased expression of NEK8 mRNA
CTD
PMID:35537566
NCBI chr10:63,060,868...63,073,546
Ensembl chr10:63,061,253...63,072,416
G
Nemp1
nuclear envelope integral membrane protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of NEMP1 mRNA
CTD
PMID:35537566
NCBI chr 7:63,514,025...63,538,791
Ensembl chr 7:63,479,951...63,534,602
G
Neo1
neogenin 1
decreases expression
ISO
trovafloxacin results in decreased expression of NEO1 mRNA
CTD
PMID:35537566
NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:59,275,569...59,430,348
G
Nes
nestin
decreases expression
ISO
trovafloxacin results in decreased expression of NES mRNA
CTD
PMID:35537566
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Neurl1b
neuralized E3 ubiquitin protein ligase 1B
decreases expression
ISO
trovafloxacin results in decreased expression of NEURL1B mRNA
CTD
PMID:35537566
NCBI chr10:16,754,002...16,785,049
Ensembl chr10:16,757,208...16,785,119
G
Nexn
nexilin (F actin binding protein)
decreases expression
ISO
trovafloxacin results in decreased expression of NEXN mRNA
CTD
PMID:35537566
NCBI chr 2:241,186,783...241,218,315
Ensembl chr 2:241,186,790...241,218,342
G
Nfatc1
nuclear factor of activated T-cells 1
increases expression
ISO
trovafloxacin results in increased expression of NFATC1 mRNA
CTD
PMID:35537566
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Nfia
nuclear factor I/A
decreases expression
ISO
trovafloxacin results in decreased expression of NFIA mRNA
CTD
PMID:35537566
NCBI chr 5:112,436,655...112,781,878
Ensembl chr 5:112,436,644...112,775,885
G
Nfil3
nuclear factor, interleukin 3 regulated
decreases expression
ISO
trovafloxacin results in decreased expression of NFIL3 mRNA
CTD
PMID:35537566
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
G
Nfkbia
NFKB inhibitor alpha
multiple interactions increases expression
ISO
[Lipopolysaccharides co-treated with trovafloxacin] results in increased expression of NFKBIA mRNA; [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NFKBIA mRNA; [trovafloxacin co-treated with TNF protein] results in decreased expression of NFKBIA protein; trovafloxacin promotes the reaction [TNF protein results in increased expression of NFKBIA mRNA] [trovafloxacin co-treated with TNF protein] results in increased expression of NFKBIA mRNA trovafloxacin results in increased expression of NFKBIA mRNA; trovafloxacin results in increased expression of NFKBIA protein
CTD
PMID:18930950 PMID:32035082 PMID:35537566
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbid
NFKB inhibitor delta
increases expression
ISO
trovafloxacin results in increased expression of NFKBID mRNA
CTD
PMID:35537566
NCBI chr 1:85,679,353...85,690,415
Ensembl chr 1:85,680,861...85,690,447
G
Nfkbiz
NFKB inhibitor zeta
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NFKBIZ mRNA trovafloxacin results in increased expression of NFKBIZ mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Nherf1
NHERF family PDZ scaffold protein 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NHERF1 mRNA
CTD
PMID:18930950
NCBI chr10:100,403,189...100,420,290
Ensembl chr10:100,403,069...100,420,598
G
Nhsl2
NHS-like 2
decreases expression
ISO
trovafloxacin results in decreased expression of NHSL2 mRNA
CTD
PMID:35537566
NCBI chr X:66,969,953...67,209,464
Ensembl chr X:66,970,151...67,200,911
G
Niban2
niban apoptosis regulator 2
increases expression
ISO
trovafloxacin results in increased expression of FAM129B mRNA
CTD
PMID:35537566
NCBI chr 3:16,174,674...16,224,293
Ensembl chr 3:16,174,659...16,224,293
G
Nid2
nidogen 2
decreases expression
ISO
trovafloxacin results in decreased expression of NID2 mRNA
CTD
PMID:35537566
NCBI chr15:4,458,082...4,513,808
Ensembl chr15:4,458,084...4,513,843
G
Nkain1
Sodium/potassium transporting ATPase interacting 1
increases expression
ISO
trovafloxacin results in increased expression of NKAIN1 mRNA
CTD
PMID:35537566
NCBI chr 5:142,747,702...142,792,665
Ensembl chr 5:142,747,505...142,791,863
G
Nlrx1
NLR family member X1
decreases expression
ISO
trovafloxacin results in decreased expression of NLRX1 mRNA
CTD
PMID:35537566
NCBI chr 8:44,588,476...44,606,678
Ensembl chr 8:44,590,048...44,606,484
G
Nme1
NME/NM23 nucleoside diphosphate kinase 1
decreases expression
EXP
trovafloxacin results in decreased expression of NME1 mRNA
CTD
PMID:24136188
NCBI chr10:78,907,036...78,929,659
Ensembl chr10:78,906,083...78,916,408
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
decreases expression
EXP
trovafloxacin results in decreased expression of NME2 mRNA
CTD
PMID:24136188
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538
G
Nmral1
NmrA like redox sensor 1
decreases expression
ISO
trovafloxacin results in decreased expression of NMRAL1 mRNA
CTD
PMID:35537566
NCBI chr10:10,841,693...10,850,199
Ensembl chr10:10,841,799...10,850,192
G
Nnat
neuronatin
increases expression
ISO
trovafloxacin results in increased expression of NNAT mRNA
CTD
PMID:35537566
NCBI chr 3:146,225,941...146,228,868
Ensembl chr 3:146,226,407...146,228,834
G
Nnt
nicotinamide nucleotide transhydrogenase
decreases expression
ISO
trovafloxacin results in decreased expression of NNT mRNA
CTD
PMID:35537566
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
G
Noct
nocturnin
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NOCT mRNA
CTD
PMID:18930950
NCBI chr 2:135,271,189...135,291,407
Ensembl chr 2:135,271,189...135,291,400
G
Nos1
nitric oxide synthase 1
decreases expression
ISO
trovafloxacin results in decreased expression of NOS1 mRNA
CTD
PMID:35537566
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nos2
nitric oxide synthase 2
decreases expression
ISO
trovafloxacin results in decreased expression of NOS2 mRNA
CTD
PMID:35537566
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Notch2
notch receptor 2
decreases expression
EXP
trovafloxacin results in decreased expression of NOTCH2 mRNA
CTD
PMID:24136188
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
G
Noxred1
NADP-dependent oxidoreductase domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of NOXRED1 mRNA
CTD
PMID:35537566
NCBI chr 6:106,862,350...106,888,113
Ensembl chr 6:106,862,343...106,884,712
G
Nphp4
nephrocystin 4
decreases expression
ISO
trovafloxacin results in decreased expression of NPHP4 mRNA
CTD
PMID:35537566
NCBI chr 5:162,986,157...163,073,708
Ensembl chr 5:162,988,370...163,073,706
G
Npnt
nephronectin
decreases expression
ISO
trovafloxacin results in decreased expression of NPNT mRNA
CTD
PMID:35537566
NCBI chr 2:221,391,151...221,459,527
Ensembl chr 2:221,391,153...221,459,401
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
increases expression
ISO
trovafloxacin results in increased expression of NR1D1 mRNA
CTD
PMID:35537566
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
G
Nr2f6
nuclear receptor subfamily 2, group F, member 6
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of NR2F6 mRNA
CTD
PMID:18930950
NCBI chr16:18,046,012...18,053,914
Ensembl chr16:18,046,013...18,053,459
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
increases expression
EXP
trovafloxacin results in increased expression of NR3C1 mRNA
CTD
PMID:24136188
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
increases expression
ISO
trovafloxacin results in increased expression of NR4A1 mRNA
CTD
PMID:35537566
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression
ISO
trovafloxacin results in increased expression of NR4A2 mRNA
CTD
PMID:35537566
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
G
Nradd
neurotrophin receptor associated death domain
increases expression
ISO
trovafloxacin results in increased expression of NRADD mRNA
CTD
PMID:35537566
NCBI chr 8:110,599,667...110,603,068
Ensembl chr 8:110,599,667...110,603,149
G
Nsl1
NSL1 component of MIS12 kinetochore complex
decreases expression
ISO
trovafloxacin results in decreased expression of NSL1 mRNA
CTD
PMID:35537566
NCBI chr13:102,649,050...102,674,059
Ensembl chr13:102,649,058...102,674,054
G
Nt5dc2
5'-nucleotidase domain containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of NT5DC2 mRNA
CTD
PMID:35537566
NCBI chr16:6,322,485...6,330,538
Ensembl chr16:6,322,236...6,330,537
G
Nuak2
NUAK family kinase 2
increases expression
ISO
trovafloxacin results in increased expression of NUAK2 mRNA
CTD
PMID:35537566
NCBI chr13:43,753,454...43,770,604
Ensembl chr13:43,753,832...43,770,604
G
Nudt22
nudix hydrolase 22
increases expression
ISO
trovafloxacin results in increased expression of NUDT22 mRNA
CTD
PMID:35537566
NCBI chr 1:204,182,797...204,186,421
Ensembl chr 1:204,182,802...204,186,280
G
Nudt6
nudix hydrolase 6
decreases expression
ISO
trovafloxacin results in decreased expression of NUDT6 mRNA
CTD
PMID:35537566
NCBI chr 2:120,289,908...120,306,197
Ensembl chr 2:120,290,847...120,306,230
G
Nudt7
nudix hydrolase 7
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of NUDT7 mRNA
CTD
PMID:18930950
NCBI chr19:42,125,679...42,151,198
Ensembl chr19:42,125,711...42,151,081
G
Nuf2
NUF2 component of NDC80 kinetochore complex
decreases expression
ISO
trovafloxacin results in decreased expression of NUF2 mRNA
CTD
PMID:35537566
NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766
G
Nup205
nucleoporin 205
decreases expression
ISO
trovafloxacin results in decreased expression of NUP205 mRNA
CTD
PMID:35537566
NCBI chr 4:63,854,934...63,920,852
Ensembl chr 4:63,854,783...63,920,844
G
Nup210
nucleoporin 210
decreases expression
ISO
trovafloxacin results in decreased expression of NUP210 mRNA
CTD
PMID:35537566
NCBI chr 4:123,511,558...123,609,874
Ensembl chr 4:123,511,559...123,609,874
G
Nup98
nucleoporin 98 and 96 precursor
increases expression
EXP
trovafloxacin results in increased expression of NUP98 mRNA
CTD
PMID:24136188
NCBI chr 1:156,494,423...156,591,415
Ensembl chr 1:156,494,423...156,591,415
G
Nupr1
nuclear protein 1, transcriptional regulator
decreases expression
ISO
trovafloxacin results in decreased expression of NUPR1 mRNA
CTD
PMID:35537566
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Nusap1
nucleolar and spindle associated protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of NUSAP1 mRNA
CTD
PMID:35537566
NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624
G
Nxn
nucleoredoxin
decreases expression
ISO
trovafloxacin results in decreased expression of NXN mRNA
CTD
PMID:35537566
NCBI chr10:61,109,322...61,247,578
Ensembl chr10:61,110,020...61,248,251
G
Nxnl1
nucleoredoxin-like 1
increases expression
ISO
trovafloxacin results in increased expression of NXNL1 mRNA
CTD
PMID:35537566
NCBI chr16:18,270,604...18,279,797
Ensembl chr16:18,262,688...18,279,987
G
Nxph4
neurexophilin 4
decreases expression
ISO
trovafloxacin results in decreased expression of NXPH4 mRNA
CTD
PMID:35537566
NCBI chr 7:63,367,758...63,376,579
Ensembl chr 7:63,367,761...63,376,579
G
Oas2
2'-5' oligoadenylate synthetase 2
increases expression
ISO
trovafloxacin results in increased expression of OAS2 mRNA
CTD
PMID:35537566
NCBI chr12:35,802,824...35,830,778
Ensembl chr12:35,806,759...35,829,371
G
Oasl
2'-5'-oligoadenylate synthetase-like
increases expression
ISO
trovafloxacin results in increased expression of OASL1 mRNA
CTD
PMID:35537566
NCBI chr12:41,682,900...41,695,641
Ensembl chr12:41,682,900...41,695,641
G
Obp3
alpha-2u globulin PGCL4
increases expression
EXP
trovafloxacin results in increased expression of OBP3 mRNA
CTD
PMID:24136188
NCBI chr 5:74,842,316...74,845,858
Ensembl chr 5:74,842,316...74,845,757
G
Ogfrl1
opioid growth factor receptor-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of OGFRL1 mRNA
CTD
PMID:35537566
NCBI chr 9:25,828,865...25,842,424
Ensembl chr 9:25,828,869...25,842,352
G
Oip5
Opa interacting protein 5
decreases expression
ISO
trovafloxacin results in decreased expression of OIP5 mRNA
CTD
PMID:35537566
NCBI chr 3:106,593,746...106,603,281
Ensembl chr 3:106,593,760...106,603,250
G
Olr1271
olfactory receptor 1271
decreases expression
ISO
trovafloxacin results in decreased expression of OR8D1B mRNA
CTD
PMID:35537566
NCBI chr 8:39,127,409...39,131,889
Ensembl chr 8:39,127,352...39,131,900
G
Oplah
5-oxoprolinase (ATP-hydrolysing)
decreases expression
ISO
trovafloxacin results in decreased expression of OPLAH mRNA
CTD
PMID:35537566
NCBI chr 7:108,011,472...108,051,751
Ensembl chr 7:108,011,475...108,035,297
G
Optn
optineurin
decreases expression
ISO
trovafloxacin results in decreased expression of OPTN mRNA
CTD
PMID:35537566
NCBI chr17:73,209,572...73,260,251
Ensembl chr17:73,209,575...73,260,251
G
Orai2
ORAI calcium release-activated calcium modulator 2
increases expression
ISO
trovafloxacin results in increased expression of ORAI2 mRNA
CTD
PMID:35537566
NCBI chr12:20,500,308...20,520,428
Ensembl chr12:20,497,317...20,520,428
G
Osbpl10
oxysterol binding protein-like 10
decreases expression
ISO
trovafloxacin results in decreased expression of OSBPL10 mRNA
CTD
PMID:35537566
NCBI chr 8:114,661,050...114,918,664
Ensembl chr 8:114,660,743...114,918,625
G
Osbpl1a
oxysterol binding protein-like 1A
decreases expression
ISO
trovafloxacin results in decreased expression of OSBPL1A mRNA
CTD
PMID:35537566
NCBI chr18:3,904,006...4,094,635
Ensembl chr18:3,904,006...4,094,585
G
Osgep
O-sialoglycoprotein endopeptidase
decreases expression
ISO
trovafloxacin results in decreased expression of OSGEP mRNA
CTD
PMID:35537566
NCBI chr15:24,137,149...24,144,568
Ensembl chr15:24,137,153...24,144,568
G
Ost4
oligosaccharyltransferase complex subunit 4, non-catalytic
increases expression
ISO
trovafloxacin results in increased expression of OST4 mRNA
CTD
PMID:35537566
NCBI chr 6:25,471,254...25,472,478
G
P2ry2
purinergic receptor P2Y2
decreases expression
EXP
trovafloxacin results in decreased expression of P2RY2 mRNA
CTD
PMID:24136188
NCBI chr 1:155,352,050...155,367,423
Ensembl chr 1:155,351,165...155,367,632
G
P3h3
prolyl 3-hydroxylase 3
decreases expression
ISO
trovafloxacin results in decreased expression of P3H3 mRNA
CTD
PMID:35537566
NCBI chr 4:157,646,242...157,662,035
Ensembl chr 4:157,646,243...157,662,035
G
Pabir2
PABIR family member 2
decreases expression
ISO
trovafloxacin results in decreased expression of PABIR2 mRNA
CTD
PMID:35537566
NCBI chr X:132,989,124...133,015,625
Ensembl chr X:132,989,124...133,015,580
G
Pabpc1l
poly(A) binding protein, cytoplasmic 1-like
increases expression
ISO
trovafloxacin results in increased expression of PABPC1L mRNA
CTD
PMID:35537566
NCBI chr 3:152,692,825...152,725,997
Ensembl chr 3:152,693,700...152,725,997
G
Pacsin2
protein kinase C and casein kinase substrate in neurons 2
decreases expression
EXP
trovafloxacin results in decreased expression of PACSIN2 mRNA
CTD
PMID:24136188
NCBI chr 7:114,505,525...114,599,087
Ensembl chr 7:114,505,152...114,598,546
G
Pag1
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
decreases expression
ISO
trovafloxacin results in decreased expression of PAG1 mRNA
CTD
PMID:35537566
NCBI chr 2:91,935,378...92,076,937
Ensembl chr 2:92,057,216...92,069,849
G
Pald1
phosphatase domain containing, paladin 1
decreases expression
ISO
trovafloxacin results in decreased expression of PALD1 mRNA
CTD
PMID:35537566
NCBI chr20:29,269,814...29,334,850
Ensembl chr20:29,270,193...29,334,858
G
Pals2
protein associated with LIN7 2, MAGUK p55 family member
decreases expression
ISO
trovafloxacin results in decreased expression of MPP6 mRNA
CTD
PMID:35537566
NCBI chr 4:79,173,488...79,257,542
Ensembl chr 4:79,124,806...79,254,140
G
Paox
polyamine oxidase
decreases expression
ISO
trovafloxacin results in decreased expression of PAOX mRNA
CTD
PMID:35537566
NCBI chr 1:194,919,655...194,928,498
Ensembl chr 1:194,903,273...194,928,504
G
Pard6a
par-6 family cell polarity regulator alpha
decreases expression
ISO
trovafloxacin results in decreased expression of PARD6A mRNA
CTD
PMID:35537566
NCBI chr19:33,589,531...33,591,900
Ensembl chr19:33,589,542...33,591,900
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage multiple interactions
ISO
trovafloxacin results in increased cleavage of PARP1 protein ATG5 protein affects the reaction [trovafloxacin results in increased cleavage of PARP1 protein]
CTD
PMID:33609687
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Parp10
poly (ADP-ribose) polymerase family, member 10
increases expression
ISO
trovafloxacin results in increased expression of PARP10 mRNA
CTD
PMID:35537566
NCBI chr 7:107,949,031...107,958,377
Ensembl chr 7:107,949,043...107,958,304
G
Parp14
poly (ADP-ribose) polymerase family, member 14
increases expression
ISO
trovafloxacin results in increased expression of PARP14 mRNA
CTD
PMID:35537566
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
G
Parpbp
PARP1 binding protein
decreases expression
ISO
trovafloxacin results in decreased expression of PARPBP mRNA
CTD
PMID:35537566
NCBI chr 7:22,511,427...22,580,834
Ensembl chr 7:22,511,427...22,573,695
G
Pask
PAS domain containing serine/threonine kinase
decreases expression
ISO
trovafloxacin results in decreased expression of PASK mRNA
CTD
PMID:35537566
NCBI chr 9:93,844,275...93,886,036
Ensembl chr 9:93,844,278...93,885,111
G
Pax6
paired box 6
decreases expression
ISO
trovafloxacin results in decreased expression of PAX6 mRNA
CTD
PMID:35537566
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
G
Pbk
PDZ binding kinase
decreases expression
ISO
trovafloxacin results in decreased expression of PBK mRNA
CTD
PMID:35537566
NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
G
Pbld1
phenazine biosynthesis-like protein domain containing 1
increases expression
EXP
trovafloxacin results in increased expression of PBLD1 mRNA
CTD
PMID:24136188
NCBI chr20:25,551,274...25,566,543
Ensembl chr20:25,551,275...25,565,614
G
Pbx3
PBX homeobox 3
decreases expression
ISO
trovafloxacin results in decreased expression of PBX3 mRNA
CTD
PMID:35537566
NCBI chr 3:17,488,691...17,682,412
Ensembl chr 3:17,488,693...17,682,791
G
Pc
pyruvate carboxylase
decreases expression
ISO
trovafloxacin results in decreased expression of PCX mRNA
CTD
PMID:35537566
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
G
Pcdhb19
protocadherin beta 19
increases expression
ISO
trovafloxacin results in increased expression of PCDHB12 mRNA
CTD
PMID:35537566
NCBI chr18:29,204,838...29,207,646
G
Pcdhb20
protocadherin beta 20
increases expression
ISO
trovafloxacin results in increased expression of PCDHB14 mRNA
CTD
PMID:35537566
NCBI chr18:29,211,878...29,215,272
Ensembl chr18:29,211,883...29,215,258
G
Pcdhb22
protocadherin beta 22
increases expression
ISO
trovafloxacin results in increased expression of PCDHB22 mRNA
CTD
PMID:35537566
NCBI chr18:29,223,028...29,229,132
Ensembl chr18:29,223,149...29,225,536
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
decreases expression
ISO
trovafloxacin results in decreased expression of PCK2 mRNA
CTD
PMID:35537566
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
G
Pclaf
PCNA clamp associated factor
decreases expression
ISO
trovafloxacin results in decreased expression of PCLAF mRNA
CTD
PMID:35537566
NCBI chr 8:66,420,606...66,432,994
Ensembl chr 8:66,420,587...66,432,994 Ensembl chr 8:66,420,587...66,432,994
G
Pcnt
pericentrin
decreases expression
ISO
trovafloxacin results in decreased expression of PCNT mRNA
CTD
PMID:35537566
NCBI chr20:12,190,597...12,278,723
Ensembl chr20:12,191,648...12,278,710
G
Pcsk6
proprotein convertase subtilisin/kexin type 6
decreases expression
EXP
trovafloxacin results in decreased expression of PCSK6 mRNA
CTD
PMID:24136188
NCBI chr 1:119,428,978...119,627,626
Ensembl chr 1:119,429,265...119,627,596
G
Pctp
phosphatidylcholine transfer protein
decreases expression
EXP
trovafloxacin results in decreased expression of PCTP mRNA
CTD
PMID:24136188
NCBI chr10:74,808,887...74,856,260
Ensembl chr10:74,808,887...74,849,867
G
Pcyox1l
prenylcysteine oxidase 1 like
decreases expression
ISO
trovafloxacin results in decreased expression of PCYOX1L mRNA
CTD
PMID:35537566
NCBI chr18:55,150,637...55,161,334
Ensembl chr18:55,150,650...55,161,327
G
Pde1b
phosphodiesterase 1B
increases expression
ISO
trovafloxacin results in increased expression of PDE1B mRNA
CTD
PMID:35537566
NCBI chr 7:134,627,378...134,654,581
Ensembl chr 7:134,627,322...134,654,580
G
Pde4b
phosphodiesterase 4B
decreases expression multiple interactions
EXP ISO
trovafloxacin results in decreased expression of PDE4B mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PDE4B mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
G
Pde4d
phosphodiesterase 4D
decreases expression
ISO
trovafloxacin results in decreased expression of PDE4D mRNA
CTD
PMID:35537566
NCBI chr 2:40,014,933...41,529,190
Ensembl chr 2:40,019,933...41,525,884
G
Pde6b
phosphodiesterase 6B
decreases expression
ISO
trovafloxacin results in decreased expression of PDE6B mRNA
CTD
PMID:35537566
NCBI chr14:1,323,310...1,366,450
Ensembl chr14:1,323,310...1,366,450
G
Pdhx
pyruvate dehydrogenase complex, component X
decreases expression
EXP
trovafloxacin results in decreased expression of PDHX mRNA
CTD
PMID:24136188
NCBI chr 3:89,372,248...89,431,779
Ensembl chr 3:89,371,497...89,431,773
G
Pdlim1
PDZ and LIM domain 1
decreases expression
EXP
trovafloxacin results in decreased expression of PDLIM1 mRNA
CTD
PMID:24136188
NCBI chr 1:239,042,372...239,091,074
Ensembl chr 1:239,042,385...239,091,076
G
Pdpr
pyruvate dehydrogenase phosphatase regulatory subunit
decreases expression
ISO
trovafloxacin results in decreased expression of PDPR mRNA
CTD
PMID:35537566
NCBI chr19:39,065,226...39,109,695
Ensembl chr19:39,065,157...39,109,688
G
Pds5b
PDS5 cohesin associated factor B
decreases expression
ISO
trovafloxacin results in decreased expression of PDS5B mRNA
CTD
PMID:35537566
NCBI chr12:202,481...345,596
Ensembl chr12:255,313...345,596
G
Per1
period circadian regulator 1
increases expression
ISO
trovafloxacin results in increased expression of PER1 mRNA
CTD
PMID:35537566
NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431
G
Per2
period circadian regulator 2
increases expression
ISO
trovafloxacin results in increased expression of PER2 mRNA
CTD
PMID:35537566
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
G
Perm1
PPARGC1 and ESRR induced regulator, muscle 1
increases expression
ISO
trovafloxacin results in increased expression of PERM1 mRNA
CTD
PMID:35537566
NCBI chr 5:166,800,030...166,805,323
Ensembl chr 5:166,800,030...166,805,323
G
Perp
p53 apoptosis effector related to PMP22
decreases expression
EXP
trovafloxacin results in decreased expression of PERP mRNA
CTD
PMID:24136188
NCBI chr 1:13,542,067...13,554,514
Ensembl chr 1:13,542,067...13,554,511
G
Pex2
peroxisomal biogenesis factor 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of PEX2 mRNA
CTD
PMID:18930950
NCBI chr 2:96,050,380...96,072,928
Ensembl chr 2:96,045,958...96,073,404
G
Pex7
peroxisomal biogenesis factor 7
decreases expression
ISO
trovafloxacin results in decreased expression of PEX7 mRNA
CTD
PMID:35537566
NCBI chr 1:14,582,698...14,646,686
Ensembl chr 1:14,582,699...14,646,748
G
Pgap1
post-GPI attachment to proteins inositol deacylase 1
decreases expression
ISO
trovafloxacin results in decreased expression of PGAP1 mRNA
CTD
PMID:35537566
NCBI chr 9:55,975,574...56,044,325
Ensembl chr 9:55,975,667...56,044,464
G
Pgghg
protein-glucosylgalactosylhydroxylysine glucosidase
decreases expression
ISO
trovafloxacin results in decreased expression of PGGHG mRNA
CTD
PMID:35537566
NCBI chr 1:196,038,276...196,044,561
Ensembl chr 1:196,039,103...196,044,372
G
Pgk1
phosphoglycerate kinase 1
decreases expression
EXP
trovafloxacin results in decreased expression of PGK1 mRNA
CTD
PMID:24136188
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
G
Pgm1
phosphoglucomutase 1
decreases expression
EXP
trovafloxacin results in decreased expression of PGM1 mRNA
CTD
PMID:24136188
NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:114,595,293...114,654,728
G
Pgm2l1
phosphoglucomutase 2-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of PGM2L1 mRNA
CTD
PMID:35537566
NCBI chr 1:154,571,410...154,620,901
Ensembl chr 1:154,571,766...154,620,902
G
Pheta1
PH domain containing endocytic trafficking adaptor 1
increases expression
ISO
trovafloxacin results in increased expression of FAM109A mRNA
CTD
PMID:35537566
NCBI chr12:34,711,831...34,717,601
Ensembl chr12:34,711,810...34,717,081
G
Phf10
PHD finger protein 10
decreases expression
ISO
trovafloxacin results in decreased expression of PHF10 mRNA
CTD
PMID:35537566
NCBI chr 1:55,952,249...55,968,994
Ensembl chr 1:55,952,253...55,969,038
G
Phf11
PHD finger protein 11
increases expression
ISO
trovafloxacin results in increased expression of PHF11D mRNA
CTD
PMID:35537566
NCBI chr15:33,390,290...33,414,647
Ensembl chr15:33,390,292...33,413,009
G
Phf19
PHD finger protein 19
decreases expression
ISO
trovafloxacin results in decreased expression of PHF19 mRNA
CTD
PMID:35537566
NCBI chr 3:18,175,281...18,197,289
Ensembl chr 3:18,175,282...18,196,405
G
Phf7
PHD finger protein 7
decreases expression
ISO
trovafloxacin results in decreased expression of PHF7 mRNA
CTD
PMID:35537566
NCBI chr16:6,433,535...6,446,314
Ensembl chr16:6,433,537...6,446,911
G
Phgdh
phosphoglycerate dehydrogenase
decreases expression
ISO
trovafloxacin results in decreased expression of PHGDH mRNA
CTD
PMID:35537566
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
G
Phka2
phosphorylase kinase regulatory subunit alpha 2
decreases expression
ISO
trovafloxacin results in decreased expression of PHKA2 mRNA
CTD
PMID:35537566
NCBI chr X:34,170,959...34,293,498
Ensembl chr X:34,171,323...34,293,466
G
Phkb
phosphorylase kinase regulatory subunit beta
decreases expression
ISO
trovafloxacin results in decreased expression of PHKB mRNA
CTD
PMID:35537566
NCBI chr19:21,013,719...21,210,671
Ensembl chr19:21,025,733...21,210,633
G
Phlda1
pleckstrin homology-like domain, family A, member 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PHLDA1 mRNA
CTD
PMID:18930950
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Phlda3
pleckstrin homology-like domain, family A, member 3
increases expression
ISO
trovafloxacin results in increased expression of PHLDA3 mRNA
CTD
PMID:35537566
NCBI chr13:47,193,250...47,196,335
Ensembl chr13:47,193,086...47,196,335
G
Pi16
peptidase inhibitor 16
decreases expression
ISO
trovafloxacin results in decreased expression of PI16 mRNA
CTD
PMID:35537566
NCBI chr20:7,376,073...7,385,386
Ensembl chr20:7,376,126...7,385,383
G
Pi4ka
phosphatidylinositol 4-kinase alpha
decreases expression
ISO
trovafloxacin results in decreased expression of PI4KA mRNA
CTD
PMID:35537566
NCBI chr11:83,609,148...83,726,876
Ensembl chr11:83,609,069...83,724,080
G
Pif1
PIF1 5'-to-3' DNA helicase
decreases expression
ISO
trovafloxacin results in decreased expression of PIF1 mRNA
CTD
PMID:35537566
NCBI chr 8:66,110,641...66,120,202
Ensembl chr 8:66,111,072...66,120,200
G
Pign
phosphatidylinositol glycan anchor biosynthesis, class N
decreases expression
ISO
trovafloxacin results in decreased expression of PIGN mRNA
CTD
PMID:35537566
NCBI chr13:21,659,092...21,812,932
Ensembl chr13:21,662,455...21,806,790
G
Pigv
phosphatidylinositol glycan anchor biosynthesis, class V
decreases expression
ISO
trovafloxacin results in decreased expression of PIGV mRNA
CTD
PMID:35537566
NCBI chr 5:145,889,642...145,901,533
Ensembl chr 5:145,889,646...145,901,533
G
Pih1d1
PIH1 domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of PIH1D1 mRNA
CTD
PMID:35537566
NCBI chr 1:95,639,597...95,645,295
Ensembl chr 1:95,639,592...95,645,290
G
Pih1d2
PIH1 domain containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of PIH1D2 mRNA
CTD
PMID:35537566
NCBI chr 8:50,966,885...50,976,901
Ensembl chr 8:50,966,885...50,975,656
G
Pik3ap1
phosphoinositide-3-kinase adaptor protein 1
increases expression
ISO
trovafloxacin results in increased expression of PIK3AP1 mRNA
CTD
PMID:35537566
NCBI chr 1:240,090,854...240,245,007
Ensembl chr 1:240,093,065...240,204,828
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
decreases expression
ISO
trovafloxacin results in decreased expression of PIK3CG mRNA
CTD
PMID:35537566
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
G
Pimreg
PICALM interacting mitotic regulator
decreases expression
ISO
trovafloxacin results in decreased expression of FAM64A mRNA
CTD
PMID:35537566
NCBI chr10:56,669,603...56,674,540
Ensembl chr10:56,669,675...56,674,791
G
Pink1
PTEN induced kinase 1
increases expression
EXP
trovafloxacin results in increased expression of PINK1 mRNA
CTD
PMID:24136188
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
G
Pip5k1a
phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PIP5K1A mRNA
CTD
PMID:18930950
NCBI chr 2:182,628,299...182,671,584
Ensembl chr 2:182,628,300...182,671,598
G
Pisd
phosphatidylserine decarboxylase
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of PISD mRNA
CTD
PMID:18930950
NCBI chr14:77,941,927...77,991,021
Ensembl chr14:77,941,948...77,991,003
G
Piwil2
piwi-like RNA-mediated gene silencing 2
decreases expression
ISO
trovafloxacin results in decreased expression of PIWIL2 mRNA
CTD
PMID:35537566
NCBI chr15:45,431,402...45,498,034
Ensembl chr15:45,431,703...45,497,702
G
Pkmyt1
protein kinase, membrane associated tyrosine/threonine 1
decreases expression
ISO
trovafloxacin results in decreased expression of PKMYT1 mRNA
CTD
PMID:35537566
NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995
G
Plau
plasminogen activator, urokinase
increases expression
ISO
trovafloxacin results in increased expression of PLAU mRNA
CTD
PMID:35537566
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Plbd1
phospholipase B domain containing 1
decreases expression
EXP
trovafloxacin results in decreased expression of PLBD1 mRNA
CTD
PMID:24136188
NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277
G
Plcg1
phospholipase C, gamma 1
decreases expression
ISO
trovafloxacin results in decreased expression of PLCG1 mRNA
CTD
PMID:35537566
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
G
Plcxd1
phosphatidylinositol-specific phospholipase C, X domain containing 1
increases expression
ISO
trovafloxacin results in increased expression of PLCXD1 mRNA
CTD
PMID:35537566
NCBI chr12:46,578,917...46,582,181
Ensembl chr12:46,579,225...46,582,392
G
Pld6
phospholipase D family, member 6
increases expression
ISO
trovafloxacin results in increased expression of PLD6 mRNA
CTD
PMID:35537566
NCBI chr10:44,578,536...44,581,187
Ensembl chr10:44,577,675...44,581,077
G
Plekhh2
pleckstrin homology, MyTH4 and FERM domain containing H2
decreases expression
ISO
trovafloxacin results in decreased expression of PLEKHH2 mRNA
CTD
PMID:35537566
NCBI chr 6:10,032,837...10,132,081
Ensembl chr 6:10,032,660...10,140,794
G
Plekhn1
pleckstrin homology domain containing N1
increases expression
ISO
trovafloxacin results in increased expression of PLEKHN1 mRNA
CTD
PMID:35537566
NCBI chr 5:166,805,309...166,813,339
Ensembl chr 5:166,804,837...166,813,155
G
Plin2
perilipin 2
decreases expression
EXP
trovafloxacin results in decreased expression of PLIN2 mRNA
CTD
PMID:24136188
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
G
Plin3
perilipin 3
decreases expression
EXP
trovafloxacin results in decreased expression of PLIN3 mRNA
CTD
PMID:24136188
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
G
Plk1
polo-like kinase 1
decreases expression
ISO
trovafloxacin results in decreased expression of PLK1 mRNA
CTD
PMID:35537566
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
G
Plk2
polo-like kinase 2
increases expression
ISO
trovafloxacin results in increased expression of PLK2 mRNA
CTD
PMID:35537566
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
G
Plk3
polo-like kinase 3
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PLK3 mRNA trovafloxacin results in increased expression of PLK3 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
G
Plpp3
phospholipid phosphatase 3
increases expression
EXP
trovafloxacin results in increased expression of PLPP3 mRNA
CTD
PMID:24136188
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
G
Plppr3
phospholipid phosphatase related 3
increases expression
ISO
trovafloxacin results in increased expression of PLPPR3 mRNA
CTD
PMID:35537566
NCBI chr 7:9,831,162...9,842,434
Ensembl chr 7:9,831,162...9,845,296
G
Plxna3
plexin A3
decreases expression
ISO
trovafloxacin results in decreased expression of PLXNA3 mRNA
CTD
PMID:35537566
NCBI chr X:152,115,699...152,131,608
Ensembl chr X:152,115,819...152,131,603
G
Plxnd1
plexin D1
decreases expression
ISO
trovafloxacin results in decreased expression of PLXND1 mRNA
CTD
PMID:35537566
NCBI chr 4:149,002,786...149,043,097
Ensembl chr 4:149,002,784...149,043,244
G
Pmepa1
prostate transmembrane protein, androgen induced 1
increases expression
ISO
trovafloxacin results in increased expression of PMEPA1 mRNA
CTD
PMID:35537566
NCBI chr 3:162,011,884...162,060,343
Ensembl chr 3:162,012,751...162,060,454
G
Pms1
PMS1 homolog 1, mismatch repair system component
decreases expression
ISO
trovafloxacin results in decreased expression of PMS1 mRNA
CTD
PMID:35537566
NCBI chr 9:48,229,403...48,340,237
Ensembl chr 9:48,253,410...48,340,237
G
Pnp
purine nucleoside phosphorylase
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PNP2 mRNA
CTD
PMID:18930950
NCBI chr15:24,170,607...24,178,269
Ensembl chr15:24,170,602...24,203,986
G
Poc1a
POC1 centriolar protein A
decreases expression
ISO
trovafloxacin results in decreased expression of POC1A mRNA
CTD
PMID:35537566
NCBI chr 8:106,922,058...106,991,678
Ensembl chr 8:106,922,978...106,991,089
G
Poglut2
protein O-glucosyltransferase 2
decreases expression
ISO
trovafloxacin results in decreased expression of KDELC1 mRNA
CTD
PMID:35537566
NCBI chr 9:46,256,388...46,268,714
Ensembl chr 9:46,256,390...46,268,532
G
Pola1
DNA polymerase alpha 1, catalytic subunit
decreases expression
ISO
trovafloxacin results in decreased expression of POLA1 mRNA
CTD
PMID:35537566
NCBI chr X:58,034,617...58,348,612
Ensembl chr X:58,034,619...58,348,536
G
Pold1
DNA polymerase delta 1, catalytic subunit
decreases expression
ISO
trovafloxacin results in decreased expression of POLD1 mRNA
CTD
PMID:35537566
NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:95,025,499...95,036,465
G
Pole
DNA polymerase epsilon, catalytic subunit
decreases expression
ISO
trovafloxacin results in decreased expression of POLE mRNA
CTD
PMID:35537566
NCBI chr12:46,345,420...46,393,984
Ensembl chr12:46,345,420...46,393,939
G
Polq
DNA polymerase theta
decreases expression
ISO
trovafloxacin results in decreased expression of POLQ mRNA
CTD
PMID:35537566
NCBI chr11:63,673,796...63,775,905
Ensembl chr11:63,673,816...63,775,878
G
Polr2d
RNA polymerase II subunit D
increases expression
ISO
trovafloxacin results in increased expression of POLR2D mRNA
CTD
PMID:35537566
NCBI chr18:23,418,097...23,425,228
Ensembl chr18:23,418,097...23,425,228
G
Polr2k
RNA polymerase II, I and III subunit K
increases expression
ISO
trovafloxacin results in increased expression of POLR2K mRNA
CTD
PMID:35537566
NCBI chr 7:67,347,118...67,359,466
Ensembl chr 7:67,356,113...67,357,668
G
Polr3b
RNA polymerase III subunit B
decreases expression
ISO
trovafloxacin results in decreased expression of POLR3B mRNA
CTD
PMID:35537566
NCBI chr 7:19,039,179...19,142,450
Ensembl chr 7:19,038,552...19,142,598
G
Polr3g
RNA polymerase III subunit G
increases expression
ISO
trovafloxacin results in increased expression of POLR3G mRNA
CTD
PMID:35537566
NCBI chr 2:11,945,215...11,986,125
Ensembl chr 2:11,945,217...11,986,125
G
Polrmt
RNA polymerase mitochondrial
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of POLRMT mRNA
CTD
PMID:18930950
NCBI chr 7:9,959,532...9,969,791
Ensembl chr 7:9,959,576...9,969,791
G
Pomc
proopiomelanocortin
increases expression
ISO
trovafloxacin results in increased expression of POMC mRNA
CTD
PMID:35537566
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Pomt1
protein-O-mannosyltransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of POMT1 mRNA
CTD
PMID:35537566
NCBI chr 3:15,520,717...15,538,579
Ensembl chr 3:15,520,481...15,538,581
G
Poted
POTE ankyrin domain family member D
increases expression
ISO
trovafloxacin results in increased expression of POTEFAM3E mRNA
CTD
PMID:35537566
NCBI chr17:57,942,124...57,975,149
Ensembl chr17:57,942,162...57,975,654
G
Ppa1
inorganic pyrophosphatase 1
decreases expression
EXP
trovafloxacin results in decreased expression of PPA1 mRNA
CTD
PMID:24136188
NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215
G
Ppara
peroxisome proliferator activated receptor alpha
decreases expression
ISO
trovafloxacin results in decreased expression of PPARA mRNA
CTD
PMID:25689681
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppfia4
PTPRF interacting protein alpha 4
decreases expression
ISO
trovafloxacin results in decreased expression of PPFIA4 mRNA
CTD
PMID:35537566
NCBI chr13:45,753,827...45,802,305
Ensembl chr13:45,753,827...45,802,261
G
Ppid
peptidylprolyl isomerase D
increases expression
ISO
trovafloxacin results in increased expression of PPID mRNA
CTD
PMID:35537566
NCBI chr 2:164,727,803...164,740,168
Ensembl chr 2:164,727,779...164,740,221
G
Ppie
peptidylprolyl isomerase E
decreases expression
ISO
trovafloxacin results in decreased expression of PPIE mRNA
CTD
PMID:35537566
NCBI chr 5:135,406,172...135,419,332
Ensembl chr 5:135,406,176...135,419,235
G
Ppm1f
protein phosphatase, Mg2+/Mn2+ dependent, 1F
increases expression
ISO
trovafloxacin results in increased expression of PPM1F mRNA
CTD
PMID:35537566
NCBI chr11:84,064,422...84,094,410
Ensembl chr11:84,064,420...84,094,340
G
Ppm1m
protein phosphatase, Mg2+/Mn2+ dependent, 1M
decreases expression
ISO
trovafloxacin results in decreased expression of PPM1M mRNA
CTD
PMID:35537566
NCBI chr 8:106,836,221...106,843,472
Ensembl chr 8:106,837,037...106,842,057
G
Ppox
protoporphyrinogen oxidase
decreases expression
EXP
trovafloxacin results in decreased expression of PPOX mRNA
CTD
PMID:24136188
NCBI chr13:83,697,661...83,701,998
Ensembl chr13:83,664,891...83,701,805
G
Ppp1r10
protein phosphatase 1, regulatory subunit 10
increases expression
ISO
trovafloxacin results in increased expression of PPP1R10 mRNA
CTD
PMID:35537566
NCBI chr20:2,822,995...2,838,125
Ensembl chr20:2,822,995...2,837,611
G
Ppp1r11
protein phosphatase 1, regulatory (inhibitor) subunit 11
increases expression
ISO
trovafloxacin results in increased expression of PPP1R11 mRNA
CTD
PMID:35537566
NCBI chr20:1,601,350...1,604,857
Ensembl chr20:1,601,346...1,604,846
G
Ppp1r14a
protein phosphatase 1, regulatory (inhibitor) subunit 14A
decreases expression
EXP
trovafloxacin results in decreased expression of PPP1R14A mRNA
CTD
PMID:24136188
NCBI chr 1:84,583,127...84,590,743
Ensembl chr 1:84,586,627...84,590,671
G
Ppp1r14b
protein phosphatase 1, regulatory (inhibitor) subunit 14B
decreases expression
EXP
trovafloxacin results in decreased expression of PPP1R14B mRNA
CTD
PMID:24136188
NCBI chr 1:204,165,210...204,167,320
Ensembl chr 1:204,163,299...204,167,319
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PPP1R15A mRNA
CTD
PMID:18930950
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r3f
protein phosphatase 1, regulatory subunit 3F
decreases expression
ISO
trovafloxacin results in decreased expression of PPP1R3F mRNA
CTD
PMID:35537566
NCBI chr X:14,915,740...14,945,249
Ensembl chr X:14,929,323...14,945,193
G
Ppp2r3a
protein phosphatase 2, regulatory subunit B'', alpha
decreases expression
ISO
trovafloxacin results in decreased expression of PPP2R3A mRNA
CTD
PMID:35537566
NCBI chr 8:101,703,512...101,841,530
Ensembl chr 8:101,704,778...101,841,502
G
Ppp3cb
protein phosphatase 3 catalytic subunit beta
decreases expression
ISO
trovafloxacin results in decreased expression of PPP3CB mRNA
CTD
PMID:35537566
NCBI chr15:3,759,950...3,804,976
Ensembl chr15:3,760,030...3,804,981
G
Ppp3cc
protein phosphatase 3 catalytic subunit gamma
decreases expression
ISO
trovafloxacin results in decreased expression of PPP3CC mRNA
CTD
PMID:35537566
NCBI chr15:45,289,917...45,362,012
Ensembl chr15:45,290,373...45,361,832
G
Pram1
PML-RARA regulated adaptor molecule 1
decreases expression
ISO
trovafloxacin results in decreased expression of PRAM1 mRNA
CTD
PMID:35537566
NCBI chr 7:14,428,548...14,438,081
Ensembl chr 7:14,420,165...14,438,166
G
Prc1
protein regulator of cytokinesis 1
decreases expression
ISO
trovafloxacin results in decreased expression of PRC1 mRNA
CTD
PMID:35537566
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
G
Prdm1
PR/SET domain 1
increases expression
ISO
trovafloxacin results in increased expression of PRDM1 mRNA
CTD
PMID:35537566
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
G
Prdm13
PR/SET domain 13
decreases expression
ISO
trovafloxacin results in decreased expression of PRDM13 mRNA
CTD
PMID:35537566
NCBI chr 5:35,220,815...35,232,866
Ensembl chr 5:35,225,435...35,232,881
G
Preb
prolactin regulatory element binding
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of PREB mRNA
CTD
PMID:18930950
NCBI chr 6:25,418,805...25,422,594
Ensembl chr 6:25,418,776...25,422,590
G
Prickle2
prickle planar cell polarity protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of PRICKLE2 mRNA
CTD
PMID:35537566
NCBI chr 4:124,869,655...125,214,862
Ensembl chr 4:124,869,552...125,214,824
G
Prim1
DNA primase subunit 1
decreases expression
ISO
trovafloxacin results in decreased expression of PRIM1 mRNA
CTD
PMID:35537566
NCBI chr 7:446,342...462,526
Ensembl chr 7:431,805...462,526
G
Prim2
DNA primase subunit 2
decreases expression
ISO
trovafloxacin results in decreased expression of PRIM2 mRNA
CTD
PMID:35537566
NCBI chr 9:35,692,376...35,904,521
Ensembl chr 9:35,692,376...35,903,030
G
Prkar1b
protein kinase cAMP-dependent type I regulatory subunit beta
decreases expression
ISO
trovafloxacin results in decreased expression of PRKAR1B mRNA
CTD
PMID:35537566
NCBI chr12:15,492,233...15,624,942
Ensembl chr12:15,511,801...15,624,942
G
Prkcg
protein kinase C, gamma
increases expression
ISO
trovafloxacin results in increased expression of PRKCG mRNA
CTD
PMID:35537566
NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:65,832,855...65,859,384
G
Prkdc
protein kinase, DNA-activated, catalytic subunit
decreases expression
ISO
trovafloxacin results in decreased expression of PRKDC mRNA
CTD
PMID:35537566
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
G
Prkg2
protein kinase cGMP-dependent 2
decreases expression
ISO
trovafloxacin results in decreased expression of PRKG2 mRNA
CTD
PMID:35537566
NCBI chr14:10,559,882...10,668,479
Ensembl chr14:10,559,882...10,666,888
G
Prkrip1
PRKR interacting protein 1
increases expression
ISO
trovafloxacin results in increased expression of PRKRIP1 mRNA
CTD
PMID:35537566
NCBI chr12:20,470,802...20,491,789
Ensembl chr12:20,470,820...20,489,115
G
Prmt6
protein arginine methyltransferase 6
increases expression
ISO
trovafloxacin results in increased expression of PRMT6 mRNA
CTD
PMID:35537566
NCBI chr 2:197,927,750...197,932,760
Ensembl chr 2:197,927,220...197,933,648
G
Procr
protein C receptor
increases expression
ISO
trovafloxacin results in increased expression of PROCR mRNA
CTD
PMID:35537566
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
G
Prokr1
prokineticin receptor 1
increases expression
ISO
trovafloxacin results in increased expression of PROKR1 mRNA
CTD
PMID:35537566
NCBI chr 4:120,022,301...120,033,367
Ensembl chr 4:120,021,747...120,033,379
G
Proser2
proline and serine rich 2
increases expression
EXP
trovafloxacin results in increased expression of PROSER2 mRNA
CTD
PMID:24136188
NCBI chr17:72,151,961...72,187,524
Ensembl chr17:72,151,872...72,185,825
G
Proser3
proline and serine rich 3
decreases expression
ISO
trovafloxacin results in decreased expression of PROSER3 mRNA
CTD
PMID:35537566
NCBI chr 1:85,793,363...85,806,682
Ensembl chr 1:85,793,358...85,805,909
G
Prox2
prospero homeobox 2
decreases expression
ISO
trovafloxacin results in decreased expression of PROX2 mRNA
CTD
PMID:35537566
NCBI chr 6:104,731,385...104,758,619
Ensembl chr 6:104,733,002...104,742,093
G
Prpf3
pre-mRNA processing factor 3
increases expression
ISO
trovafloxacin results in increased expression of PRPF3 mRNA
CTD
PMID:35537566
NCBI chr 2:183,379,041...183,403,526
Ensembl chr 2:183,378,718...183,403,489
G
Prpf39
pre-mRNA processing factor 39
increases expression
ISO
trovafloxacin results in increased expression of PRPF39 mRNA
CTD
PMID:35537566
NCBI chr 6:83,088,981...83,113,826
Ensembl chr 6:83,088,986...83,113,825
G
Prr7
proline rich 7 (synaptic)
increases expression
ISO
trovafloxacin results in increased expression of PRR7 mRNA
CTD
PMID:35537566
NCBI chr17:9,164,375...9,173,669
Ensembl chr17:9,165,269...9,172,536
G
Prss16
serine protease 16
decreases expression
ISO
trovafloxacin results in decreased expression of PRSS16 mRNA
CTD
PMID:35537566
NCBI chr17:42,514,306...42,521,885
Ensembl chr17:42,514,306...42,521,884
G
Prss23
serine protease 23
decreases expression
EXP
trovafloxacin results in decreased expression of PRSS23 mRNA
CTD
PMID:24136188
NCBI chr 1:143,402,725...143,422,182
Ensembl chr 1:143,401,396...143,422,091
G
Prss36
serine protease 36
decreases expression
ISO
trovafloxacin results in decreased expression of PRSS36 mRNA
CTD
PMID:35537566
NCBI chr 1:182,543,085...182,561,141
Ensembl chr 1:182,543,085...182,559,280
G
Psat1
phosphoserine aminotransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of PSAT1 mRNA
CTD
PMID:35537566
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Psd
pleckstrin and Sec7 domain containing
increases expression
ISO
trovafloxacin results in increased expression of PSD mRNA
CTD
PMID:35537566
NCBI chr 1:245,173,279...245,188,681
Ensembl chr 1:245,173,279...245,189,356
G
Psenen
presenilin enhancer gamma secretase subunit
increases expression
ISO
trovafloxacin results in increased expression of PSENEN mRNA
CTD
PMID:35537566
NCBI chr 1:85,814,905...85,816,654
Ensembl chr 1:85,814,905...85,816,192
G
Psip1
PC4 and SRSF1 interacting protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of PSIP1 mRNA
CTD
PMID:35537566
NCBI chr 5:97,847,010...97,879,280
Ensembl chr 5:97,847,015...97,879,257
G
Psma5
proteasome 20S subunit alpha 5
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PSMA5 mRNA
CTD
PMID:18930950
NCBI chr 2:195,896,369...195,919,733
Ensembl chr 2:195,896,365...195,919,731
G
Psmb10
proteasome 20S subunit beta 10
decreases expression
EXP
trovafloxacin results in decreased expression of PSMB10 mRNA
CTD
PMID:24136188
NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626
G
Psph
phosphoserine phosphatase
decreases expression
ISO
trovafloxacin results in decreased expression of PSPH mRNA
CTD
PMID:35537566
NCBI chr12:26,882,524...26,905,084
Ensembl chr12:26,883,133...26,905,074
G
Ptbp2
polypyrimidine tract binding protein 2
increases expression
ISO
trovafloxacin results in increased expression of PTBP2 mRNA
CTD
PMID:35537566
NCBI chr 2:207,812,659...207,874,019
Ensembl chr 2:207,812,920...207,873,506
G
Pten
phosphatase and tensin homolog
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of PTEN mRNA
CTD
PMID:18930950
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptger1
prostaglandin E receptor 1
increases expression
ISO
trovafloxacin results in increased expression of PTGER1 mRNA
CTD
PMID:35537566
NCBI chr19:24,470,258...24,473,687
Ensembl chr19:24,467,532...24,473,559
G
Ptgr2
prostaglandin reductase 2
decreases expression
EXP
trovafloxacin results in decreased expression of PTGR2 mRNA
CTD
PMID:24136188
NCBI chr 6:103,931,367...103,963,113
Ensembl chr 6:103,931,409...103,963,111
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
trovafloxacin results in increased expression of PTGS2 mRNA
CTD
PMID:35537566
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptma
prothymosin alpha
decreases expression
EXP
trovafloxacin results in decreased expression of PTMA mRNA
CTD
PMID:24136188
NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333
G
Ptms
parathymosin
decreases expression
ISO
trovafloxacin results in decreased expression of PTMS mRNA
CTD
PMID:35537566
NCBI chr 4:157,722,384...157,726,575
Ensembl chr 4:157,722,386...157,727,009
G
Ptp4a1
protein tyrosine phosphatase 4A1
increases expression multiple interactions
EXP ISO
trovafloxacin results in increased expression of PTP4A1 mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PTP4A1 mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr 9:33,214,201...33,245,046
Ensembl chr 9:33,214,208...33,221,964
G
Ptpn2
protein tyrosine phosphatase, non-receptor type 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PTPN2 mRNA
CTD
PMID:18930950
NCBI chr18:61,229,012...61,294,662
Ensembl chr18:61,229,014...61,294,627
G
Ptpn21
protein tyrosine phosphatase, non-receptor type 21
decreases expression
EXP
trovafloxacin results in decreased expression of PTPN21 mRNA
CTD
PMID:24136188
NCBI chr 6:117,933,066...117,998,095
Ensembl chr 6:117,933,066...117,998,095
G
Ptpn5
protein tyrosine phosphatase, non-receptor type 5
decreases expression
ISO
trovafloxacin results in decreased expression of PTPN5 mRNA
CTD
PMID:35537566
NCBI chr 1:97,620,638...97,681,186
Ensembl chr 1:97,620,642...97,679,882
G
Pts
6-pyruvoyl-tetrahydropterin synthase
decreases expression
ISO
trovafloxacin results in decreased expression of PTS mRNA
CTD
PMID:35537566
NCBI chr 8:50,870,838...50,877,869
Ensembl chr 8:50,870,841...50,877,869
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
decreases expression
EXP ISO
trovafloxacin results in decreased expression of PTTG1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
G
Pvt1
Pvt1 oncogene
increases expression
ISO
trovafloxacin results in increased expression of PVT1 mRNA
CTD
PMID:35537566
NCBI chr 7:93,656,528...93,879,938
G
Pxmp2
peroxisomal membrane protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of PXMP2 mRNA
CTD
PMID:35537566
NCBI chr12:46,394,051...46,404,561
Ensembl chr12:46,394,193...46,404,557
G
Pycr1
pyrroline-5-carboxylate reductase 1
decreases expression
ISO
trovafloxacin results in decreased expression of PYCR1 mRNA
CTD
PMID:35537566
NCBI chr10:105,917,732...105,922,658
Ensembl chr10:105,917,680...105,922,549
G
Qars1
glutaminyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of QARS1 mRNA
CTD
PMID:35537566
NCBI chr 8:109,207,705...109,215,738
Ensembl chr 8:109,207,705...109,215,739
G
Rab11fip4
RAB11 family interacting protein 4
decreases expression
ISO
trovafloxacin results in decreased expression of RAB11FIP4 mRNA
CTD
PMID:35537566
NCBI chr10:64,550,109...64,658,123
Ensembl chr10:64,550,177...64,654,759
G
Rab32
RAB32, member RAS oncogene family
decreases expression
ISO
trovafloxacin results in decreased expression of RAB32 mRNA
CTD
PMID:35537566
NCBI chr 1:4,946,193...4,961,003
Ensembl chr 1:4,945,036...4,960,934
G
Rab7b
Rab7b, member RAS oncogene family
increases expression
ISO
trovafloxacin results in increased expression of RAB7B mRNA
CTD
PMID:35537566
NCBI chr13:43,121,168...43,147,581
Ensembl chr13:43,121,226...43,147,581
G
Rabggtb
Rab geranylgeranyltransferase subunit beta
increases expression
ISO
trovafloxacin results in increased expression of RABGGTB mRNA
CTD
PMID:35537566
NCBI chr 2:242,844,758...242,850,951
Ensembl chr 2:242,844,762...242,851,050
G
Rac3
Rac family small GTPase 3
increases expression
ISO
trovafloxacin results in increased expression of RAC3 mRNA
CTD
PMID:35537566
NCBI chr10:106,002,808...106,005,243
Ensembl chr10:105,993,087...106,005,260
G
Racgap1
Rac GTPase-activating protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of RACGAP1 mRNA
CTD
PMID:35537566
NCBI chr 7:130,750,936...130,780,891
Ensembl chr 7:130,750,936...130,780,831
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
decreases expression
ISO
trovafloxacin results in decreased expression of RAD23A mRNA
CTD
PMID:35537566
NCBI chr19:23,313,563...23,320,702
Ensembl chr19:23,314,797...23,320,695
G
Rad50
RAD50 double strand break repair protein
decreases expression
ISO
trovafloxacin results in decreased expression of RAD50 mRNA
CTD
PMID:35537566
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
G
Rad51
RAD51 recombinase
decreases expression
ISO
trovafloxacin results in decreased expression of RAD51 mRNA
CTD
PMID:35537566
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
G
Rad51ap1
RAD51 associated protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of RAD51AP1 mRNA
CTD
PMID:35537566
NCBI chr 4:159,759,454...159,772,473
Ensembl chr 4:159,759,459...159,772,524
G
Rad51b
RAD51 paralog B
decreases expression
ISO
trovafloxacin results in decreased expression of RAD51B mRNA
CTD
PMID:35537566
NCBI chr 6:98,096,525...98,640,988
Ensembl chr 6:98,098,868...98,640,979
G
Rad51c
RAD51 paralog C
decreases expression
ISO
trovafloxacin results in decreased expression of RAD51C mRNA
CTD
PMID:35537566
NCBI chr10:72,205,032...72,231,643
Ensembl chr10:72,205,032...72,231,248
G
Rad54b
RAD54 homolog B
decreases expression
ISO
trovafloxacin results in decreased expression of RAD54B mRNA
CTD
PMID:35537566
NCBI chr 5:25,032,112...25,104,630
Ensembl chr 5:25,032,066...25,104,616
G
Rad54l
RAD54 like
decreases expression
ISO
trovafloxacin results in decreased expression of RAD54L mRNA
CTD
PMID:35537566
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
G
Radx
RPA1 related single stranded DNA binding protein, X-linked
decreases expression
ISO
trovafloxacin results in decreased expression of RADX mRNA
CTD
PMID:35537566
NCBI chr X:103,089,284...103,176,840
Ensembl chr X:103,089,284...103,176,838
G
Ralgapa2
Ral GTPase activating protein catalytic subunit alpha 2
decreases expression
ISO
trovafloxacin results in decreased expression of RALGAPA2 mRNA
CTD
PMID:35537566
NCBI chr 3:133,658,725...133,938,821
Ensembl chr 3:133,659,761...133,938,916
G
Ran
RAN, member RAS oncogene family
decreases expression
EXP
trovafloxacin results in decreased expression of RAN mRNA
CTD
PMID:24136188
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
G
Ranbp3l
RAN binding protein 3-like
decreases expression
ISO
trovafloxacin results in decreased expression of RANBP3L mRNA
CTD
PMID:35537566
NCBI chr 2:58,057,887...58,113,158
Ensembl chr 2:58,058,263...58,113,172
G
Ranbp6
RAN binding protein 6
increases expression
ISO
trovafloxacin results in increased expression of RANBP6 mRNA
CTD
PMID:35537566
NCBI chr 1:227,572,394...227,576,915
Ensembl chr 1:227,572,105...227,576,942
G
Rangap1
RAN GTPase activating protein 1
decreases expression
EXP
trovafloxacin results in decreased expression of RANGAP1 mRNA
CTD
PMID:24136188
NCBI chr 7:113,224,695...113,250,441
Ensembl chr 7:113,224,703...113,250,438
G
Rarb
retinoic acid receptor, beta
decreases expression
EXP
trovafloxacin results in decreased expression of RARB mRNA
CTD
PMID:24136188
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
G
Rasal1
RAS protein activator like 1
decreases expression
ISO
trovafloxacin results in decreased expression of RASAL1 mRNA
CTD
PMID:35537566
NCBI chr12:35,881,269...35,913,727
Ensembl chr12:35,881,270...35,913,727
G
Rasgef1b
RasGEF domain family, member 1B
increases expression
ISO
trovafloxacin results in increased expression of RASGEF1B mRNA
CTD
PMID:35537566
NCBI chr14:9,859,512...10,380,044
Ensembl chr14:9,860,247...10,379,741
G
Rassf1
Ras association domain family member 1
increases expression
ISO
trovafloxacin results in increased expression of RASSF1 mRNA
CTD
PMID:35537566
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
G
Rassf8
Ras association domain family member 8
increases expression
ISO
trovafloxacin results in increased expression of RASSF8 mRNA
CTD
PMID:35537566
NCBI chr 4:178,716,110...178,798,042
Ensembl chr 4:178,719,992...178,796,690
G
Rb1
RB transcriptional corepressor 1
decreases expression
EXP ISO
trovafloxacin results in decreased expression of RB1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rb1cc1
RB1-inducible coiled-coil 1
multiple interactions increases expression
ISO
TNF protein inhibits the reaction [trovafloxacin results in increased expression of RB1CC1 mRNA]
CTD
PMID:33609687
NCBI chr 5:13,161,648...13,225,560
Ensembl chr 5:13,161,648...13,225,560
G
Rbak
RB-associated KRAB zinc finger
increases expression
ISO
trovafloxacin results in increased expression of RBAK mRNA
CTD
PMID:35537566
NCBI chr12:11,375,314...11,388,937
Ensembl chr12:11,375,318...11,388,934
G
Rbbp8
RB binding protein 8, endonuclease
decreases expression
ISO
trovafloxacin results in decreased expression of RBBP8 mRNA
CTD
PMID:35537566
NCBI chr18:2,922,985...2,988,851
Ensembl chr18:2,921,286...2,988,846
G
Rbl1
RB transcriptional corepressor like 1
decreases expression
ISO
trovafloxacin results in decreased expression of RBL1 mRNA
CTD
PMID:35537566
NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330
G
Rbm18
RNA binding motif protein 18
increases expression
ISO
trovafloxacin results in increased expression of RBM18 mRNA
CTD
PMID:35537566
NCBI chr 3:19,467,333...19,487,171
Ensembl chr 3:19,467,335...19,487,178
G
Rbx1
ring-box 1
increases expression
ISO
trovafloxacin results in increased expression of RBX1 mRNA
CTD
PMID:35537566
NCBI chr 7:112,976,863...113,001,051
Ensembl chr 7:112,990,835...113,001,051
G
Rc3h1
ring finger and CCCH-type domains 1
increases expression
ISO
trovafloxacin results in increased expression of RC3H1 mRNA
CTD
PMID:35537566
NCBI chr13:73,174,075...73,245,762
Ensembl chr13:73,173,946...73,238,839
G
Rcan1
regulator of calcineurin 1
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of RCAN1 mRNA trovafloxacin results in increased expression of RCAN1 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr11:31,622,208...31,702,150
Ensembl chr11:31,622,210...31,702,045
G
Rcbtb1
RCC1 and BTB domain containing protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of RCBTB1 mRNA
CTD
PMID:35537566
NCBI chr15:33,319,586...33,362,421
Ensembl chr15:33,319,586...33,365,302
G
Rdh12
retinol dehydrogenase 12
decreases expression
ISO
trovafloxacin results in decreased expression of RDH12 mRNA
CTD
PMID:35537566
NCBI chr 6:98,015,465...98,028,388
Ensembl chr 6:98,015,465...98,028,388
G
Rdh14
retinol dehydrogenase 14
decreases expression
ISO
trovafloxacin results in decreased expression of RDH14 mRNA
CTD
PMID:35537566
NCBI chr 6:33,156,569...33,161,712
Ensembl chr 6:33,156,569...33,161,712
G
Rdm1
RAD52 motif containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of RDM1 mRNA
CTD
PMID:35537566
NCBI chr10:86,562,871...86,573,034
Ensembl chr10:86,539,553...86,573,034
G
Rdx
radixin
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of RDX mRNA
CTD
PMID:18930950
NCBI chr 8:52,379,494...52,437,673
Ensembl chr 8:52,379,494...52,437,678
G
Recql4
RecQ like helicase 4
decreases expression
ISO
trovafloxacin results in decreased expression of RECQL4 mRNA
CTD
PMID:35537566
NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619
G
Reep6
receptor accessory protein 6
decreases expression
EXP ISO
trovafloxacin results in decreased expression of REEP6 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 7:9,373,927...9,380,845
Ensembl chr 7:9,373,927...9,380,597
G
Rel
REL proto-oncogene, NF-kB subunit
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of REL mRNA
CTD
PMID:18930950
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions affects localization
ISO
trovafloxacin affects the reaction [TNF protein affects the localization of RELA protein modified form]; trovafloxacin affects the reaction [TNF protein results in increased phosphorylation of RELA protein] trovafloxacin affects the localization of RELA protein trovafloxacin affects the reaction [Lipopolysaccharides affects the localization of RELA protein]
CTD
PMID:32035082
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rell1
RELT-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of RELL1 mRNA
CTD
PMID:35537566
NCBI chr14:44,318,640...44,378,541
Ensembl chr14:44,303,009...44,378,500
G
Rfc2
replication factor C subunit 2
decreases expression
ISO
trovafloxacin results in decreased expression of RFC2 mRNA
CTD
PMID:35537566
NCBI chr12:22,120,449...22,133,576
Ensembl chr12:22,120,010...22,133,557
G
Rfc5
replication factor C subunit 5
decreases expression
ISO
trovafloxacin results in decreased expression of RFC5 mRNA
CTD
PMID:35537566
NCBI chr12:39,207,484...39,217,041
Ensembl chr12:39,207,484...39,217,312
G
Rft1
RFT1 homolog
decreases expression
ISO
trovafloxacin results in decreased expression of RFT1 mRNA
CTD
PMID:35537566
NCBI chr16:5,827,063...5,861,120
Ensembl chr16:5,827,088...5,861,120
G
Rfx2
regulatory factor X2
decreases expression
ISO
trovafloxacin results in decreased expression of RFX2 mRNA
CTD
PMID:35537566
NCBI chr 9:1,604,636...1,671,220
Ensembl chr 9:1,604,646...1,671,027
G
Rgcc
regulator of cell cycle
increases expression
ISO
trovafloxacin results in increased expression of RGCC mRNA
CTD
PMID:35537566
NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141
G
Rgs1
regulator of G-protein signaling 1
increases expression
ISO
trovafloxacin results in increased expression of RGS1 mRNA
CTD
PMID:35537566
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
G
Rgs16
regulator of G-protein signaling 16
increases expression
ISO
trovafloxacin results in increased expression of RGS16 mRNA
CTD
PMID:35537566
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rgs2
regulator of G-protein signaling 2
increases expression
ISO
trovafloxacin results in increased expression of RGS2 mRNA
CTD
PMID:35537566
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
G
Rgs20
regulator of G-protein signaling 20
increases expression
ISO
trovafloxacin results in increased expression of RGS20 mRNA
CTD
PMID:35537566
NCBI chr 5:14,484,436...14,614,317
Ensembl chr 5:14,534,775...14,614,084
G
Rhbdd3
rhomboid domain containing 3
increases expression decreases expression
ISO
trovafloxacin results in increased expression of RHBDD3 mRNA trovafloxacin results in decreased expression of RHBDD3 mRNA
CTD
PMID:35537566
NCBI chr14:79,994,111...80,000,294
Ensembl chr14:79,994,158...80,000,175
G
Rhbdf1
rhomboid 5 homolog 1
increases expression
ISO
trovafloxacin results in increased expression of RHBDF1 mRNA
CTD
PMID:35537566
NCBI chr10:15,406,832...15,419,765
Ensembl chr10:15,406,859...15,419,763
G
Rhbdl1
rhomboid like 1
increases expression
ISO
trovafloxacin results in increased expression of RHBDL1 mRNA
CTD
PMID:35537566
NCBI chr10:14,854,514...14,858,848
Ensembl chr10:14,854,514...14,857,430
G
Rhod
ras homolog family member D
increases expression
ISO
trovafloxacin results in increased expression of RHOD mRNA
CTD
PMID:35537566
NCBI chr 1:201,708,699...201,724,405
Ensembl chr 1:201,708,699...201,722,632
G
Rhoj
ras homolog family member J
decreases expression
ISO
trovafloxacin results in decreased expression of RHOJ mRNA
CTD
PMID:35537566
NCBI chr 6:94,035,307...94,117,642
Ensembl chr 6:94,035,483...94,118,275
G
Rhoq
ras homolog family member Q
decreases expression
ISO
trovafloxacin results in decreased expression of RHOQ mRNA
CTD
PMID:35537566
NCBI chr 6:7,613,632...7,652,047
G
Rhov
ras homolog family member V
increases expression
ISO
trovafloxacin results in increased expression of RHOV mRNA
CTD
PMID:35537566
NCBI chr 3:106,260,774...106,270,009
Ensembl chr 3:106,260,776...106,269,479
G
Ric8a
RIC8 guanine nucleotide exchange factor A
decreases expression
ISO
trovafloxacin results in decreased expression of RIC8A mRNA
CTD
PMID:35537566
NCBI chr 1:195,935,162...195,941,469
Ensembl chr 1:195,935,349...195,941,467
G
Ripor3
RIPOR family member 3
decreases expression
ISO
trovafloxacin results in decreased expression of FAM65C mRNA
CTD
PMID:35537566
NCBI chr 3:156,687,253...156,760,524
Ensembl chr 3:156,687,517...156,715,061
G
Rmdn1
regulator of microtubule dynamics 1
decreases expression
ISO
trovafloxacin results in decreased expression of RMDN1 mRNA
CTD
PMID:35537566
NCBI chr 5:33,070,267...33,093,922
Ensembl chr 5:33,070,265...33,127,328
G
Rmdn2
regulator of microtubule dynamics 2
decreases expression
EXP
trovafloxacin results in decreased expression of RMDN2 mRNA
CTD
PMID:24136188
NCBI chr 6:15,372,569...15,443,000
Ensembl chr 6:15,375,496...15,441,480
G
Rmi2
RecQ mediated genome instability 2
decreases expression
ISO
trovafloxacin results in decreased expression of RMI2 mRNA
CTD
PMID:35537566
NCBI chr10:4,829,333...4,837,264
Ensembl chr10:4,830,553...4,837,235
G
Rmnd1
required for meiotic nuclear division 1 homolog
decreases expression
ISO
trovafloxacin results in decreased expression of RMND1 mRNA
CTD
PMID:35537566
NCBI chr 1:40,859,829...40,894,376
Ensembl chr 1:40,859,829...40,894,314
G
Rnaseh2c
ribonuclease H2, subunit C
decreases expression
ISO
trovafloxacin results in decreased expression of RNASEH2C mRNA
CTD
PMID:35537566
NCBI chr 1:202,894,626...202,895,675
Ensembl chr 1:202,894,643...202,897,516
G
Rnd1
Rho family GTPase 1
decreases expression
ISO
trovafloxacin results in decreased expression of RND1 mRNA
CTD
PMID:35537566
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
G
Rnd3
Rho family GTPase 3
multiple interactions decreases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of RND3 mRNA trovafloxacin results in decreased expression of RND3 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr 3:35,571,929...35,589,283
Ensembl chr 3:35,571,143...35,589,327
G
Rnf145
ring finger protein 145
increases expression
ISO
trovafloxacin results in increased expression of RNF145 mRNA
CTD
PMID:35537566
NCBI chr10:29,006,391...29,050,788
Ensembl chr10:29,011,548...29,050,781
G
Rnf151
ring finger protein 151
increases expression
ISO
trovafloxacin results in increased expression of RNF151 mRNA
CTD
PMID:35537566
NCBI chr10:13,742,682...13,747,192
Ensembl chr10:13,742,682...13,745,000
G
Rnf157
ring finger protein 157
decreases expression
ISO
trovafloxacin results in decreased expression of RNF157 mRNA
CTD
PMID:35537566
NCBI chr10:101,571,972...101,639,874
Ensembl chr10:101,566,295...101,639,942
G
Rnf180
ring finger protein 180
decreases expression
ISO
trovafloxacin results in decreased expression of RNF180 mRNA
CTD
PMID:35537566
NCBI chr 2:36,330,285...36,511,168
Ensembl chr 2:36,330,292...36,512,614
G
Rnf183
ring finger protein 183
increases expression
ISO
trovafloxacin results in increased expression of RNF183 mRNA
CTD
PMID:35537566
NCBI chr 5:75,877,111...75,886,253
Ensembl chr 5:75,876,003...75,886,191
G
Rnf26
ring finger protein 26
decreases expression
EXP
trovafloxacin results in decreased expression of RNF26 mRNA
CTD
PMID:24136188
NCBI chr 8:44,454,551...44,456,745
Ensembl chr 8:44,454,292...44,457,331
G
Rnf39
ring finger protein 39
increases expression
EXP
trovafloxacin results in increased expression of RNF39 mRNA
CTD
PMID:24136188
NCBI chr20:1,604,794...1,610,283
Ensembl chr20:1,604,794...1,610,283
G
Rnf6
ring finger protein 6
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of RNF6 mRNA
CTD
PMID:18930950
NCBI chr12:8,816,797...8,826,870
Ensembl chr12:8,816,833...8,826,847
G
Rock2
Rho-associated coiled-coil containing protein kinase 2
decreases expression
ISO
trovafloxacin results in decreased expression of ROCK2 mRNA
CTD
PMID:35537566
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
G
Rora
RAR-related orphan receptor A
decreases expression
ISO
trovafloxacin results in decreased expression of RORA mRNA
CTD
PMID:35537566
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
G
Rpa1
replication protein A1
decreases expression
EXP
trovafloxacin results in decreased expression of RPA1 mRNA
CTD
PMID:24136188
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
G
Rpain
RPA interacting protein
decreases expression
ISO
trovafloxacin results in decreased expression of RPAIN mRNA
CTD
PMID:35537566
NCBI chr10:55,692,410...55,699,910
Ensembl chr10:55,692,417...55,699,933
G
Rpl10a
ribosomal protein L10A
increases expression
ISO
trovafloxacin results in increased expression of RPL10A mRNA
CTD
PMID:35537566
NCBI chr20:6,388,800...6,391,358
Ensembl chr20:6,385,823...6,391,357
G
Rpl18
ribosomal protein L18
increases expression
ISO
trovafloxacin results in increased expression of RPL18 mRNA
CTD
PMID:35537566
NCBI chr 1:96,188,811...96,191,452
Ensembl chr 1:96,188,112...96,191,452
G
Rpl3l
ribosomal protein L3-like
increases expression
ISO
trovafloxacin results in increased expression of RPL3L mRNA
CTD
PMID:35537566
NCBI chr10:13,753,914...13,764,458
Ensembl chr10:13,753,886...13,764,457
G
Rpl7l1
ribosomal protein L7-like 1
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of RPL7L1 mRNA trovafloxacin results in increased expression of RPL7L1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 9:14,198,101...14,206,119
Ensembl chr 9:14,198,092...14,206,110
G
Rpph1
ribonuclease P RNA component H1
increases expression
ISO
trovafloxacin results in increased expression of RPPH1 mRNA
CTD
PMID:35537566
NCBI chr15:24,033,679...24,033,935
Ensembl chr15:24,033,662...24,033,959
G
Rps27l
ribosomal protein S27-like
increases expression
ISO
trovafloxacin results in increased expression of RPS27L mRNA
CTD
PMID:35537566
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418
G
Rps6ka2
ribosomal protein S6 kinase A2
decreases expression
ISO
trovafloxacin results in decreased expression of RPS6KA2 mRNA
CTD
PMID:35537566
NCBI chr 1:52,631,582...52,906,739
Ensembl chr 1:52,631,736...52,906,739
G
Rps6ka4
ribosomal protein S6 kinase A4
decreases expression
ISO
trovafloxacin results in decreased expression of RPS6KA4 mRNA
CTD
PMID:35537566
NCBI chr 1:204,021,805...204,032,781
Ensembl chr 1:204,021,806...204,032,761
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions
ISO
[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of RPS6KB1 protein
CTD
PMID:33609687
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Rrm1
ribonucleotide reductase catalytic subunit M1
decreases expression
ISO
trovafloxacin results in decreased expression of RRM1 mRNA
CTD
PMID:35537566
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
EXP ISO
trovafloxacin results in decreased expression of RRM2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Rsad2
radical S-adenosyl methionine domain containing 2
increases expression
ISO
trovafloxacin results in increased expression of RSAD2 mRNA
CTD
PMID:35537566
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
G
Rsbn1
round spermatid basic protein 1
increases expression
ISO
trovafloxacin results in increased expression of RSBN1 mRNA
CTD
PMID:35537566
NCBI chr 2:191,416,631...191,470,711
Ensembl chr 2:191,416,631...191,470,711
G
Rsrp1
arginine and serine rich protein 1
increases expression
EXP
trovafloxacin results in increased expression of RSRP1 mRNA
CTD
PMID:24136188
NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523
G
RT1-CE16
RT1 class I, locus CE16
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of HLA-A mRNA
CTD
PMID:18930950
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
G
Rtel1
regulator of telomere elongation helicase 1
decreases expression
ISO
trovafloxacin results in decreased expression of RTEL1 mRNA
CTD
PMID:35537566
NCBI chr 3:168,427,247...168,465,349
Ensembl chr 3:168,419,579...168,465,348
G
Rtkn2
rhotekin 2
decreases expression
ISO
trovafloxacin results in decreased expression of RTKN2 mRNA
CTD
PMID:35537566
NCBI chr20:20,536,628...20,609,951
Ensembl chr20:20,525,256...20,609,951
G
Rtp4
receptor (chemosensory) transporter protein 4
increases expression
ISO
trovafloxacin results in increased expression of RTP4 mRNA
CTD
PMID:35537566
NCBI chr11:77,237,341...77,249,194
Ensembl chr11:77,238,216...77,335,437
G
Rttn
rotatin
decreases expression
ISO
trovafloxacin results in decreased expression of RTTN mRNA
CTD
PMID:35537566
NCBI chr18:82,220,999...82,398,334
Ensembl chr18:82,221,050...82,398,333
G
Rubcnl
rubicon like autophagy enhancer
decreases expression
ISO
trovafloxacin results in decreased expression of RUBCNL mRNA
CTD
PMID:35537566
NCBI chr15:50,332,458...50,377,494
Ensembl chr15:50,332,418...50,400,849
G
Rundc1
RUN domain containing 1
increases expression
ISO
trovafloxacin results in increased expression of RUNDC1 mRNA
CTD
PMID:35537566
NCBI chr10:86,361,635...86,375,446
Ensembl chr10:86,361,051...86,370,878
G
Runx2
RUNX family transcription factor 2
decreases expression
ISO
trovafloxacin results in decreased expression of RUNX2 mRNA
CTD
PMID:35537566
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
G
Rwdd2a
RWD domain containing 2A
decreases expression
ISO
trovafloxacin results in decreased expression of RWDD2A mRNA
CTD
PMID:35537566
NCBI chr 8:87,536,153...87,539,301
Ensembl chr 8:87,536,176...87,539,300
G
S100a11
S100 calcium binding protein A11
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of S100A11 mRNA
CTD
PMID:18930950
NCBI chr 2:179,191,688...179,197,098
Ensembl chr 2:179,191,715...179,197,044
G
S100a3
S100 calcium binding protein A3
increases expression
ISO
trovafloxacin results in increased expression of S100A3 mRNA
CTD
PMID:35537566
NCBI chr 2:176,034,283...176,089,702
Ensembl chr 2:176,049,520...176,089,702
G
S1pr1
sphingosine-1-phosphate receptor 1
decreases expression
ISO
trovafloxacin results in decreased expression of S1PR1 mRNA
CTD
PMID:35537566
NCBI chr 2:203,624,752...203,629,110
Ensembl chr 2:203,621,587...203,629,681
G
Sae1
SUMO1 activating enzyme subunit 1
decreases expression
EXP
trovafloxacin results in decreased expression of SAE1 mRNA
CTD
PMID:24136188
NCBI chr 1:77,030,961...77,086,937
Ensembl chr 1:77,030,965...77,086,986
G
Samd9l
sterile alpha motif domain containing 9 like
increases expression
ISO
trovafloxacin results in increased expression of SAMD9L mRNA
CTD
PMID:35537566
NCBI chr 4:31,362,054...31,376,412
Ensembl chr 4:31,361,669...31,376,415
G
Sapcd2
suppressor APC domain containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of SAPCD2 mRNA
CTD
PMID:35537566
NCBI chr 3:8,186,089...8,195,119
Ensembl chr 3:8,187,266...8,192,546
G
Sarnp
SAP domain containing ribonucleoprotein
decreases expression
EXP
trovafloxacin results in decreased expression of SARNP mRNA
CTD
PMID:24136188
NCBI chr 7:1,251,096...1,305,335
Ensembl chr 7:1,251,098...1,305,332
G
Sash3
SAM and SH3 domain containing 3
decreases expression
ISO
trovafloxacin results in decreased expression of SASH3 mRNA
CTD
PMID:35537566
NCBI chr X:127,326,815...127,341,521
Ensembl chr X:127,326,859...127,341,519
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
EXP
trovafloxacin results in increased expression of SAT1 mRNA
CTD
PMID:24136188
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Sbds
Sbds, ribosome maturation factor
increases expression
ISO
trovafloxacin results in increased expression of SBDS mRNA
CTD
PMID:35537566
NCBI chr12:26,420,410...26,429,650
Ensembl chr12:26,420,414...26,429,649
G
Scap
SREBF chaperone
decreases expression
ISO
trovafloxacin results in decreased expression of SCAP mRNA
CTD
PMID:35537566
NCBI chr 8:110,306,026...110,360,677
Ensembl chr 8:110,306,031...110,360,666
G
Scd
stearoyl-CoA desaturase
decreases expression
EXP ISO
trovafloxacin results in decreased expression of SCD1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Scd4
stearoyl-coenzyme A desaturase 4
decreases expression
ISO
trovafloxacin results in decreased expression of SCD4 mRNA
CTD
PMID:35537566
NCBI chr 1:243,203,433...243,216,007
Ensembl chr 1:243,203,881...243,215,148
G
Scel
sciellin
decreases expression
ISO
trovafloxacin results in decreased expression of SCEL mRNA
CTD
PMID:35537566
NCBI chr15:80,339,661...80,456,546
Ensembl chr15:80,339,951...80,456,372
G
Scin
scinderin
increases expression
ISO
trovafloxacin results in increased expression of SCIN mRNA
CTD
PMID:35537566
NCBI chr 6:57,109,500...57,188,123
Ensembl chr 6:57,109,403...57,188,242
G
Sclt1
sodium channel and clathrin linker 1
decreases expression
ISO
trovafloxacin results in decreased expression of SCLT1 mRNA
CTD
PMID:35537566
NCBI chr 2:124,605,445...124,763,964
Ensembl chr 2:124,605,658...124,764,065
G
Scly
selenocysteine lyase
decreases expression
ISO
trovafloxacin results in decreased expression of SCLY mRNA
CTD
PMID:35537566
NCBI chr 9:91,890,269...91,910,947
Ensembl chr 9:91,890,306...91,910,941
G
Scml4
Scm polycomb group protein like 4
decreases expression
ISO
trovafloxacin results in decreased expression of SCML4 mRNA
CTD
PMID:35537566
NCBI chr20:46,347,350...46,441,246
Ensembl chr20:46,347,413...46,440,103
G
Scn11a
sodium voltage-gated channel alpha subunit 11
decreases expression
ISO
trovafloxacin results in decreased expression of SCN11A mRNA
CTD
PMID:35537566
NCBI chr 8:119,495,550...119,567,044
Ensembl chr 8:119,496,769...119,567,044
G
Scrn2
secernin 2
decreases expression
ISO
trovafloxacin results in decreased expression of SCRN2 mRNA
CTD
PMID:35537566
NCBI chr10:82,016,604...82,020,676
Ensembl chr10:82,016,649...82,020,675
G
Sdf2l1
stromal cell-derived factor 2-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of SDF2L1 mRNA
CTD
PMID:35537566
NCBI chr11:83,872,659...83,874,902
Ensembl chr11:83,872,659...83,874,902
G
Sds
serine dehydratase
increases expression
EXP
trovafloxacin results in increased expression of SDS mRNA
CTD
PMID:24136188
NCBI chr12:36,083,226...36,090,540
Ensembl chr12:36,083,229...36,088,203
G
Sec24d
SEC24 homolog D, COPII coat complex component
decreases expression
EXP
trovafloxacin results in decreased expression of SEC24D mRNA
CTD
PMID:24136188
NCBI chr 2:211,418,557...211,526,588
Ensembl chr 2:211,418,623...211,526,587
G
Sele
selectin E
multiple interactions
ISO
[trovafloxacin co-treated with IL1B protein] affects the localization of SELE protein; [trovafloxacin co-treated with IL1B protein] results in increased expression of SELE mRNA; trovafloxacin promotes the reaction [IL1B protein results in increased secretion of SELE protein] [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SELE mRNA
CTD
PMID:10822086 PMID:18930950
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Selenbp1
selenium binding protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of SELENBP1 mRNA
CTD
PMID:35537566
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
G
Sell
selectin L
decreases expression
ISO
trovafloxacin results in decreased expression of SELL mRNA
CTD
PMID:35537566
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Sema3e
semaphorin 3E
decreases expression
ISO
trovafloxacin results in decreased expression of SEMA3E mRNA
CTD
PMID:35537566
NCBI chr 4:20,297,534...20,555,287
Ensembl chr 4:20,299,718...20,555,229
G
Sema4b
semaphorin 4B
increases expression
ISO
trovafloxacin results in increased expression of SEMA4B mRNA
CTD
PMID:35537566
NCBI chr 1:134,136,646...134,177,777
Ensembl chr 1:134,149,536...134,177,775
G
Sema6d
semaphorin 6D
increases expression
ISO
trovafloxacin results in increased expression of SEMA6D mRNA
CTD
PMID:35537566
NCBI chr 3:111,883,415...111,941,100
Ensembl chr 3:111,883,872...111,941,094
G
Senp2
SUMO specific peptidase 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SENP2 mRNA
CTD
PMID:18930950
NCBI chr11:78,981,429...79,018,274
Ensembl chr11:78,981,432...79,018,238
G
Senp8
SUMO peptidase family member, NEDD8 specific
decreases expression
ISO
trovafloxacin results in decreased expression of SENP8 mRNA
CTD
PMID:35537566
NCBI chr 8:60,135,446...60,148,836
Ensembl chr 8:60,121,714...60,148,928
G
Septin10
septin 10
decreases expression
ISO
trovafloxacin results in decreased expression of SEPTIN10 mRNA
CTD
PMID:35537566
NCBI chr20:27,101,764...27,194,997
Ensembl chr20:27,101,752...27,194,780
G
Serhl2
serine hydrolase-like 2
decreases expression
ISO
trovafloxacin results in decreased expression of SERHL mRNA
CTD
PMID:35537566
NCBI chr 7:114,246,035...114,266,298
Ensembl chr 7:114,246,056...114,272,781
G
Serpinb12
serpin family B member 12
decreases expression
ISO
trovafloxacin results in decreased expression of SERPINB12 mRNA
CTD
PMID:35537566
NCBI chr13:23,052,384...23,083,691
Ensembl chr13:23,052,448...23,083,691
G
Serpine1
serpin family E member 1
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SERPINE1 mRNA; SERPINE1 protein results in increased susceptibility to [trovafloxacin co-treated with Lipopolysaccharides]; trovafloxacin promotes the reaction [Lipopolysaccharides results in increased expression of SERPINE1 protein] trovafloxacin results in increased expression of SERPINE1 mRNA
CTD
PMID:18930950 PMID:19367693 PMID:35537566
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serpinf1
serpin family F member 1
decreases expression
ISO
trovafloxacin results in decreased expression of SERPINF1 mRNA
CTD
PMID:35537566
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
G
Setd6
SET domain containing 6, protein lysine methyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of SETD6 mRNA
CTD
PMID:35537566
NCBI chr19:9,343,309...9,350,477
Ensembl chr19:9,347,458...9,350,453
G
Sf3a3
splicing factor 3a, subunit 3
decreases expression
EXP
trovafloxacin results in decreased expression of SF3A3 mRNA
CTD
PMID:24136188
NCBI chr 5:136,967,713...136,987,345
Ensembl chr 5:136,967,691...136,987,361
G
Sfpq
splicing factor proline and glutamine rich
decreases expression
EXP
trovafloxacin results in decreased expression of SFPQ mRNA
CTD
PMID:24136188
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
G
Sgcb
sarcoglycan, beta
decreases expression
ISO
trovafloxacin results in decreased expression of SGCB mRNA
CTD
PMID:35537566
NCBI chr14:34,563,614...34,578,614
Ensembl chr14:34,563,608...34,578,583
G
Sgf29
SAGA complex associated factor 29
decreases expression
ISO
trovafloxacin results in decreased expression of SGF29 mRNA
CTD
PMID:35537566
NCBI chr 1:181,238,458...181,271,931
Ensembl chr 1:181,238,468...181,274,781
G
Sgk1
serum/glucocorticoid regulated kinase 1
decreases expression
ISO
trovafloxacin results in decreased expression of SGK1 mRNA
CTD
PMID:35537566
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Sgo1
shugoshin 1
decreases expression
ISO
trovafloxacin results in decreased expression of SGO1 mRNA
CTD
PMID:35537566
NCBI chr 9:6,672,109...6,687,908
Ensembl chr 9:6,672,123...6,687,805
G
Sgo2
shugoshin 2
decreases expression
ISO
trovafloxacin results in decreased expression of SGO2A mRNA
CTD
PMID:35537566
NCBI chr 9:59,548,605...59,573,229
Ensembl chr 9:59,548,683...59,573,229
G
Sh2d6
SH2 domain containing 6
decreases expression
ISO
trovafloxacin results in decreased expression of SH2D6 mRNA
CTD
PMID:35537566
NCBI chr 4:104,566,210...104,574,176
Ensembl chr 4:104,566,211...104,574,118
G
Sh3bp2
SH3-domain binding protein 2
increases expression
ISO
trovafloxacin results in increased expression of SH3BP2 mRNA
CTD
PMID:35537566
NCBI chr14:76,176,097...76,213,300
Ensembl chr14:76,176,101...76,213,251
G
Sh3bp5
SH3-domain binding protein 5
increases expression
EXP
trovafloxacin results in increased expression of SH3BP5 mRNA
CTD
PMID:24136188
NCBI chr16:6,583,462...6,678,344
Ensembl chr16:6,583,465...6,698,975
G
Shc4
SHC adaptor protein 4
decreases expression
ISO
trovafloxacin results in decreased expression of SHC4 mRNA
CTD
PMID:35537566
NCBI chr 3:112,880,598...112,974,216
Ensembl chr 3:112,880,600...112,974,366
G
Shcbp1
SHC binding and spindle associated 1
decreases expression
ISO
trovafloxacin results in decreased expression of SHCBP1 mRNA
CTD
PMID:35537566
NCBI chr16:84,672,277...84,703,843
Ensembl chr16:84,672,321...84,703,844
G
Shcbp1l
SHC binding and spindle associated 1 like
decreases expression
ISO
trovafloxacin results in decreased expression of SHCBP1L mRNA
CTD
PMID:35537566
NCBI chr13:65,568,863...65,599,155
Ensembl chr13:65,568,863...65,599,154
G
Shisa3
shisa family member 3
decreases expression
ISO
trovafloxacin results in decreased expression of SHISA3 mRNA
CTD
PMID:35537566
NCBI chr14:40,563,672...40,568,244
Ensembl chr14:40,563,673...40,568,244
G
Shmt1
serine hydroxymethyltransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of SHMT1 mRNA
CTD
PMID:35537566
NCBI chr10:45,468,698...45,490,833
Ensembl chr10:45,468,700...45,497,820
G
Shmt2
serine hydroxymethyltransferase 2
decreases expression
ISO
trovafloxacin results in decreased expression of SHMT2 mRNA
CTD
PMID:35537566
NCBI chr 7:63,358,961...63,364,293
Ensembl chr 7:63,358,961...63,364,236
G
Siah2
siah E3 ubiquitin protein ligase 2
decreases expression
ISO
trovafloxacin results in decreased expression of SIAH2 mRNA
CTD
PMID:35537566
NCBI chr 2:142,913,924...142,931,752
Ensembl chr 2:142,914,003...142,931,950
G
Sik1
salt-inducible kinase 1
increases expression
ISO
trovafloxacin results in increased expression of SIK1 mRNA
CTD
PMID:35537566
NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
G
Six1
SIX homeobox 1
increases expression
ISO
trovafloxacin results in increased expression of SIX1 mRNA
CTD
PMID:35537566
NCBI chr 6:91,746,739...91,751,975
Ensembl chr 6:91,746,739...91,751,975
G
Six5
SIX homeobox 5
increases expression
ISO
trovafloxacin results in increased expression of SIX5 mRNA
CTD
PMID:35537566
NCBI chr 1:78,740,812...78,745,890
Ensembl chr 1:78,741,367...78,745,890
G
Ska1
spindle and kinetochore associated complex subunit 1
decreases expression
ISO
trovafloxacin results in decreased expression of SKA1 mRNA
CTD
PMID:35537566
NCBI chr18:67,794,722...67,805,037
Ensembl chr18:67,794,725...67,805,037
G
Ska3
spindle and kinetochore associated complex subunit 3
decreases expression
ISO
trovafloxacin results in decreased expression of SKA3 mRNA
CTD
PMID:35537566
NCBI chr15:31,951,812...31,971,010
Ensembl chr15:31,951,825...31,971,010
G
Skil
SKI-like proto-oncogene
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SKIL mRNA
CTD
PMID:18930950
NCBI chr 2:112,247,047...112,275,176
Ensembl chr 2:112,247,051...112,275,080
G
Sla
src-like adaptor
decreases expression
ISO
trovafloxacin results in decreased expression of SLA mRNA
CTD
PMID:35537566
NCBI chr 7:98,534,431...98,584,810
Ensembl chr 7:98,535,368...98,584,648
G
Slamf9
SLAM family member 9
decreases expression
ISO
trovafloxacin results in decreased expression of SLAMF9 mRNA
CTD
PMID:35537566
NCBI chr13:84,941,896...84,944,749
Ensembl chr13:84,941,982...84,944,748
G
Slc11a2
solute carrier family 11 member 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SLC11A2 mRNA
CTD
PMID:18930950
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
G
Slc13a3
solute carrier family 13 member 3
decreases expression
ISO
trovafloxacin results in decreased expression of SLC13A3 mRNA
CTD
PMID:35537566
NCBI chr 3:154,141,878...154,204,604
Ensembl chr 3:154,141,872...154,204,606
G
Slc17a2
solute carrier family 17, member 2
increases expression
EXP
trovafloxacin results in increased expression of SLC17A2 mRNA
CTD
PMID:24136188
NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325
G
Slc17a3
solute carrier family 17 member 3
decreases expression multiple interactions
EXP ISO
trovafloxacin results in decreased expression of SLC17A3 mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SLC17A3 mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr17:41,270,804...41,300,132
Ensembl chr17:41,270,812...41,295,256
G
Slc17a5
solute carrier family 17 member 5
decreases expression
ISO
trovafloxacin results in decreased expression of SLC17A5 mRNA
CTD
PMID:35537566
NCBI chr 8:79,394,416...79,429,387
G
Slc17a9
solute carrier family 17 member 9
decreases expression
ISO
trovafloxacin results in decreased expression of SLC17A9 mRNA
CTD
PMID:35537566
NCBI chr 3:167,839,246...167,857,462
Ensembl chr 3:167,839,385...167,855,985
G
Slc18a2
solute carrier family 18 member A2
decreases expression
ISO
trovafloxacin results in decreased expression of SLC18A2 mRNA
CTD
PMID:35537566
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
G
Slc19a2
solute carrier family 19 member 2
increases expression
ISO
trovafloxacin results in increased expression of SLC19A2 mRNA
CTD
PMID:35537566
NCBI chr13:76,601,975...76,616,175
Ensembl chr13:76,601,900...76,616,172
G
Slc1a4
solute carrier family 1 member 4
decreases expression
ISO
trovafloxacin results in decreased expression of SLC1A4 mRNA
CTD
PMID:35537566
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
G
Slc1a5
solute carrier family 1 member 5
decreases expression
ISO
trovafloxacin results in decreased expression of SLC1A5 mRNA
CTD
PMID:35537566
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
G
Slc22a1
solute carrier family 22 member 1
decreases expression
EXP
trovafloxacin results in decreased expression of SLC22A1 mRNA
CTD
PMID:24136188
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
G
Slc23a1
solute carrier family 23 member 1
increases expression
ISO
trovafloxacin results in increased expression of SLC23A1 mRNA
CTD
PMID:35537566
NCBI chr18:27,214,940...27,230,564
Ensembl chr18:27,216,281...27,230,697
G
Slc25a10
solute carrier family 25 member 10
decreases expression
ISO
trovafloxacin results in decreased expression of SLC25A10 mRNA
CTD
PMID:35537566
NCBI chr10:105,765,598...105,775,159
Ensembl chr10:105,765,372...105,773,556
G
Slc25a38
solute carrier family 25, member 38
increases expression
ISO
trovafloxacin results in increased expression of SLC25A38 mRNA
CTD
PMID:35537566
NCBI chr 8:119,835,546...119,848,334
Ensembl chr 8:119,835,634...119,848,332
G
Slc25a40
solute carrier family 25, member 40
decreases expression
ISO
trovafloxacin results in decreased expression of SLC25A40 mRNA
CTD
PMID:35537566
NCBI chr 4:25,631,447...25,676,454
Ensembl chr 4:25,589,360...25,676,472
G
Slc27a3
solute carrier family 27 member 3
increases expression
ISO
trovafloxacin results in increased expression of SLC27A3 mRNA
CTD
PMID:35537566
NCBI chr 2:175,853,241...175,857,909
Ensembl chr 2:175,853,241...175,857,909
G
Slc28a2
solute carrier family 28 member 2
decreases expression
ISO
trovafloxacin results in decreased expression of SLC28A2 mRNA
CTD
PMID:35537566
NCBI chr 3:109,324,815...109,387,702
Ensembl chr 3:109,366,996...109,387,702
G
Slc29a1
solute carrier family 29 member 1
decreases expression
ISO
trovafloxacin results in decreased expression of SLC29A1 mRNA
CTD
PMID:35537566
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
G
Slc2a8
solute carrier family 2 member 8
decreases expression
ISO
trovafloxacin results in decreased expression of SLC2A8 mRNA
CTD
PMID:35537566
NCBI chr 3:16,274,918...16,284,536
Ensembl chr 3:16,274,925...16,284,464
G
Slc30a9
solute carrier family 30 member 9
decreases expression
ISO
trovafloxacin results in decreased expression of SLC30A9 mRNA
CTD
PMID:35537566
NCBI chr14:40,816,284...40,870,992
Ensembl chr14:40,816,290...40,870,929
G
Slc34a2
solute carrier family 34 member 2
decreases expression
EXP
trovafloxacin results in decreased expression of SLC34A2 mRNA
CTD
PMID:24136188
NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436
G
Slc35e3
solute carrier family 35, member E3
decreases expression
EXP
trovafloxacin results in decreased expression of SLC35E3 mRNA
CTD
PMID:24136188
NCBI chr 7:53,337,091...53,350,152
Ensembl chr 7:53,337,095...53,350,165
G
Slc35f1
solute carrier family 35, member F1
decreases expression
ISO
trovafloxacin results in decreased expression of SLC35F1 mRNA
CTD
PMID:35537566
NCBI chr20:32,030,350...32,418,762
Ensembl chr20:32,030,368...32,418,611
G
Slc37a2
solute carrier family 37 member 2
increases expression
ISO
trovafloxacin results in increased expression of SLC37A2 mRNA
CTD
PMID:35537566
NCBI chr 8:36,945,787...36,971,748
Ensembl chr 8:36,946,930...36,971,482
G
Slc38a7
solute carrier family 38, member 7
decreases expression
ISO
trovafloxacin results in decreased expression of SLC38A7 mRNA
CTD
PMID:35537566
NCBI chr19:9,209,203...9,225,472
Ensembl chr19:9,209,257...9,225,454
G
Slc39a14
solute carrier family 39 member 14
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SLC39A14 mRNA
CTD
PMID:18930950
NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524
G
Slc39a4
solute carrier family 39 member 4
decreases expression
ISO
trovafloxacin results in decreased expression of SLC39A4 mRNA
CTD
PMID:35537566
NCBI chr 7:108,333,368...108,337,553
Ensembl chr 7:108,333,381...108,337,553
G
Slc41a2
solute carrier family 41 member 2
decreases expression
EXP
trovafloxacin results in decreased expression of SLC41A2 mRNA
CTD
PMID:24136188
NCBI chr 7:20,383,714...20,491,178
Ensembl chr 7:20,383,757...20,491,166
G
Slc43a3
solute carrier family 43, member 3
decreases expression
ISO
trovafloxacin results in decreased expression of SLC43A3 mRNA
CTD
PMID:35537566
NCBI chr 3:70,008,160...70,030,324
Ensembl chr 3:70,009,313...70,029,749
G
Slc45a3
solute carrier family 45, member 3
increases expression
ISO
trovafloxacin results in increased expression of SLC45A3 mRNA
CTD
PMID:35537566
NCBI chr13:43,407,293...43,427,588
Ensembl chr13:43,407,293...43,427,588
G
Slc45a4
solute carrier family 45, member 4
decreases expression
ISO
trovafloxacin results in decreased expression of SLC45A4 mRNA
CTD
PMID:35537566
NCBI chr 7:105,478,886...105,550,160
Ensembl chr 7:105,481,792...105,550,170
G
Slc46a1
solute carrier family 46 member 1
increases expression
EXP
trovafloxacin results in increased expression of SLC46A1 mRNA
CTD
PMID:24136188
NCBI chr10:63,361,504...63,367,940
Ensembl chr10:63,361,486...63,368,848
G
Slc46a3
solute carrier family 46, member 3
decreases expression
ISO
trovafloxacin results in decreased expression of SLC46A3 mRNA
CTD
PMID:35537566
NCBI chr12:7,140,610...7,157,093
Ensembl chr12:7,140,668...7,157,092
G
Slc49a3
solute carrier family 49 member 3
increases expression
ISO
trovafloxacin results in increased expression of SLC49A3 mRNA
CTD
PMID:35537566
NCBI chr14:1,305,091...1,319,723
Ensembl chr14:1,305,680...1,314,132
G
Slc4a3
solute carrier family 4 member 3
increases expression
ISO
trovafloxacin results in increased expression of SLC4A3 mRNA
CTD
PMID:35537566
NCBI chr 9:77,036,243...77,053,940
Ensembl chr 9:77,037,016...77,049,105
G
Slc4a8
solute carrier family 4 member 8
decreases expression
ISO
trovafloxacin results in decreased expression of SLC4A8 mRNA
CTD
PMID:35537566
NCBI chr 7:131,861,284...131,939,295
Ensembl chr 7:131,864,102...131,931,051
G
Slc52a2
solute carrier family 52 member 2
decreases expression
ISO
trovafloxacin results in decreased expression of SLC52A2 mRNA
CTD
PMID:35537566
NCBI chr 7:108,246,003...108,267,642
Ensembl chr 7:108,262,612...108,268,034
G
Slc6a4
solute carrier family 6 member 4
increases expression
ISO
trovafloxacin results in increased expression of SLC6A4 mRNA
CTD
PMID:35537566
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Slc6a9
solute carrier family 6 member 9
decreases expression
ISO
trovafloxacin results in decreased expression of SLC6A9 mRNA
CTD
PMID:35537566
NCBI chr 5:131,374,562...131,408,733
Ensembl chr 5:131,374,542...131,408,728
G
Slc7a1
solute carrier family 7 member 1
decreases expression
ISO
trovafloxacin results in decreased expression of SLC7A1 mRNA
CTD
PMID:35537566
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
G
Slc7a11
solute carrier family 7 member 11
decreases expression
ISO
trovafloxacin results in decreased expression of SLC7A11 mRNA
CTD
PMID:35537566
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slc7a2
solute carrier family 7 member 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SLC7A2 mRNA
CTD
PMID:18930950
NCBI chr16:51,417,478...51,470,784
Ensembl chr16:51,417,493...51,470,784
G
Slc7a5
solute carrier family 7 member 5
decreases expression
ISO
trovafloxacin results in decreased expression of SLC7A5 mRNA
CTD
PMID:35537566
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Slc9a9
solute carrier family 9 member A9
decreases expression
ISO
trovafloxacin results in decreased expression of SLC9A9 mRNA
CTD
PMID:35537566
NCBI chr 8:95,232,889...95,797,262
Ensembl chr 8:95,232,905...95,796,318
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
increases expression
EXP
trovafloxacin results in increased expression of SLCO1A2 mRNA
CTD
PMID:24136188
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
G
Slco1b2
solute carrier organic anion transporter family member 1B2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SLCO1B3 mRNA
CTD
PMID:18930950
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
G
Slco4a1
solute carrier organic anion transporter family, member 4a1
increases expression
ISO
trovafloxacin results in increased expression of SLCO4A1 mRNA
CTD
PMID:35537566
NCBI chr 3:167,559,177...167,578,307
Ensembl chr 3:167,559,316...167,578,305
G
Slfn2
schlafen family member 2
increases expression
ISO
trovafloxacin results in increased expression of SLFN2 mRNA
CTD
PMID:35537566
NCBI chr10:67,953,322...67,959,659
Ensembl chr10:67,953,171...67,959,458
G
Slfn4
schlafen family member 4
increases expression
ISO
trovafloxacin results in increased expression of SLFN4 mRNA
CTD
PMID:35537566
NCBI chr10:67,994,601...68,018,141
Ensembl chr10:68,000,028...68,018,138 Ensembl chr10:68,000,028...68,018,138
G
Slfn5
schlafen family member 5
increases expression
ISO
trovafloxacin results in increased expression of SLFN5 mRNA
CTD
PMID:35537566
NCBI chr10:67,881,068...67,895,013
Ensembl chr10:67,880,009...67,893,109
G
Smad6
SMAD family member 6
decreases expression
ISO
trovafloxacin results in decreased expression of SMAD6 mRNA
CTD
PMID:35537566
NCBI chr 8:64,450,114...64,519,673
Ensembl chr 8:64,450,114...64,519,763
G
Smarcd2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SMARCD2 mRNA
CTD
PMID:18930950
NCBI chr10:91,193,752...91,202,817
Ensembl chr10:91,193,752...91,204,341
G
Smarcd3
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
increases expression
ISO
trovafloxacin results in increased expression of SMARCD3 mRNA
CTD
PMID:35537566
NCBI chr 4:10,548,693...10,580,334
Ensembl chr 4:10,548,751...10,580,326
G
Smc2
structural maintenance of chromosomes 2
decreases expression
ISO
trovafloxacin results in decreased expression of SMC2 mRNA
CTD
PMID:35537566
NCBI chr 5:66,806,882...66,853,478
Ensembl chr 5:66,807,011...66,853,242
G
Smc4
structural maintenance of chromosomes 4
decreases expression
ISO
trovafloxacin results in decreased expression of SMC4 mRNA
CTD
PMID:35537566
NCBI chr 2:153,240,243...153,268,722
Ensembl chr 2:153,240,283...153,271,571
G
Smg7
SMG7 nonsense mediated mRNA decay factor
increases expression
ISO
trovafloxacin results in increased expression of SMG7 mRNA
CTD
PMID:35537566
NCBI chr13:64,986,145...65,050,698
Ensembl chr13:64,987,434...65,050,582
G
Smim11
small integral membrane protein 11
increases expression
ISO
trovafloxacin results in increased expression of SMIM11 mRNA
CTD
PMID:35537566
NCBI chr11:31,533,257...31,543,002
Ensembl chr11:31,532,764...31,543,002
G
Smim14
small integral membrane protein 14
decreases expression
ISO
trovafloxacin results in decreased expression of SMIM14 mRNA
CTD
PMID:35537566
NCBI chr14:42,783,361...42,829,762
Ensembl chr14:42,783,332...42,829,760
G
Smim27
small integral membrane protein 27
increases expression
ISO
trovafloxacin results in increased expression of SMIM27 mRNA
CTD
PMID:35537566
NCBI chr 5:55,399,637...55,400,304
Ensembl chr 5:55,398,723...55,400,869
G
Smim5
small integral membrane protein 5
increases expression
ISO
trovafloxacin results in increased expression of SMIM5 mRNA
CTD
PMID:35537566
NCBI chr10:101,134,033...101,139,814
Ensembl chr10:101,134,033...101,139,813
G
Smim7
small integral membrane protein 7
increases expression
ISO
trovafloxacin results in increased expression of SMIM7 mRNA
CTD
PMID:35537566
NCBI chr16:17,274,417...17,278,336
Ensembl chr16:17,273,258...17,278,336
G
Smndc1
survival motor neuron domain containing 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SMNDC1 mRNA
CTD
PMID:18930950
NCBI chr 1:252,389,675...252,400,749
Ensembl chr 1:252,389,673...252,401,616
G
Smpdl3b
sphingomyelin phosphodiesterase, acid-like 3B
decreases expression
ISO
trovafloxacin results in decreased expression of SMPDL3B mRNA
CTD
PMID:35537566
NCBI chr 5:144,944,618...144,966,703
Ensembl chr 5:144,944,636...144,966,720
G
Smtn
smoothelin
decreases expression
ISO
trovafloxacin results in decreased expression of SMTN mRNA
CTD
PMID:35537566
NCBI chr14:78,398,595...78,420,908
Ensembl chr14:78,397,778...78,420,886
G
Snapc4
small nuclear RNA activating complex, polypeptide 4
increases expression
ISO
trovafloxacin results in increased expression of SNAPC4 mRNA
CTD
PMID:35537566
NCBI chr 3:9,182,061...9,200,819
Ensembl chr 3:9,182,067...9,199,518
G
Snd1
staphylococcal nuclease and tudor domain containing 1
decreases expression
EXP ISO
trovafloxacin results in decreased expression of SND1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 4:57,095,205...57,494,501
Ensembl chr 4:57,095,208...57,530,843
G
Snora23
small nucleolar RNA, H/ACA box 23
increases expression
ISO
trovafloxacin results in increased expression of SNORA23 mRNA
CTD
PMID:35537566
NCBI chr 1:164,091,024...164,091,206
Ensembl chr 1:164,091,024...164,091,206
G
Snora31
small nucleolar RNA, H/ACA box 31
increases expression
ISO
trovafloxacin results in increased expression of SNORA31 mRNA
CTD
PMID:35537566
NCBI chr15:51,159,220...51,159,349
Ensembl chr15:51,159,220...51,159,349
G
Snora3A
small nucleolar RNA, H/ACA box 3A
increases expression
ISO
trovafloxacin results in increased expression of SNORA3 mRNA
CTD
PMID:35537566
NCBI chr 1:163,540,664...163,540,793
Ensembl chr 1:163,540,664...163,540,793
G
Snora47
small nucleolar RNA, H/ACA box 47
increases expression
ISO
trovafloxacin results in increased expression of SNORA47 mRNA
CTD
PMID:35537566
NCBI chr 2:26,594,260...26,594,397
Ensembl chr 2:26,594,260...26,594,397
G
Snora52
small nucleolar RNA, H/ACA box 52
increases expression
ISO
trovafloxacin results in increased expression of SNORA52 mRNA
CTD
PMID:35537566
NCBI chr 1:196,547,488...196,547,621
Ensembl chr 1:196,547,488...196,547,621
G
Snora5c
small nucleolar RNA, H/ACA box 5C
increases expression
ISO
trovafloxacin results in increased expression of SNORA5C mRNA
CTD
PMID:35537566
NCBI chr14:81,487,218...81,487,354
Ensembl chr14:81,487,218...81,487,354
G
Snora64
small nucleolar RNA, H/ACA box 64
increases expression
ISO
trovafloxacin results in increased expression of SNORA64 mRNA
CTD
PMID:35537566
NCBI chr10:13,748,139...13,748,272
Ensembl chr10:13,748,139...13,748,272
G
Snora65
small nucleolar RNA, H/ACA box 65
increases expression
ISO
trovafloxacin results in increased expression of SNORA65 mRNA
CTD
PMID:35537566
NCBI chr 3:16,265,801...16,265,930
Ensembl chr 3:16,265,801...16,265,930
G
Snora73b
small nucleolar RNA, H/ACA box 73b
increases expression
ISO
trovafloxacin results in increased expression of SNORA73B mRNA
CTD
PMID:35537566
NCBI chr 5:144,545,179...144,545,382
Ensembl chr 5:144,545,179...144,545,382
G
Snora81
small nucleolar RNA, H/ACA box 81
increases expression
ISO
trovafloxacin results in increased expression of SNORA81 mRNA
CTD
PMID:35537566
NCBI chr11:77,767,579...77,767,756
Ensembl chr11:77,767,579...77,767,756
G
Snord104
small nucleolar RNA, C/D box 104
increases expression
ISO
trovafloxacin results in increased expression of SNORD104 mRNA
CTD
PMID:35537566
NCBI chr10:91,435,313...91,435,382
Ensembl chr10:91,435,313...91,435,382
G
Snord14d
small nucleolar RNA, C/D box 14D
increases expression
ISO
trovafloxacin results in increased expression of SNORD14D mRNA
CTD
PMID:35537566
NCBI chr 8:41,186,057...41,186,142
Ensembl chr 8:41,186,057...41,186,142
G
Snord16
small nucleolar RNA, C/D box 16
increases expression
ISO
trovafloxacin results in increased expression of SNORD16A mRNA
CTD
PMID:35537566
NCBI chr 8:64,673,195...64,673,293
Ensembl chr 8:64,673,195...64,673,293
G
Snord17
small nucleolar RNA, C/D box 17
increases expression
ISO
trovafloxacin results in increased expression of SNORD17 mRNA
CTD
PMID:35537566
NCBI chr 3:131,636,460...131,636,698
Ensembl chr 3:131,636,460...131,636,698
G
Snord19
small nucleolar RNA, C/D box 19
increases expression
ISO
trovafloxacin results in increased expression of SNORD19 mRNA
CTD
PMID:35537566
NCBI chr16:6,210,838...6,210,914
Ensembl chr16:6,210,838...6,210,914
G
Snord1c
small nucleolar RNA, C/D box 1C
increases expression
ISO
trovafloxacin results in increased expression of SNORD1C mRNA
CTD
PMID:35537566
NCBI chr10:101,905,797...101,905,872
Ensembl chr10:101,905,797...101,905,872
G
Snord2
small nucleolar RNA, C/D box 2
increases expression
ISO
trovafloxacin results in increased expression of SNORD2 mRNA
CTD
PMID:35537566
NCBI chr11:77,769,475...77,769,543
Ensembl chr11:77,769,475...77,769,543
G
Snord22
small nucleolar RNA, C/D box 22
increases expression
ISO
trovafloxacin results in increased expression of SNORD22 mRNA
CTD
PMID:35537566
NCBI chr11:9,097,799...9,097,923
Ensembl chr11:9,097,799...9,097,923
G
Snord42b
small nucleolar RNA, C/D box 42B
increases expression
ISO
trovafloxacin results in increased expression of SNORD42B mRNA
CTD
PMID:35537566
NCBI chr10:63,078,825...63,078,893
Ensembl chr10:63,078,825...63,078,893
G
Snord43
small nucleolar RNA, C/D box 43
increases expression
ISO
trovafloxacin results in increased expression of SNORD43 mRNA
CTD
PMID:35537566
NCBI chr 7:111,627,136...111,627,199
Ensembl chr 7:111,627,136...111,627,199
G
Snord49a
small nucleolar RNA, C/D box 49A
increases expression
ISO
trovafloxacin results in increased expression of SNORD49A mRNA
CTD
PMID:35537566
NCBI chr10:47,297,488...47,297,559
Ensembl chr10:47,297,488...47,297,559
G
Snord4a
small nucleolar RNA, C/D box 4A
increases expression
ISO
trovafloxacin results in increased expression of SNORD4A mRNA
CTD
PMID:35537566
NCBI chr10:63,077,419...63,077,489
Ensembl chr10:63,077,419...63,077,489
G
Snord53
small nucleolar RNA, C/D box 53
increases expression
ISO
trovafloxacin results in increased expression of SNORD53 mRNA
CTD
PMID:35537566
NCBI chr 6:23,861,377...23,861,454
Ensembl chr 6:23,861,377...23,861,454
G
Snord55
small nucleolar RNA, C/D box 55
increases expression
ISO
trovafloxacin results in increased expression of SNORD55 mRNA
CTD
PMID:35537566
NCBI chr 5:130,632,614...130,632,692
Ensembl chr 5:130,632,614...130,632,692
G
Snord57
small nucleolar RNA, C/D box 57
increases expression
ISO
trovafloxacin results in increased expression of SNORD57 mRNA
CTD
PMID:35537566
NCBI chr 3:117,480,517...117,480,588
Ensembl chr 3:117,480,517...117,480,588
G
Snord58b
small nucleolar RNA, C/D box 58B
increases expression
ISO
trovafloxacin results in increased expression of SNORD58B mRNA
CTD
PMID:35537566
NCBI chr18:68,581,864...68,581,929
Ensembl chr18:68,581,864...68,581,929
G
Snord69
small nucleolar RNA, C/D box 69
increases expression
ISO
trovafloxacin results in increased expression of SNORD69 mRNA
CTD
PMID:35537566
NCBI chr16:6,208,922...6,209,001
Ensembl chr16:6,208,922...6,209,001
G
Snord72
small nucleolar RNA, C/D box 72
increases expression
ISO
trovafloxacin results in increased expression of SNORD72 mRNA
CTD
PMID:35537566
NCBI chr 2:54,217,160...54,217,239
Ensembl chr 2:54,217,160...54,217,239
G
Snord73b
small nucleolar RNA, C/D box U73B
increases expression
ISO
trovafloxacin results in increased expression of SNORD73B mRNA
CTD
PMID:35537566
NCBI chr 2:171,527,196...171,527,269
Ensembl chr 2:171,527,196...171,527,269
G
Snord8
small nucleolar RNA, C/D box 8
increases expression
ISO
trovafloxacin results in increased expression of SNORD8 mRNA
CTD
PMID:35537566
NCBI chr15:24,917,836...24,917,945
Ensembl chr15:24,917,836...24,917,945
G
Snord83b
small nucleolar RNA, C/D box 83B
increases expression
ISO
trovafloxacin results in increased expression of SNORD83B mRNA
CTD
PMID:35537566
NCBI chr 7:111,622,885...111,622,978
Ensembl chr 7:111,622,885...111,622,978
G
Snord89
small nucleolar RNA, C/D box 89
increases expression
ISO
trovafloxacin results in increased expression of SNORD89 mRNA
CTD
PMID:35537566
NCBI chr 9:41,827,972...41,828,086
Ensembl chr 9:41,827,972...41,828,086
G
Snord99
small nucleolar RNA, C/D box 99
increases expression
ISO
trovafloxacin results in increased expression of SNORD99 mRNA
CTD
PMID:35537566
NCBI chr 5:144,506,901...144,506,974
Ensembl chr 5:144,506,901...144,506,974
G
Snrnp48
small nuclear ribonucleoprotein U11/U12 subunit 48
increases expression
ISO
trovafloxacin results in increased expression of SNRNP48 mRNA
CTD
PMID:35537566
NCBI chr17:26,596,266...26,616,058
Ensembl chr17:26,596,275...26,616,040
G
Snrpd3
small nuclear ribonucleoprotein D3 polypeptide
increases expression
ISO
trovafloxacin results in increased expression of SNRPD3 mRNA
CTD
PMID:35537566
NCBI chr20:13,130,112...13,145,947
Ensembl chr20:13,130,119...13,145,978
G
Snx22
sorting nexin 22
increases expression
ISO
trovafloxacin results in increased expression of SNX22 mRNA
CTD
PMID:35537566
NCBI chr 8:66,609,914...66,612,932
Ensembl chr 8:66,609,970...66,612,850
G
Snx25
sorting nexin 25
decreases expression
ISO
trovafloxacin results in decreased expression of SNX25 mRNA
CTD
PMID:35537566
NCBI chr16:46,134,552...46,238,471
Ensembl chr16:46,125,804...46,238,440
G
Snx32
sorting nexin 32
decreases expression
ISO
trovafloxacin results in decreased expression of SNX32 mRNA
CTD
PMID:35537566
NCBI chr 1:202,801,090...202,818,731
Ensembl chr 1:202,802,394...202,818,743
G
Snx4
sorting nexin 4
multiple interactions
ISO
[trovafloxacin co-treated with TNF protein] results in decreased expression of SNX4 mRNA
CTD
PMID:33609687
NCBI chr11:67,460,872...67,518,143
Ensembl chr11:67,460,870...67,518,174
G
Soat2
sterol O-acyltransferase 2
decreases expression
ISO
trovafloxacin results in decreased expression of SOAT2 mRNA
CTD
PMID:35537566
NCBI chr 7:133,281,818...133,294,915
Ensembl chr 7:133,281,818...133,294,915
G
Socs2
suppressor of cytokine signaling 2
increases expression multiple interactions
EXP ISO
trovafloxacin results in increased expression of SOCS2 mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SOCS2 mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
G
Socs3
suppressor of cytokine signaling 3
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SOCS3 mRNA trovafloxacin results in increased expression of SOCS3 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sod2
superoxide dismutase 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SOD2 mRNA
CTD
PMID:18930950
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sorbs1
sorbin and SH3 domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of SORBS1 mRNA
CTD
PMID:35537566
NCBI chr 1:239,107,882...239,330,276
Ensembl chr 1:239,108,777...239,330,169
G
Sorbs3
sorbin and SH3 domain containing 3
decreases expression
ISO
trovafloxacin results in decreased expression of SORBS3 mRNA
CTD
PMID:35537566
NCBI chr15:45,252,921...45,284,758
Ensembl chr15:45,253,379...45,284,758
G
Sorl1
sortilin related receptor 1
decreases expression
ISO
trovafloxacin results in decreased expression of SORL1 mRNA
CTD
PMID:35537566
NCBI chr 8:42,341,704...42,504,435
Ensembl chr 8:42,341,704...42,504,513
G
Sp4
Sp4 transcription factor
decreases expression
ISO
trovafloxacin results in decreased expression of SP4 mRNA
CTD
PMID:35537566
NCBI chr 6:139,187,458...139,252,741
Ensembl chr 6:139,192,147...139,252,126
G
Spag17
sperm associated antigen 17
increases expression
ISO
trovafloxacin results in increased expression of SPAG17 mRNA
CTD
PMID:35537566
NCBI chr 2:187,264,004...187,511,061
Ensembl chr 2:187,264,009...187,510,501
G
Spag5
sperm associated antigen 5
decreases expression
ISO
trovafloxacin results in decreased expression of SPAG5 mRNA
CTD
PMID:35537566
NCBI chr10:63,198,717...63,216,746
Ensembl chr10:63,198,768...63,216,745
G
Spart
spartin
decreases expression
EXP
trovafloxacin results in decreased expression of SPART mRNA
CTD
PMID:24136188
NCBI chr 2:139,292,630...139,319,248
Ensembl chr 2:139,292,355...139,319,248
G
Spata24
spermatogenesis associated 24
decreases expression
ISO
trovafloxacin results in decreased expression of SPATA24 mRNA
CTD
PMID:35537566
NCBI chr18:27,249,047...27,257,129
Ensembl chr18:27,248,609...27,257,124
G
Spc24
SPC24 component of NDC80 kinetochore complex
decreases expression
ISO
trovafloxacin results in decreased expression of SPC24 mRNA
CTD
PMID:35537566
NCBI chr 8:20,300,315...20,305,354
Ensembl chr 8:20,300,319...20,305,310
G
Spc25
SPC25 component of NDC80 kinetochore complex
decreases expression
ISO
trovafloxacin results in decreased expression of SPC25 mRNA
CTD
PMID:35537566
NCBI chr 3:53,930,013...53,988,940
Ensembl chr 3:53,975,704...53,988,959
G
Spdl1
spindle apparatus coiled-coil protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of SPDL1 mRNA
CTD
PMID:35537566
NCBI chr10:19,269,125...19,294,213
Ensembl chr10:19,269,127...19,294,127
G
Spef1
sperm flagellar 1
decreases expression
ISO
trovafloxacin results in decreased expression of SPEF1 mRNA
CTD
PMID:35537566
NCBI chr 3:118,390,659...118,396,842
Ensembl chr 3:118,390,575...118,394,531
G
Spg7
SPG7 matrix AAA peptidase subunit, paraplegin
decreases expression
ISO
trovafloxacin results in decreased expression of SPG7 mRNA
CTD
PMID:35537566
NCBI chr19:51,117,088...51,151,228
Ensembl chr19:51,117,057...51,150,484
G
Spn
sialophorin
decreases expression
ISO
trovafloxacin results in decreased expression of SPN mRNA
CTD
PMID:35537566
NCBI chr 1:181,746,937...181,759,564
Ensembl chr 1:181,746,429...181,759,628
G
Spred2
sprouty-related, EVH1 domain containing 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SPRED2 mRNA
CTD
PMID:18930950
NCBI chr14:94,149,210...94,250,787
Ensembl chr14:94,148,837...94,249,162
G
Spry2
sprouty RTK signaling antagonist 2
increases expression
ISO
trovafloxacin results in increased expression of SPRY2 mRNA
CTD
PMID:35537566
NCBI chr15:82,692,291...82,697,408
Ensembl chr15:82,692,143...82,698,009
G
Sptbn4
spectrin, beta, non-erythrocytic 4
increases expression
ISO
trovafloxacin results in increased expression of SPTBN4 mRNA
CTD
PMID:35537566
NCBI chr 1:82,650,750...82,738,345
Ensembl chr 1:82,650,751...82,737,228
G
Sptssa
serine palmitoyltransferase, small subunit A
increases expression
EXP
trovafloxacin results in increased expression of SPTSSA mRNA
CTD
PMID:24136188
NCBI chr 6:72,144,714...72,156,130
Ensembl chr 6:72,144,714...72,156,214
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
increases expression
ISO
trovafloxacin results in increased expression of SRC mRNA
CTD
PMID:35537566
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
EXP
trovafloxacin results in decreased expression of SREBF1 mRNA
CTD
PMID:24136188
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srgap3
SLIT-ROBO Rho GTPase activating protein 3
increases expression
ISO
trovafloxacin results in increased expression of SRGAP3 mRNA
CTD
PMID:35537566
NCBI chr 4:145,839,369...146,070,556
Ensembl chr 4:145,840,078...146,070,575
G
Srm
spermidine synthase
decreases expression
EXP
trovafloxacin results in decreased expression of SRM mRNA
CTD
PMID:24136188
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
G
Srp72
signal recognition particle 72
decreases expression
EXP
trovafloxacin results in decreased expression of SRP72 mRNA
CTD
PMID:24136188
NCBI chr14:31,168,175...31,195,717
Ensembl chr14:31,168,293...31,195,729
G
Srrm2
serine/arginine repetitive matrix 2
increases expression
EXP
trovafloxacin results in increased expression of SRRM2 mRNA
CTD
PMID:24136188
NCBI chr10:12,815,471...12,848,750
Ensembl chr10:12,815,471...12,848,751
G
Srsf1
serine and arginine rich splicing factor 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SRSF1 mRNA
CTD
PMID:18930950
NCBI chr10:72,838,926...72,859,066
Ensembl chr10:72,839,274...72,845,336
G
Srsf2
serine and arginine rich splicing factor 2
decreases expression multiple interactions
EXP ISO
trovafloxacin results in decreased expression of SRSF2 mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SRSF2 mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
G
Srsf3
serine and arginine rich splicing factor 3
decreases expression
EXP
trovafloxacin results in decreased expression of SRSF3 mRNA
CTD
PMID:24136188
NCBI chr20:7,091,928...7,101,860
Ensembl chr20:7,091,910...7,101,078
G
Srsf4
serine and arginine rich splicing factor 4
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SRSF4 mRNA
CTD
PMID:18930950
NCBI chr 5:144,060,981...144,090,798
Ensembl chr 5:144,061,463...144,089,229
G
Srsf5
serine and arginine rich splicing factor 5
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SRSF5 mRNA
CTD
PMID:18930950
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:100,605,456...100,610,177
G
Ssbp4
single stranded DNA binding protein 4
decreases expression
ISO
trovafloxacin results in decreased expression of SSBP4 mRNA
CTD
PMID:35537566
NCBI chr16:18,828,014...18,838,941
Ensembl chr16:18,828,054...18,838,947
G
Ssh2
slingshot protein phosphatase 2
decreases expression
ISO
trovafloxacin results in decreased expression of SSH2 mRNA
CTD
PMID:35537566
NCBI chr10:62,057,400...62,309,328
Ensembl chr10:62,057,044...62,306,563
G
Ssx2ip
SSX family member 2 interacting protein
decreases expression
EXP
trovafloxacin results in decreased expression of SSX2IP mRNA
CTD
PMID:24136188
NCBI chr 2:235,298,012...235,330,750
Ensembl chr 2:235,298,088...235,330,745
G
St6gal1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ST6GAL1 mRNA
CTD
PMID:35537566
NCBI chr11:77,526,837...77,653,474
Ensembl chr11:77,526,837...77,653,310
G
Stag2
STAG2 cohesin complex component
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of STAG2 mRNA
CTD
PMID:18930950
NCBI chr X:120,974,687...121,105,677
Ensembl chr X:120,974,857...121,105,677
G
Stard4
StAR-related lipid transfer domain containing 4
increases expression
EXP
trovafloxacin results in increased expression of STARD4 mRNA
CTD
PMID:24136188
NCBI chr18:24,814,683...24,830,024
Ensembl chr18:24,817,107...24,830,024
G
Stard5
StAR-related lipid transfer domain containing 5
multiple interactions decreases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of STARD5 mRNA trovafloxacin results in decreased expression of STARD5 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr 1:137,606,151...137,616,017
Ensembl chr 1:137,606,177...137,616,469
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of STAT3 mRNA
CTD
PMID:18930950
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stbd1
starch binding domain 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of STBD1 mRNA
CTD
PMID:18930950
NCBI chr14:15,470,452...15,473,857
Ensembl chr14:15,469,582...15,477,443
G
Stc2
stanniocalcin 2
decreases expression
ISO
trovafloxacin results in decreased expression of STC2 mRNA
CTD
PMID:35537566
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Stil
STIL, centriolar assembly protein
decreases expression
ISO
trovafloxacin results in decreased expression of STIL mRNA
CTD
PMID:35537566
NCBI chr 5:128,520,837...128,573,732
Ensembl chr 5:128,520,953...128,573,730
G
Stip1
stress-induced phosphoprotein 1
decreases expression
EXP
trovafloxacin results in decreased expression of STIP1 mRNA
CTD
PMID:24136188
NCBI chr 1:204,209,433...204,228,452
Ensembl chr 1:204,178,932...204,228,476
G
Stkld1
serine/threonine kinase-like domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of STKLD1 mRNA
CTD
PMID:35537566
NCBI chr 3:10,261,583...10,280,850
Ensembl chr 3:10,261,828...10,280,566
G
Stmn1
stathmin 1
decreases expression
EXP ISO
trovafloxacin results in decreased expression of STMN1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
G
Strbp
spermatid perinuclear RNA binding protein
decreases expression
ISO
trovafloxacin results in decreased expression of STRBP mRNA
CTD
PMID:35537566
NCBI chr 3:21,328,310...21,467,753
Ensembl chr 3:21,337,855...21,414,949
G
Sts
steroid sulfatase
increases expression
EXP
trovafloxacin results in increased expression of STS mRNA
CTD
PMID:24136188
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
G
Stx1a
syntaxin 1A
increases expression
ISO
trovafloxacin results in increased expression of STX1A mRNA
CTD
PMID:35537566
NCBI chr12:21,641,971...21,670,022
Ensembl chr12:21,641,969...21,669,930
G
Stxbp5
syntaxin binding protein 5
decreases expression
ISO
trovafloxacin results in decreased expression of STXBP5 mRNA
CTD
PMID:35537566
NCBI chr 1:4,182,489...4,335,290
Ensembl chr 1:4,185,529...4,335,101
G
Sulf2
sulfatase 2
increases expression
ISO
trovafloxacin results in increased expression of SULF2 mRNA
CTD
PMID:35537566
NCBI chr 3:154,822,079...154,904,566
Ensembl chr 3:154,822,085...154,904,415
G
Sumo2
small ubiquitin-like modifier 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SUMO2 mRNA
CTD
PMID:18930950
NCBI chr10:100,771,941...100,784,503
Ensembl chr10:100,686,797...100,784,513
G
Sun2
Sad1 and UNC84 domain containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of SUN2 mRNA
CTD
PMID:35537566
NCBI chr 7:111,275,374...111,292,565
Ensembl chr 7:111,275,380...111,292,553
G
Supt4h1
SPT4 homolog, DSIF elongation factor subunit
increases expression
ISO
trovafloxacin results in increased expression of SUPT4A mRNA
CTD
PMID:35537566
NCBI chr10:72,539,323...72,545,582
Ensembl chr10:72,539,382...72,545,831
G
Surf1
SURF1, cytochrome c oxidase assembly factor
decreases expression
ISO
trovafloxacin results in decreased expression of SURF1 mRNA
CTD
PMID:35537566
NCBI chr 3:10,241,793...10,244,686
Ensembl chr 3:10,241,837...10,263,315
G
Suv39h1
SUV39H1 histone lysine methyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of SUV39H1 mRNA
CTD
PMID:35537566
NCBI chr X:14,421,028...14,433,993
Ensembl chr X:14,421,109...14,433,982
G
Suv39h1-ps1
SUV39H1 histone lysine methyltransferase, pseudogene 1
decreases expression
ISO
trovafloxacin results in decreased expression of SUV39H1 mRNA
CTD
PMID:35537566
NCBI chr X:141,792,589...141,795,257
G
Svil
supervillin
decreases expression
ISO
trovafloxacin results in decreased expression of SVIL mRNA
CTD
PMID:35537566
NCBI chr17:52,648,502...52,844,114
Ensembl chr17:52,648,502...52,793,404
G
Sycp1
synaptonemal complex protein 1
increases expression
ISO
trovafloxacin results in increased expression of SYCP1 mRNA
CTD
PMID:35537566
NCBI chr 2:190,296,688...190,456,687
Ensembl chr 2:190,296,954...190,456,737
G
Syn3
synapsin III
decreases expression
ISO
trovafloxacin results in decreased expression of SYN3 mRNA
CTD
PMID:35537566
NCBI chr 7:16,216,055...17,808,790
Ensembl chr 7:17,376,372...17,808,790
G
Syncrip
synaptotagmin binding, cytoplasmic RNA interacting protein
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SYNCRIP mRNA
CTD
PMID:18930950
NCBI chr 8:89,402,487...89,435,517
Ensembl chr 8:89,402,866...89,435,515
G
Syne1
spectrin repeat containing nuclear envelope protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of SYNE1 mRNA
CTD
PMID:35537566
NCBI chr 1:41,512,146...41,983,382
Ensembl chr 1:41,512,030...41,983,322
G
Syne2
spectrin repeat containing nuclear envelope protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of SYNE2 mRNA
CTD
PMID:35537566
NCBI chr 6:94,537,088...94,848,085
Ensembl chr 6:94,537,088...94,848,064
G
Synrg
synergin, gamma
increases expression
EXP
trovafloxacin results in increased expression of SYNRG mRNA
CTD
PMID:24136188
NCBI chr10:68,848,828...68,931,252
Ensembl chr10:68,849,642...68,931,250
G
Syt7
synaptotagmin 7
decreases expression
ISO
trovafloxacin results in decreased expression of SYT7 mRNA
CTD
PMID:35537566
NCBI chr 1:207,031,359...207,093,787
Ensembl chr 1:207,031,592...207,089,026
G
Taf1a
TATA-box binding protein associated factor, RNA polymerase I subunit A
increases expression
ISO
trovafloxacin results in increased expression of TAF1A mRNA
CTD
PMID:35537566
NCBI chr13:95,012,160...95,048,131
Ensembl chr13:95,029,225...95,048,087
G
Taf1c
TATA-box binding protein associated factor, RNA polymerase 1 subunit C
increases expression
ISO
trovafloxacin results in increased expression of TAF1C mRNA
CTD
PMID:35537566
NCBI chr19:47,652,451...47,658,971
Ensembl chr19:47,652,452...47,658,971
G
Taf1d
TATA-box binding protein associated factor, RNA polymerase I subunit D
increases expression
ISO
trovafloxacin results in increased expression of TAF1D mRNA
CTD
PMID:35537566
NCBI chr 8:12,146,511...12,156,647
Ensembl chr 8:12,146,605...12,156,618
G
Taf7
TATA-box binding protein associated factor 7
increases expression
ISO
trovafloxacin results in increased expression of TAF7 mRNA
CTD
PMID:35537566
NCBI chr18:29,459,937...29,462,086
Ensembl chr18:29,452,943...29,462,134
G
Tagap
T-cell activation RhoGTPase activating protein
decreases expression
ISO
trovafloxacin results in decreased expression of TAGAP mRNA
CTD
PMID:35537566
NCBI chr 1:47,170,725...47,179,705
Ensembl chr 1:47,170,725...47,179,792
G
Tanc2
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of TANC2 mRNA
CTD
PMID:35537566
NCBI chr10:90,553,124...90,873,477
Ensembl chr10:90,553,002...90,868,756
G
Tarm1
T cell-interacting, activating receptor on myeloid cells 1
decreases expression
ISO
trovafloxacin results in decreased expression of TARM1 mRNA
CTD
PMID:35537566
NCBI chr 1:65,666,742...65,682,402
Ensembl chr 1:65,671,902...65,679,626
G
Tars3
threonyl-tRNA synthetase 3
decreases expression
ISO
trovafloxacin results in decreased expression of TARS3 mRNA
CTD
PMID:35537566
NCBI chr 1:119,213,189...119,265,492
Ensembl chr 1:119,213,213...119,265,488
G
Tat
tyrosine aminotransferase
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of TAT mRNA
CTD
PMID:18930950
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
G
Tbc1d14
TBC1 domain family, member 14
increases expression
EXP
trovafloxacin results in increased expression of TBC1D14 mRNA
CTD
PMID:24136188
NCBI chr14:74,172,652...74,272,182
Ensembl chr14:74,172,664...74,272,183
G
Tbc1d31
TBC1 domain family, member 31
decreases expression
ISO
trovafloxacin results in decreased expression of TBC1D31 mRNA
CTD
PMID:35537566
NCBI chr 7:89,427,354...89,506,894
Ensembl chr 7:89,426,780...89,506,894
G
Tbc1d32
TBC1 domain family, member 32
decreases expression
ISO
trovafloxacin results in decreased expression of TBC1D32 mRNA
CTD
PMID:35537566
NCBI chr20:35,359,865...35,590,992
Ensembl chr20:35,359,863...35,590,415
G
Tbc1d8
TBC1 domain family, member 8
increases expression
ISO
trovafloxacin results in increased expression of TBC1D8 mRNA
CTD
PMID:35537566
NCBI chr 9:41,651,394...41,761,432
Ensembl chr 9:41,651,395...41,761,409
G
Tbl3
transducin (beta)-like 3
decreases expression
ISO
trovafloxacin results in decreased expression of TBL3 mRNA
CTD
PMID:35537566
NCBI chr10:13,726,127...13,731,340
Ensembl chr10:13,726,129...13,731,372
G
Tcaim
T cell activation inhibitor, mitochondrial
increases expression
ISO
trovafloxacin results in increased expression of TCAIM mRNA
CTD
PMID:35537566
NCBI chr 8:122,414,827...122,446,105
Ensembl chr 8:122,414,818...122,446,092
G
Tcea2
transcription elongation factor A2
decreases expression
ISO
trovafloxacin results in decreased expression of TCEA2 mRNA
CTD
PMID:35537566
NCBI chr 3:168,796,244...168,804,125
Ensembl chr 3:168,796,331...168,804,116
G
Tcf19
transcription factor 19
decreases expression
ISO
trovafloxacin results in decreased expression of TCF19 mRNA
CTD
PMID:35537566
NCBI chr20:3,218,756...3,222,861
Ensembl chr20:3,218,693...3,223,271
G
Tcirg1
T-cell immune regulator 1, ATPase H+ transporting V0 subunit A3
decreases expression
EXP
trovafloxacin results in decreased expression of TCIRG1 mRNA
CTD
PMID:24136188
NCBI chr 1:201,127,034...201,138,787
Ensembl chr 1:201,127,034...201,138,742
G
Tcof1
treacle ribosome biogenesis factor 1
decreases expression
ISO
trovafloxacin results in decreased expression of TCOF1 mRNA
CTD
PMID:35537566
NCBI chr18:54,267,015...54,300,324
Ensembl chr18:54,267,026...54,300,324
G
Tctn2
tectonic family member 2
decreases expression
ISO
trovafloxacin results in decreased expression of TCTN2 mRNA
CTD
PMID:35537566
NCBI chr12:31,982,440...32,007,242
Ensembl chr12:31,822,733...32,007,069
G
Tdp1
tyrosyl-DNA phosphodiesterase 1
decreases expression
ISO
trovafloxacin results in decreased expression of TDP1 mRNA
CTD
PMID:35537566
NCBI chr 6:119,163,192...119,231,029
Ensembl chr 6:119,163,166...119,231,021
G
Tecpr1
tectonin beta-propeller repeat containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of TECPR1 mRNA
CTD
PMID:35537566
NCBI chr12:10,391,587...10,420,462
Ensembl chr12:10,391,696...10,419,611
G
Tent2
terminal nucleotidyltransferase 2
decreases expression
EXP
trovafloxacin results in decreased expression of TENT2 mRNA
CTD
PMID:24136188
NCBI chr 2:24,380,135...24,432,099
Ensembl chr 2:24,380,225...24,432,099
G
Tent5b
terminal nucleotidyltransferase 5B
decreases expression
ISO
trovafloxacin results in decreased expression of FAM46B mRNA
CTD
PMID:35537566
NCBI chr 5:145,695,358...145,702,668
Ensembl chr 5:145,695,362...145,706,073
G
Tert
telomerase reverse transcriptase
increases expression
ISO
trovafloxacin results in increased expression of TERT mRNA
CTD
PMID:35537566
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tfb1m
transcription factor B1, mitochondrial
decreases expression
ISO
trovafloxacin results in decreased expression of TFB1M mRNA
CTD
PMID:35537566
NCBI chr 1:44,115,240...44,161,737
Ensembl chr 1:44,119,166...44,161,709
G
Tfdp1
transcription factor Dp-1
decreases expression
EXP
trovafloxacin results in decreased expression of TFDP1 mRNA
CTD
PMID:24136188
NCBI chr16:76,162,040...76,200,871
Ensembl chr16:76,162,043...76,200,817
G
Tfdp2
transcription factor Dp-2
decreases expression
ISO
trovafloxacin results in decreased expression of TFDP2 mRNA
CTD
PMID:35537566
NCBI chr 8:96,760,459...96,901,466
Ensembl chr 8:96,760,504...96,896,682
G
Tfg
trafficking from ER to golgi regulator
multiple interactions decreases expression
ISO EXP
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of TFG mRNA trovafloxacin results in decreased expression of TFG mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr11:43,885,542...43,911,976
Ensembl chr11:43,885,661...43,911,976
G
Tfrc
transferrin receptor
increases expression
ISO
trovafloxacin results in increased expression of TFRC mRNA
CTD
PMID:35537566
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tgif1
TGFB-induced factor homeobox 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of TGIF1 mRNA
CTD
PMID:18930950
NCBI chr 9:110,748,094...110,757,714
Ensembl chr 9:110,720,921...110,757,802
G
Tgm2
transglutaminase 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of TGM2 mRNA
CTD
PMID:18930950
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
G
Thbs1
thrombospondin 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of THBS1 mRNA
CTD
PMID:18930950
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Thrap3
thyroid hormone receptor associated protein 3
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of THRAP3 mRNA
CTD
PMID:18930950
NCBI chr 5:138,445,284...138,487,544
Ensembl chr 5:138,445,295...138,487,477
G
Thrsp
thyroid hormone responsive
decreases expression
EXP
trovafloxacin results in decreased expression of THRSP mRNA
CTD
PMID:24136188
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
G
Thumpd3-as1
THUMPD3 antisense RNA 1
increases expression
ISO
trovafloxacin results in increased expression of GT(ROSA)26SOR mRNA
CTD
PMID:35537566
NCBI chr 4:146,210,520...146,217,026
G
Ticam2
TIR domain containing adaptor molecule 2
decreases expression
ISO
trovafloxacin results in decreased expression of TICAM2 mRNA
CTD
PMID:35537566
NCBI chr18:39,289,902...39,311,462
Ensembl chr18:39,294,453...39,311,462
G
Ticrr
TOPBP1-interacting checkpoint and replication regulator
decreases expression
ISO
trovafloxacin results in decreased expression of TICRR mRNA
CTD
PMID:35537566
NCBI chr 1:133,597,618...133,639,513
Ensembl chr 1:133,597,716...133,639,523
G
Timeless
timeless circadian regulator
decreases expression
ISO
trovafloxacin results in decreased expression of TIMELESS mRNA
CTD
PMID:35537566
NCBI chr 7:654,804...678,769
Ensembl chr 7:654,822...678,738
G
Tinf2
TERF1 interacting nuclear factor 2
decreases expression
ISO
trovafloxacin results in decreased expression of TINF2 mRNA
CTD
PMID:35537566
NCBI chr15:29,170,663...29,178,015
Ensembl chr15:29,170,652...29,176,984
G
Tjp3
tight junction protein 3
decreases expression
ISO
trovafloxacin results in decreased expression of TJP3 mRNA
CTD
PMID:35537566
NCBI chr 7:8,427,650...8,446,279
Ensembl chr 7:8,432,811...8,446,279
G
Tk1
thymidine kinase 1
decreases expression
ISO
trovafloxacin results in decreased expression of TK1 mRNA
CTD
PMID:35537566
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
G
Tkfc
triokinase and FMN cyclase
decreases expression
EXP
trovafloxacin results in decreased expression of TKFC mRNA
CTD
PMID:24136188
NCBI chr 1:207,238,230...207,253,035
Ensembl chr 1:207,236,557...207,252,737
G
Tkt
transketolase
decreases expression
EXP
trovafloxacin results in decreased expression of TKT mRNA
CTD
PMID:24136188
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
G
Tle1
TLE family member 1, transcriptional corepressor
increases expression
EXP
trovafloxacin results in increased expression of TLE1 mRNA
CTD
PMID:24136188
NCBI chr 5:85,851,827...85,934,806
Ensembl chr 5:85,851,827...85,934,774
G
Tln2
talin 2
decreases expression
ISO
trovafloxacin results in decreased expression of TLN2 mRNA
CTD
PMID:35537566
NCBI chr 8:67,830,920...68,252,240
Ensembl chr 8:67,834,326...68,252,219
G
Tm2d3
TM2 domain containing 3
increases expression
ISO
trovafloxacin results in increased expression of TM2D3 mRNA
CTD
PMID:35537566
NCBI chr 1:119,267,194...119,277,094
Ensembl chr 1:119,264,576...119,277,099
G
Tm7sf2
transmembrane 7 superfamily member 2
decreases expression
ISO
trovafloxacin results in decreased expression of TM7SF2 mRNA
CTD
PMID:35537566
NCBI chr 1:203,355,930...203,360,287
Ensembl chr 1:203,355,931...203,360,270
G
Tm9sf4
transmembrane 9 superfamily member 4
decreases expression
ISO
trovafloxacin results in decreased expression of TM9SF4 mRNA
CTD
PMID:35537566
NCBI chr 3:141,627,128...141,675,386
Ensembl chr 3:141,627,346...141,675,386
G
Tmc8
transmembrane channel-like 8
decreases expression
ISO
trovafloxacin results in decreased expression of TMC8 mRNA
CTD
PMID:35537566
NCBI chr10:103,000,038...103,010,601
Ensembl chr10:102,998,402...103,010,590
G
Tmco4
transmembrane and coiled-coil domains 4
decreases expression
ISO
trovafloxacin results in decreased expression of TMCO4 mRNA
CTD
PMID:35537566
NCBI chr 5:151,216,499...151,294,726
Ensembl chr 5:151,216,812...151,294,723
G
Tmco5a
transmembrane and coiled-coil domains 5A
increases expression
ISO
trovafloxacin results in increased expression of TMCO5 mRNA
CTD
PMID:35537566
NCBI chr 3:103,732,936...103,746,242
Ensembl chr 3:103,732,945...103,746,249
G
Tmco6
transmembrane and coiled-coil domains 6
decreases expression
ISO
trovafloxacin results in decreased expression of TMCO6 mRNA
CTD
PMID:35537566
NCBI chr18:28,349,248...28,355,843
Ensembl chr18:28,349,248...28,355,843
G
Tmem106b
transmembrane protein 106B
increases expression
EXP
trovafloxacin results in increased expression of TMEM106B mRNA
CTD
PMID:24136188
NCBI chr 4:41,328,125...41,347,315
Ensembl chr 4:41,327,994...41,345,619
G
Tmem107
transmembrane protein 107
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM107 mRNA
CTD
PMID:35537566
NCBI chr10:53,772,153...53,774,685
Ensembl chr10:53,771,784...53,774,676
G
Tmem123
transmembrane protein 123
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM123 mRNA
CTD
PMID:35537566
NCBI chr 8:4,922,077...4,952,228
Ensembl chr 8:4,922,098...4,952,224
G
Tmem128
transmembrane protein 128
increases expression
ISO
trovafloxacin results in increased expression of TMEM128 mRNA
CTD
PMID:35537566
NCBI chr14:72,539,530...72,548,623
Ensembl chr14:72,539,532...72,548,550
G
Tmem144
transmembrane protein 144
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM144 mRNA
CTD
PMID:35537566
NCBI chr 2:164,960,649...164,993,562
Ensembl chr 2:164,961,247...164,992,368
G
Tmem158
transmembrane protein 158
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM158 mRNA
CTD
PMID:35537566
NCBI chr 8:122,913,675...122,914,673
Ensembl chr 8:122,913,675...122,914,673
G
Tmem171
transmembrane protein 171
increases expression
ISO
trovafloxacin results in increased expression of TMEM171 mRNA
CTD
PMID:35537566
NCBI chr 2:30,035,278...30,045,996
Ensembl chr 2:30,035,278...30,045,049
G
Tmem191c
transmembrane protein 191C
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM191C mRNA
CTD
PMID:35537566
NCBI chr11:83,726,155...83,728,926
Ensembl chr11:83,725,185...83,730,172
G
Tmem209
transmembrane protein 209
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM209 mRNA
CTD
PMID:35537566
NCBI chr 4:59,102,943...59,128,636
Ensembl chr 4:59,101,550...59,128,630
G
Tmem216
transmembrane protein 216
increases expression
ISO
trovafloxacin results in increased expression of TMEM216 mRNA
CTD
PMID:35537566
NCBI chr 1:207,196,454...207,201,704
Ensembl chr 1:207,196,454...207,201,754
G
Tmem221
transmembrane protein 221
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM221 mRNA
CTD
PMID:35537566
NCBI chr16:18,253,622...18,271,094
Ensembl chr16:18,262,052...18,266,967
G
Tmem260
transmembrane protein 260
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM260 mRNA
CTD
PMID:35537566
NCBI chr15:21,734,119...21,804,049
Ensembl chr15:21,734,151...21,806,801
G
Tmem267
transmembrane protein 267
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM267 mRNA
CTD
PMID:35537566
NCBI chr 2:51,580,210...51,588,937
Ensembl chr 2:51,581,252...51,587,636
G
Tmem41a
transmembrane protein 41a
decreases expression
EXP
trovafloxacin results in decreased expression of TMEM41A mRNA
CTD
PMID:24136188
NCBI chr11:79,084,005...79,090,613
Ensembl chr11:79,084,001...79,090,613
G
Tmem71
transmembrane protein 71
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM71 mRNA
CTD
PMID:35537566
NCBI chr 7:98,276,975...98,323,161
Ensembl chr 7:98,276,975...98,315,858
G
Tmem74
transmembrane protein 74
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM74 mRNA
CTD
PMID:35537566
NCBI chr 7:74,929,290...74,937,929
Ensembl chr 7:74,931,694...74,937,934
G
Tmem79
transmembrane protein 79
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM79 mRNA
CTD
PMID:35537566
NCBI chr 2:173,798,267...173,803,151
Ensembl chr 2:173,798,267...173,803,046
G
Tmem94
transmembrane protein 94
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM94 mRNA
CTD
PMID:35537566
NCBI chr10:100,991,523...101,027,046
Ensembl chr10:100,991,573...101,027,394
G
Tmod4
tropomodulin 4
increases expression
ISO
trovafloxacin results in increased expression of TMOD4 mRNA
CTD
PMID:35537566
NCBI chr 2:182,695,709...182,700,540
Ensembl chr 2:182,695,709...182,700,540
G
Tmpo
thymopoietin
decreases expression
EXP ISO
trovafloxacin results in decreased expression of TMPO mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 7:25,642,752...25,667,756
Ensembl chr 7:25,586,725...25,667,727
G
Tmx2
thioredoxin-related transmembrane protein 2
decreases expression
EXP
trovafloxacin results in decreased expression of TMX2 mRNA
CTD
PMID:24136188
NCBI chr 3:69,754,937...69,762,587
Ensembl chr 3:69,754,939...69,762,587
G
Tmx4
thioredoxin-related transmembrane protein 4
increases expression
EXP
trovafloxacin results in increased expression of TMX4 mRNA
CTD
PMID:24136188
NCBI chr 3:121,856,237...121,899,680
Ensembl chr 3:121,856,261...121,899,641
G
Tnf
tumor necrosis factor
multiple interactions decreases uptake decreases expression increases expression increases response to substance increases secretion
ISO EXP
4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of ATR protein]; [IFNG protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to trovafloxacin; [IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to trovafloxacin; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [trovafloxacin results in increased activity of CASP3 protein]; [TNF protein co-treated with trovafloxacin] results in increased activity of CASP3 protein; [TNF protein co-treated with trovafloxacin] results in increased expression of H2AX protein modified form; [trovafloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [trovafloxacin co-treated with TNF protein] results in decreased expression of ATG4C mRNA; [trovafloxacin co-treated with TNF protein] results in decreased expression of BIRC2 mRNA; [trovafloxacin co-treated with TNF protein] results in decreased expression of SNX4 mRNA; [trovafloxacin co-treated with TNF protein] results in decreased expression of XIAP mRNA; [trovafloxacin co-treated with TNF protein] results in increased activity of CASP3 protein; [trovafloxacin co-treated with TNF protein] results in increased activity of CASP8 protein; [trovafloxacin co-treated with TNF protein] results in increased activity of CASP9 protein; [trovafloxacin co-treated with TNF protein] results in increased expression of ATG10 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of ATG16L1 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of ATG2A mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of ATG3 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of ATG4A mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of BIRC3 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of GABARAPL1 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of ICAM1 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of MAP1LC3B mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of NFKBIA mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 protein; [trovafloxacin co-treated with TNF protein] results in increased expression of ULK2 mRNA; [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of and results in increased activity of ATR protein; [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of EIF4EBP1 protein; [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of MAPK1 protein; [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of MAPK3 protein; [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of RPS6KB1 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[TNF protein co-treated with trovafloxacin] results in increased expression of H2AX protein modified form]; Sirolimus inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of EIF4EBP1 protein]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of and results in increased lipidation of MAP1LC3B protein]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of ATG14 mRNA]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of ATG5 mRNA]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of GABARAPL2 mRNA]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of MAP1LC3A mRNA]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of MAP1LC3B2 mRNA]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of MAP1LC3C mRNA]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of RB1CC1 mRNA]; TNF protein promotes the reaction [trovafloxacin results in increased expression of ATG9B mRNA]; TNF protein promotes the reaction [trovafloxacin results in increased expression of H2AX protein modified form]; TNF protein promotes the reaction [trovafloxacin results in increased phosphorylation of AKT1 protein]; trovafloxacin affects the reaction [TNF protein affects the localization of RELA protein modified form]; trovafloxacin affects the reaction [TNF protein results in increased phosphorylation of RELA protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of ATG9B mRNA]; U 0126 inhibits the reaction [[TNF protein co-treated with trovafloxacin] results in increased activity of CASP3 protein] trovafloxacin results in decreased uptake of TNF protein trovafloxacin results in decreased expression of TNF trovafloxacin results in increased expression of TNF mRNA; trovafloxacin results in increased expression of TNF protein trovafloxacin results in increased susceptibility to TNF protein trovafloxacin results in increased secretion of TNF protein 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin results in increased expression of and results in increased stability of TNF mRNA]; 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin results in increased expression of TNF protein]; [Lipopolysaccharides co-treated with trovafloxacin] results in increased expression of TNF mRNA; [Pentoxifylline results in decreased expression of TNF mRNA] results in decreased susceptibility to [lipopolysaccharide, E coli O55-B5 co-treated with trovafloxacin]; [TNF protein co-treated with trovafloxacin] results in increased cleavage of CASP3 protein; [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of TNF protein; [trovafloxacin co-treated with TNF protein] results in decreased expression of NFKBIA protein; IFNG protein promotes the reaction [[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of TNF protein]; pyrazolanthrone inhibits the reaction [trovafloxacin promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; pyrazolanthrone inhibits the reaction [trovafloxacin results in increased expression of TNF mRNA]; TNF protein affects the susceptibility to [lipopolysaccharide, E coli O55-B5 co-treated with trovafloxacin]; TNF protein results in increased susceptibility to [Lipopolysaccharides co-treated with trovafloxacin]; trovafloxacin inhibits the reaction [TNF protein results in increased expression of BIRC2 mRNA]; trovafloxacin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; trovafloxacin promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]; trovafloxacin promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of CCL2 protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of CXCL1 protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of CXCL2 protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of IFNG protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of IL18 protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of IL1B protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of IL6 protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of NFKBIA mRNA]; trovafloxacin promotes the reaction [TNF protein results in increased expression of TNFAIP3 mRNA]; trovafloxacin results in increased expression of and results in increased stability of TNF mRNA; U 0126 inhibits the reaction [trovafloxacin promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; U 0126 inhibits the reaction [trovafloxacin results in increased expression of TNF mRNA] TNF protein results in increased susceptibility to trovafloxacin
CTD
PMID:17709330 PMID:18930950 PMID:19362101 PMID:19638433 PMID:24097668 PMID:24136188 PMID:24525298 PMID:24817034 PMID:25748550 PMID:30876886 PMID:32035082 PMID:33609687 PMID:35537566 More...
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
multiple interactions increases expression
ISO
[Lipopolysaccharides co-treated with trovafloxacin] results in increased expression of TNFAIP3 mRNA; [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of TNFAIP3 mRNA; trovafloxacin promotes the reaction [TNF protein results in increased expression of TNFAIP3 mRNA] [trovafloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 protein trovafloxacin results in increased expression of TNFAIP3 mRNA trovafloxacin results in increased expression of TNFAIP3 mRNA; trovafloxacin results in increased expression of TNFAIP3 protein
CTD
PMID:18930950 PMID:32035082 PMID:35537566
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfaip8l1
TNF alpha induced protein 8 like 1
decreases expression
ISO
trovafloxacin results in decreased expression of TNFAIP8L1 mRNA
CTD
PMID:35537566
NCBI chr 9:988,587...999,342
Ensembl chr 9:988,594...1,002,254
G
Tnfrsf10b
TNF receptor superfamily member 10b
increases expression
ISO
trovafloxacin results in increased expression of TNFRSF10B mRNA
CTD
PMID:35537566
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
G
Tnfrsf11a
TNF receptor superfamily member 11A
increases expression
ISO
trovafloxacin results in increased expression of TNFRSF11A mRNA
CTD
PMID:35537566
NCBI chr13:21,928,370...21,986,719
Ensembl chr13:21,928,408...21,986,695
G
Tnfrsf4
TNF receptor superfamily member 4
increases expression
ISO
trovafloxacin results in increased expression of TNFRSF4 mRNA
CTD
PMID:35537566
NCBI chr 5:166,606,909...166,609,599
Ensembl chr 5:166,606,909...166,609,599
G
Tnfrsf9
TNF receptor superfamily member 9
decreases expression
ISO
trovafloxacin results in decreased expression of TNFRSF9 mRNA
CTD
PMID:35537566
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Tnfsf13
TNF superfamily member 13
increases expression
ISO
trovafloxacin results in increased expression of TNFSF13 mRNA
CTD
PMID:35537566
NCBI chr10:54,400,054...54,403,723
Ensembl chr10:54,400,065...54,403,042
G
Tnfsf14
TNF superfamily member 14
decreases expression
ISO
trovafloxacin results in decreased expression of TNFSF14 mRNA
CTD
PMID:35537566
NCBI chr 9:2,068,295...2,073,128
Ensembl chr 9:2,069,104...2,073,216
G
Tnfsf18
TNF superfamily member 18
decreases expression
ISO
trovafloxacin results in decreased expression of TNFSF18 mRNA
CTD
PMID:35537566
NCBI chr13:73,833,478...73,907,249
Ensembl chr13:73,831,252...73,843,169
G
Tnip3
TNFAIP3 interacting protein 3
increases expression
ISO
trovafloxacin results in increased expression of TNIP3 mRNA
CTD
PMID:35537566
NCBI chr 4:94,867,258...94,908,780
Ensembl chr 4:94,811,097...94,907,605
G
Tnks1bp1
tankyrase 1 binding protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of TNKS1BP1 mRNA
CTD
PMID:35537566
NCBI chr 3:70,135,335...70,160,071
Ensembl chr 3:70,137,837...70,160,038
G
Tnnc1
troponin C1, slow skeletal and cardiac type
increases expression
ISO
trovafloxacin results in increased expression of TNNC1 mRNA
CTD
PMID:35537566
NCBI chr16:6,400,801...6,405,634
Ensembl chr16:6,402,171...6,405,634
G
Tns2
tensin 2
decreases expression
ISO
trovafloxacin results in decreased expression of TNS2 mRNA
CTD
PMID:35537566
NCBI chr 7:133,229,746...133,247,889
Ensembl chr 7:133,206,364...133,247,888
G
Tob2
transducer of ERBB2, 2
increases expression
EXP
trovafloxacin results in increased expression of TOB2 mRNA
CTD
PMID:24136188
NCBI chr 7:113,362,703...113,371,423
Ensembl chr 7:113,361,148...113,372,688
G
Tomm70
translocase of outer mitochondrial membrane 70
decreases expression
EXP
trovafloxacin results in decreased expression of TOMM70A mRNA
CTD
PMID:24136188
NCBI chr11:43,378,719...43,417,166
Ensembl chr11:43,377,216...43,417,202
G
Top2a
DNA topoisomerase II alpha
decreases activity decreases expression
ISO
trovafloxacin results in decreased activity of TOP2A protein trovafloxacin results in decreased expression of TOP2A mRNA
CTD
PMID:24817034 PMID:35537566
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Topbp1
DNA topoisomerase II binding protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of TOPBP1 mRNA
CTD
PMID:35537566
NCBI chr 8:103,887,805...103,931,662
Ensembl chr 8:103,887,865...103,931,674
G
Tor1aip2
torsin 1A interacting protein 2
increases expression
ISO
trovafloxacin results in increased expression of TOR1AIP2 mRNA
CTD
PMID:35537566
NCBI chr13:68,225,226...68,256,536
Ensembl chr13:68,230,009...68,256,536 Ensembl chr13:68,230,009...68,256,536
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
increases expression
ISO
trovafloxacin results in increased expression of TRP53INP1 mRNA
CTD
PMID:35537566
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
G
Tpi1
triosephosphate isomerase 1
decreases expression
EXP
trovafloxacin results in decreased expression of TPI1 mRNA
CTD
PMID:24136188
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
G
Tpm3
tropomyosin 3
decreases expression
EXP
trovafloxacin results in decreased expression of TPM3 mRNA
CTD
PMID:24136188
NCBI chr 2:175,517,198...175,545,014
Ensembl chr 2:175,517,226...175,545,013
G
Tpst1
tyrosylprotein sulfotransferase 1
increases expression
EXP
trovafloxacin results in increased expression of TPST1 mRNA
CTD
PMID:24136188
NCBI chr12:26,544,536...26,605,706
Ensembl chr12:26,544,536...26,605,704
G
Tpx2
TPX2, microtubule nucleation factor
decreases expression
ISO
trovafloxacin results in decreased expression of TPX2 mRNA
CTD
PMID:35537566
NCBI chr 3:141,318,428...141,360,684
Ensembl chr 3:141,318,455...141,360,468
G
Traf1
TNF receptor-associated factor 1
increases expression
ISO
trovafloxacin results in increased expression of TRAF1 mRNA
CTD
PMID:35537566
NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807
G
Traf2
Tnf receptor-associated factor 2
increases expression
ISO
trovafloxacin results in increased expression of TRAF2 mRNA
CTD
PMID:35537566
NCBI chr 3:8,341,950...8,366,609
Ensembl chr 3:8,341,951...8,366,538
G
Traf3ip3
TRAF3 interacting protein 3
decreases expression
ISO
trovafloxacin results in decreased expression of TRAF3IP3 mRNA
CTD
PMID:35537566
NCBI chr13:104,694,802...104,719,655
Ensembl chr13:104,694,805...104,719,673
G
Trafd1
TRAF type zinc finger domain containing 1
increases expression
ISO
trovafloxacin results in increased expression of TRAFD1 mRNA
CTD
PMID:35537566
NCBI chr12:35,165,606...35,179,525
Ensembl chr12:35,165,606...35,179,525
G
Traip
TRAF-interacting protein
decreases expression
ISO
trovafloxacin results in decreased expression of TRAIP mRNA
CTD
PMID:35537566
NCBI chr 8:108,641,860...108,661,640
Ensembl chr 8:108,641,852...108,661,638
G
Trak1
trafficking kinesin protein 1
increases expression
EXP
trovafloxacin results in increased expression of TRAK1 mRNA
CTD
PMID:24136188
NCBI chr 8:120,984,445...121,139,357
Ensembl chr 8:120,984,431...121,139,367
G
Triap1
TP53 regulated inhibitor of apoptosis 1
increases expression
ISO
trovafloxacin results in increased expression of TRIAP1 mRNA
CTD
PMID:35537566
NCBI chr12:41,267,534...41,270,053
Ensembl chr12:41,267,549...41,270,042
G
Trib3
tribbles pseudokinase 3
decreases expression
ISO
trovafloxacin results in decreased expression of TRIB3 mRNA
CTD
PMID:35537566
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Trim11
tripartite motif-containing 11
increases expression
ISO
trovafloxacin results in increased expression of TRIM11 mRNA
CTD
PMID:35537566
NCBI chr10:43,758,299...43,771,138
Ensembl chr10:43,758,354...43,771,138
G
Trim21
tripartite motif-containing 21
increases expression
ISO
trovafloxacin results in increased expression of TRIM21 mRNA
CTD
PMID:35537566
NCBI chr 1:156,964,896...156,987,504
Ensembl chr 1:156,964,913...156,987,440
G
Trim25
tripartite motif-containing 25
increases expression
ISO
trovafloxacin results in increased expression of TRIM25 mRNA
CTD
PMID:35537566
NCBI chr10:73,812,818...73,831,271
Ensembl chr10:73,812,818...73,831,257
G
Trim26
tripartite motif-containing 26
increases expression
ISO
trovafloxacin results in increased expression of TRIM26 mRNA
CTD
PMID:35537566
NCBI chr20:1,708,297...1,731,176
Ensembl chr20:1,709,788...1,731,120
G
Trim34
tripartite motif-containing 34
increases expression
ISO
trovafloxacin results in increased expression of TRIM34A mRNA
CTD
PMID:35537566
NCBI chr 1:158,707,172...158,720,214
Ensembl chr 1:158,707,172...158,718,674
G
Trim37
tripartite motif-containing 37
decreases expression
ISO
trovafloxacin results in decreased expression of TRIM37 mRNA
CTD
PMID:35537566
NCBI chr10:71,943,384...72,075,563
Ensembl chr10:71,943,375...72,075,558
G
Trim39
tripartite motif-containing 39
increases expression
ISO
trovafloxacin results in increased expression of TRIM39 mRNA
CTD
PMID:35537566
NCBI chr20:2,003,320...2,017,175
Ensembl chr20:1,983,533...2,020,117
G
Trim45
tripartite motif-containing 45
decreases expression
ISO
trovafloxacin results in decreased expression of TRIM45 mRNA
CTD
PMID:35537566
NCBI chr 2:188,349,979...188,359,205
Ensembl chr 2:188,349,744...188,359,204
G
Trim46
tripartite motif-containing 46
decreases expression
ISO
trovafloxacin results in decreased expression of TRIM46 mRNA
CTD
PMID:35537566
NCBI chr 2:174,641,494...174,654,237
Ensembl chr 2:174,641,496...174,654,141
G
Trim47
tripartite motif-containing 47
decreases expression
ISO
trovafloxacin results in decreased expression of TRIM47 mRNA
CTD
PMID:35537566
NCBI chr10:101,337,573...101,342,044
Ensembl chr10:101,337,573...101,342,044
G
Trim7
tripartite motif-containing 7
increases expression
ISO
trovafloxacin results in increased expression of TRIM7 mRNA
CTD
PMID:35537566
NCBI chr10:33,205,491...33,221,482
Ensembl chr10:33,205,491...33,221,468
G
Trip13
thyroid hormone receptor interactor 13
decreases expression
ISO
trovafloxacin results in decreased expression of TRIP13 mRNA
CTD
PMID:35537566
NCBI chr 1:29,357,093...29,402,078
Ensembl chr 1:29,357,130...29,402,074
G
Trmt2a
tRNA methyltransferase 2 homolog A
increases expression
ISO
trovafloxacin results in increased expression of TRMT2A mRNA
CTD
PMID:35537566
NCBI chr11:82,737,689...82,742,423
Ensembl chr11:82,737,689...82,742,336
G
Trmt44
tRNA methyltransferase 44
increases expression
ISO
trovafloxacin results in increased expression of TRMT44 mRNA
CTD
PMID:35537566
NCBI chr14:75,175,331...75,204,291
Ensembl chr14:75,182,029...75,200,147
G
Trmu
tRNA mitochondrial 2-thiouridylase
decreases expression
ISO
trovafloxacin results in decreased expression of TRMU mRNA
CTD
PMID:35537566
NCBI chr 7:116,969,750...116,987,704
Ensembl chr 7:116,969,756...116,986,355
G
Troap
trophinin associated protein
decreases expression
ISO
trovafloxacin results in decreased expression of TROAP mRNA
CTD
PMID:35537566
NCBI chr 7:130,233,534...130,242,369
Ensembl chr 7:130,234,544...130,242,365
G
Trpt1
tRNA phosphotransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of TRPT1 mRNA
CTD
PMID:35537566
NCBI chr 1:204,186,295...204,191,294
Ensembl chr 1:204,186,295...204,191,294
G
Tsc22d3
TSC22 domain family, member 3
decreases expression
ISO
trovafloxacin results in decreased expression of TSC22D3 mRNA
CTD
PMID:35537566
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
G
Tshz1
teashirt zinc finger homeobox 1
decreases expression
ISO
trovafloxacin results in decreased expression of TSHZ1 mRNA
CTD
PMID:35537566
NCBI chr18:77,376,399...77,452,815
Ensembl chr18:77,377,394...77,453,509
G
Tsku
tsukushi, small leucine rich proteoglycan
increases expression
ISO
trovafloxacin results in increased expression of TSKU mRNA
CTD
PMID:35537566
NCBI chr 1:152,660,259...152,671,682
Ensembl chr 1:152,656,693...152,672,588
G
Tspan10
tetraspanin 10
decreases expression
ISO
trovafloxacin results in decreased expression of TSPAN10 mRNA
CTD
PMID:35537566
NCBI chr10:105,715,803...105,721,503
Ensembl chr10:105,715,961...105,719,813
G
Tspan13
tetraspanin 13
decreases expression
ISO
trovafloxacin results in decreased expression of TSPAN13 mRNA
CTD
PMID:35537566
NCBI chr 6:52,738,748...52,765,503
Ensembl chr 6:52,738,758...52,765,547
G
Tspoap1
TSPO associated protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of TSPOAP1 mRNA
CTD
PMID:35537566
NCBI chr10:72,554,220...72,586,402
Ensembl chr10:72,560,980...72,586,412
G
Tspyl2
TSPY-like 2
increases expression
ISO
trovafloxacin results in increased expression of TSPYL2 mRNA
CTD
PMID:35537566
NCBI chr X:21,439,478...21,445,208
Ensembl chr X:21,439,478...21,445,089
G
Tsr1
TSR1, ribosome maturation factor
increases expression
ISO
trovafloxacin results in increased expression of TSR1 mRNA
CTD
PMID:35537566
NCBI chr10:59,760,420...59,771,868
Ensembl chr10:59,760,409...59,771,864
G
Tssk4
testis-specific serine kinase 4
decreases expression
ISO
trovafloxacin results in decreased expression of TSSK4 mRNA
CTD
PMID:35537566
NCBI chr15:29,140,803...29,144,128
Ensembl chr15:29,141,792...29,144,128
G
Tst
thiosulfate sulfurtransferase
decreases expression
ISO
trovafloxacin results in decreased expression of TST mRNA
CTD
PMID:35537566
NCBI chr 7:109,948,061...109,955,378
Ensembl chr 7:109,948,062...109,957,216
G
Tstd2
thiosulfate sulfurtransferase like domain containing 2
increases expression
ISO
trovafloxacin results in increased expression of TSTD2 mRNA
CTD
PMID:35537566
NCBI chr 5:60,371,751...60,415,916
Ensembl chr 5:60,393,454...60,415,916
G
Ttc28
tetratricopeptide repeat domain 28
decreases expression
ISO
trovafloxacin results in decreased expression of TTC28 mRNA
CTD
PMID:35537566
NCBI chr12:45,342,986...45,783,968
Ensembl chr12:45,345,399...45,783,547
G
Ttc3
tetratricopeptide repeat domain 3
decreases expression
ISO
trovafloxacin results in decreased expression of TTC3 mRNA
CTD
PMID:35537566
NCBI chr11:33,689,119...33,788,976
Ensembl chr11:33,688,952...33,788,975
G
Ttc39a
tetratricopeptide repeat domain 39A
decreases expression
ISO
trovafloxacin results in decreased expression of TTC39A mRNA
CTD
PMID:35537566
NCBI chr 5:124,165,102...124,204,740
Ensembl chr 5:124,151,760...124,204,973
G
Ttc39b
tetratricopeptide repeat domain 39B
decreases expression
ISO
trovafloxacin results in decreased expression of TTC39B mRNA
CTD
PMID:35537566
NCBI chr 5:97,603,329...97,708,103
Ensembl chr 5:97,609,392...97,736,270
G
Ttc7a
tetratricopeptide repeat domain 7A
decreases expression
EXP ISO
trovafloxacin results in decreased expression of TTC7A mRNA trovafloxacin results in decreased expression of TTC7 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 6:7,159,285...7,261,826
Ensembl chr 6:7,159,061...7,261,892
G
Ttf2
transcription termination factor 2
decreases expression
ISO
trovafloxacin results in decreased expression of TTF2 mRNA
CTD
PMID:35537566
NCBI chr 2:188,366,321...188,397,750
Ensembl chr 2:188,366,331...188,397,689
G
Ttk
Ttk protein kinase
decreases expression
ISO
trovafloxacin results in decreased expression of TTK mRNA
CTD
PMID:35537566
NCBI chr 8:84,754,329...84,792,653
Ensembl chr 8:84,754,315...84,792,651
G
Ttll3
tubulin tyrosine ligase like 3
increases expression
ISO
trovafloxacin results in increased expression of TTLL3 mRNA
CTD
PMID:35537566
NCBI chr 4:146,532,958...146,558,425
Ensembl chr 4:146,533,953...146,557,889
G
Ttll5
tubulin tyrosine ligase like 5
decreases expression
ISO
trovafloxacin results in decreased expression of TTLL5 mRNA
CTD
PMID:35537566
NCBI chr 6:105,483,091...105,700,920
Ensembl chr 6:105,483,191...105,700,934
G
Tuba1c
tubulin, alpha 1C
decreases expression
EXP
trovafloxacin results in decreased expression of TUBA1C mRNA
CTD
PMID:24136188
NCBI chr 7:130,192,050...130,199,655
Ensembl chr 7:130,192,016...130,199,647 Ensembl chr X:130,192,016...130,199,647
G
Tuba4a
tubulin, alpha 4A
decreases expression
EXP
trovafloxacin results in decreased expression of TUBA4A mRNA
CTD
PMID:24136188
NCBI chr 9:76,709,617...76,714,327
Ensembl chr 9:76,709,614...76,713,918
G
Tubb2a
tubulin, beta 2A class IIa
decreases expression
EXP
trovafloxacin results in decreased expression of TUBB2A mRNA
CTD
PMID:24136188
NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714
G
Tubb4b
tubulin, beta 4B class IVb
multiple interactions decreases expression
ISO EXP
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of TUBB4B mRNA trovafloxacin results in decreased expression of TUBB4B mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Tubb5
tubulin, beta 5 class I
decreases expression
EXP
trovafloxacin results in decreased expression of TUBB5 mRNA
CTD
PMID:24136188
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Tube1
tubulin, epsilon 1
decreases expression
ISO
trovafloxacin results in decreased expression of TUBE1 mRNA
CTD
PMID:35537566
NCBI chr20:42,552,390...42,570,324
Ensembl chr20:42,552,437...42,570,314
G
Tubg1
tubulin, gamma 1
decreases expression
ISO
trovafloxacin results in decreased expression of TUBG1 mRNA
CTD
PMID:35537566
NCBI chr10:86,052,845...86,059,436
Ensembl chr10:86,052,743...86,059,433
G
Tubgcp2
tubulin gamma complex component 2
decreases expression
ISO
trovafloxacin results in decreased expression of TUBGCP2 mRNA
CTD
PMID:35537566
NCBI chr 1:194,791,113...194,817,807
Ensembl chr 1:194,792,142...194,817,619
G
Tug1
taurine up-regulated 1
increases expression
ISO
trovafloxacin results in increased expression of TUG1 mRNA
CTD
PMID:35537566
NCBI chr14:78,519,894...78,526,927
Ensembl chr14:78,522,506...78,526,927
G
Tulp2
TUB like protein 2
increases expression
ISO
trovafloxacin results in increased expression of TULP2 mRNA
CTD
PMID:35537566
NCBI chr 1:95,962,496...95,999,775
Ensembl chr 1:95,962,496...96,000,628
G
Txlng
taxilin gamma
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of TXLNG mRNA
CTD
PMID:18930950
NCBI chr X:31,864,111...31,912,931
Ensembl chr X:31,864,111...31,912,926
G
Txndc15
thioredoxin domain containing 15
decreases expression
ISO
trovafloxacin results in decreased expression of TXNDC15 mRNA
CTD
PMID:35537566
NCBI chr17:8,898,074...8,910,538
Ensembl chr17:8,845,084...8,910,539
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
EXP
trovafloxacin results in decreased expression of UBE2C mRNA
CTD
PMID:24136188
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ube2g2
ubiquitin-conjugating enzyme E2G 2
increases expression
ISO
trovafloxacin results in increased expression of UBE2G2 mRNA
CTD
PMID:35537566
NCBI chr20:10,983,734...11,005,468
Ensembl chr20:10,983,742...11,005,447
G
Ube2i
ubiquitin-conjugating enzyme E2I
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of UBE2I mRNA
CTD
PMID:18930950
NCBI chr10:14,277,749...14,294,681
Ensembl chr10:69,701,618...69,702,443 Ensembl chr10:69,701,618...69,702,443
G
Ube2t
ubiquitin-conjugating enzyme E2T
decreases expression
ISO
trovafloxacin results in decreased expression of UBE2T mRNA
CTD
PMID:35537566
NCBI chr13:46,403,352...46,413,854
Ensembl chr13:46,403,375...46,414,835
G
Ube3b
ubiquitin protein ligase E3B
decreases expression
ISO
trovafloxacin results in decreased expression of UBE3B mRNA
CTD
PMID:35537566
NCBI chr12:42,183,756...42,230,094
Ensembl chr12:42,183,760...42,230,094
G
Ube3d
ubiquitin protein ligase E3D
decreases expression
ISO
trovafloxacin results in decreased expression of UBE3D mRNA
CTD
PMID:35537566
NCBI chr 8:87,245,503...87,413,104
Ensembl chr 8:87,245,589...87,413,057
G
Ubqln1
ubiquilin 1
decreases expression
EXP
trovafloxacin results in decreased expression of UBQLN1 mRNA
CTD
PMID:24136188
NCBI chr17:6,439,002...6,477,096
Ensembl chr17:6,439,002...6,477,090
G
Ubxn6
UBX domain protein 6
decreases expression
ISO
trovafloxacin results in decreased expression of UBXN6 mRNA
CTD
PMID:35537566
NCBI chr 9:900,883...906,047
Ensembl chr 9:900,884...906,124
G
Uck1
uridine-cytidine kinase 1
increases expression
ISO
trovafloxacin results in increased expression of UCK1 mRNA
CTD
PMID:35537566
NCBI chr 3:15,538,580...15,544,465
Ensembl chr 3:15,538,591...15,544,465
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
decreases expression
EXP
trovafloxacin results in decreased expression of UGT2B17 mRNA
CTD
PMID:24136188
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
G
Uhrf1
ubiquitin-like with PHD and ring finger domains 1
decreases expression
ISO
trovafloxacin results in decreased expression of UHRF1 mRNA
CTD
PMID:35537566
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
G
Ulk1
unc-51 like autophagy activating kinase 1
increases expression
EXP
trovafloxacin results in increased expression of ULK1 mRNA
CTD
PMID:24136188
NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
G
Ulk2
unc-51 like autophagy activating kinase 2
increases expression decreases expression multiple interactions
ISO
trovafloxacin results in increased expression of ULK2 mRNA trovafloxacin results in decreased expression of ULK2 mRNA [trovafloxacin co-treated with TNF protein] results in increased expression of ULK2 mRNA
CTD
PMID:33609687 PMID:35537566
NCBI chr10:46,451,578...46,530,462
Ensembl chr10:46,454,030...46,530,407
G
Ulk4
unc-51 like kinase 4
decreases expression
ISO
trovafloxacin results in decreased expression of ULK4 mRNA
CTD
PMID:35537566
NCBI chr 8:120,670,879...120,966,026
Ensembl chr 8:120,670,866...120,966,924
G
Umps
uridine monophosphate synthetase
decreases expression
EXP
trovafloxacin results in decreased expression of UMPS mRNA
CTD
PMID:24136188
NCBI chr11:66,806,107...66,816,520
Ensembl chr11:66,806,045...66,821,903
G
Unc119b
unc-119 lipid binding chaperone B
increases expression
ISO
trovafloxacin results in increased expression of UNC119B mRNA
CTD
PMID:35537566
NCBI chr12:41,478,808...41,491,432
Ensembl chr12:41,478,808...41,491,432
G
Unc5b
unc-5 netrin receptor B
decreases expression
ISO
trovafloxacin results in decreased expression of UNC5B mRNA
CTD
PMID:35537566
NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537
G
Unkl
unk like zinc finger
increases expression
ISO
trovafloxacin results in increased expression of UNKL mRNA
CTD
PMID:35537566
NCBI chr10:14,206,125...14,252,226
Ensembl chr10:14,206,189...14,252,225
G
Upf1
UPF1, RNA helicase and ATPase
increases expression
ISO
trovafloxacin results in increased expression of UPF1 mRNA
CTD
PMID:35537566
NCBI chr16:19,076,594...19,097,365
Ensembl chr16:19,076,322...19,096,568
G
Upk1a
uroplakin 1A
increases expression
ISO
trovafloxacin results in increased expression of UPK1A mRNA
CTD
PMID:35537566
NCBI chr 1:85,859,672...85,870,147
Ensembl chr 1:85,859,671...85,870,354
G
Upp1
uridine phosphorylase 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of UPP1 mRNA
CTD
PMID:18930950
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Uqcc1
ubiquinol-cytochrome c reductase complex assembly factor 1
increases expression
ISO
trovafloxacin results in increased expression of UQCC1 mRNA
CTD
PMID:35537566
NCBI chr 3:144,353,276...144,445,810
Ensembl chr 3:144,353,287...144,445,711
G
Urm1
ubiquitin related modifier 1
increases expression
ISO
trovafloxacin results in increased expression of URM1 mRNA
CTD
PMID:35537566
NCBI chr 3:13,100,340...13,117,064
Ensembl chr 3:13,092,200...13,117,642 Ensembl chr 3:13,092,200...13,117,642
G
Usp1
ubiquitin specific peptidase 1
decreases expression
ISO
trovafloxacin results in decreased expression of USP1 mRNA
CTD
PMID:35537566
NCBI chr 5:113,587,564...113,598,934
Ensembl chr 5:113,587,564...113,598,932
G
Usp18
ubiquitin specific peptidase 18
increases expression
ISO
trovafloxacin results in increased expression of USP18 mRNA
CTD
PMID:35537566
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
G
Usp2
ubiquitin specific peptidase 2
decreases expression
ISO
trovafloxacin results in decreased expression of USP2 mRNA
CTD
PMID:35537566
NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331
G
Usp27x
ubiquitin specific peptidase 27, X-linked
increases expression
ISO
trovafloxacin results in increased expression of USP27X mRNA
CTD
PMID:35537566
NCBI chr X:15,123,620...15,126,855
Ensembl chr X:15,124,596...15,125,912
G
Usp39
ubiquitin specific peptidase 39
decreases expression
ISO
trovafloxacin results in decreased expression of USP39 mRNA
CTD
PMID:35537566
NCBI chr 4:104,373,948...104,406,359
Ensembl chr 4:104,373,955...104,406,359
G
Uspl1
ubiquitin specific peptidase like 1
increases expression
ISO
trovafloxacin results in increased expression of USPL1 mRNA
CTD
PMID:35537566
NCBI chr12:5,823,460...5,850,470
Ensembl chr12:5,823,359...5,850,366
G
Utrn
utrophin
decreases expression
ISO
trovafloxacin results in decreased expression of UTRN mRNA
CTD
PMID:35537566
NCBI chr 1:6,720,854...7,224,313
Ensembl chr 1:6,722,594...7,224,313
G
Vash1
vasohibin 1
decreases expression
ISO
trovafloxacin results in decreased expression of VASH1 mRNA
CTD
PMID:35537566
NCBI chr 6:106,330,374...106,345,740
Ensembl chr 6:106,329,123...106,345,726
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of VEGFA mRNA
CTD
PMID:18930950
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vegfc
vascular endothelial growth factor C
increases expression
ISO
trovafloxacin results in increased expression of VEGFC mRNA
CTD
PMID:35537566
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
G
Vps13a
vacuolar protein sorting 13 homolog A
decreases expression
ISO
trovafloxacin results in decreased expression of VPS13A mRNA
CTD
PMID:35537566
NCBI chr 1:213,901,999...214,128,638
Ensembl chr 1:213,901,999...214,128,555
G
Vps13b
vacuolar protein sorting 13 homolog B
decreases expression
ISO
trovafloxacin results in decreased expression of VPS13B mRNA
CTD
PMID:35537566
NCBI chr 7:66,557,862...67,128,429
Ensembl chr 7:66,558,471...67,128,429
G
Vps13c
vacuolar protein sorting 13 homolog C
decreases expression
ISO
trovafloxacin results in decreased expression of VPS13C mRNA
CTD
PMID:35537566
NCBI chr 8:68,478,366...68,651,893
Ensembl chr 8:68,478,395...68,651,895
G
Vps16
VPS16 core subunit of CORVET and HOPS complexes
decreases expression
ISO
trovafloxacin results in decreased expression of VPS16 mRNA
CTD
PMID:35537566
NCBI chr 3:117,622,534...117,644,041
Ensembl chr 3:117,622,542...117,646,441
G
Vsig8
V-set and immunoglobulin domain containing 8
increases expression
ISO
trovafloxacin results in increased expression of VSIG8 mRNA
CTD
PMID:35537566
NCBI chr13:85,023,177...85,031,364
Ensembl chr13:85,023,177...85,031,364
G
Vwa8
von Willebrand factor A domain containing 8
decreases expression
ISO
trovafloxacin results in decreased expression of VWA8 mRNA
CTD
PMID:35537566
NCBI chr15:54,252,703...54,576,871
Ensembl chr15:54,252,584...54,576,870
G
Wbp1l
WW domain binding protein 1-like
increases expression
EXP
trovafloxacin results in increased expression of WBP1L mRNA
CTD
PMID:24136188
NCBI chr 1:245,472,292...245,528,627
Ensembl chr 1:245,472,296...245,528,627
G
Wdfy4
WDFY family member 4
decreases expression
ISO
trovafloxacin results in decreased expression of WDFY4 mRNA
CTD
PMID:35537566
NCBI chr16:8,221,853...8,450,494
Ensembl chr16:8,221,719...8,450,491
G
Wdhd1
WD repeat and HMG-box DNA binding protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of WDHD1 mRNA
CTD
PMID:35537566
NCBI chr15:20,478,310...20,523,106
Ensembl chr15:20,489,291...20,523,096
G
Wdpcp
WD repeat containing planar cell polarity effector
decreases expression
ISO
trovafloxacin results in decreased expression of WDPCP mRNA
CTD
PMID:35537566
NCBI chr14:95,645,955...95,977,120
Ensembl chr14:95,646,038...95,977,113
G
Wdr11
WD repeat domain 11
decreases expression
ISO
trovafloxacin results in decreased expression of WDR11 mRNA
CTD
PMID:35537566
NCBI chr 1:184,165,260...184,210,834
Ensembl chr 1:184,165,571...184,210,846
G
Wdr45b
WD repeat domain 45B
increases expression
ISO
trovafloxacin results in increased expression of WDR45B mRNA
CTD
PMID:35537566
NCBI chr10:106,597,558...106,629,488
Ensembl chr10:106,599,364...106,629,441
G
Wdr62
WD repeat domain 62
decreases expression
ISO
trovafloxacin results in decreased expression of WDR62 mRNA
CTD
PMID:35537566
NCBI chr 1:85,491,531...85,530,643
Ensembl chr 1:85,491,533...85,530,637
G
Wdr76
WD repeat domain 76
decreases expression
ISO
trovafloxacin results in decreased expression of WDR76 mRNA
CTD
PMID:35537566
NCBI chr 3:108,456,784...108,491,528
Ensembl chr 3:108,456,815...108,490,840
G
Wdr86
WD repeat domain 86
increases expression
ISO
trovafloxacin results in increased expression of WDR86 mRNA
CTD
PMID:35537566
NCBI chr 4:10,423,496...10,443,473
Ensembl chr 4:10,424,008...10,441,465
G
Wdr90
WD repeat domain 90
decreases expression
ISO
trovafloxacin results in decreased expression of WDR90 mRNA
CTD
PMID:35537566
NCBI chr10:14,864,672...14,881,285
Ensembl chr10:14,864,670...14,881,292
G
Wee1
WEE1 G2 checkpoint kinase
decreases expression
ISO
trovafloxacin results in decreased expression of WEE1 mRNA
CTD
PMID:35537566
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
G
Wfikkn1
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1
increases expression
ISO
trovafloxacin results in increased expression of WFIKKN1 mRNA
CTD
PMID:35537566
NCBI chr10:14,896,442...14,898,770
Ensembl chr10:14,896,378...14,899,863
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
decreases expression
ISO
trovafloxacin results in decreased expression of WIPI1 mRNA
CTD
PMID:33609687
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
G
Wnt2b
Wnt family member 2B
decreases expression
ISO
trovafloxacin results in decreased expression of WNT2B mRNA
CTD
PMID:35537566
NCBI chr 2:192,454,226...192,468,599
Ensembl chr 2:192,453,824...192,470,308
G
Wrn
WRN RecQ like helicase
decreases expression
ISO
trovafloxacin results in decreased expression of WRN mRNA
CTD
PMID:35537566
NCBI chr16:58,763,517...58,898,604
Ensembl chr16:58,763,504...58,895,450
G
Xaf1
XIAP associated factor 1
increases expression
ISO
trovafloxacin results in increased expression of XAF1 mRNA
CTD
PMID:35537566
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
G
Xbp1
X-box binding protein 1
increases expression
EXP
trovafloxacin results in increased expression of XBP1 mRNA
CTD
PMID:24136188
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Xdh
xanthine dehydrogenase
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of XDH mRNA
CTD
PMID:18930950
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Xiap
X-linked inhibitor of apoptosis
multiple interactions decreases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of XIAP mRNA [trovafloxacin co-treated with TNF protein] results in decreased expression of XIAP mRNA trovafloxacin results in decreased expression of XIAP mRNA
CTD
PMID:18930950 PMID:32035082
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
G
Xkr5
XK related 5
decreases expression
ISO
trovafloxacin results in decreased expression of XKR5 mRNA
CTD
PMID:35537566
NCBI chr16:70,874,983...70,892,972
Ensembl chr16:70,875,093...70,892,967
G
Xpnpep2
X-prolyl aminopeptidase 2
decreases expression
EXP
trovafloxacin results in decreased expression of XPNPEP2 mRNA
CTD
PMID:24136188
NCBI chr X:127,287,765...127,317,036
Ensembl chr X:127,287,979...127,317,223
G
Xpo1
exportin 1
decreases expression
EXP
trovafloxacin results in decreased expression of XPO1 mRNA
CTD
PMID:24136188
NCBI chr14:97,233,282...97,275,536
Ensembl chr14:97,233,270...97,275,498
G
Xpot
exportin for tRNA
decreases expression
ISO
trovafloxacin results in decreased expression of XPOT mRNA
CTD
PMID:35537566
NCBI chr 7:57,111,536...57,152,013
Ensembl chr 7:57,111,536...57,152,099
G
Xylt2
xylosyltransferase 2
increases expression
ISO
trovafloxacin results in increased expression of XYLT2 mRNA
CTD
PMID:35537566
NCBI chr10:79,605,910...79,619,482
Ensembl chr10:79,606,007...79,619,391
G
Yars1
tyrosyl-tRNA synthetase 1
decreases expression
EXP
trovafloxacin results in decreased expression of YARS1 mRNA
CTD
PMID:24136188
NCBI chr 5:141,535,815...141,564,029
Ensembl chr 5:141,535,759...141,563,833
G
Ydjc
YdjC chitooligosaccharide deacetylase homolog
decreases expression
ISO
trovafloxacin results in decreased expression of YDJC mRNA
CTD
PMID:35537566
NCBI chr11:83,832,177...83,844,691
Ensembl chr11:83,841,306...83,846,336
G
Ykt6
YKT6 v-SNARE homolog
increases expression
ISO
trovafloxacin results in increased expression of YKT6 mRNA
CTD
PMID:35537566
NCBI chr14:80,832,187...80,843,394
Ensembl chr14:80,832,187...80,843,385
G
Ypel3
yippee-like 3
increases expression
EXP
trovafloxacin results in increased expression of YPEL3 mRNA
CTD
PMID:24136188
NCBI chr 1:181,384,385...181,387,706
Ensembl chr 1:181,384,357...181,387,705
G
Ypel5
yippee-like 5
increases expression
EXP
trovafloxacin results in increased expression of YPEL5 mRNA
CTD
PMID:24136188
NCBI chr 6:22,656,284...22,671,741
Ensembl chr 6:22,656,285...22,671,691
G
Yy2
YY2 transcription factor
increases expression
ISO
trovafloxacin results in increased expression of YY2 mRNA
CTD
PMID:35537566
NCBI chr X:37,438,425...37,442,047
Ensembl chr X:37,410,811...37,464,430
G
Zan
zonadhesin
decreases expression
ISO
trovafloxacin results in decreased expression of ZAN mRNA
CTD
PMID:35537566
NCBI chr12:19,215,018...19,322,789
Ensembl chr12:19,215,102...19,271,240
G
Zbed5
zinc finger BED-type containing 5
increases expression
ISO
trovafloxacin results in increased expression of ZBED5 mRNA
CTD
PMID:35537566
NCBI chr12:26,807,652...26,813,706
Ensembl chr12:26,807,600...26,813,664
G
Zbp1
Z-DNA binding protein 1
increases expression
ISO
trovafloxacin results in increased expression of ZBP1 mRNA
CTD
PMID:35537566
NCBI chr 3:161,993,351...162,009,297
Ensembl chr 3:161,993,351...162,003,870
G
Zbtb48
zinc finger and BTB domain containing 48
increases expression
ISO
trovafloxacin results in increased expression of ZBTB48 mRNA
CTD
PMID:35537566
NCBI chr 5:162,525,234...162,533,604
Ensembl chr 5:162,525,235...162,533,585
G
Zbtb49
zinc finger and BTB domain containing 49
increases expression
ISO
trovafloxacin results in increased expression of ZBTB49 mRNA
CTD
PMID:35537566
NCBI chr14:72,590,692...72,612,404
Ensembl chr14:72,590,708...72,612,404
G
Zc2hc1c
zinc finger, C2HC-type containing 1C
increases expression
ISO
trovafloxacin results in increased expression of ZC2HC1C mRNA
CTD
PMID:35537566
NCBI chr 6:104,932,631...104,941,555
Ensembl chr 6:104,932,631...104,941,554
G
Zc3h12c
zinc finger CCCH type containing 12C
increases expression
ISO
trovafloxacin results in increased expression of ZC3H12C mRNA
CTD
PMID:35537566
NCBI chr 8:52,443,791...52,508,643
Ensembl chr 8:52,448,320...52,504,315
G
Zc3h6
zinc finger CCCH type containing 6
decreases expression
ISO
trovafloxacin results in decreased expression of ZC3H6 mRNA
CTD
PMID:35537566
NCBI chr 3:116,203,466...116,254,186
Ensembl chr 3:116,204,197...116,253,282
G
Zcchc24
zinc finger CCHC-type containing 24
decreases expression
ISO
trovafloxacin results in decreased expression of ZCCHC24 mRNA
CTD
PMID:35537566
NCBI chr16:1,274,544...1,326,664
Ensembl chr16:1,274,548...1,326,696
G
Zcwpw1
zinc finger CW-type and PWWP domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of ZCWPW1 mRNA
CTD
PMID:35537566
NCBI chr12:18,880,625...18,910,713
Ensembl chr12:18,880,633...18,910,711
G
Zfand2a
zinc finger AN1-type containing 2A
increases expression
ISO
trovafloxacin results in increased expression of ZFAND2A mRNA
CTD
PMID:35537566
NCBI chr12:15,161,601...15,172,679
Ensembl chr12:15,161,639...15,172,677
G
Zfand4
zinc finger AN1-type containing 4
decreases expression
ISO
trovafloxacin results in decreased expression of ZFAND4 mRNA
CTD
PMID:35537566
NCBI chr 4:149,327,339...149,399,495
Ensembl chr 4:149,327,412...149,399,487
G
Zfand5
zinc finger AN1-type containing 5
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ZFAND5 mRNA
CTD
PMID:18930950
NCBI chr 1:218,765,735...218,780,391
Ensembl chr 1:218,766,614...218,775,843
G
Zfp142
zinc finger protein 142
increases expression
ISO
trovafloxacin results in increased expression of ZFP142 mRNA
CTD
PMID:35537566
NCBI chr 9:76,141,053...76,164,784
Ensembl chr 9:76,142,227...76,164,856
G
Zfp157
zinc finger protein 157
increases expression
ISO
trovafloxacin results in increased expression of ZFP157 mRNA
CTD
PMID:35537566
NCBI chr12:16,248,230...16,279,459
Ensembl chr12:16,248,230...16,270,698
G
Zfp2
zinc finger protein 2
increases expression
ISO
trovafloxacin results in increased expression of ZFP2 mRNA
CTD
PMID:35537566
NCBI chr10:35,209,187...35,228,849
Ensembl chr10:35,207,260...35,228,853
G
Zfp263
zinc finger protein 263
increases expression
ISO
trovafloxacin results in increased expression of ZFP263 mRNA
CTD
PMID:35537566
NCBI chr10:11,764,424...11,774,324
Ensembl chr10:11,764,427...11,771,235
G
Zfp275
zinc finger protein 275
increases expression
ISO
trovafloxacin results in increased expression of ZFP275 mRNA
CTD
PMID:35537566
NCBI chr X:151,057,530...151,074,392
Ensembl chr X:151,057,573...151,074,276
G
Zfp334
zinc finger protein 334
increases expression
ISO
trovafloxacin results in increased expression of ZFP334 mRNA
CTD
PMID:35537566
NCBI chr 3:154,112,537...154,125,087
Ensembl chr 3:154,113,561...154,125,057
G
Zfp346
zinc finger protein 346
decreases expression
ISO
trovafloxacin results in decreased expression of ZFP346 mRNA
CTD
PMID:35537566
NCBI chr17:9,493,787...9,523,681
Ensembl chr17:9,493,803...9,523,635
G
Zfp36
zinc finger protein 36
increases expression
ISO
trovafloxacin results in increased expression of ZFP36 mRNA
CTD
PMID:35537566
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
G
Zfp420
zinc finger protein 420
decreases expression
ISO
trovafloxacin results in decreased expression of ZFP420 mRNA
CTD
PMID:35537566
NCBI chr 1:85,092,810...85,143,682
Ensembl chr 1:85,093,085...85,106,693 Ensembl chr 1:85,093,085...85,106,693
G
Zfp422
zinc finger protein 422
increases expression
ISO
trovafloxacin results in increased expression of ZFP422 mRNA
CTD
PMID:35537566
NCBI chr 4:149,885,805...149,893,287
Ensembl chr 4:149,885,600...149,893,257
G
Zfp449
zinc finger protein 449
increases expression
ISO
trovafloxacin results in increased expression of ZFP449 mRNA
CTD
PMID:35537566
NCBI chr X:134,120,820...134,140,921
Ensembl chr X:134,122,636...134,140,924
G
Zfp457
zinc finger protein 457
decreases expression
ISO
trovafloxacin results in decreased expression of ZFP457 mRNA
CTD
PMID:35537566
NCBI chr 2:84,625,360...84,642,535
Ensembl chr 2:84,608,705...84,684,942
G
Zfp462
zinc finger protein 462
increases expression
ISO
trovafloxacin results in increased expression of ZFP462 mRNA
CTD
PMID:35537566
NCBI chr 5:69,670,085...69,810,729
Ensembl chr 5:69,670,328...69,810,327
G
Zfp469
zinc finger protein 469
increases expression
ISO
trovafloxacin results in increased expression of ZFP469 mRNA
CTD
PMID:35537566
NCBI chr19:50,282,337...50,324,010
G
Zfp473
zinc finger protein 473
decreases expression
ISO
trovafloxacin results in decreased expression of ZFP473 mRNA
CTD
PMID:35537566
NCBI chr 1:95,222,683...95,243,328
Ensembl chr 1:95,223,433...95,243,325
G
Zfp513
zinc finger protein 513
increases expression
ISO
trovafloxacin results in increased expression of ZFP513 mRNA
CTD
PMID:35537566
NCBI chr 6:25,174,181...25,177,442
Ensembl chr 6:25,174,178...25,177,439
G
Zfp551
zinc finger protein 551
increases expression
ISO
trovafloxacin results in increased expression of ZFP551 mRNA
CTD
PMID:35537566
NCBI chr 1:72,543,815...72,554,060
Ensembl chr 1:72,540,108...72,554,071
G
Zfp574
zinc finger protein 574
increases expression
ISO
trovafloxacin results in increased expression of ZFP574 mRNA
CTD
PMID:35537566
NCBI chr 1:80,667,984...80,678,257
Ensembl chr 1:80,664,259...80,679,427
G
Zfp579
zinc finger protein 579
increases expression
ISO
trovafloxacin results in increased expression of ZFP579 mRNA
CTD
PMID:35537566
NCBI chr 1:68,847,547...68,850,751
Ensembl chr 1:68,847,500...68,850,751
G
Zfp58
zinc finger protein 58
increases expression
ISO
trovafloxacin results in increased expression of ZFP58 mRNA
CTD
PMID:35537566
NCBI chr 1:35,020,477...35,053,203
Ensembl chr 1:35,002,321...35,033,216
G
Zfp580
zinc finger protein 580
decreases expression
ISO
trovafloxacin results in decreased expression of ZFP580 mRNA
CTD
PMID:35537566
NCBI chr 1:68,787,118...68,789,286
Ensembl chr 1:68,787,118...68,789,286
G
Zfp599
zinc finger protein 599
increases expression
ISO
trovafloxacin results in increased expression of ZFP599 mRNA
CTD
PMID:35537566
NCBI chr 8:20,756,257...20,772,683
Ensembl chr 8:20,757,584...20,772,663
G
Zfp619
zinc finger protein 619
increases expression
ISO
trovafloxacin results in increased expression of ZFP619 mRNA
CTD
PMID:35537566
NCBI chr 1:91,148,016...91,167,764
Ensembl chr 1:91,148,121...91,166,403
G
Zfp629
zinc finger protein 629
increases expression
ISO
trovafloxacin results in increased expression of ZFP629 mRNA
CTD
PMID:35537566
NCBI chr 1:182,217,499...182,258,585
Ensembl chr 1:182,210,935...182,230,016
G
Zfp748
zinc finger protein 748
increases expression
ISO
trovafloxacin results in increased expression of ZFP748 mRNA
CTD
PMID:35537566
NCBI chr 1:35,075,408...35,091,416
Ensembl chr 1:35,074,172...35,091,389
G
Zfp768
zinc finger protein 768
increases expression
ISO
trovafloxacin results in increased expression of ZFP768 mRNA
CTD
PMID:35537566
NCBI chr 1:181,966,314...181,968,950
Ensembl chr 1:181,966,316...181,969,147
G
Zfp770
zinc finger protein 770
increases expression
ISO
trovafloxacin results in increased expression of ZFP770 mRNA
CTD
PMID:35537566
NCBI chr 3:100,963,430...100,971,663
Ensembl chr 3:100,963,427...100,971,684
G
Zfp791
zinc finger protein 791
increases expression
ISO
trovafloxacin results in increased expression of ZFP791 mRNA
CTD
PMID:35537566
NCBI chr19:23,018,418...23,033,580
Ensembl chr19:23,018,918...23,033,504
G
Zfp799
zinc finger protein 799
increases expression
ISO
trovafloxacin results in increased expression of ZFP799 mRNA
CTD
PMID:35537566
NCBI chr 7:11,894,224...11,910,809
Ensembl chr 7:11,898,149...11,910,798
G
Zfp84
zinc finger protein 84
increases expression
ISO
trovafloxacin results in increased expression of ZFP84 mRNA
CTD
PMID:35537566
NCBI chr 1:84,987,352...85,015,478
Ensembl chr 1:85,004,920...85,015,478 Ensembl chr 1:85,004,920...85,015,478
G
Zfp870
zinc finger protein 870
increases expression
ISO
trovafloxacin results in increased expression of ZFP870 mRNA
CTD
PMID:35537566
NCBI chr 7:11,990,146...12,003,813
Ensembl chr 7:11,990,148...12,003,813
G
Zfp955b
zinc finger protein 955B
increases expression
ISO
trovafloxacin results in increased expression of ZFP955B mRNA
CTD
PMID:35537566
NCBI chr 7:12,610,224...12,625,537
Ensembl chr 7:12,610,196...12,622,587
G
Zfta
zinc finger translocation associated
increases expression
ISO
trovafloxacin results in increased expression of ZFTA mRNA
CTD
PMID:35537566
NCBI chr 1:204,604,557...204,612,688
Ensembl chr 1:204,604,103...204,612,688
G
Zglp1
zinc finger, GATA-like protein 1
increases expression
ISO
trovafloxacin results in increased expression of ZGLP1 mRNA
CTD
PMID:35537566
NCBI chr 8:19,599,871...19,604,762
Ensembl chr 8:19,599,998...19,604,547
G
Zmat3
zinc finger, matrin type 3
increases expression
ISO
trovafloxacin results in increased expression of ZMAT3 mRNA
CTD
PMID:35537566
NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863
G
Znf408
zinc finger protein 408
increases expression
ISO
trovafloxacin results in increased expression of ZFP408 mRNA
CTD
PMID:35537566
NCBI chr 3:77,615,595...77,621,325
G
Znf780b
zinc finger protein 780B
increases expression
ISO
trovafloxacin results in increased expression of ZFP780B mRNA
CTD
PMID:35537566
NCBI chr 1:83,009,174...83,030,463
Ensembl chr 1:83,009,189...83,082,107
G
Znfx1
zinc finger, NFX1-type containing 1
increases expression
ISO
trovafloxacin results in increased expression of ZNFX1 mRNA
CTD
PMID:35537566
NCBI chr 3:155,764,073...155,791,777
Ensembl chr 3:155,764,980...155,821,242
G
Znrd2
zinc ribbon domain containing 2
increases expression
ISO
trovafloxacin results in increased expression of ZNRD2 mRNA
CTD
PMID:35537566
NCBI chr 1:203,017,682...203,019,465
Ensembl chr 1:203,017,682...203,019,465
G
Zscan25
zinc finger and SCAN domain containing 25
increases expression
ISO
trovafloxacin results in increased expression of ZSCAN25 mRNA
CTD
PMID:35537566
NCBI chr12:9,327,347...9,338,206
Ensembl chr12:9,326,404...9,338,221
G
Zscan30
zinc finger and SCAN domain containing 30
increases expression
ISO
trovafloxacin results in increased expression of ZSCAN30 mRNA
CTD
PMID:35537566
NCBI chr18:15,245,140...15,266,204
Ensembl chr18:15,244,379...15,264,632
G
Zwilch
zwilch kinetochore protein
decreases expression
ISO
trovafloxacin results in decreased expression of ZWILCH mRNA
CTD
PMID:35537566
NCBI chr 8:64,638,401...64,670,911
Ensembl chr 8:64,637,672...64,675,916
G
Zxdb
zinc finger, X-linked, duplicated B
increases expression
ISO
trovafloxacin results in increased expression of ZXDA mRNA; trovafloxacin results in increased expression of ZXDB mRNA
CTD
PMID:35537566
NCBI chr X:59,700,765...59,706,737
Ensembl chr X:59,701,178...59,703,871 Ensembl chr X:59,701,178...59,703,871
G
Zyg11a
zyg-11 family member A, cell cycle regulator
decreases expression
ISO
trovafloxacin results in decreased expression of ZYG11A mRNA
CTD
PMID:35537566
NCBI chr 5:122,935,439...122,973,766
Ensembl chr 5:122,937,136...122,973,649
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all